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Ablation-catheter
Acute Efficacy and Safety of Closed Loop Irrigated Tip 
Catheter Ablation for Ventricular Tachycardia After Failed 
Standard 4 mm Radiofrequency Ablation: Benefit of a 
Dual Catheter Approach##916-239·35A
Atrial Resynchronization Therapy in Patients Unsuitable for 
Left Atrial Ablation Procedures for the Management of 
Atrial Fibrillation##902-239·13A
Atrial Strain Rate Echocardiography Can Predict Maintenance 
of Sinus Rhythm After Pulmonary Vein Isolation in 
Paroxysmal Atrial Fibrillation##913-226·160A
Catheter Ablation of Atrial Fibrillation and Flutter Using a 
New Robotic Navigation System: Interim Follow-Up 
Results## 846-8·10A
Comparison of Left Atrial Volume Using Gated Cardiac 
Fluoroscopy 3-D Image Rendering Versus Cardiac 
Computed Tomography## 846-6·9A
Delineation of Reentrant Circuit in Atypical Atrioventricular 
Nodal Reentrant Tachycardia With Eccentric Coronary 
Sinus Activation##905-237·17A
Early Atrial Remodeling Can Predict Maintenance of Sinus 
Rhythm at 6 Months in Patients With Atrial Fibrillation 
Undergoing Pulmonary Vein Antral Isolation##901-
239·11A
Early Experience of Cryoablation for Accessory Pathways in 
Children##1017-29·261A
Effects of Adenosine on Canine and Human Reentrant 
Ventricular Tachycardia## 836-8·8A
Improved Regional Left Atrial Motion After Pulmonary Vein 
Isolation##906-237·19A
Improvement of Cardiac Function Early After Circumferential 
Pulmonary Vein Ablation for Atrial Fibrillation: Serial 
Observation by Echocardiography##918-222·177A
Incidence of Left Atrial Thrombus by Transesophageal 
Echocardiography Prior to Pulmonary Vein Isolation 
Procedures for Atrial Fibrillation##913-223·159A
Intracardiac Echo-Guided Image Integration: Optimizing 
Strategies for Registration## 846-5·9A
Intraoperative Cooled-Tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation##917-
237·36A
Location on Left Atrial 3-D Computer Tomography of Lesions 
Delivered Through Balloon-Based Ablation Systems## 
846-4·9A
Long-Term Success of Radiofrequency Ablation of Ventricular 
Tachycardia in Arrhythmogenic Right Ventricular 
Dysplasia/Cardiomyopathy##911-239·27A
Macroscopic Anatomy of Atrial Muscular Connections With 
the Central Fibrous Body of the Aorta-Functional and 
Arrhythmic Implications##911-237·27A
Mechanism of Coagulum Formation in Radiofrequency 
Ablation and a Novel Method to Prevent it## 410-6·422A
Mechanisms of Recurrent Atrial Fibrillation After Left 
Atrial Radiofrequency Ablation Guided by Complex 
Electrograms##914-237·32A
Mid-Term Follow-Up of Cryoballoon Technique in Drug 
Resistant Atrial Fibrillation##913-238·31A
Monitoring of Esophageal Temperature During Pulmonary 
Vein Isolation: New Computational Method for 
Assessment of Proximity of Ablation Site to 
Esophagus##905-238·17A
Outcome After Third Atrial Fibrillation Ablation: Whittling 
Away, Versus, Too Much Already!##916-238·35A
Pulmonary Vein Occlusion: Structural and Functional Severity 
Indices##901-238·11A
Radiofrequency Ablation of Atypical Atrial Flutter Following 
Cardiac Surgery or Atrial Fibrillation Ablation: 
Comparison of Open Irrigation-Tip Versus 8-mm-Tip 
Catheters##912-238·29A
Radiofrequency Ablation Unmasks Multiple Accessory 
Pathways in a Mouse Model of Familial Wolff-Parkinson-
White Syndrome##912-234·28A
Regional Scar Encircling Catheter Ablation t Treat Ventricular 
Tachycardia in Patients With Remote Myocardial 
Infarction##909-239·24A
Relationship Between the Coronary Artery Anatomy and 
the Subeustachian Isthmus, Coronary Sinus Os-Middle 
Cardiac Vein, and Floor of Coronary Sinus##910-238·25A
Remote Magnetic Navigation to Map and Ablate Arrhythmias 
in the Pericardial Space##912-239·29A
Sequential Changes in Left Atrial Function After Pulmonary 
Vein Isolation in Patients With Atrial Fibrillation##917-
221·173A
Smaller Pulmonary Vein Ostia Area Is Associated With 
Recurrent Arrhythmia Following Pulmonary Vein Antral 
Isolation for Atrial Fibrillation##914-231·165A
Unique Electrophysiological Characteristics of Irregular 
Atypical Atrioventricular Nodal Reentrant 
Tachycardia##914-238·32A
Use of a Standard Radiofrequency Energy Delivery System to 
Facilitate Transseptal Puncture##908-238·22A
Accessory pathways
A Comparative Study on the Feasibility and Safety of 
Transulnar Artery Versus Transradial Artery Access for 
Percutaneous Coronary Intervention in Patients With 
Coronary Heart Disease##1012-191·281A
Accessory pathways, ablation
Early Experience of Cryoablation for Accessory Pathways in 
Children##1017-29·261A
Remote Magnetic Navigation to Map and Ablate Arrhythmias 
in the Pericardial Space##912-239·29A
ACE inhibitor
Aliskiren-Based Therapy Lowers Blood Pressure More 
Effectively Than Ramipril-Based Therapy in Patients 
With Hypertension: A 6-Month, Randomized, Double-
Blind Trial##1014-173·371A
Aliskiren-Based Therapy Provides Long-Term Suppression 
of Plasma Renin Activity That Persists After Treatment 
Withdrawal in Patients With Hypertension##1020-
168·390A
Angiotensin Converting Enzyme Inhibitors Beneficially 
Modify Vascular Endothelial Growth factor gene 
expression and protein levels in Stable Coronary Artery 
Disease##1007-180·206A
Angiotensin-Converting Enzymel inhibitors Did Not Prevent 
Atrial Fibrillation in the Pacemaker Mode Selection 
Trial##902-237·12A
Are Angiotensin Receptor Blockers as Safe as Angiotensin 
Converting Enzyme Inhibitors in Patients With Heart 
Failure? A Systematic Review and Meta-Analysis of 
Randomized Controlled Trials##1201-247·52A
Assessment of Angiopoietin 1 and Angiopoietin 2 Gene 
Expression in Stable Coronary Artery Disease 
After Angiotensin-Converting Enzyme Inhibitor 
Treatment##1007-177·205A
Blood Pressure Lowering Effects Persist Following the Last 
Dose of Long-Term Therapy With Aliskiren, an Oral 
Direct Renin Inhibitor##1014-204·372A
Comparing Early and Delayed Enalapril Therapy on Long-
Term Cardiovascular Morbidity and Mortality in Patients 
With Reduced Ejection Fractions From SOLVD##1016-
68·67A
Comparison of Heart Failure Patients Who Achieve, With 
Treatment, an Ejection Fraction >35% Versus Those Who 
Remain ≤35%##1004-97·45A
Did Blood Pressure Medication Withdrawal Prior to 
Randomization Influence Subsequent Rates of Heart 
Failure in the Antihypertensive and Lipid-Lowering 
Treatment to Prevent Heart Attack Trial?##1008-
206·350A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Converting-Enzyme 
Inhibitors: Final Results of Captopril Combined With 
Valsartan in Acute Myocardial Infarction Study##1002-
6·316A
Effects of Standard Heart Failure Medications on Outcomes of 
Placebo-Treated Patients in the African-American Heart 
Failure Trial## 835-4·87A
Effects of the Angiotensin-Converting Enzyme Inhibitor 
Perindopril on Markers of Inflammation in Response 
to Physical Stress: Studies in the Metabolic 
Syndrome##1020-41·381A
High-Risk Patients Benefit Most From Angiotensin- 
Converting Enzyme Inhibition After an Acute Myocardial 
Infarction## 843-6·248A
Long-Term Mortality Benefits From Early Enalapril Therapy 
in Patients With Left Ventricular Systolic Dysfunction: A 
20-Year Follow-Up of SOLVD##1018-181·283A
Outpatient Medication Usage Is Not Associated With Anemia 
in Patients Hospitalized for Decompensated Heart 
Failure##1028-68·92A
Refractory End-Stage Chronic Heart Failure Day Care Service: 
A 5-Year Single Center Experience##1012-187·280A
Renin System Suppression With the Oral Direct Renin 
Inhibitor Aliskiren Administered Alone or in 
Combination: A Pooled Analysis of 1,093 Patients With 
Hypertension##1014-170·370A
Reversal of Left Atrial Remodeling in Patients With “Isolated” 
Left Ventricular Diastolic Dysfunction##1028-64·91A
The Role of Quinapril in the Presence of a Weight Loss 
Regimen: Endothelial Function and Markers of Obesity in 
Patients with the Metabolic Syndrome##1026-202·414A
Tissue Angiotensin-Converting Enzyme Inhibitors for 
Secondary Prevention of Adverse Cardiovascular Events 
in Patients With Preserved Left Ventricular Function: A 
Pooled Bayesian Meta-Analysis##1028-63·90A
Tissue-Specific Angiotensin-Converting Enzyme (ACE) 
Inhibitors in Prevention of Cardiovascular Disease 
in Patients with Diabetes Mellitus and Preserved 
Left Ventricular Function: A Pooled Bayesian Meta-
Analysis##1026-173·414A
Utilization and Impact of Angiotensin-Converting Enzyme 
Inhibitors on Recurrent Ischemic Events Following 
Coronary Artery Bypass Graft Surgery## 804-7·351A
Acetylcholine
Coronary Endothelial Dysfunction Associated With Depressive 
Mood in Patients Without Coronary Artery Disease## 
805-4·352A
Experience of 1,000 Acetylcholine Spasm Provocation Tests: 
What Have We Learned?##1013-176·218A
Having a Hobby Produces Desirable Cardiovascular Prognosis 
by Maintaining Favorable Coronary Endothelial 
Function##1008-161·346A
Incidence of Coronary Artery Ectasia and Its Relationship 
With Coronary Endothelial Dysfunction in Asian 
Population##1026-8·406A
Restoration of Vagal Tone by Donepezil Markedly Prevents 
Progression of Ventricular Remodeling and Dysfunction 
in Rats With Extensive Myocardial Infarction## 829-
4·86A
Adenosine
24-Month Outcome Following Negative Adenosine Stress 
Magnetic Resonance Imaging Perfusion Imaging in 92 
Patients Presenting With Chest Pain##915-233·169A
Assessment of Myocardial Perfusion and Coronary Flow 
Reserve in Children, Using 3-Tesla Cardiac Magnetic 
Resonance##1005-28·254A
Calculation of Peak Filling Rate by Real-Time Three-
Dimensional Echocardiography for Detection of Diastolic 
Abnormalities During Adenosine Stress Nuclear Perfusion 
Imaging##908-225·141A
Different Biological Pattern in Adenosine Sensitive Syncope 
and Tilt-Induced Vasovagal Syncope## 818-5·3A
Effects of Adenosine on Canine and Human Reentrant 
Ventricular Tachycardia## 836-8·8A
Glucose Suppresses Endothelial Cell Proliferation by Inhibiting 
Adenosine-Stimulated Erk1/2 Activation##1014-12·358A
Persistent Reduction in Myocardial Infarct Size After a Brief 




Predictive Value of Normal Adenosine-Stress Cardiac 
Magnetic Resonance Imaging Exams: A Prospective 
Follow-Up Study Over 12 Months After Diagnosis##909-
233·147A
The Oral Adenosine A1 Receptor Agonist, BAY 68-4986, 
Reduces Heart Rate at Peak Exercise in Patients With 
Chronic Stable Angina## 825-6·232A
The Role of Adenosine in Activation of Endothelial Nitric 
Oxide Synthase by Atorvastatin: Adenosine, Generated by 
Ecto-5’-Nucleotidase, Is Needed for Akt Phosphorylation 
by Phosphorylated 3-Phosphoinositide-Dependent Kinase 
1##1001-70·184A
Adverse Events/cardiovascular care
Analysis of Multiple Methylation Derivatives of Amino Acids 
Suggests That Factors Independent of Nitric Oxide 
Synthase Inhibition Are Responsible for Their Prognostic 
Value for Cardiovascular Risk Prediction## 809-4·354A
Are Angiotensin Receptor Blockers as Safe as Angiotensin 
Converting Enzyme Inhibitors in Patients With Heart 
Failure? A Systematic Review and Meta-Analysis of 
Randomized Controlled Trials##1201-247·52A
Association Between Admission Neutrophil to Lymphocyte 
Ratio and 6-Month Mortality in Patients With Acute 
Coronary Syndrome##1012-148·278A
Celecoxib Increases the Risk of Myocardial Infarction but 
Not of Death or Stroke: A Meta-Analysis of Randomized 
Controlled Trials##1030-148·294A
Clinical and Electrophysiological Data of Patients With a 
Rapid Atrial Fibrillation as the First Manifestation of 
Wolff-Parkinson-White Syndrome##1001-198·195A
Do Hospitals With Lower Risk-Adjusted Infection Rates 
Among Coronary Artery Bypass Graft Patients Have 
More Evidence-Based Clinical Processes and Structures 
in Place?##1006-184·274A
Gender Differences in Complication Rates Among Medicare 
Beneficiaries Undergoing Coronary Artery Bypass Graft 
Surgery##1015-17·304A
Impact of Body Mass Index on Mortality in Patients Presenting 
With Acute ST-Elevation Myocardial Infarctions##1006-
183·273A
Incremental Prognostic Value of Left Ventricular Ejection 
Fraction Assessment Over Myocardial Perfusion 
Imaging: A Rubidium-82 Positron Emission Tomography/
Computed Tomography Study## 841-5·109A
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Is There a Gap in Long-Term Clinical Outcome in Patients 
With Complicated Versus Noncomplicated Acute 
Myocardial Infarction Who Survived Hospitalization?## 
843-3·247A
Major Bleeding in Acute Coronary Syndrome Patients is 
Associated with a Marked Pro-Inflammatory Response: 
Results from the ACUITY Inflammatory Biomarker Sub-
Study## 615-5·209A
Morbidity and Mortality Associated With Device Generator 
Replacement##911-241·28A
Periprocedural Aprotinin Use is Associated With an 
Increase in Adverse Events: An Analysis of 2,761 
Patients Undergoing Coronary Artery Bypass Graft 
Surgery##1026-122·409A
Relationship Between Neutrophil Count on Admission, 
Microvascular Injury, and Long-Term Outcomes in 
Patients Treated With Primary Coronary Angioplasty for 
Acute Myocardial Infarction##1001-159·192A
Use of Simulation-Based Training to Enhance Patient Safety 
for Cardiac Catheterization: A Randomized Controlled 
Multi-Center Study##1024-189·289A
Aging
Aging-Related Myocardial Intolerence to Stress: Recapitulated 
in Adults by K
ATP




Candesartan Benefits and Safety Observed Regardless of Age- 
Insights From CHARM Program##1010-97·55A
Changing Age Distribution of Death in Congenital Heart 
Disease From 1988 to 2005: A Population-Based Study## 
837-6·268A
Cognition and Brachial Endothelial Responses in Older Adults 
With Cardiovascular Disease## 805-3·352A
Drug-Eluting Stents in the Elderly: Long-Term Clinical 
Outcomes of Octogenarians in the DESIRE 
Registry##1025-195·246A
End-Systolic Volume: Best Predictor of Mortality in 1,898 
Elderly Dual Isotope Pharmacologic Stress Patients##918-
235·180A
Endothelial Layer Restoration After Vascular Injury Is Delayed 
With Aging Bone Marrow While the Inflammatory 
Response and Intimal Formation are Increased##1002-
38·319A
Hospital Discharge Status Following Percutaneous Coronary 
Intervention for ST-Elevation Myocardial Infarction in 
Octogenarians## 847-7·251A
Impaired Regulation of Arterial Shear Rate With Aging: 
Assessment Using Magnetic Resonance Imaging##1014-
76·361A
Is the Efficacy of Invasive Therapies in Myocardial Infarction 
Different in Elderly or Younger Patients?##1007-
138·203A
Mechanism of Ventricular Fibrillation in the Aged Hearts 
Expsoed to Glycolytic Inhibition: A New Model of 
Sudden Cardiac Death## 406-5·420A
Metabolic Profile of the Elderly With a Calcific Aortic Stenosis 
and Its Relation With the Valvular Calcium Content## 
839-3·310A
Myocardial Infarction After Age 90: Outcomes in 10,213 
Nonagenarians##1007-74·198A
Parental Coronary Heart Disease Increases Vulnerability of 
the Arterial Wall to Metabolic Syndrome and Aging: The 
Bogalusa Heart Study##1026-38·403A
Prediction of Transition to Chronic Atrial Fibrillation in Elderly 
Patients With Nonvalvular Paroxysmal Atrial Fibrillation 
by Transthoracic Doppler Echocardiography##918-
221·177A
Predictors of Total Mortality Among Individuals With 
Cardiovascular Disease Ages 75 Years or Over##1002-
164·328A
Regional Nonuniformity of Left Ventricular Strain, Rotation 
and Twist Assessed by Two-Dimensional Speckle 
Tracking Imaging## 834-7·108A
Regression of Coronary Atherosclerosis During Treatment 
With Statins: Does Age Make a Difference?##1008-
12·336A
Rimonabant Improves Body Weight and Cardiometabolic Risk 
Factors in Older Adults##1002-124·325A
Sumative Effect of ALT-711 and Exercise in Improving Age-
Related Arterial Stiffness, Myocardial Dysfunction and 
Ventricular-Vascular Coupling## 832-6·395A
Temporal Evolution in Management of Elderly Patients 
Admitted for ST-Segment Elevation Myocardial Infarction 
and Impact on Mortality in the Franche-Comte Region of 
France##1013-153·216A
The Administration of Subcutaneous Erythropoietin in Anemic 
Elderly Patients With Heart Failure and Normal Ejection 
Fraction Over 3 Months Is Associated With Improvement 
in Exercise Capacity and Quality of Life##1016-97·67A
The False Paradox of Higher Case-Fatality of Acute 
Myocardial Infarction Among Young Women Compared 
to Men##1019-93·223A
The Shrinking Heart: Normal Right Ventricular Structure and 
Function##904-232·128A
Vascular Stiffness Is Attenuated by Arginase Inhibition in Aged 
Rats## 832-7·395A
Alcohol
Alcohol Induces Tissue Plasminogen Activator Expression 
Through P38 Mitogen-Activated Protein Kinase, Sp1, and 
NF-κb in Human Endothelial Cells##1026-12·401A
Percutaneous Transluminal Septal Ablation Therapy for 
Hypertrophic Obstructive Cardiomyopathy: Procedural 
Success and In-Hospital Complications From the Emory 
University Experience##1022-145·81A
Preconditioning-Like Cardioprotection by Regular Ethanol 
Consumption Lasts at Least 7 Days After Abstention and 
Is Associated With eNOS Upregulation## 803-5·235A
Time Course of Gradient Reduction During Septal Ethanol 
Ablation for Obstructive Hypertrophic Cardiomyopathy 
Is Related to Changes in Myocardial Mechanics##1010-
105·57A
Aldosterone
Brain Natriuretic Peptide and Severity of Diastolic 
Dysfunction: Interaction With Left Ventricular Geometry 
and Function in Mild-Moderate Heart Failure: The 
AREA-IN-CHF Study##1010-68·55A
Diastolic Function in Primary Aldosteronism: A Tissue Doppler 
Imaging Approach##1002-206·332A
Dietary Salt Restriction Accelerates Myocardial Fibrosis 
But Not Hypertrophy Of Cardiomyocyte In Volume 
Overloaded Rat Heart##1026-89·408A
Ambulatory blood pressure
Ambulatory Blood Pressure Monitoring Improves the 
Prediction of On-Treatment Risk in The Anglo-
Scandinavian Cardiac Outcomes Trial##1020-202·392A
Ambulatory ECG
Adverse Cardiovascular Effects of Air Pollution in Patients 
With Coronary Heart Disease## 805-5·352A
Association Between Recurrent Ischemia on Continuous ECG 
Holter Monitoring and Short- and Long-Term Mortality 
in Patients With Non-ST-Elevation Acute Coronary 
Syndrome in the MERLIN-TIMI 36 Trial##1019-
155·227A
C-Reactive Protein and B-Type Natriuretic Peptide 
Independently Predict Hospitalization for Heart Failure 
After Acute Coronary Syndromes and Identify Patients 
Who Benefit From Intensive Statin Therapy in the 
PROVE IT-TIMI 22 Trial##1007-174·204A
Composite Holter-Based Risk Stratifier Identifies Low-
Risk Postinfarction Patients With Left Ventricular 
Dysfunction##911-242·28A
Deceleration Capacity In Post-MI Patients on and off Beta-
Blockers## 818-7·3A
Heart Rate Variability Is Significantly Increased by Ivabradine 
Compared With Amlodipine in Patients With Chronic 
Stable Angina: A Prospective Randomized Double-Blind 
Controlled Study##908-242·23A
New ECG Pattern in Young Patients With Polymorphic 
Catecholaminergic Ventricular Tachycardia##916-
242·36A
Smart ECG: Solution for Mobile Heart Work Analysis 
and Medical Interventions in Case of Heart Work 
Problems##1012-190·280A
Amiodarone
Does the Use of Amiodarone Impact the Ability of Anterior 
Fat Pad Retention to Prevent Postoperative Atrial 
Fibrillation?##1027-19·312A
Should Intravenous Amiodarone Be Utilized for 
Hemodynamically Tolerated Sustained Monomorphic 
Ventricular Tachycardia?##906-239·19A
Aneurysms
A Novel Noninvasive Technique for Pulse-Wave Imaging and 
Characterization of Vascular Mechanical Properties In 
Vivo##906-228·135A
Bicuspid Calcified Aortic Valves Are Associated With 
a Splice Variant of Notch1 Expression in Human 
Tissues and Stenotic Bicuspid Aortic Valve From the 
Hypercholesterolemic eNOS Null Mouse, Which 
Improves With Atorvastatin##1003-25·300A
Clinical Characteristics and Outcomes of Behcet’s Disease 
With Cardiovascular Involvement##1014-81·362A
Differences in Clinical Profiles of Patients With Nonascending 
vs. Ascending Thoracic Aortic Aneurysms##1008-
45·339A
Noninvasive Detection and Characterization of Abdominal 
Aortic Aneurysms in Mice Using Ultrasound##909-
222·144A
Pre-Existing True Aortic Aneurysms in Patients Presenting 
With Acute Aortic Dissection##1008-6·334A
Predictive Value of High-Sensitivity C-Reactive Protein 
in the Diagnosis and Prognosis of Acute Aortic 
Syndromes##1008-84·341A
Rapid True Aneurysm Formation After Healing of Thrombosed 
Aortic Dissection##1008-1·333A
Short-Term Statin Therapy Is Associated With Marked 
Reduction of C-Jun N-Terminal Kinase of Aortic Wall 
in Patients With Abdominal Aortic Aneurysm##1008-
44·339A
Stem Cell-Mediated Natural Intraventricular Tissue 
Engineering##1019-91·222A
Angina pectoris
Cardiac Release of Urocortin Precedes the Occurrence of 
Irreversible Myocardial Damage in the Rat Heart Exposed 
to Ischemia/Reperfusion Injury##1013-90·211A
Combination Therapy of Calcium Channel Blocker and 
Angiotensin-Converting Enzyme Inhibitor Improves 
Endothelial Function and Arterial Stiffness in Patients 
With Angina Pectoris##1008-8·335A
Comparison Of Angiopoietin-1 And Angiopoietin-2 Gene 
Expression Levels Among Patients Treated With 
Sirolimus-eluting Versus Bare Metal Stents##1007-
179·205A
Creatinine Kinase-MB Enzyme Elevation in the Presence 
of Normal Troponin Is a Powerful Predictor of 
Cardiovascular Complications in Non-ST-Segment 
Elevation Acute Coronary Syndrome##1019-158·228A
Cystatin C Is Lower in Acute Coronary Syndrome Than in 
Stable Angina and Nonischemic Chest Pain: An Apparent 
Paradox?##1019-157·228A
Diagnosis of Coronary Artery Disease by Detection of 
Post-Ischemic Diastolic Dyssynchrony After Treadmill 
Exercise Using Strain Image Derived From 2D Speckle 
Tracking##918-224·177A
Diagnostic Accuracy of 64-Slice Computed Tomography 
Versus Conventional Coronary Angiography: Results of 
300 Consecutive Patients##904-229·128A
Enhanced External Counterpulsation Treatment Decreases 
Arterial Stiffness and Myocardial Oxygen Demand in 
Patients With Refractory Angina## 842-4·110A
Favorable Effect of Statins on Local Inflammatory Activation 
in Nonculprit Lesions of Patients With Multivessel 
Coronary Artery Disease##1019-94·223A
Growth-Differentiation Factor-15 for Early Risk Stratification 
in Patients With Acute Chest Pain##1007-111·200A
Increased Red Blood Cell Aggregation and Blood Viscosity 
in Cardiac Syndrome X as a Cause of Microcirculatory 
Dysfunction## 825-8·233A
Less is Better, None is Best: Angina and Health Related 
Quality of Life##1019-178·229A
Low Incidence of Significant Bradycardia During Therapy 
With an I
f
 Current Inhibitor Ivabradine: Heart Rate 
Reduction Depends on Baseline Heart Rate##1007-
195·206A
Nicorandil Prevents Initial and Recurrent Events in Patients 
With Stable Angina Pectoris##1025-91·238A
Predictors of Persistent Angina Among Coronary Disease 
Patients## 825-3·232A
Prevalence and Prognosis of Silent Ischemia in Outpatients 
With Stable Coronary Heart Disease: The Heart and Soul 
Study## 825-7·233A
Relationship of Mild Renal Insufficiency to C-Reactive 
Protein and Coronary Plaque Morphology as Determined 
by Intravascular Ultrasound-Virtual Histology##1013-
180·219A
Risk Factors for Angina in Women Without Atherosclerosis: 
The Dallas Heart Study## 833-6·397A
Safety and Efficacy of Bivalirudin in High-Risk Patients 
With Acute Coronary Syndrome Admitted Through the 
Emergency Department: Implications for Upstream 
Management## 802-4·208A
Serum Cystatin C Reflects the Presence and Severity 
of Coronary Artery Disease in Stable Angina 
Patients##1007-175·205A
Systemic Inflammation 12-Months After Stent Implantation: 
Comparison Between Sirolimus-Eluting Stent and Bare-
Metal Stent##1001-178·193A
The Cost Effectiveness of Functional Cardiac Testing in the 
Diagnosis and Management of Coronary Artery Disease: 
Principal Results From the CECaT Trial## 817-4·291A
The Oral Adenosine A1 Receptor Agonist, BAY 68-4986, 
Reduces Heart Rate at Peak Exercise in Patients With 
Chronic Stable Angina## 825-6·232A
Angiocardiography
Diagnostic Accuracy of Coronary 64-Row Multi Detector 
Computed Tomography in Clinical Setting##905-
229·131A
Experience of 1,000 Acetylcholine Spasm Provocation Tests: 
What Have We Learned?##1013-176·218A
Multidetector Computed Tomographic Angiography Results in 
a Lower Radiation Dose Than Diagnostic Catheterization 
in Pediatric Patients##1023-28·264A
Prolonged Inflammatory Activity Is Associated With Rapid 
Progression of Nonculprit Complex Lesion in Non-ST-
Segment Elevation Acute Coronary Syndromes##1001-
111·187A
Type of Glycoprotein IIb/IIIa Inhibitor and In-Hospital 
Outcome in STEMI Patients Treated With Primary 
Percutaneous Coronary Intervention: Results From the 
Nationwide French FAST-MI Registry##1019-114·224A
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Angiogenesis
Angiotensin Converting Enzyme Inhibitors Beneficially 
Modify Vascular Endothelial Growth factor gene 
expression and protein levels in Stable Coronary Artery 
Disease##1007-180·206A
Assessment of Efficacy With Allogenic Mesenchymal 
Precursor Cells: A Targeted Translational Model of Acute 
MI##1013-117·214A
Cardiac Side Population Cells Represent Endothelial 
Differentiation Potential##1025-70·236A
Cardiomyocyte Engraftment in Human Gender-Mismatched 
Heart Transplantation Preserves Microvascular 
Function##1028-106·94A
Combination Therapy of Targeted Anti-Angiogenic Drug 
Delivery and Oral Statin Against Atherosclerosis##910-
233·151A
Comparison Of Angiopoietin-1 And Angiopoietin-2 Gene 
Expression Levels Among Patients Treated With 
Sirolimus-eluting Versus Bare Metal Stents##1007-
179·205A
Contrast-Enhanced Carotid Ultrasound Shows Greater 
Intraplaque Neovascularization in High Risk 
Plaques##903-226·124A
Direct Collagen Injection to Thicken the Infarct Scar: Collagen 
Density Determines Angiogenesis##1001-75·185A
Endothelial Progenitor Cells Do Not Incorporate Into New 
Vessels but Indirectly Augment Angiogenesis: Insights 
From a Novel In Vitro Human Angiogenesis Assay## 
832-4·394A
Experimental Application of Bevacizumab-Eluting PC Coated 
Stent for Inhibition of Vasa Vasorum of Atherosclerotic 
Plaque##1020-47·382A
Gene Delivery for Therapeutic Angiogenesis Is More 
Effective by Ultrasound-Mediated Destruction of 
Carrier Microbubbles Than by Direct Intramuscular 
Injection##918-225·178A
Hepatocyte Growth Factor Is a Key Paracrine Molecule 
Mediating the Angiogenic and Therapeutic Effects of 
Adipose Stromal Cells##1020-39·381A
Imaging and Quantification of Coronary Plaque 
Neovascularization With Contrast-Enhanced Intravascular 
Ultrasound and a New Computational Image Analysis 
Technique##905-228·131A
Impaired Therapeutic Potential of Bone Marrow-Derived 
Endothelial Progenitor Cells in the Metabolic Syndrome 
and Diabetes Mellitus##1026-39·403A
Lack of Clinical Response in Diabetic Patients After 
Transendocardial Injection of Bone Marrow Mononuclear 
Cells##1016-139·71A
Long-Term Outcome of Autologous Transplantation of 
Bone Marrow Mononuclear Cells in Patients With 
Thromboangiitis Obliterans##1008-40·338A
Nitric Oxide Production in Freshly Isolated Circulating 
Endothelial Progenitor Cells: A Marker of Cellular 
Functional Status and Clinical Disease?##1002-3·315A
Role of Nox2-Containing NADPH Oxidase in Cigarette 
Smoke-Induced Impairment of Angiogenesis##1002-
39·319A
Short-Term Exposure to Secondhand Smoke Leads to 
Mobilization of Dysfunctional Endothelial Progenitor 
Cells in Nonsmokers##1014-41·360A
Stem Cell-Mediated Natural Intraventricular Tissue 
Engineering##1019-91·222A
Sustained Release of Prostaglandin E1 Ameliorates 
the Impaired Therapeutic Angiogenesis by Basic 
Fibroblast Growth Factor in Diabetic Murine Hindlimb 
Ischemia##1014-39·359A
Angiography
Accuracy of 64-Slice Computed Tomography for Evaluating 
Bypass Grafts and Corresponding Peripheral Coronary 
Arteries##917-229·175A
Accuracy of Three-Dimensional Quantititive Coronary 
Analysis by Comparison With Intravascular 
Ultrasound and Two-Dimensional Quantitive Coronary 
Analysis##1013-179·219A
Acute Coronary Angiographic Findings in Survivors of Out-of-
Hospital Cardiac Arrest##1013-197·219A
Adult Treatment Panel III 2001 but Not International Diabetes 
Federation 2005 Criteria of the Metabolic Syndrome 
Predict Future Vascular Events Among Women 
Undergoing Coronary Angiography##1025-176·245A
Angiographic Based Prevalence of Cardiovascular Disease in 
Pre-renal Transplant Patients##1019-180·230A
Angiographic Estimates of Myocardium at Risk During Acute 
Myocardial Infarction: A Validation Study Using Cardiac 
Magnetic Resonance Imaging## 824-8·105A
Atrial Fibrillation Is a Strong Predictor of Death and of Cardiac 
Events in Angiographied Coronary Patients##913-
237·30A
Bridging of Chronically Anticoagulated Patients With 
Low Molecular Weight Heparin Prior to Cardiac 
Catheterization: Experience in 203 Patients From the 
BRAVE Registry##1025-180·245A
Cardiac Computed Tomographic Angiography in an Outpatient 
Setting: An Analysis of Patient Outcomes Over a 30-
Month Period## 852-7·114A
Comparison Between Coronary Anatomy and Physiology 
in Predicting Hard Events in Symptomatic Patients 
Undergoing Coronary Angiography##901-235·117A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography, Radionuclide Myocardial Perfusion 
Imaging, and Stress Echocardiogram in the Detection of 
Significant Coronary Artery Stenosis##908-229·142A
Coronary and Left Ventricular Angiographic Correlates of 
Chronic Kidney Disease Following Acute Myocardial 
Infarction: Data From the Survival and Ventricular 
Enlargement Trial## 805-7·353A
Coronary Artery Image Quality Using Multidetector Computed 
Tomography to Simultaneously Evaluate for Coronary 
Artery Stenosis, Aortic Dissection and Pulmonary 
Embolism##916-229·171A
Coronary Calcium Scanning Before Cardiac Computed 
Tomographic Angiography Reduces the Total Effective 
Radiation Dose##916-228·171A
Coronary Computed Tomography Angiography Decreases 
Need for Invasive Cardiac Catheterization in Patients 
With Indeterminate Stress Test##901-231·117A
Coronary Computed Tomography Angiography in Elderly 
High Risk Patients Presenting With Atypical Cardiac 
Symptoms##914-229·164A
Coronary Intervention Rates Following Coronary 
Angiography Without Prior Stress Testing: Results 
From the Investigation of National Coronary Disease 
Identification##1013-75·210A
Coronary Revascularization Procedure in Patients >80 Years 
Presenting With Acute Myocardial Infarction##1001-
116·188A
Cystatin C Is Lower in Acute Coronary Syndrome Than in 
Stable Angina and Nonischemic Chest Pain: An Apparent 
Paradox?##1019-157·228A
Demand Ischemia Is the Predominant Etiology of Perioperative 
Myocardial Infarction: Implications for Perioperative Risk 
Stratification##1025-111·239A
Determination of Optimal Viewing Angles for X-Ray Coronary 
Angiography Based on a Quantitative Analysis of 3D 
Reconstructed Models##1030-188·296A
Diagnostic accuracy of 64-Slice Computed Tomography 
Coronary Angiography in Patients With Unstable 
Angina and Non-ST-Segment Elevation Myocardial 
Infarction##915-230·168A
Diagnostic Accuracy of 64-Slice Computed Tomography 
Versus Conventional Coronary Angiography: Results of 
300 Consecutive Patients##904-229·128A
Diagnostic Accuracy of Dual Source Coronary Tomography 
Coronary Angiography in Patients Referred for 
Conventional Angiography## 852-6·114A
Fate of Small-Sized Side Branches After Coronary Stent 
Implantation##1013-156·217A
Incidence of Coronary Artery Ectasia and Its Relationship 
With Coronary Endothelial Dysfunction in Asian 
Population##1026-8·406A
Incremental Benefit of Strain Rate Imaging to the Accuracy 
of Novice and Expert Interpreters of Dobutamine Stress 
Echocardiography##906-225·134A
Infarct Size, Viability, and Correlates in Patients Presenting 
With a Persistent Total Occlusion of the Infarct-Related 
Artery 3-28 Days Post-Myocardial Infarction: An OAT 
Substudy##1007-94·199A
Intensive Lowering of the Low-Density Lipoprotein 
Cholesterol/High Density Lipoprotein Cholesterol Ratio 
With High-Dose Statin Therapy Promotes Regression 
of Obstructive Coronary Artery Disease: Insights From 
ASTEROID## 820-4·393A
Is In-Stent Late Loss Related to the Risk of Drug-Eluting Stent 
Thrombosis? A Meta-Regression From 21 Randomized 
Trials##1001-156·191A
Left Ventricular Function Rather Than Coronary Anatomy 
Predicts Survival in Patients With End-Stage Renal 
Disease##1014-128·367A
Multidetector Computed Tomographic Angiography Results in 
a Lower Radiation Dose Than Diagnostic Catheterization 
in Pediatric Patients##1023-28·264A
Multislice Computed Tomography and Intravascular 
Ultrasound for Risk Stratification in Non-ST-Elevation 
Myocardial Infarction and Unstable Angina##902-
230·121A
Myocardial Perfusion in ST-Elevation Myocardial Infarction 
Patients Following Primary Percutaneous Coronary 
Intervention: Insights From the Electrocardiography/
Angiography Substudy of APEX AMI## 844-4·249A
Relative Value of Electrocardiogram, Magnetic Resonance 
Imaging, Angiography, and Contrast Echocardiography 
for Analyzing Microcirculation After Reperfused 
Myocardial Infarction##917-225·174A
Statin Therapy Decreases Contrast-Induced Nephropathy in 
Patients Undergoing Cardiac Catheterization##1014-
126·367A
Three-Dimensional Quantification of Coronary Plaque Burden 
by 64-Slice Computed Tomography: A PROSPECT-
MSCT Substudy## 852-5·114A
Use of Multidetector Computer Tomography Angiography 
Following Abnormal Myocardial Perfusion Stress Testing 
in a Large Single-Specialty Cardiology Practice## 831-
6·106A
Variation of Coronary Artery Size With End-Systolic to 
Mid-Diastolic Triggering With Computed Tomography 
Angiography##912-229·157A
We Are Getting Fatter - But Are Our Cath Labs 
Ready?##1006-186·274A
Angioplasty
A Comparative Study on the Feasibility and Safety of 
Transulnar Artery Versus Transradial Artery Access for 
Percutaneous Coronary Intervention in Patients With 
Coronary Heart Disease##1012-191·281A
A Randomized, Double-Blind, Placebo-Controlled Study of 
the Safety and Efficacy of Intravenous MCC-135 as an 
Adjunct to Primary Percutaneous Coronary Intervention 
in Patients With Acute Myocardial Infarction##1025-
133·241A
Assessing Individual Response to Clopidogrel in Patients 
Undergoing Coronary Intervention##1014-121·365A
Association of Primary Percutaneous Coronary Intervention 
Door-to-Balloon Time and Mortality in Patients 
Hospitalized With ST-Elevation Myocardial Infarction: 
Findings From the American College of Cardiology-
National Cadiovascular Data Registry CathPCI 
Registry##1202-254·197A
Bare Metal Stent Implantation Is Independent Predictor of 
Cardiac Death After Percutaneous Interventions on 
Unprotected Left Main Coronary Artery##1025-156·243A
Chronic Obstructive Pulmonary Disease Was an Independent 
Predictor of Sudden Cardiac Death, Cardiac Death, 
and All-Cause Mortality After Percutaneous 
Coronary Intervention and Coronary Artery Bypass 
Grafting##1001-179·194A
Comparison of Drug-Eluting Versus Bare Metal Stents: Timing 
of Subacute Thrombosis up to 2 Years##1019-154·227A
Comparison of Effects of Sirolimus-Eluting Stent, Bare 
Metal Stent, and Plain Only Balloon Angioplasty on 
Inflammatory Markers##1001-196·194A
Comparison of Hospital Door-to-Balloon Times Reported 
by Centers for Medicare and Medicaid Services and the 
American College of Cardiology-National Cardiovascular 
Data Registry: Apples and Oranges?##1204-264·277A
Culprit Coronary Lesions Requiring Percutaneous Coronary 
Intervention Following Vascular Surgery Often Arise 
From Non-Obstructive Disease##1013-159·217A
Diagnostic Accuracy of Coronary 64-Row Multi Detector 
Computed Tomography in Clinical Setting##905-
229·131A
Direct (Ambulance-Based) Referral to Coronary Care Unit for 
Primary Percutaneous Coronary Intervention Improves 
Door-to-Catheterization Time and Final TIMI Flow: 
Should We Bypass the Emergency Room?##1025-
137·242A
Direct Transport of Patients With Acute Myocardial 
Infarction to Interventional Cardiology Center 
Following Electrocardiogram Transmission From Home 
Shortens Delay to Primary Percutaneous Coronary 
Intervention##1013-133·214A
Do Drug-Eluting Stents Impact Survival in Patients With 
Chronic Renal Insufficiency?##1025-178·245A
Do the Results of the Arterial Revascularization Therapies 
Study Trial Generalize to Current Revascularization 
Practices in Northern New England?##1018-146·282A
Effect of Amlodipine on the Clinical Outcome in Diabetic 
Patients With Coronary Artery Disease After Angioplasty: 
Results From the Cardiovascular Events Follow-Up Trial 
in Kokura##1007-176·205A
Effects of Balloon Angioplasty on the Tissue Composition of 
Acute Coronary Lesions: In Vivo Spectral Analysis of 
Intravascular Ultrasound Radiofrequency Data##1019-
116·225A
Elective Percutaneous Coronary Intervention Without 
On-Site Surgical Backup: A Community Hospital 
Experience##1012-193·281A
Hematological and Biochemical Variables Strongly 
Predict Death at 1 Year After Percutaneous Coronary 
Intervention##1030-189·297A
Hospital Discharge Status Following Percutaneous Coronary 
Intervention for ST-Elevation Myocardial Infarction in 
Octogenarians## 847-7·251A
Impact of GP IIB/IIIA Receptor Inhibitors and Clopidogrel 
Treatment on 30-Day and 1-year All-Cause Mortality of 
Patients With ST-Elevation Myocardial Infarction Treated 
by Primary Percutaneous Coronary Intervention## 847-
5·251A
Impact of Payer Type on the Utilization of Drug-Eluting 
Stents for Patients With and Without Acute Myocardial 
Infarction##1030-147·294A
Impact of Stent Fractures After Femoropopliteal 
Stenting##1008-81·341A
Inhibition of Platelet Aggregation by Clopidogrel Is Unaffected 
by the CYP2C19 681G>A Polymorphism in Patients With 
Coronary Artery Disease## 815-4·375A
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Is Diabetes a Significant Risk Factor in Contemporary 
Percutaneous Coronary Intervention (PCI)?##1007-
178·205A
Is It Possible to Predict Which Patients Need Distal 
Protection During Primary Percutaneous Coronary 
Intervention?##1001-133·189A
Left Ventricular End-Diastolic Pressure Is a Predictor 
of Suboptimal Myocardial Reperfusion in Patients 
Undergoing Percutaneous Coronary Intervention for ST-
Elevation Myocardial Infarction##1013-93·211A
Levosimendan Echocardiography Allows Detection of 
Contractile Reserve in Post-Myocardial Infarction Patients 
That Do Not Improve Function With Dobutamine##917-
224·174A
Long-Term Clinical Outcome After Coronary Balloon 
Angioplasty: A 25-Year Follow-Up Study##1001-
174·192A
Long-Term Effects (up to 18 Years) of Balloon Angioplasty 
of Coarctation of the Aorta on Systemic Hypertension 
and Left Ventricular Hypertrophy in Adolescents and 
Adults##1005-52·256A
Long-Term Follow-Up of Patients With ST-Segment Elevation 
Myocardial Infarction Treated With Sirolimus-Eluting 
Stents##1025-153·243A
Long-Term Results (18 Years) of Balloon Angioplasty for 
Discreet Coarctation of the Aorta: Comparison With the 
Reported Series of Stenting##1005-54·256A
Meta-Analysis of 1,193 Patients Shows That Late Percutaneous 
Coronary Intervention for the Occluded Infarct-Related 
Artery Improves Survival## 844-3·249A
Mortality Following Percutaneous Coronary Intervention 
for Cardiogenic Shock: Is It Fair to Publicly Report 
Outcomes?##1007-199·207A
Myocardial Protection by Intravenous 5-Lipoxygenase 
Inhibitor Quercetin Administration Before Primary 
Angioplasty in Patients With Acute Myocardial Infarction: 
Short-Term Results an Open Blind Randomized 
Trial##1019-136·226A
Patients Transferred for Primary Percutaneous Coronary 
Intervention (PCI) in the APEX-AMI Trial Have Only 
Modest Symptom Onset to PCI Delays and Good 
Outcomes##1025-132·241A
Percutaneous Coronary Intervention: It Is Safe for Women as 
Long as They Receive the Right Medications##1012-
186·280A
Post-Percutaneous Coronary Intervention Statin Usage and 
Long-Term Mortality: Is Statin Intolerance a Predictor of 
Adverse Outcome?## 804-3·350A
Predictors for Developing a New Significant Lesion After 
Percutaneous Coronary Intervention: The Impact of 
Clinical Syndrome and the Smokers Paradox##1014-
6·356A
Primary Percutaneous Coronary Intervention Lowers Incidence 
of Ischemic Mitral Regurgitation## 816-6·309A
Real-Time Assessment of Clinical Appropriateness in Ad 
Hoc Percutaneous Coronary Intervention for 1,211 
Consecutive Patients##1204-262·276A
Reperfusion BURST Arrhythmias as a Biomarker of 
Myocellular Damage Despite TIMI 3 Epicardial 
Flow##1019-96·223A
Retroperitoneal Hematoma After Percutaneous Coronary 
Intervention: Prevalence, Risk Factors, Predictors, 
Management, and Outcomes. Results From the Blue Cross 
Blue Shield of Michigan Cardiovascular Consortium 
Registry##1024-146·286A
Risk Factors for Stroke Complicating Coronary 
Angioplasty##1012-182·279A
Safety and Efficacy of the Use of Endothelial Progenitor 
Cell Capture Stent Genous® Bio-Engineered R Stent in 
the Setting of Acute Myocardial Infarction: A Clinico-
Angiographic Follow-Up##1019-137·227A
Stabilization of Renal Function With Intra-Aortic Balloon 
Counterpulsation Therapy in Acute Myocardial 
Infarction Patients Undergoing Percutaneous Coronary 
Intervention##1025-135·242A
Tenecteplase-Pretreated ST-Elevated Myocardial Infarction 
Patients With TIMI 0-2 Flow Before Percutaneous 
Coronary Infarction Are Less Likely to Have TIMI 3 Flow 
After PCI##1019-153·227A
The Effectiveness of Improvement on Activities of Daily 
Living in Intermediate-Term With Percutaneous 
Peripheral Intervention of Lower Limbs in Hemodialysis 
Patients##1008-83·341A
The SIRIUS Study: 5-Year Outcomes##1025-159·244A
Towards Reduced Symptoms-to-Balloon Times in Primary 
Percutaneous Coronary Intervention: Effects of 
Prehospital Triage and Off-Site PCI##1001-136·190A
Transradial Approach In Percutaneous Coronary Intervention 
Following Prehospital Fibrinolysis Reduces Vascular 
Access Site Complication: Data From the French National 
OPTIMAL Study##1001-74·185A
Variation in Coronary Artery Bypass Grafting and 
Percutaneous Coronary Intervention Outcomes Across 
Four Revascularization Centers in Northern New England 
and Its Relation to Community Survival##1030-186·296A
Vascular Disease Burden and In-Hospital Outcomes Among 
Patients With Coronary Artery Disease Undergoing 
Percutaneous Coronary Intervention##1008-85·341A
Vascular Stenosis Response to Balloon-Injury Is Inhibited 
Following Local Intramural Delivery of Rapamycin With 
avb3-Integrin-Targeted Perfluorocarbon Nanoparticles## 
849-6·418A
Vasp Phosphorylation Analysis Predicts Ischemic Recurrence 
in Patients Undergoing Coronary Angioplasty## 409-
5·421A
Ventricular Arrhythmia Bursts in the Setting of Acute Anterior 
Infarct Artery Recanalization: A Re-Definition of 
Reperfusion Arrhythmias##905-239·17A
Angiotensin II
Angiotensin 1-7 Protects Against Angiotensin II Mediated 
Apoptotic Cell Death in Cardiomyocytes and Might Partly 
Explain Benefits of ACE-Inhibition##1016-59·65A
Angiotensin II Production During Exercise Is Augmented 
in Patients With a Hypertensive Response to 
Exercise##1014-171·371A
Angiotensin II-Induced Increase in Myocardial Distensibility Is 
Modulated by the Endocardial Endothelium, Endothelin-1 
and Nitric Oxide##1010-57·53A
Angiotensin-Receptor Blocker, Not Calcium Channel 
Blocker, Reduced Plasma Osteopontin Level in Essential 
Hypertensive Patients With no Cardiovascular Events## 
848-7·417A
Are Angiotensin Receptor Blockers as Safe as Angiotensin 
Converting Enzyme Inhibitors in Patients With Heart 
Failure? A Systematic Review and Meta-Analysis of 
Randomized Controlled Trials##1201-247·52A
Association Between an Angiotensin II Receptor Gene 
Polymorphism and Left Ventricular Systolic Dysfunction 
in Sarcomere Gene Mutation-Induced Hypertrophic 
Cardiomyopathy##1010-100·56A
Benefits of Candesartan Are Consistent Regardless of 
Pretreatment Systolic Blood Pressure in the CHARM 
Program##1002-204·331A
Blood Pressure Lowering And cGMP Activating Actions Of 
Oral Human BNP In Experimental Hypertension##1026-
170·413A
Candesartan Benefits and Safety Observed Regardless of Age- 
Insights From CHARM Program##1010-97·55A
Combined Valsartan (Vn) and Simvastatin (Sn) Therapy 
Decreases Early and Late Manifestations of Vulnerable 
Atherosclerostic Plaque in Diabetic Hyperlipidemic Pigs: 
A Longitudinal Intravascular Ultrasound (IVUS) and 
Histology Study##1026-87·407A
Diastolic Index of Color Kinesis Can Noninvasively Detect 
Therapeutic Effects of Angiotensin II Receptor Blocker 
on Left Ventricular Diastolic Function In Hypertensive 
Diastolic Heart Failure Model.##911-228·153A
Effects of Candesartan Versus Losartan on Insulin Levels, 
Lipid Profile and Blood Pressure in Patients With Mild 
Hypertension, Hyperinsulinism and Dyslipidemia## 
848-6·417A
Increased Oxidative Stress via Activation of NADPH Oxidase 
Mediates Angiotensin II-Induced Skeletal Muscle 
Wasting: Potential Mechanism of Cachexia in Congestive 
Heart Failure## 845-7·98A
Successful In Vivo Imaging of the Enhanced Transcriptional 
Activity of GATA in the Heart During the Progression 
of Angiotensin II-Induced Hypertrophy in Mice##1010-
62·54A
The Association of Angiotensin Converting Enzyme (ACE) 
gene Insertion/Deletion polymorphism with Carotid 
Augmentation index in Hypertensive Patients##1026-
172·414A
Antiarrhythmia agents
Is the pH-Induced Change in IK
r
 Inhibition by Ibutilide 
Arrhythmogenic?##1002-118·324A
Magnesium Therapy for the Acute Management of Atrial 
Fibrillation: A Meta-Analysis##918-237·38A
Orally Administered Vanoxerine, a Cardiac Multichannel 
Blocker, Terminates Atrial Flutter and Prevents Its 
Reinducibility in the Canine Sterile Pericarditis 
Model##918-238·38A
Antibodies
Immunotargeting of Vascular Inflammation##1014-7·356A
Nitric Oxide Production in Freshly Isolated Circulating 
Endothelial Progenitor Cells: A Marker of Cellular 
Functional Status and Clinical Disease?##1002-3·315A
Reverse Remodeling of Failing Myocardium Is Associated 
With Decreased Deposition of Anti-Cardiac 
Antibodies: Observations in Patients Following Cardiac 
Resynchronization Therapy##1022-58·73A
Anticoagulants
“Virtual Superiority”: A New Composite Score for Grading 
the Quality of Noninferiority Cardiovascular Clinical 
Trials##1024-149·287A
A Novel, Rationally Engineered Heparin (M118) Prevents 
Thrombosis More Effectively Than Unfractionated 
Heparin in a Canine Model of Deep Arterial 
Injury##1020-34·379A
A Rapid Genotyping Assay for Polymorphisms Affecting the 
Dose-Response to Warfarin Therapy##1020-89·385A
Activated Partial Thromboplastin Time Measurement Is Not 
Associated With Clinical Outcomes in Patients With 
High-Risk Non-ST-Segment Elevation Acute Coronary 
Syndromes Treated With Unfractionated Heparin##1001-
93·186A
Anticoagulation After Anterior Myocardial Infarction and the 
Risk of Stroke## 410-7·422A
Aspirin and Coumadin Are Safe and Effective Therapies After 
the Fontan Operation##1023-29·264A
AZD6140 Suppresses Platelet Aggregation in Clopidogrel-
Treated Patients Even in Those With High Aggregation 
Levels## 802-7·208A
Beneficial Effects of Optimized Antithrombotic Therapy With 
Aspirin, Clopidogrel and Enoxaparin Versus Standard 
Therapy in Non-ST-Elevation Acute Coronary Syndromes 
in Clinical Practice## 851-3·252A
Bleeding Is Common Among Patients Treated With 
Heparin Experiencing Thrombocytopenia and Confers 
a High Mortality Risk: Report From the CATCH 
Registry##1008-77·340A
Bridging of Chronically Anticoagulated Patients With 
Low Molecular Weight Heparin Prior to Cardiac 
Catheterization: Experience in 203 Patients From the 
BRAVE Registry##1025-180·245A
Comparison Of Outcomes In Patients Randomized To Warfarin 
According To Anticoagulant Control: Results From 
Sportif III And V.##1026-121·408A
Comparison of Quality of Life in Patients With/Without 
Normal Sinus Rhythm After Transesophageal 
Echocardiography-Guided Cardioversion: Results From 
the Acute II Study##1012-184·279A
Continuation of Warfarin at Hospital Discharge in Patients 
With Acute Coronary Syndromes on Chronic Warfarin 
Anticoagulation## 847-6·251A
Efficacy and Safety of Fondaparinux in Elderly Patients With 
ST-Segment Elevation Myocardial Infarction: Data From 
the OASIS 6 Trial##1025-138·242A
Efficacy of Intravenous Prothrombin Complex Concentrate for 
Emergent Reversal of Oral Anticoagulation in Patients 
With Left Ventricular Assist System##1028-108·94A
Elevated Fibrinogen, Higher Body Mass Index, and Diabetes 
Mellitus Are Associated With Lower Platelet Inhibition in 
Patients Treated With Clopidogrel##1020-122·387A
Enoxaparin Versus Unfractionated Heparin in Women 
Undergoing Fibrinolysis for ST-Elevation Myocardial 
Infarction in ExTRACT-TIMI 25##1007-136·202A
Enoxaparin Versus Unfractionated Heparin With Fibrinolysis 
for ST-Elevation Myocardial Infarction In Patients ≥75 
Years Compared With <75 Years## 844-5·249A
Logistic Regression Models to Identify Predictors of 
Deep Venous Thrombosis and Pulmonary Arterial 
Thromboembolism After Total Knee Replacement Using 
Multislice Computed Tomography##1014-85·363A
Non-ST-Segment Elevation Acute Coronary Syndrome 
Patients on Chronic Warfarin Anticoagulation: Care and 
Outcomes##1013-114·213A
Outcome in Acute Coronary Syndrome Patients Managed 
Surgically Based on Clopidogrel Exposure and Delay to 
Surgery: A Report From the ACUITY Trial## 851-5·252A
Pharmacological Venous Thromboembolism Prophylaxis 
in Hospitalized Medical Patients: A Meta-Analysis of 
Randomized Controlled Trials##1002-89·324A
Relationship Between Circulating Uncarboxylated Matrix-Gla 
Protein Concentrations and Aortic Valve Calcification## 
839-7·311A
Safety and Efficacy of Bivalirudin in High-Risk Patients 
With Acute Coronary Syndrome Admitted Through the 
Emergency Department: Implications for Upstream 
Management## 802-4·208A
Safety and Tolerability of a Novel Tissue Factor/Factor VIIa 
Inhibitor rNAPc2 in Patients With Non-ST Elevation 
Acute Coronary Syndrome Managed Invasively: Results 
From the ANTHEM-TIMI 32 Trial##1202-252·196A
Three-Month Cumulative Incidence of Thromboembolism 
and Bleeding After Periprocedural Anticoagulation 
Management of Nonvalvular Atrial Fibrillation Patients: A 
Single Center Retrospective Cohort Study##915-238·33A
Upstream Therapy With Bivalirudin Is as Safe and Effective 
as Heparin for Patients With Acute Coronary Syndrome 
Undergoing Coronary Artery Bypass Surgery: A Report 
From the ACUITY Trial## 851-7·253A
Use and Outcomes of Acute Clopidogrel Therapy in Non-ST-
Segment Elevation Myocardial Infarction in Community 
Practice: Results From CRUSADE## 802-3·207A
Use of Low Molecular Weight Heparin Is Associated 
With Improved In-Hospital Survival of ST-Elevation 
Myocardial Infarction Patients Who Receive Reperfusion 
Therapy: Results From the Nationwide French FAST-MI 
Registry##1025-94·238A
Warfarin Treatment in Patients With Giant Coronary 
Aneurysms Caused by Kawasaki Disease##1023-27·264A
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Antihypertensive therapy
Aliskiren-Based Therapy Lowers Blood Pressure More 
Effectively Than Ramipril-Based Therapy in Patients 
With Hypertension: A 6-Month, Randomized, Double-
Blind Trial##1014-173·371A
Aliskiren-Based Therapy Provides Long-Term Suppression 
of Plasma Renin Activity That Persists After Treatment 
Withdrawal in Patients With Hypertension##1020-
168·390A
Antihypertensive Efficacy of the Direct Renin Inhibitor 
Aliskiren When Added to Hydrochlorothiazide 
Treatment in Patients With Extreme Obesity and 
Hypertension##1014-169·370A
Beneficial Effect of Angiotensin-II Type 1 Receptor Blocker 
Antihypertensive Treatment on Arterial Stiffness. The 
Role of Smoking##1026-171·413A
Benefits of Candesartan Are Consistent Regardless of 
Pretreatment Systolic Blood Pressure in the CHARM 
Program##1002-204·331A
Blood Pressure Lowering Effects Persist Following the Last 
Dose of Long-Term Therapy With Aliskiren, an Oral 
Direct Renin Inhibitor##1014-204·372A
Does a Single-Pill Antihypertensive/Lipid-Lowering Regimen 
Improve Adherence in United States Managed Care 
Enrollees?##1024-184·288A
Economic Evaluation of the Anglo-Scandinavian Cardiac 
Outcomes Trial Blood Pressure Lowering Arm: 
A Substudy on Incremental Cost-Effectiveness of 
Amlodipine-Based Regimen Versus Atenolol-Based 
Regimen in Primary Prevention Among Hypertensive 
Patients With Additional Risk Factors##1020-173·392A
Importance of Pain and Hypertension in Acute Type B Aortic 
Dissection: Insights From the International Registry of 
Acute Aortic Dissection##1018-184·284A
Prevention of Myocardial Infarction by Antihypertensive 
Drugs: An Updated Network Meta-Analysis## 848-
3·416A
The Effect of Valsartan Compared to Valsartan/
Hydrochlorothiazide on Plasma Levels of Cellular 
Adhesion Molecules: The Val-MARC Trial## 848-8·418A
Antioxidants
Active Atorvastatin Metabolite Preferentially Inhibits 
Oxidation of Small Dense Low-Density Lipoproteins: A 
Comparative Analysis##1008-13·336A
Chronic Treatment With Folic Acid Improves Nitric Oxide 
Bioavailability and Decreases Superoxide Production in 
Human Vessels Through Tetrahydrobiopterin-Mediated 
Improvement of eNOS Coupling## 832-3·394A
Fenofibrate Reduces Lipoprotein-Associated Phospholipase 
A2 Mass and Oxidative Stress in Hypertriglyceridemia 
Subjects With the Metabolic Syndrome## 809-5·354A
Lipoprotein-Associated Phospholipase A
2
 Inhibition Reduces 
Generation of Hydroxy-Fatty Acids##1014-87·364A
Low Levels of Paraoxonase Activity are Associated with 
Systemic Oxidative Stress, Extensive Coronary Artery 
Disease and Need for Coronary Revascularization## 
651-5·394A
Potent Mitochondria-Targeted Peptides Reduce Myocardial 
Infarction in Rats##1001-71·184A
Pretreatment With Epigallocatechin-3-Gallate, Green Tea 
Polyphenol, in Oral Uptake Attenuates Myocardial 
Ischemia/Reperfusion Injury in a Rat Heart Perfusion 
Model## 803-6·235A
Protective Effects of a Novel Long-Acting Calcium Channel 
Blocker Azelnidipine Against Cardiac Hypertrophy and 
Failure in Dahl Salt-Sensitive Rats##1002-205·331A
The Impact of Acute Consumption of Corn Oil, Liver Oil, 
Olive Oil, or Soya Oil on Endothelial Function and 
Oxidative Stress Status in Healthy Adults##1020-13·379A
Aorta
A Biomarker for Diagnosing Acute Aortic Dissection: 
Preliminary Experience With the Smooth Muscle 
Troponin-Like Protein, Calponin## 814-3·374A
Congenital Vascular Rings and Slings Are a Significantly 
Underdiagnosed Cause of Childhood Diseases: 
Screening of 186,213 School-Aged Children by 
Echocardiography##1005-32·255A
Impaired Aortic Distensibility as an Independent Marker of 
Coronary Artery Disease##1014-44·360A
Improved Ex-Vivo MR Imaging of Human Aortic 
Atherosclerosis with Macrophage-Specific 
Immunomicelles##1026-78·405A
Increased Aortic Stiffness Predicts Lower Exercise Stress 
Test Work Capacity in Subjects With Essential 
Hypertension##906-236·136A
Insulin-Like Growth Factor I Prevents Atherosclerosis 
Progression in Aged Apolipoprotein E Deficient 
Mice##1008-38·337A
Obstructive Sleep Apnea Is the Strongest Risk for Thoracic 
Aortic Expansion##1026-42·403A
Pressure Recovery, as Assessed by Cardiovascular Magnetic 
Resonance Imaging, Is Most Related to Aortic Impedance 
Rather Than Proximal Aortic Area##1003-24·300A
Systolic Tissue Doppler Velocity of the Ascending Aorta is 
an Index of Vascular Remodeling and Stiffness##1026-
81·406A
Aortic coarctation
Accuracy of Cuff and Echo Doppler Blood Pressure Gradients 
to Detect Recurrent Aortic Arch Obstruction in Infants 
After the Norwood Stage I Palliation##1005-33·255A
Effects of Ramipril on Endothelial Function and Inflammatory 
Process in Young Normotensive Patients With 
Successfully Repaired Coarctation of the Aorta## 837-
7·268A
Long-Term Effects (up to 18 Years) of Balloon Angioplasty 
of Coarctation of the Aorta on Systemic Hypertension 
and Left Ventricular Hypertrophy in Adolescents and 
Adults##1005-52·256A
Long-Term Results (18 Years) of Balloon Angioplasty for 
Discreet Coarctation of the Aorta: Comparison With the 
Reported Series of Stenting##1005-54·256A
Stent Implantation for the Treatment of Adult Aortic 
Coarctation: Initial and 5-Year Results##1005-51·256A
Aortic diseases
A Biomarker for Diagnosing Acute Aortic Dissection: 
Preliminary Experience With the Smooth Muscle 
Troponin-Like Protein, Calponin## 814-3·374A
Bicuspid Aortic Valve Is Associated With Atrial Septal 
Aneurysm and Mitral Valve Abnormalities##1027-
24·314A
Comparison of Stentless Valve Implantation Techniques 
in Large Cohort of Patients From the Freestyle Valve 
Registry##1027-15·401A
Coronary Artery Image Quality Using Multidetector Computed 
Tomography to Simultaneously Evaluate for Coronary 
Artery Stenosis, Aortic Dissection and Pulmonary 
Embolism##916-229·171A
Emergency Treatment of Acute Type B Dissection: Is Surgery 
Still Justified? Results From the International Registry of 
Aortic Dissection## 814-4·374A
Importance of Pain and Hypertension in Acute Type B Aortic 
Dissection: Insights From the International Registry of 
Acute Aortic Dissection##1018-184·284A
Intraoperative Monitoring by Transesophageal 
Echocardiography of Surgical Implantation of a Novel 
Prosthesis-Stent Combination in Aortic Dissection 
Involving Arch and Descending Aorta##910-224·149A
Is Elastin Really Useful for Marker of Acute Aortic 
Dissection?##1002-76·321A
LXR Agonist T1317 Inhibits the Aortic Valve Calcification in 
ApoE-/- Mice##1021-23·308A
Mortality of Acute Aortic Dissection After Surgical 
Repair##1021-18·307A
Noninvasive Detection and Characterization of Abdominal 
Aortic Aneurysms in Mice Using Ultrasound##909-
222·144A
Obstructive Sleep Apnea Is the Strongest Risk for Thoracic 
Aortic Expansion##1026-42·403A
Perivascular Adipose Tissue With Chlamydophyla Pneumoniae 
Antigens Is Associated With Positive Remodeling In 
Severe Abdominal Aortic Atherosclerosis.##1026-
82·406A
Pre-Existing True Aortic Aneurysms in Patients Presenting 
With Acute Aortic Dissection##1008-6·334A
Predictive Value of High-Sensitivity C-Reactive Protein 
in the Diagnosis and Prognosis of Acute Aortic 
Syndromes##1008-84·341A
Rapid True Aneurysm Formation After Healing of Thrombosed 
Aortic Dissection##1008-1·333A
Tear Size and Location Impacts False Lumen Pressure in an Ex 
Vivo Model of Chronic Type B Aortic Dissection##1020-
80·383A
Usefulness of Computed Tomography Angiography in 
the Follow-Up of Abdominal Aortic Aneurysm 
Treatment##911-231·154A
Utility of Transthoracic Three-Dimensional Color Doppler 
Echocardiography for Diagnosis of Congenital Aortic 
Arch Anomalies##1005-31·255A
Aortic regurgitation
Aortic Regurgitation: Role of Proteoglycans in Myocardial 
Fibrosis?##1021-20·307A
Epidemiology of Valvular Regurgitation in the Large Middle-
Aged African American Cohort of the Atherosclerosis 
Risk in Communities Study##1003-21·299A
Increased Pulse Pressure Reduces Coronary Flow Reserve 
in Patients With Chronic Aortic Regurgitation##1008-
202·349A
Intracardiac Echocardiography for Conservative Aortic Valve 
Surgery: A New Investigative Tool##914-224·163A
Aortic valve sclerosis
A Unique Animal Model of Aortic Valve Calcification Using 
High Adenine Diet##1012-192·281A
Aortic Valve Calcifications Are Associated With an Ischemic 
Perfusion Study in Individuals With Minimal Coronary 
Calcifications##1020-76·382A
Calcific Aortic Stenosis Is Independently Associated With 
Increased Parathormone Serum Level in Coronary Artery 
Disease Patients## 839-4·310A
Low Fetuin-A Concentrations Predict the Progression of Aortic 
Valve Calcification## 839-6·311A
Relationship Between Circulating Uncarboxylated Matrix-Gla 
Protein Concentrations and Aortic Valve Calcification## 
839-7·311A
Aortic valve stenosis
An Endocardial to Epicardial Myocardial Contraction Gradient 
Is Present in Severe Compensated Aortic Stenosis: Does 
It Reverse After Aortic Valve Replacement?##1003-
18·298A
Are There Gender Differences in Clinical Presentation and 
Surgical Outcome of Aortic Stenosis?##1015-23·305A
Association Between Plasma Low-Density Lipoprotein Particle 
Size, Valvular Infiltration by Oxidized Low-Density 
Lipoprotein and Inflammation in Patients With Severe 
Aortic Stenosis## 839-5·311A
Calcific Aortic Stenosis Is Independently Associated With 
Increased Parathormone Serum Level in Coronary Artery 
Disease Patients## 839-4·310A
Cardiac Computed Tomography Measurement of Aortic 
Annular Diameter: Implications for Percutaneous Aortic 
Valve Implantation##907-231·139A
Correlation of Aortic Valve Area Obtained by the Velocity-
Encoded Phase Contrast Continuity Method to Direct 
Planimetry Using Cardiovascular Magnetic Resonance 
Imaging##909-232·147A
Discrepancies in the Degree of Aortic Valve Stenosis Based on 
the Assessment of Valve Area, Mean Pressure Gradient 
and Maximal Flow Velocity##902-221·119A
Early Improvement in Left Ventricular Systolic Function 
Following Retrograde Transfemoral Aortic Valve 
Implantation## 816-3·309A
Early North American Experience With Percutaneous Aortic 
Valve Replacement in Patients Unsuitable for Surgical 
Aortic Valve Replacement## 816-5·309A
Effect of Mild to Moderate Chronic Kidney Disease on 
Progression of Calcific Aortic Stenosis##1021-22·308A
Impact of Left Ventricular Geometry on Stress-Corrected Left 
Ventricular Systolic Function in Asymptomatic Aortic 
Valve Stenosis: A SEAS Substudy##1003-19·298A
In-Hospital and 30-Day Outcomes Following Retrograde 
Trans-Femoral Aortic Valve Replacement in High-Risk 
Patients: A Report From the REVIVAL-II Trial## 816-
4·309A
Increased Local Inflammatory Activation in Stenotic 
Nonrheumatic Aortic Valves: New Implications of 
Inflammation##1009-23·303A
Is B-Type Natriuretic Peptide Superior to Contractile Reserve 
in Predicting Outcome in Low-Flow Aortic Stenosis? 
Results From the Multicenter TOPAS Study##1205-
269·300A
Is Calcific Aortic Stenosis Progression Accompanied by 
a Higher Rate of Atherosclerotic Cardiovascular 
Events?##1002-13·317A
Metabolic Profile of the Elderly With a Calcific Aortic Stenosis 
and Its Relation With the Valvular Calcium Content## 
839-3·310A
Multi-Slice Cardiac Computed Tomography Imaging 
of Patients Undergoing Percutaneous Aortic Valve 
Replacement##904-231·128A
Novel Assessment of Aortic Stenosis Using Real-Time 
Three-Dimensional Echocardiography: Comparison of 
Continuity Equation-Derived Aortic Valve Area With 
Planimetry##908-223·141A
Pressure Recovery, as Assessed by Cardiovascular Magnetic 
Resonance Imaging, Is Most Related to Aortic Impedance 
Rather Than Proximal Aortic Area##1003-24·300A
Regional Strain Values Are Different According to the Type 
of Left Ventricular Hypertrophy: Demonstration by 2-D 
Speckle Tracking Imaging##901-221·115A
Transesophageal Echocardiographic Direct Measurement of 
Left Ventricular Outflow Tract Area Improves Accuracy 
of Aortic Valve Area Determination by the Continuity 
Equation in Aortic Stenosis##909-224·145A
Aortocoronary bypass
Accuracy of 64-Slice Computed Tomography for Evaluating 
Bypass Grafts and Corresponding Peripheral Coronary 
Arteries##917-229·175A
Are There Any Differences in the Clinical and Angiographic 
Correlates of Short- and Long-Term Mortality in Patients 
Undergoing Coronary Artery Bypass Surgery?##1013-
198·220A
Broad Spectrum Adenoviral CC-Chemokine Blockade 
Attenuates Long-Term Vein Graft Accelerated 
Atherosclerosis in ApoE-Knockout Mice##1013-
200·220A
Chronic Obstructive Pulmonary Disease Was an Independent 
Predictor of Sudden Cardiac Death, Cardiac Death, 
and All-Cause Mortality After Percutaneous 
Coronary Intervention and Coronary Artery Bypass 
Grafting##1001-179·194A
Gender-Specific Effect of Previous Percutaneous Coronary 
Intervention on Early Mortality After Coronary Artery 
Bypass Surgery##1019-197·230A
Patients Treated With Clopidogrel Before Coronary Artery 
Bypass Grafting Surgery: Detrimental or Merely a 
Bother?##1025-198·246A
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Platelet Activity and Aspirin Efficacy After Off-Pump 
Compared to On-Pump Coronary Artery Bypass 
Surgery##1013-201·220A
Temporary Cardiac Resynchronization Therapy for Post 
Operative CABG Patients With Left Ventricular 
Dysfunction## 410-8·423A
Tetrahydrobiopterin-dependent eNOS Coupling Determines 
Vascular Remodeling Through Accelerated Endothelial 
Regeneration## 409-8·421A
Utilization and Impact of Angiotensin-Converting Enzyme 
Inhibitors on Recurrent Ischemic Events Following 
Coronary Artery Bypass Graft Surgery## 804-7·351A
Apolipoproteins
Effect Of Co-administration Of Ezetimibe/Simvastatin And 
Fenofibrate On Apolipoproteins (A-III, B, and C-III) In 
Patients With Mixed Hyperlipidemia##1002-122·325A
ISIS 301012, an Antisense Inhibitor of Apolipoprotein B, 
Produces Significant Additional Reduction of Low-
Density Lipoprotein Cholesterol and Apolipoprotein B in 
Hypercholesterolemic Subjects on Statins Not Meeting 
Target## 820-7·393A
Location of Tendon Xanthomata and Prevalence of Coronary 
Artery Disease Among Heterozygous Familial 
Hypercholesterolemia Patients.##1026-118·408A
LY518674, a Potent and Selective Peroxisome Proliferator 
Activated Receptor Alpha Agonist, Reduces Triglycerides, 
Total Cholesterol, Low-Density Lipoprotein Cholesterol, 
and Apolipoproteins B and C3##1026-5·405A
Randomized Placebo-Controlled Trial of Nicotinic Acid in 
Patients With Coronary Heart Disease and Low High-
Density Lipoprotein Cholesterol Despite 6 Weeks of 
Statin Therapy (LOW Study)##1014-124·366A
Statin-Like, Dose-Dependent Reductions in LDL-C and 
Apolipoprotein B With ISIS 301012, an Antisense 
Inhibitor of Apolipoprotein B, in Subjects With Polygenic 
Hypercholesterolemia##1206-278·333A
Apoptosis
Amino Acid Supplementation Differentially Modulates STAT1 
and STAT3 Activation in the Myocardium Exposed to 
Ischemia/Reperfusion Injury##1013-72·210A
Angiotensin 1-7 Protects Against Angiotensin II Mediated 
Apoptotic Cell Death in Cardiomyocytes and Might Partly 
Explain Benefits of ACE-Inhibition##1016-59·65A
Effect of Iron Supplementation on Cardiomyocyte 
Apoptosis Involves Modulation of Tissue Inhibitor of 
Metalloproteinases and Matrix Metalloproteinase in a 
Model of Doxorubicin-Induced Cardiomyopathy##1004-
104·46A
Excess Endothelin-1 Results in Fatal Calcium Overload 
in Porcine Myocardial Infarction and Isolated Rabbit 
Myocytes##1019-75·222A
Hemodynamic Load-Dependent Activation of Cardiac Stem 
Cells and Myocyte Turnover in Mitral Regurgitation## 
822-8·84A
Identification of 5-, 12/15-Lipoxygenase and NADPH 
Oxidase as Key Mediators of Oxidized Low-Density 
Lipoprotein-Induced Apoptosis of Human Aortic Smooth 
Muscle Cells: Implications for Atherosclerotic Plaque 
Destabilization##1008-4·334A
Increased Glucose Uptake by Amphiphysin SH3 Reduces 
Hypoxia-Induced Apoptosis in Cultured Neonatal Rat 
Cardiomyocytes##1007-75·198A
Opening of Mitochondria Permeability Transition Pores Is a 
Key Factor in Increased Hypoxia-Induced Susceptibility 
of Failing Cardiomyocytes to Undergo Apoptosis##1010-
58·53A
Oral Supplementation With Mixed Essential Amino Acids 
Protects the Human Heart From the Iatrogenic Ischemia/
Reperfusion Injury Associated With Cardioplegic Arrest 
Reducing Myocyte Cell Loss and Exerting Favorable 
Metabolic and Hemodynamic Effects##1019-199·231A
Presence of C-Reactive Protein in Left Atrium Is Associated 
With Atrial Fibrillation Irrespective of Serum CRP##908-
234·22A
Protein Disulfide Isomerase Prevents Apoptosis and 
Remodeling After Acute Myocardial Infarction##1025-
90·238A
S100B Human Heart Expression and Myocardial Apoptosis 
in the Peri-Infarct Viable Myocardium of Patients Dying 
After Acute Myocardial Infarction##1028-56·89A
Sildenafil Exerts Direct Cardioprotective Effects on HL-1 Cells 
Inducing Nitric Oxide-Mediated Opening of MitoKATP 
Channels##1019-70·221A
Stat3 Signal Transduction Pathway Correlates With 
Proliferation and Apoptosis of Rat Vascular Smooth 
Muscle Cells## 849-3·418A
Time Course of Endothelial Dysfunction and Endothelial 
Microparticle Generation After Acute Secondhand Smoke 
Exposure in Healthy Nonsmokers##1206-274·332A
Arrhythmias
A New Familial Syndrome Induced by the Interaction of 
Trypanosoma Cruzi With the Cardiac Sodium Channel 
Gene SCN5A##1010-103·56A
Anatomic Evaluation of the Right Atrial Cavo-Tricuspid 
Isthmus by Multi-Detector Computed Tomography##903-
237·14A
Asians Are Less Susceptible to Atrial Fibrillation: A Meta-
Analysis## 819-3·4A
Association Between KCNE1 Potassium Channel 
Polymorphism Mink38g and Lone Atrial 
Fibrillation##906-234·18A
Association of Myocardial Fibrosis Detected by Magnetic 
Resonance Imaging and Ventricular Tachyarrhythmia in 
Hypertrophic Cardiomyopathy##915-232·169A
Chronic Atrial Fibrillation Is Associated With Dysregulation 
of Sarcoplasmic Reticular Ca2+-ATPase and 
Protein Kinase A-Mediated Ser 16-Phosphorylated 
Phospholamban##1004-55·42A
Effects of Adenosine on Canine and Human Reentrant 
Ventricular Tachycardia## 836-8·8A
Identifying the Origin of Ventricular Arrhythmias Using 3D 
Echocardiographic Tissue Tracking Imaging##919-
223·181A
Incidence, Predictors, and Outcomes of Ventricular 
Arrhythmias During Angioplasty for Acute Myocardial 
Infarction##910-239·26A
Increased Inducibility of Ventricular Tachyarrhythmias 
at the Right Ventricular Outflow Tract in Brugada 
Syndrome##913-239·31A
Is the Heart Close Enough to the Skin Surface of the Chest 
Wall to Allow a Taser® to Potentially Cause Ventricular 
Fibrillation?##914-239·32A
Is Wider Worse? Increasing QRS Duration Predicts Cardiac 
Mortality in Patients With Complete and Persistent Right 
Bundle Branch Block##909-242·25A
Isoproterenol Increases QT Dynamicity in the Conscious 
Rabbit With Chronic Heart Failure## 818-8·4A
Macroscopic Anatomy of Atrial Muscular Connections With 
the Central Fibrous Body of the Aorta-Functional and 
Arrhythmic Implications##911-237·27A
Meta-Analysis of Randomized Controlled Trials Found No 
Benefit of Fish Oil or Omega-3 Fatty Acids on Sudden 
Cardiac Death or Ventricular Arrhythmias##1018-
185·284A
Possible Increased Risk of Cardiac Arrhythmias in Patients 
With Acquired Short QT Interval## 836-6·8A
Prevalence of Long QT Syndrome and Identification of Genetic 
Alterations in a Population of Japanese Children##903-
239·14A
Progression of Atrial Fibrillation in Patients With a First-
Detected Episode: A Long-Term Prospective Follow-Up 
Study##910-237·25A
Ranolazine Normalizes Action Potential Duration of 
Hypertrophied Ventricular Cardiomyocytes##909-
234·24A
Shock-Free Survival in Patients With Hypertrophic Obstructive 
Cardiomyopathy and Implantable Defibrillators Following 
Alcohol Septal Ablation##919-241·40A
Sympathetic Nerve Activation Predicts Origin of 
Tachyarrhythmia in Patients With a History Taking 
Paroxysmal Palpitation##902-235·122A
The Atrial Vulnerability Parameters in Lone Atrial Fibrillation 
Patients With Subclinical Hypothyroidism: A New Entity 
in Idiopathic Atrial Fibrillation?##916-237·35A
Arrhythmias, treatment of
Comparison Of Outcomes In Patients Randomized To Warfarin 
According To Anticoagulant Control: Results From 
Sportif III And V.##1026-121·408A
Intracardiac Echo-Guided Image Integration: Optimizing 
Strategies for Registration## 846-5·9A
Intraoperative Cooled-Tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation##917-
237·36A
Intraoperative Radiofrequency Ablation With an Irrigated 
Unipolar Probe in Patients Undergoing Fontan 
Conversion: A Safe and Effective Approach for the 
Treatment of Atrial Tachyarrhythmias##907-237·20A
The Efficacy of Ablation Techniques for the Treatment of 
Atrial Fibrillation: Is Pulmonary Vein Isolation Adequate 
as Lone Ablation Therapy?##904-237·15A
Arterial stiffness
Aortic Augmentation Index Is Associated With Ankle Brachial 
Index: A Community-Based Study##1002-11·317A
Aortic Stiffness Is Increased in Patients With Hepatitis C Virus 
Seropositivity##1020-79·383A
Associations of Left Atrium Volume With Aortic Stiffness and 
Neurohumoral Factors in the Early Stages of Essential 
Hypertension##912-221·155A
Beneficial Effect of Angiotensin-II Type 1 Receptor Blocker 
Antihypertensive Treatment on Arterial Stiffness. The 
Role of Smoking##1026-171·413A
Beta 1-Adrenergic Receptor Gene Modulates the Effect of 
Heart Rate on Arterial Stiffness: The Bogalusa Heart 
Study## 838-6·398A
Carotid Intima-Media Thickness and Stiffness, Aortic Stiffness, 
and Pulse Pressure: Association With Hormone Therapy 
in Postmenopausal Women-Baseline Findings From the 
CASHMERE Trial##1014-42·360A
Central Aortic Stiffness Is Increased in Stable Heart Transplant 
Patients and Is Associated With Higher Mortality## 
828-4·84A
Circulating Endothelial Cells, Arterial Stiffness and 
Cardiovascular Mortality Risk Stratification in 
Hypertension## 838-5·398A
Cross-Sectional Relationships of Urinary Albumin Excretion 
With Arterial Stiffness and Left Ventricular Mass 
in Essential Hypertensive Subjects: Data From the 
Hippokration Hellenic Hypertension (3H) Study##1008-
204·349A
Effects of Diet-Induced Weight Loss in Obese Males on 
Cardiac and Vascular Function##1020-1·377A
Ejection Duration Is the Predictor of Acute Decompensation in 
Patients With Congestive Heart Failure##1028-98·92A
Enhanced External Counterpulsation Treatment Decreases 
Arterial Stiffness and Myocardial Oxygen Demand in 
Patients With Refractory Angina## 842-4·110A
Graded Relationship Between Adiponectin Levels and Arterial 
Stiffening in Newly Diagnosed Essential Hypertensive 
Subjects## 840-7·416A
Increase in Arterial Stiffness in Patients With Obstructive Sleep 
Apnea##1008-80·340A
Increased Aortic Stiffness Predicts Lower Exercise Stress 
Test Work Capacity in Subjects With Essential 
Hypertension##906-236·136A
Is Vascular Dysfunction the Forerunner of Paroxysmal Atrial 
Fibrillation in Hypertensive Subjects?##1002-34·318A
Low-Grade Inflammation and Hypoadiponectinemia Have 
an Additive Detrimental Effect on Aortic Stiffness in 
Essential Hypertensive Patients: A “Double-Edged 
Sword” of Vascular Damage##1002-36·318A
Microalbuminuria Is Correlated With Endothelin-1, 
Adiponectin, C-Reactive Protein, and Arterial Stiffness 
in Essential Hypertension: Reflections Beyond the 
Glomerulus##1002-79·322A
Postchallenge Plasma Glucose Is Associated With Arterial 
Stiffness in Nondiabetic Healthy Men##1002-85·323A
Prehypertension Is Associated With Increased Aortic Stiffness 
but Not Muscular Artery Stiffness: A Population-Based 
Study## 838-4·398A
Proximal Aortic Stiffness Is Associated With Advanced 
Diastolic Dysfunction in Dilated Cardiomyopathy##1016-
101·68A
Similar Unfavorable Effects of Diabetes Mellitus and 
Metabolic Syndrome on Hypertensive Target Organ 
Damage: Data From the 3H Study##902-222·119A
Sumative Effect of ALT-711 and Exercise in Improving Age-
Related Arterial Stiffness, Myocardial Dysfunction and 
Ventricular-Vascular Coupling## 832-6·395A
Synergistic Effects of Systolic Hypertension and Female 
Sex on the Arterial-Ventricular Coupling Ratio##904-
236·129A
Systolic Tissue Doppler Velocity of the Ascending Aorta is 
an Index of Vascular Remodeling and Stiffness##1026-
81·406A
The Association of Angiotensin Converting Enzyme (ACE) 
gene Insertion/Deletion polymorphism with Carotid 
Augmentation index in Hypertensive Patients##1026-
172·414A
The Metabolic Syndrome Is Associated With Increased 
Stiffness of Large Arteries but Not of Muscular Arteries: 
A Population-Based Study## 840-6·416A
Vascular Stiffness Is Attenuated by Arginase Inhibition in Aged 
Rats## 832-7·395A
Ventricular Vascular Coupling in Obesity Is Affected by an 
Adverse Temporal Profile of Wave Reflections and 
Ventricular Ejection: A Population-Based Study## 840-
5·415A
Arteries
Accelerated Vascular Damage in Hypertensive Subjects 
With Obstructive Sleep Apnea Syndrome: An Adverse 
Nocturnal Stimulus on Arterial Properties##1002-45·320A
Aortic Augmentation Index Is Associated With Ankle Brachial 
Index: A Community-Based Study##1002-11·317A
Circulating Levels of Endogenous Nitric Oxide Synthase 
Inhibitors Independently Predict Carotid Intima-Media 
Thickness: A Population-Based Study##1002-12·317A
Effects of Sustained Ingestion of Cocoa on Endothelial 
Function in Adults With Body Mass Index between 25-35 
kg/m2: A Randomized, Single-Blind, Placebo-Controlled 
Trial##1026-34·399A
Mesenchymal Stem Cell Therapy in a Rabbit Hindlimb 
Ischemia Model##1014-77·362A
Peripheral Arterial Disease Is Associated With Increased Serum 
Myeloperoxidase Levels Independently of the Presence of 
Severity of Coronary Artery Disease##1002-81·322A
Wall Thickness in Human Carotid Arteries Correlates 
Negatively With Plaque Inflammation Measured 
by Fluorodeoxyglucose Positron Emission 
Tomography##914-235·166A
Aspirin
Aspirin Before Reperfusion Blunts the Infarct Size Limiting 
Effect of Atorvastatin##1001-69·184A
Aspirin Resistance and Long-Term Prognosis After Successful 
Coronary Stenting##1025-174·244A
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Comparison of Four Commercial Platelet Function Assays 
Abilities to Detect Response to Aspirin at 81 and 325 mg 
Doses##1002-35·318A
Dual Antiplatelet Agent Failure: A New Syndrome or a Clinical 
Non-Entity?##1024-186·289A
Effects of Diabetes on the Prevalence of Aspirin Resistance 
During Low Dose Aspirin Therapy##1019-179·230A
Inhibition of HERG Channel by Aspirin: pH or Direct 
Effect##1002-119·324A
Initial Aspirin Dose for the Treatment of ST-Elevation 
Myocardial Infarction##1007-135·202A
Mechanisms of Platelet Hyperreactivity in Type One and Type 
Two Diabetes##1026-2·399A
Non-Steroidal Anti-Inflammatory Drugs Antagonize the 
Irreversible Antiplatelet Effect of Aspirin##1008-
129·345A
Platelet Activity and Aspirin Efficacy After Off-Pump 
Compared to On-Pump Coronary Artery Bypass 
Surgery##1013-201·220A
The Impact of Aspirin Resistance on Long-Term 
Cardiovascular Mortality in Patients With Non-ST 
Elevation Acute Coronary Syndromes##1025-116·240A
Use of Aspirin Among Patients with Atherothrombotic Disease 
in the United States: The REduction of Atherothrombosis 
for Continued Health (REACH) Registry##1026-
123·409A
Assisted circulation
Are Initial Indications for Left Ventricular Assist Support 
Necessary?##1022-109·79A
Efficacy of Intravenous Prothrombin Complex Concentrate for 
Emergent Reversal of Oral Anticoagulation in Patients 
With Left Ventricular Assist System##1028-108·94A
New Generation Axial-Flow Left Ventricular Assist Device 
Can Support Patients With Various Degrees of Right 
Ventricular Dysfunction##1022-108·78A
Normalization of Fixed Pulmonary Hypertension in Severe 
Heart Failure Patients With Placement of Left Ventricular 
Assist Device##1010-109·58A
Omega-3 Fatty Acids Cause Blood Cells to Become Insensitive 
to Mechanical Stress in Patients With Cardiac Assist 
Devices## 828-7·85A
Percutaneous Right Heart Catheterization With Ventricular 
Assist Device for Right Ventricular Infarction##1007-
132·201A
Use of Implantable Cardioverter Defibrillators in Patients With 
Left Ventricular Assist Devices##909-241·24A
Use of the Percutaneous Left Ventricular Assist Device 
to Reverse Cardiogenic Shock in Nonischemic 
Cardiomyopathy Patients Failing Intra-Aortic Balloon 
Pump Support##1010-110·58A
Velocity Vector Imaging Characterizes Systolic and Diastolic 
Augmentation of the Failing Heart During Nonblood 
Contacting Ventricular Actuation##1016-109·70A
Atherosclerosis
A New Automated Method for Quantitative Computed 
Tomography Coronary Angiography: An In Vivo 
Validation Study With Intracoronary Ultrasound as a 
Reference##909-229·146A
A New Automated Method for Quantitative Coronary Plaque 
Compositional Imaging by Multislice Computed 
Tomography: An Ex Vivo Feasibility Study##1006-
190·275A
A School-Based Health Education Program Identifies Children 
at Risk for Cardiovascular Disease and Diabetes: Baseline 
Data From the Project Healthy Schools 2005-06 Pilot 
Program## 817-5·291A
Activated Platelets Can Be Imaged by Activation-Specific 
Glycoprotein IIb/IIIa Antibodies Conjugated to Iron 
Oxide Microparticles in an Ex Vivo Magnetic Resonance 
Imaging Mouse Model##907-232·139A
An Abbreviated Carotid Intima-Media Thickness Scanning 
Protocol to Facilitate Clinical Screening for Subclinical 
Atherosclerosis##1002-78·321A
An Atherosclerotic Process Is Involved in the Structural Valve 
Deterioration of Bioprostheses## 839-8·311A
An Intravascular Ultrasound Simulator of Coronary Plaques 
Based on Histopathology##1006-189·275A
Analysis of Multiple Methylation Derivatives of Amino Acids 
Suggests That Factors Independent of Nitric Oxide 
Synthase Inhibition Are Responsible for Their Prognostic 
Value for Cardiovascular Risk Prediction## 809-4·354A
Anatomical Correlates of a Normal Perfusion Scan 
Using 64-Slice Computed Tomography Coronary 
Angiography##901-229·117A
Aortic Valve Calcifications Are Associated With an Ischemic 
Perfusion Study in Individuals With Minimal Coronary 
Calcifications##1020-76·382A
Apolipoprotein E Derived Peptide Containing Gadolinium 
Mixed Micelles for Macrophage Imaging in 
Atherosclerotic Plaque of Apoe -/- Mice##910-232·150A
Assessment of Angiopoietin 1 and Angiopoietin 2 Gene 
Expression in Stable Coronary Artery Disease 
After Angiotensin-Converting Enzyme Inhibitor 
Treatment##1007-177·205A
Association Between Plasma Low-Density Lipoprotein Particle 
Size, Valvular Infiltration by Oxidized Low-Density 
Lipoprotein and Inflammation in Patients With Severe 
Aortic Stenosis## 839-5·311A
Association Between the TaqIB Polymorphism of the 
Cholesteryl Ester Transfer Protein Gene and Postprandial 
Triglyceride Levels in Patients With Familial 
Hypercholesterolemia##1002-121·325A
Associations of Serum Uric Acid With Markers of 
Inflammation, Metabolic Syndrome, and Subclinical 
Coronary Atherosclerosis##1002-10·317A
Atherogenic Vascular and Lipid Phenotypes in Juvenile Type 
One Diabetes Are Influenced by HLA-Related Diabetes 
Susceptibility##1026-11·401A
Atherosclerotic Plaque Inflammation and Calcification: A 
Negative Relationship Imaged Using Fluorodeoxyglucose 
Positron Emission Tomography and Computed 
Tomography##1014-35·358A
Atorvastatin Exhibits Differential Effects on Circulating 
OxLDL Markers in Patients With Acute Coronary 
Syndromes in the MIRACL Trial According to 
the Severity of Underlying Cardiovascular Risk 
Factors##1008-37·337A
Balance Between Serum S100A12 and S100A8 Predicts 
Presence and Complications of Coronary Artery 
Disease##1014-37·359A
Baseline Lipid Status Does Not Influence the Promotion 
of Coronary Atheroma Regression in Response to 
Use of High-Dose Statin Therapy: Insights From 
ASTEROID##1014-119·365A
Broad Spectrum Adenoviral CC-Chemokine Blockade 
Attenuates Long-Term Vein Graft Accelerated 
Atherosclerosis in ApoE-Knockout Mice##1013-
200·220A
Can the Burden of Coronary Atherosclerosis Be Predicted 
by a Patient’s Pretest Probability for Coronary Artery 
Disease?##903-229·124A
Carbon Monoxide Donors or Heme Oxygenase-1 
Overexpression Block Interleukin-18-Mediated NF-
kB-PTEN-Dependent Human Cardiac Endothelial Cell 
Death##1020-8·378A
Chronic Treatment With Folic Acid Improves Nitric Oxide 
Bioavailability and Decreases Superoxide Production in 
Human Vessels Through Tetrahydrobiopterin-Mediated 
Improvement of eNOS Coupling## 832-3·394A
Circulating Levels of Endogenous Nitric Oxide Synthase 
Inhibitors Independently Predict Carotid Intima-Media 
Thickness: A Population-Based Study##1002-12·317A
Color-Coded Dual-Frequency Intravascular Ultrasound 
Imaging With Use of Radiofrequency Ultrasound Signals: 
A Novel Modality of Tissue Characterization of Coronary 
Plaque##916-227·171A
Combination Therapy of Targeted Anti-Angiogenic Drug 
Delivery and Oral Statin Against Atherosclerosis##910-
233·151A
Combined Valsartan (Vn) and Simvastatin (Sn) Therapy 
Decreases Early and Late Manifestations of Vulnerable 
Atherosclerostic Plaque in Diabetic Hyperlipidemic Pigs: 
A Longitudinal Intravascular Ultrasound (IVUS) and 
Histology Study##1026-87·407A
Comparison of Effects of Sirolimus-Eluting Stent, Bare 
Metal Stent, and Plain Only Balloon Angioplasty on 
Inflammatory Markers##1001-196·194A
Contrast-Enhanced Carotid Ultrasound Shows Greater 
Intraplaque Neovascularization in High Risk 
Plaques##903-226·124A
Coronary Artery Calcium Percentiles and Absolute Scores: 
Which Is a Stronger Predictor of Mortality?##912-
231·157A
Coronary Artery Calcium Score and Noninvasive Angiography 
With Multi-Slice Computed Tomography: Comparison 
to Myocardial Perfusion Imaging in Asymptomatic 
Diabetics##919-233·183A
Coronary Endothelial Dysfunction Associated With Depressive 
Mood in Patients Without Coronary Artery Disease## 
805-4·352A
Cross-Sectional Relations of Pregnancy-Associated Plasma 
Protein-A Levels With C-Reactive Protein and Urinary 
Albumin Excretion Rate in Essential Hypertensive 
Subjects: A Novel Approach to Diffuse Atherosclerosis## 
805-8·353A
Dietary Fat and Subclinical Atherosclerosis as Detected by 
Coronary Artery Calcium##902-231·121A
Differences in Clinical Profiles of Patients With Nonascending 
vs. Ascending Thoracic Aortic Aneurysms##1008-
45·339A
Differential Effects of Inhibition of Cholesterol Absorption 
by Plant Sterols Compared to Ezetimibe on 
Atherogenesis##1008-34·336A
Does Metabolic Syndrome Predict Progression of Calcified 
Coronary Atherosclerosis? The Relationship Between 
the Metabolic Score and Coronary Artery Calcium 
Progression## 833-8·397A
Does Subcutaneous Adiposity Protect Women Against 
Coronary Disease?##910-229·150A
Echocardiographic Epicardial Adipose Tissue Is Related to 
High Sensitivity C-Reactive Protein in Hypertensive 
Patients##1020-170·391A
Effect of Increasing Metabolic Syndrome Score on 
Atherosclerotic Plaque Burden in Coronary Artery 
Disease: Volumetric Assessment by Intravascular 
Ultrasound##1013-195·219A
Effect of Statins on Thermal Heterogeneity of Atherosclerotic 
Plaques in Patients With Diabetes Mellitus##1020-
35·380A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Converting-Enzyme 
Inhibitors: Final Results of Captopril Combined With 
Valsartan in Acute Myocardial Infarction Study##1002-
6·316A
Endothelial Dysfunction and Circulating Endothelial 
Progenitor Cells in Young People With Type 1 
Diabetes##1025-117·241A
Enhanced External Counterpulstion Inhibits Intimal 
Hyperplasia by Downregulating Proliferative Signaling 
Proteins##1001-90·185A
Ethnic and Geographic Differences in Coronary 
Atherosclerotic Plaque Composition: A Report From 
the Global Virtual Histology Intravascular Ultrasound 
Registry##1026-41·403A
Exaggerated Exercise Blood Pressure Response Is Related to 
a State of Pronounced Inflammatory Activation, Impaired 
Thrombosis/Fibrinolysis System, and Arterial Stiffening 
in Essential Hypertensive Subjects##1002-37·318A
Experimental Application of Bevacizumab-Eluting PC Coated 
Stent for Inhibition of Vasa Vasorum of Atherosclerotic 
Plaque##1020-47·382A
Fibrous Cap Thickness of Culprit Plaque in Subjects With 
Acute Coronary Syndromes Is Related to Individual 
Plaque Characteristics and Not to the Presence of 
Systemic Cardiovascular Risk Factors: An Intravascular 
Optical Coherence Tomography Study##1026-6·400A
Flushing Experience and Discontinuation With Niacin in 
Clinical Practice##1006-149·273A
Gender Differences in Framingham Risk and Survival 
After Percutaneous Coronary Intervention for Acute 
ST-Segment Elevation Myocardial Infarction##1014-
163·369A
Gender Differences in Insulin Resistance Among Asian Indians 
- Atherosclerosis in Asian Indians: Multiple Risk Factor 
Study Assessment##1020-12·379A
Genetic Polymorphism C807T on Platelet Glycoprotein Ia 
Affects Platelet Activation Only in the Presence of High 
Von Willebrand Levels##1001-180·194A
Genetic Variability of P22 Phox Subunit of NADPH 
Oxidase, and Risk for Myocardial Infarction in Young 
Individuals##1002-169·329A
High Molecular Weight Form of Adiponectin Levels 
Independently Predict the Progression of Carotid 
Atherosclerosis in Male Patients With Metabolic 
Syndrome##1020-44·381A
High-Density Lipoprotein Cholesterol Is an Independent Risk 
Factor for Progression of Intimal-Medial Thickness: 
Results From the Atherosclerosis Risk in Communities 
Study##1026-35·402A
High-Dose Atorvastatin Modifies the Protein Profile of 
Human Circulating Monocytes After an Acute Coronary 
Syndrome## 809-6·355A
Identification of 5-, 12/15-Lipoxygenase and NADPH 
Oxidase as Key Mediators of Oxidized Low-Density 
Lipoprotein-Induced Apoptosis of Human Aortic Smooth 
Muscle Cells: Implications for Atherosclerotic Plaque 
Destabilization##1008-4·334A
Immunolocalization of Platelet Glycoprotein IIb/IIIIa and 
P-selectin, and Neutrophil-Platelet Association in Human 
Carotid Unstable Plaques##1026-79·405A
Immunotargeting of Vascular Inflammation##1014-7·356A
Impact of Diabetes Mellitus on Local Inflammatory Activity 
in Nonculprit Lesions: An Additional Inflammatory 
Trigger?##1020-127·388A
Impact of Gene-based Intramuscular Interferon-κ Delivery 
on Diet-induced Atherosclerosis in Apolipoprotein E 
Knockout Mice## 612-5·354A
Impact of HMG-CoA Reductase Inhibitors (Statins) on 
New Cardiovascular Events Following Coronary 
Intervention and on the Progression-Regression of 
Coronary Atherosclerotic Plaque: A Three-Dimensional 
Intravascular Ultrasound Study##1002-123·325A
Impact of HMG-CoA Reductase Inhibitors on Progression 
of Coronary Atherosclerosis in Chronic Kidney 
Disease##1002-14·318A
Impact of Subclinical Hypothyroidism on Coronary Heart 
Disease, Cardiovascular, and All-Cause Mortality: A 
Meta-Analysis##1002-173·330A
Improved Ex-Vivo MR Imaging of Human Aortic 
Atherosclerosis with Macrophage-Specific 
Immunomicelles##1026-78·405A
Increase in Arterial Stiffness in Patients With Obstructive Sleep 
Apnea##1008-80·340A
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Infarct Size, Viability, and Correlates in Patients Presenting 
With a Persistent Total Occlusion of the Infarct-Related 
Artery 3-28 Days Post-Myocardial Infarction: An OAT 
Substudy##1007-94·199A
Inhalation of Particulate Air Pollution Impairs Vascular 
Function in Humans##1020-38·380A
Insulin-Like Growth Factor I Prevents Atherosclerosis 
Progression in Aged Apolipoprotein E Deficient 
Mice##1008-38·337A
Interleukin-18 Suppresses Adiponectin Expression in 3T3L1 
Adipocytes via a Novel Signal Transduction Pathway 
Involving ERK1/2 Dependent NFATc4 Activation##1008-
36·337A
Is Calcific Aortic Stenosis Progression Accompanied by 
a Higher Rate of Atherosclerotic Cardiovascular 
Events?##1002-13·317A
Is Renal Magnetic Resonance Imaging/Magnetic Resonance 
Angiography an Appropriate Screening Tool in the 
Workup of Patients With Suspected Renovascular 
Hypertension?##1008-208·350A
Long Pentraxin 3 Is More Specific Than C-Reactive Protein as 
a Marker for Vascular Inflammation##1020-2·377A
Long-Term Effects of Niacin-Simvastatin Combination 
Compared to High-Dose Simvastatin on Lipids, 
Apolipoproteins, Lipoprotein Particles and Inflammatory 
Markers in Patients With Carotid Atherosclerosis## 
820-8·394A
Low Endothelial Shear Stress Leads to Expansive Remodeling 
of Atherosclerotic Coronary Subsegments: An In-Vivo 
Follow-Up Intravascular Ultrasound Study##1008-9·335A
Low Endothelial Shear Stress Predicts the Development 
of High-Risk Coronary Atherosclerotic Plaques: A 
Correlative Intravascular Ultrasound and Histopathology 
Natural History Study##1008-3·334A
Lower Plasma Adiponectin Levels and Higher Oxidative Stress 
Are Associated With In Vivo Thin-Cap Fibroatheroma in 
Patients With Stable Angina Pectoris##1020-45·382A
LXR Agonist T1317 Inhibits the Aortic Valve Calcification in 
ApoE-/- Mice##1021-23·308A
LY518674, a Potent and Selective Peroxisome Proliferator 
Activated Receptor Alpha Agonist, Reduces Triglycerides, 
Total Cholesterol, Low-Density Lipoprotein Cholesterol, 
and Apolipoproteins B and C3##1026-5·405A
Macrophage Scavenger Receptor 1 Sequence Variations 
Are Associated With Atherosclerosis Susceptibility in 
Humans##1008-41·338A
Metabolic Profile of the Elderly With a Calcific Aortic Stenosis 
and Its Relation With the Valvular Calcium Content## 
839-3·310A
Multi-Detector Computed Tomography Coronary Angiography 
Detects a High Prevalence of Obstructive, Noncalcified 
Plaques in Symptomatic Patients and Zero Calcium 
Score##904-230·128A
Outcomes in Patients with a Previous Vascular Intervention 
Enrolled in the REduction of Atherothrombosis for 
Continued Health (REACH) Registry in the United 
States##1026-127·410A
Parental Coronary Heart Disease Increases Vulnerability of 
the Arterial Wall to Metabolic Syndrome and Aging: The 
Bogalusa Heart Study##1026-38·403A
Perivascular Adipose Tissue With Chlamydophyla Pneumoniae 
Antigens Is Associated With Positive Remodeling In 
Severe Abdominal Aortic Atherosclerosis.##1026-
82·406A
Pioglitazone Increases Adiponectin Levels in Nondiabetic 
Patients With Coronary Artery Disease##1002-125·326A
Pregnancy-Associated Plasma Protein-A Levels Are Related 
to Urinary Albumin Excretion Rate: A Novel Pathway 
Linking Atherosclerotic Processes With Microalbuminuria 
in Essential Hypertension##1002-4·315A
Preserved Endothelial Function in Subjects With Morbid 
Obesity: A New Obesity Paradox?##1026-1·399A
Prevalence and Correlates of Microalbuminuria in Essential 
Hypertensive Subjects: Insights From The Hippokration 
Hellenic Hypertension (3H) Study##1008-203·349A
Prolonged Inflammatory Activity Is Associated With Rapid 
Progression of Nonculprit Complex Lesion in Non-ST-
Segment Elevation Acute Coronary Syndromes##1001-
111·187A
Quantitative Evaluation of the Media in the Thoracic Aorta 
Using Integrated Backscatter by Transesophageal 
Echocardiography as a New Marker for Coronary Artery 
Disease##913-224·159A
Regression of Coronary Atherosclerosis During Treatment 
With Statins: Does Age Make a Difference?##1008-
12·336A
Relation of Fasting Glucose Levels to Prevalance of 
Atherosclerotic Cardiovascular Disease##1026-166·412A
Relationship of Coronary Flow Reserve With Coronary Artery 
and Thoracic Aorta Calcium in Patients With End-Stage 
Renal Disease Compared to Controls With Intermediate 
Risk Using Rubidium-82 Positron Emission Tomography/
Computed Tomography##908-231·143A
Relationships Between Adiponectin and Markers of Oxidative 
Stress in High-Risk Patients for Coronary Artery 
Disease##1002-41·319A
Rifalazil Prevents Chlamydia Pneumoniae Induced 
Acceleration of Atherosclerosis and Eradicates 
the Organism in a Rabbit Model Better Than 
Azithromycin##1002-120·324A
Risk Factors for Preclinical Atherosclerosis in Alaskan Natives: 
The GOCADAN Study##1002-42·320A
Rosuvastatin Arrests Progression of Carotid Intima Media 
Thickness in Low-Risk Individuals: Main Results of the 
METEOR Study## 820-3·392A
Serum Atherogenicity Reduction: The Novel Way to 
Atherosclerosis Prevention and Treatment##1020-
46·382A
Serum Myeloperoxidase Levels Are Associated With the 
Future Risk of Coronary Artery Disease in Apparently 
Healthy Individuals## 833-4·396A
Short-Term Statin Therapy Is Associated With Marked 
Reduction of C-Jun N-Terminal Kinase of Aortic Wall 
in Patients With Abdominal Aortic Aneurysm##1008-
44·339A
Simvastatin Attenuates Plaque Inflammation Evaluation 
by 18F-Fluoro-2-Deoxyglucose Positron Emission 
Tomography##1026-47·405A
Stat3 Signal Transduction Pathway Correlates With 
Proliferation and Apoptosis of Rat Vascular Smooth 
Muscle Cells## 849-3·418A
Statin Therapy Improves Left Ventricular Function 
and Carotid Arterial Stiffness in Patients With 
Hypercholesterolemia##1002-44·320A
Statin-Mediated Increases in High-Density Lipoprotein 
Cholesterol Promote Regression of Coronary 
Atherosclerosis: Insights From Intravascular 
Ultrasound##1014-120·365A
Statins Inhibit Cholesterol Crystallization and Prevent 
Perforation of Biological Membranes and Intima in 
Human Coronary Arteries of Patients With Acute 
Coronary Syndrome##1014-13·358A
Subendocardial Perfusion Deficits Predict the Functional 
Significance of Coronary Stenoses During Adenosine 
Stress Multi-Detector Computed Tomography in Patients 
With Chest Pain##913-231·161A
Tetrahydrobiopterin-dependent eNOS Coupling Determines 
Vascular Remodeling Through Accelerated Endothelial 
Regeneration## 409-8·421A
The Combination of Diabetes Mellitus and 
Hypercholesterolemia in Swine Leads to the Development 
of Complex, Human-Like Atherosclerosis##1002-1·315A
The Implication of Obesity on Total Antioxidant Capacity and 
Inflammatory Process in Apparently Healthy Men and 
Women: The ATTICA Study## 812-4·372A
The Influence of Oxidized Phospholipids and Lp(a) 
Lipoprotein on Coronary Artery Disease Is Conditional 
Upon Genotype at the Interleukin-1 Region##1026-
46·404A
The Influence of Renal Magnetic Resonance Imaging/Magnetic 
Resonance Angiography Diagnosed Renal Artery Stenosis 
on Glomerular Filtration Rate and Renal Parenchymal 
Volume in Patients With Atherosclerotic Renovascular 
Hypertension##1020-82·384A
The J-Shape Relationship of Alcohol Consumption With Lipid 
Levels, Inflammatory and Hemostatic Factors, in General 
Population: The ATTICA Study##1020-164·390A
The Lewis Null Blood Group Is Associated With 
Proatherogenic Inflammatory Markers in Healthy 
Subjects##1025-73·237A
The Release of Long Pentraxin 3 in Vulnerable Plaques In 
Vivo##1020-37·380A
Towards Reduced Symptoms-to-Balloon Times in Primary 
Percutaneous Coronary Intervention: Effects of 
Prehospital Triage and Off-Site PCI##1001-136·190A
Use of Aspirin Among Patients with Atherothrombotic Disease 
in the United States: The REduction of Atherothrombosis 
for Continued Health (REACH) Registry##1026-
123·409A
Utility of Diverse Inflammatory Markers in Risk Prediction of 
Coronary Atherosclerosis##1014-38·359A
Vascular Inflammation Evaluated by 18F-Fluorodeoxyglucose 
Positron Emission Tomography Is Associated With the 
Metabolic Syndrome##1014-5·356A
Waist-Hip Ratio Is the Strongest Measure of Abdominal 
Obesity in the Prediction of Subclinical Atherosclerosis 
as Measured by Coronary Artery Calcium in Persons 
Without Multiple Metabolic Syndrome Risk Factors## 
811-8·102A
Waist-to-Hip Ratio Is a Superior Predictor of Atherosclerosis 
Compared With Body Mass Index in a Population-Based 
Sample: Observations From the Dallas Heart Study## 
812-3·372A
Wall Thickness in Human Carotid Arteries Correlates 
Negatively With Plaque Inflammation Measured 
by Fluorodeoxyglucose Positron Emission 
Tomography##914-235·166A
When Should We Repeat a Coronary Calcium Scan With an 
Initial Coronary Artery Calcium Score <100?##918-
231·179A
Athletes
Evidence for Mechanically-Induced Ion-Channel Dysfunction 
as a Mechanism in Chest Blow-Induced Ventricular 
Fibrillation## 836-3·7A
Impact of Object Shape and Resultant Left Ventricular Pressure 
Is Critically Important in the Generation of Ventricular 
Fibrillation From Chest Wall Impact##904-239·16A
Major Adverse Cardiac Events During Endurance 
Sports##909-236·147A
Atrial fibrillation
A Dedicated Left Atrial Pacing and Sensing Lead Improves the 
Outcome of Atrial Resynchronization Pacing for Atrial 
Fibrillation##911-240·28A
A Novel Method to Assess Left Atrial Appendage Function in 
Atrial Fibrillation With Transthoracic Echocardiography: 
A Tissue Doppler Study##908-227·142A
A985G Polymorphism of the Endothelin-2 Gene and 
Atrial Fibrillation in Patients With Hypertrophic 
Cardiomyopathy##1016-105·69A
Angiotensin-Converting Enzymel inhibitors Did Not Prevent 
Atrial Fibrillation in the Pacemaker Mode Selection 
Trial##902-237·12A
Asians Are Less Susceptible to Atrial Fibrillation: A Meta-
Analysis## 819-3·4A
Assessment of Left Ventricular Dyssynchrony in Patients 
With Atrial Fibrillation Using Triplane Tissue Doppler 
Echocardiography##908-228·142A
Atrial Fibrillation Begets Ventricular Fibrillation in Post-
Myocardial Infarction Patients## 819-6·5A
Atrial Fibrillation Inducibility in Patients With No Prior Atrial 
Fibrillation##903-238·14A
Atrial Fibrillation Is a Strong Predictor of Death and of Cardiac 
Events in Angiographied Coronary Patients##913-
237·30A
Atrial Resynchronization Therapy in Patients Unsuitable for 
Left Atrial Ablation Procedures for the Management of 
Atrial Fibrillation##902-239·13A
Atrial Strain Rate Echocardiography Can Predict Maintenance 
of Sinus Rhythm After Pulmonary Vein Isolation in 
Paroxysmal Atrial Fibrillation##913-226·160A
B-Type Natriuretic Peptide and Recurrence of Atrial 
Fibrillation After Electrical Cardioversion: A Prospective 
Study With 1-year Follow-Up##917-238·37A
C-Reactive Protein Predicts Mortality in Patients With Atrial 
Fibrillation##911-238·27A
Can Preoperative Statin Use Reduce Atrial Fibrillation 
Incidence After Cardiac Surgery?##1015-15·304A
Catheter Ablation of Atrial Fibrillation and Flutter Using a 
New Robotic Navigation System: Interim Follow-Up 
Results## 846-8·10A
Chronic Atrial Fibrillation Is Associated With Dysregulation 
of Sarcoplasmic Reticular Ca2+-ATPase and 
Protein Kinase A-Mediated Ser 16-Phosphorylated 
Phospholamban##1004-55·42A
Clinical and Echocardiographic Measures Governing Embolic 
Destination in Atrial Fibrillation##919-238·40A
Clinical and Electrophysiological Data of Patients With a 
Rapid Atrial Fibrillation as the First Manifestation of 
Wolff-Parkinson-White Syndrome##1001-198·195A
Clusters of Cardiovascular Risk Factors as Predictors of Atrial 
Fibrillation and the Impact on Stroke##1008-166·347A
Comparison of Coupled and Paired Pacing for Rapid Rate-
Control During Atrial Fibrillation##902-241·13A
Comparison of Left Atrial Volume Using Gated Cardiac 
Fluoroscopy 3-D Image Rendering Versus Cardiac 
Computed Tomography## 846-6·9A
Comparison Of Outcomes In Patients Randomized To Warfarin 
According To Anticoagulant Control: Results From 
Sportif III And V.##1026-121·408A
Comparison of Quality of Life in Patients With/Without 
Normal Sinus Rhythm After Transesophageal 
Echocardiography-Guided Cardioversion: Results From 
the Acute II Study##1012-184·279A
Depression, Anxiety and Quality of Life in Patients With Atrial 
Fibrillation##904-238·16A
Does the Use of Amiodarone Impact the Ability of Anterior 
Fat Pad Retention to Prevent Postoperative Atrial 
Fibrillation?##1027-19·312A
Effect of Bisoprolol and Carvedilol in Atrial Fibrillation in 
Heart Failure Patients After Cardiac Surgery##1027-
16·312A
Effect of Statin Dose on Incidence of Atrial Fibrillation: Data 
From the PROVE IT-TIMI 22 and A to Z Trials##909-
237·24A
Endothelial Function, Inflammatory Process and Oxidative 
Stress in Chronic Atrial Fibrillation: The Impact of Left 
Atrium Distention##907-238·21A
Excision of the Left Atrial Appendage Is Not Associated With 
Increased Incidence of Postoperative Bleeding After 
Cardiac Surgery When Compared to Exclusion##1025-
199·247A
Functional Characterization of Epicardial Beating Heart 
Radiofrequency Left Atrial Maze##901-237·10A
Heterogeneous Innervation of the Left Atrium and Pulmonary 
Veins##907-234·20A
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High Prevalance of Left Atrial Thrombus in Patients With 
Atrial Fibrillation Undergoing Defibrillator Implantation: 
A Case for Routine Transesophageal Echocardiographic 
Screening##915-224·167A
Improved Regional Left Atrial Motion After Pulmonary Vein 
Isolation##906-237·19A
Improvement of Cardiac Function Early After Circumferential 
Pulmonary Vein Ablation for Atrial Fibrillation: Serial 
Observation by Echocardiography##918-222·177A
Inadvertent Cardioversion During Routine Defibrillation 
Testing in Patients With Atrial Fibrillation Undergoing 
Defibrillator Implantation##908-241·23A
Incidence of Left Atrial Thrombus by Transesophageal 
Echocardiography Prior to Pulmonary Vein Isolation 
Procedures for Atrial Fibrillation##913-223·159A
Increased Risk of Paroxysmal Atrial Fibrillation Episodes 
Associated With Acute Increase in Ambient Air 
Pollution##912-237·29A
Intraoperative Cooled-Tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation##917-
237·36A
Is Rhythm Control Superior to Rate Control in New Onset 
Atrial Fibrillation?## 819-4·4A
Is Rhythm Control Superior to Rate Control in Patients With 
Atrial Fibrillation and Diastolic Heart Failure?## 819-
5·5A
Is Vascular Dysfunction the Forerunner of Paroxysmal Atrial 
Fibrillation in Hypertensive Subjects?##1002-34·318A
Left Atrial Enlargement Correlates With Inflammation and 
Oxidative Stress in Patients at High Risk for Atrial 
Fibrillation## 819-7·5A
Left Atrial Phasic Dysfunction: A Potent Marker for First 
Atrial Fibrillation or Flutter in an Elderly Cohort##911-
222·152A
Left Atrial Volume and Booster Pump Function Assessed 
With Tissue Doppler Imaging Predict Paroxysmal 
Atrial Fibrillation Occurrence in Patients With 
Hypertension##912-228·157A
Left Atrium Volume Index Related With Pathological Findings 
as a Predictor of the Success of Sinus Conversion With 
the Maze Procedure in Patients With Chronic and Valvular 
Atrial Fibrillation##1027-17·312A
Location on Left Atrial 3-D Computer Tomography of Lesions 
Delivered Through Balloon-Based Ablation Systems## 
846-4·9A
Magnesium Therapy for the Acute Management of Atrial 
Fibrillation: A Meta-Analysis##918-237·38A
Major Weight Loss Prevents Long-Term Left Atrial 
Enlargement in Patients With Morbid Obesity##1008-
170·348A
Mechanisms of Recurrent Atrial Fibrillation After Left 
Atrial Radiofrequency Ablation Guided by Complex 
Electrograms##914-237·32A
Mid-Term Follow-Up of Cryoballoon Technique in Drug 
Resistant Atrial Fibrillation##913-238·31A
Monitoring of Esophageal Temperature During Pulmonary 
Vein Isolation: New Computational Method for 
Assessment of Proximity of Ablation Site to 
Esophagus##905-238·17A
Multi-Detector Computed Tomography Quantitatively 
Distinguishes Grades of Left Atrial Appendage 
Spontaneous Echo Contrast and Thrombus in Patients 
Undergoing Evaluation for Radiofrequency Pulmonary 
Vein Antral Isolation##915-231·168A
Multidetector Computed Tomography for the Detection of Left 
Atrial Appendage Thrombus: A Comparative Study With 
Transesophageal Echocardiography##919-231·182A
Myocardial Perfusion Imaging in Patients With New-Onset 
Atrial Fibrillation: Cardiac Risk Factors and Coronary 
Artery Disease Predict Perfusion Findings##917-
235·176A
Obesity and Atrial Fibrillation: A Meta-Analysis##1020-
130·388A
Observations Regarding Atrial Fibrillation/Flutter in Black 
Patients With Heart Failure##908-237·22A
Orally Administered Vanoxerine, a Cardiac Multichannel 
Blocker, Terminates Atrial Flutter and Prevents Its 
Reinducibility in the Canine Sterile Pericarditis 
Model##918-238·38A
Outcome After Third Atrial Fibrillation Ablation: Whittling 
Away, Versus, Too Much Already!##916-238·35A
Prediction of Transition to Chronic Atrial Fibrillation in Elderly 
Patients With Nonvalvular Paroxysmal Atrial Fibrillation 
by Transthoracic Doppler Echocardiography##918-
221·177A
Preoperative Statin Therapy Is Not Associated With Decrease 
Incidence of Postoperative Atrial Fibrillation in Patient 
Undergoing Coronary Artery Bypass Grafting##1015-
19·304A
Presence of C-Reactive Protein in Left Atrium Is Associated 
With Atrial Fibrillation Irrespective of Serum CRP##908-
234·22A
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United States Over the Last Decade##1001-175·193A
Cholesterol-lowering drugs
Aspirin Before Reperfusion Blunts the Infarct Size Limiting 
Effect of Atorvastatin##1001-69·184A
Atorvastatin Exhibits Differential Effects on Circulating 
OxLDL Markers in Patients With Acute Coronary 
Syndromes in the MIRACL Trial According to 
the Severity of Underlying Cardiovascular Risk 
Factors##1008-37·337A
Bicuspid Calcified Aortic Valves Are Associated With 
a Splice Variant of Notch1 Expression in Human 
Tissues and Stenotic Bicuspid Aortic Valve From the 
Hypercholesterolemic eNOS Null Mouse, Which 
Improves With Atorvastatin##1003-25·300A
Can Preoperative Statin Use Reduce Atrial Fibrillation 
Incidence After Cardiac Surgery?##1015-15·304A
Combination Therapy of Targeted Anti-Angiogenic Drug 
Delivery and Oral Statin Against Atherosclerosis##910-
233·151A
Combined Valsartan (Vn) and Simvastatin (Sn) Therapy 
Decreases Early and Late Manifestations of Vulnerable 
Atherosclerostic Plaque in Diabetic Hyperlipidemic Pigs: 
A Longitudinal Intravascular Ultrasound (IVUS) and 
Histology Study##1026-87·407A
Comparison of Statin Treatment of Hypercholesterolemic 
Patients in Ethnically Diverse Populations With and 
Without Diabetes##1002-130·327A
Differential Effects of Inhibition of Cholesterol Absorption 
by Plant Sterols Compared to Ezetimibe on 
Atherogenesis##1008-34·336A
Do Plant Sterols Provide Additional Cholesterol 
Reduction When Added to Statin-Based Combination 
Therapy?##1014-125·366A
Do Statins Improve Survival in Patients With Diastolic 
Dysfunction?##1020-121·368A
Does a Single-Pill Antihypertensive/Lipid-Lowering Regimen 
Improve Adherence in United States Managed Care 
Enrollees?##1024-184·288A
Effect of 3-Hydroxy-3-Methylglutaryl-CoA Reductase 
Inhibitiors on Fasting Blood Sugar##1008-2·334A
Effect of Atorvastatin in Patients With Metabolic Syndrome 
and Type 2 Diabetes: Subgroup Analysis of the 
Collaborative Diabetes Study##1020-118·368A
Effect Of Co-administration Of Ezetimibe/Simvastatin And 
Fenofibrate On Apolipoproteins (A-III, B, and C-III) In 
Patients With Mixed Hyperlipidemia##1002-122·325A
Effect of Early Versus Late In-Hospital Initiation of Statin 
Therapy on the Clinical Outcomes of Patients With Acute 
Coronary Syndrome##1002-129·326A
Effect of Statin Dose on Incidence of Atrial Fibrillation: Data 
From the PROVE IT-TIMI 22 and A to Z Trials##909-
237·24A
Effect of Statin Therapy on Central Aortic Pressures and 
Hemodynamics: Principal Results of the Lipid Lowering 
Arm of the Conduit Artery Function Evaluation 
Study##1026-43·404A
Effects of Candesartan Versus Losartan on Insulin Levels, 
Lipid Profile and Blood Pressure in Patients With Mild 
Hypertension, Hyperinsulinism and Dyslipidemia## 
848-6·417A
Evidence for Cholesterol Hyperabsorbers and Hyperproducers 
Based on Comparative Low-Density Lipoprotein 
Reductions Achieved by Ezetimibe Versus Statins## 
820-6·393A
Flushing Experience and Discontinuation With Niacin in 
Clinical Practice##1006-149·273A
High-Dose Atorvastatin - Better Value for Money: The Treating 
to New Targets Trial United States Economic Substudy 
in 5,308 Stable Coronary Heart Disease Patients## 817-
3·290A
High-Dose Atorvastatin Modifies the Protein Profile of 
Human Circulating Monocytes After an Acute Coronary 
Syndrome## 809-6·355A
Increased Risk of Coronary Heart Disease After Recurrent 
Cerebrovascular Events: Findings From the SPARCL 
Study## 804-4·351A
Lipid-Independent Effects of Statins on Cardiovascular 
Events in the Japanese Coronary Artery Disease Study: 
Comparison Between Hydrophilic and Lipophilic 
Statins##1008-126·344A
MRC/BHF Heart Protection Study: Mortality, Cancer 
Incidence and Major Vascular Events During 4-Year Post-
Trial Follow-Up of HPS## 820-5·393A
Rosuvastatin Arrests Progression of Carotid Intima Media 
Thickness in Low-Risk Individuals: Main Results of the 
METEOR Study## 820-3·392A
Simvastatin Enhances Endothelial Differentiation of Peripheral 
Blood Mononuclear Cells in Lone Hypercholesterolemic 
Patients and Induces Proangiogenic Cytokine Il-8 
Secretion From Monocytes: More Evidence of Statin 
Pleiotropism##1014-46·361A
Simvastatin Exerts Its Anti-Inflammatory Effect in 
Hypercholesterolemic Patients Mainly by Decreasing 
the Serum Levels of Monocyte Chemoattractant Protein-
1##1008-130·345A
Statin Therapy Improves Left Ventricular Function 
and Carotid Arterial Stiffness in Patients With 
Hypercholesterolemia##1002-44·320A
Statin Undertreatment and Its Predictors: Results From a Large 
Community Survey##1030-182·295A
Statins Decrease the Risk of Acute Myocardial Infarction and 
Coronary Heart Disease Mortality in Patients With Renal 
Failure: A Meta-Analysis##1001-117·188A
Statins Inhibit Cholesterol Crystallization and Prevent 
Perforation of Biological Membranes and Intima in 
Human Coronary Arteries of Patients With Acute 
Coronary Syndrome##1014-13·358A
The Cardiovascular Disease Prevention Model: A Model That 
Predicts Future Incidences of Cardiovascular Disease in 
Any Given Population and Undertakes Cost-Effectiveness 
Analyses of Primary Preventive Interventions##1012-
194·281A
The Effects of Extended Release Niacin on Carotid Intimal 
Media Thickness, Endothelial Function, and Inflammatory 
Markers in Patients with the Metabolic Syndrome##1026-
125·409A
The Impact of Statin Therapy on the Incidence of Atrial 
Fibrillation: A Meta-Analysis##1020-125·387A
The Pharmacokinetics of Torcetrapib/Atorvastatin Are 
Unaffected by Coadministration of Fenofibrate in Healthy 
Adult Subjects##1014-118·365A
Treatment of Severe Metabolic Syndrome With Gemfibrozil in 
a Pediatric Population##1005-27·254A
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Circadian rhythm
Circadian Variability of Deceleration Capacity of Heart 
Rate##910-242·26A
Clinical trials
“First in Human” Experience With PRT060128, A New Direct-
Acting, Reversible, P2Y
12
 Inhibitor for Intravenous and 
Oral Use##1002-128·326A
“Virtual Superiority”: A New Composite Score for Grading 
the Quality of Noninferiority Cardiovascular Clinical 
Trials##1024-149·287A
i-Trial: An Innovative Internet System for the Complete 
Management and Monitoring of International Multicenter 
Clinical Studies##1018-188·285A
24-Month Outcome Following Negative Adenosine Stress 
Magnetic Resonance Imaging Perfusion Imaging in 92 
Patients Presenting With Chest Pain##915-233·169A
A Meta-Analysis of Smoking Cessation Behavioral 
Interventions##1006-148·272A
Algal Docosahexaenoic Acid Lowers Diastolic Blood Pressure 
and Reduces Heart Rate in a Statin-Treated Cardiac Risk 
Population##1008-207·350A
AZD6140 Suppresses Platelet Aggregation in Clopidogrel-
Treated Patients Even in Those With High Aggregation 
Levels## 802-7·208A
Black Patients With Symptomatic Heart Failure Have Similar 
Outcomes and Response to Angiotensin Receptor 
Blockade as White Patients##1022-62·75A
Comparison of Statin Treatment of Hypercholesterolemic 
Patients in Ethnically Diverse Populations With and 
Without Diabetes##1002-130·327A
Daily Oral Administration of the Apolipoprotein A-I Mimetic 
Peptide D-4F in Patients With Coronary Heart Disease 
or Equivalent Risk Improves High-Density Lipoprotein 
Anti-Inflammatory Function##1014-123·366A
Does Early Invasive Strategy Provide a Clinically Important 
Advantage Over Early Conservative Strategy in the 
Management of Acute Coronary Syndromes?##1025-
114·240A
Effect of Spironolactone Use on the Benefit of Fixed-Dose 
Combination of Isosorbide Dinitrate/Hydralazine in the 
African-American Heart Failure Trial## 808-3·63A
Effect of Statin Therapy on Central Aortic Pressures and 
Hemodynamics: Principal Results of the Lipid Lowering 
Arm of the Conduit Artery Function Evaluation 
Study##1026-43·404A
Effects of Standard Heart Failure Medications on Outcomes of 
Placebo-Treated Patients in the African-American Heart 
Failure Trial## 835-4·87A
Efficacy and Safety of Conivaptan, an Arginine Vasopressin 
Antagonist in Patients With Hypervolemic 
Hyponatremia## 845-9·98A
Enoxaparin Versus Unfractionated Heparin With Fibrinolysis 
for ST-Elevation Myocardial Infarction In Patients ≥75 
Years Compared With <75 Years## 844-5·249A
Fibrates in the Prevention of Cardiovascular Events in 
Dyslipidemic Patients: A Meta-Analysis of Randomized 
Placebo-Controlled Clinical Trials##1002-127·326A
Global Outcomes of ST-Elevation Myocardial Infarction: 
Comparisons of the ExTRACT-TIMI 25 Registry and 
Trial##1001-94·186A
How Likely Are Therapeutic Interventions Recommended 
by the 2002 American College of Cardiology/American 
Heart Association Clinical Guidelines for Acute Coronary 
Syndromes to Be Clinically Worthwhile?##1013-92·211A
Interobserver Variability in Identifying the Location of 
Coronary Venous Leads##906-241·20A
ISIS 301012, an Antisense Inhibitor of Apolipoprotein B, 
Produces Significant Additional Reduction of Low-
Density Lipoprotein Cholesterol and Apolipoprotein B in 
Hypercholesterolemic Subjects on Statins Not Meeting 
Target## 820-7·393A
Long-Term Results of a Randomized Multi-Center Trial 
Comparing Adaptive Servo Ventilation Positive Airway 
Pressure to Nasal Oxygen in Heart Failure Patients With 
Central Sleep Apnea##1028-109·94A
Microalbuminuria in Chronic Heart Failure: Prevalence and 
Determinants in More Than 2,000 Patients Enrolled in the 
GISSI-HF Trial## 845-4·97A
MRC/BHF Heart Protection Study: Mortality, Cancer 
Incidence and Major Vascular Events During 4-Year Post-
Trial Follow-Up of HPS## 820-5·393A
Nesiritide Does Not Cause Renal Dysfunction in Acute 
Decompensated Heart Failure: A Randomized, Double-
Blind, Placebo-Controlled Clinical Trial## 808-4·63A
Noncardiac Findings in Patients Undergoing Coronary 
Multislice Computed Tomography: Preliminary Results 
From the Core64 International Multicenter Trial##916-
231·172A
Pro-Inflammatory Responses After Intracoronary Injections of 
Autologous Mononuclear Bone Marrow Cells in Patients 
With Acute Myocardial Infarction##1001-132·189A
Role of Metabolic Syndrome, Independent of Its Components, 
in Prediction of Cardiovascular Outcomes in Hypertensive 
Patients of ASCOT- BPLA## 848-5 ·417A
Rosuvastatin Arrests Progression of Carotid Intima Media 
Thickness in Low-Risk Individuals: Main Results of the 
METEOR Study## 820-3·392A
SCN5A Variant in Japanese Patients With Left Ventricular 
Noncompaction and Arrhythmia##1016-100·68A
Should Clinical Guidelines Emphasize Statistical Significance 
Over Clinical Importance? A Reappraisal of the 2004 
American College of Cardiology /American Heart 
Association Treatment Guidelines for ST-Elevation 
Myocardial Infarction##1007-153·203A
Sirolimus-Eluting Stent Implantation for the Percutaneous 
Treatment of Unprotected Left Main Coronary Artery 
Disease: A Clinical Analysis Based on J-CYPHER 
Registry##1013-178·218A
Statin-Like, Dose-Dependent Reductions in LDL-C and 
Apolipoprotein B With ISIS 301012, an Antisense 
Inhibitor of Apolipoprotein B, in Subjects With Polygenic 
Hypercholesterolemia##1206-278·333A
The Benefits of the Fixed-Dose Combination of Isosorbide 
Dinitrate and Hydralazine in A-HeFT Are Not Influenced 
by the Absence or Presence of Diabetes##1004-65·44A
The Effect of Valsartan Compared to Valsartan/
Hydrochlorothiazide on Plasma Levels of Cellular 
Adhesion Molecules: The Val-MARC Trial## 848-8·418A
The Long-Term Safety and Efficacy of Combined Simvastatin 
and Fenofibrate Therapy in Diabetic Patients With 
Dyslipidemia: The DIACOR Study##1008-125·344A
The SIRIUS Study: 5-Year Outcomes##1025-159·244A
The V-HeFT Paradox, Identical Doses of Different 
Formulations of Isosorbide Dinitrate and Hydralazine Are 
Not Bioequivalent and Neither Is Bioequivalent to the 
Fixed-Dose Combination of ISDN/Hydralazine Used in 
A-HeFT## 808-8·64A
Collagen
Direct Collagen Injection to Thicken the Infarct Scar: Collagen 
Density Determines Angiogenesis##1001-75·185A
Transplanted Embryonic Stem Cells Following Mouse 
Myocardial Infarction Inhibit Apoptosis and Cardiac 
Remodeling## 652-5·234A
Collateral circulation
Angiographic Estimates of Myocardium at Risk During Acute 
Myocardial Infarction: A Validation Study Using Cardiac 
Magnetic Resonance Imaging## 824-8·105A
Erythropoietin Predicts the Presence of Coronary Artery 
Collaterals in ST-Segment Elevation Myocardial 
Infarction## 851-8·253A
Hepatocyte Growth Factor Generated in the Distal Segment 
of the Occlusive Lesions Enhances the Collateral 
Development in Peripheral Artery Disease##1008-
82·341A
Long-Term Outcome of Autologous Transplantation of 
Bone Marrow Mononuclear Cells in Patients With 
Thromboangiitis Obliterans##1008-40·338A
Computer communication networks
i-Trial: An Innovative Internet System for the Complete 
Management and Monitoring of International Multicenter 
Clinical Studies##1018-188·285A
Computer-assisted instruction
A Combination of Multislice Computed Tomography 
and Coronary Flow Reserve Measured by Doppler 
Echocardiography Improves the Diagnostic Accuracy in 
the Left Anterior Descending Coronary Artery Stenosis 
With Severe Calcification##919-228·182A
Artificial Neural Networks Are a Potential Tool for Estimating 
Prognosis in Coronary Artery Disease: Are Standard 
Algorithms Sufficient?##1012-189·280A
Simulation-Based Crisis Resource Management Program 
in a Pediatric Cardiac Intensive Care Unit Improves 
Participant’s Self-Perception of Resuscitation 
Skills##1030-190·297A
Use of Simulation-Based Training to Enhance Patient Safety 
for Cardiac Catheterization: A Randomized Controlled 
Multi-Center Study##1024-189·289A
Contractile proteins
The Protein Synthesis and T-CAP Translational Control 
by AKT/mTOR/4E-BP1 Signal Prevent Dilated 
Cardiomyopathy in MLP-/- Mice##1010-61·53A
Contractility
Accurate and Reproducible Quantification of Global and 
Regional Left Ventricular Function Using Tissue Tracking 
Based Automated Function Imaging##912-227·156A
AKT Kinase Overexpression Prevents Heart Failure 
Development Modulating Cardiac Contractility in 
Pressure Overload Animal Model##1010-59·53A
Angiotensin II-Induced Increase in Myocardial Distensibility Is 
Modulated by the Endocardial Endothelium, Endothelin-1 
and Nitric Oxide##1010-57·53A
Cellular Basis for the Negative Inotropic Effects of High-
Mobility Group Box 1 in the Adult Mammalian Heart## 
829-7·86A
Developmental Changes in the Modulation of Contractility in 
the Human Ventricle##1011-33·259A
Differing Left Ventricular Contraction Patterns in Patients 
With Right Ventricular Paced Versus Native Left Bundle 
Branch Block: A 2D Strain Study## 810-4·1A
Human Amniotic Membrane-Derived Stem Cell With Lack of 
HLA-DR Expression Can Be a Promising Cellular Source 
for Cardiac Stem Cell Therapy##1004-108·47A
Improvement of Clinical Status and Cardiac Function by 
Cardiac Contractility Modulation for Patients With 
Advanced Heart Failure##1022-110·79A
Intravenous Nesiritide Decreases Contractility in Humans: 
Observations From Pressure-Volume Analysis##1022-
63·75A
Left Ventricular Longitudinal Contractile Reserve Is 
Abnormal in Hypertensive Patients With Left Ventricular 
Hypertrophy##911-225·153A
Longitudinal Rotation of the Left Ventricle Is a Marker of 
Asymmetric Strain Distribution##907-228·138A
Longitudinal Strain and Torsion Assessed by 2-D Speckle 
Tracking Correlates With the Serum Level of Tissue 
Inhibitor of Matrix Metalloproteinase-1a: A Marker of 
Myocardial Fibrosis in Patients With Hypertension## 
806-7·100A
Pure HNO Donors Increase Myofilament Ca2+ Responsiveness 
in Cardiac Muscle##1004-62·43A
Quantification of Global Left Ventricular Early Diastolic 
Expansion and Its Coupling to Systolic Contraction 
in Normal and Hypertrophic Myocardium by Speckle 
Tracking Global Strain and Strain Rate Imaging##910-
228·150A
Contrast media
A New Approach to Noninvasive Coronary Angiography 
by Multidetector Computed Tomography: Preliminary 
Experience Using Gadolinium##915-229·168A
Incidence of Contrast-Induced Nephropathy in Patients 
With Acute Chest Pain Undergoing Contrast-Enhanced 
Coronary Multi-Detector Computed Tomography##901-
230·117A
Multi-Functional Echogenic Liposomes for Image-Guided and 
Ultrasound-Controlled PPAR Agonist Delivery##1014-
89·365A
Statin Therapy Decreases Contrast-Induced Nephropathy in 
Patients Undergoing Cardiac Catheterization##1014-
126·367A
The Effect of Echocardiographic Contrast on Velocity Vector 
Imaging Myocardial Tracking##909-226·145A
The Effect of Sodium Bicarbonate on Short- and Long-Term 
Renal Outcomes in Patients Undergoing an Emergent 
Cardiac Catheterization: A Prospective Randomized 
Controlled Trial##1001-113·187A
Coronary artery disease
18F-Fluoromisonidazole Is Selectively Retained in Ischemic 
Human Myocardium During Dobutamine Stress: A Pilot 
Study##913-235·162A
64 Multi-Detector Computed Tomography Coronary 
Angiography: Effect of Sublingual Nitroglycerin on 
Coronary Luminal Diameter and Image Quality##918-
230·179A
A Combination of Multislice Computed Tomography 
and Coronary Flow Reserve Measured by Doppler 
Echocardiography Improves the Diagnostic Accuracy in 
the Left Anterior Descending Coronary Artery Stenosis 
With Severe Calcification##919-228·182A
A Comparative Study on the Feasibility and Safety of 
Transulnar Artery Versus Transradial Artery Access for 
Percutaneous Coronary Intervention in Patients With 
Coronary Heart Disease##1012-191·281A
A Cost-Effective Analysis of 64-Row Cardiac Computed 
Tomography for the Diagnosis of Coronary Artery 
Disease in the Intermediate-Risk Population: A Reflection 
on Recent ACC CCT Appropriateness Criteria## 831-
8·107A
A New Approach to Noninvasive Coronary Angiography 
by Multidetector Computed Tomography: Preliminary 
Experience Using Gadolinium##915-229·168A
A New Automated Method for Quantitative Computed 
Tomography Coronary Angiography: An In Vivo 
Validation Study With Intracoronary Ultrasound as a 
Reference##909-229·146A
A New Automated Method for Quantitative Coronary Plaque 
Compositional Imaging by Multislice Computed 
Tomography: An Ex Vivo Feasibility Study##1006-
190·275A
A Prospective Study Comparing Two Different Algorithms 
for Predicting Cardiovascular Events in Renal Transplant 
Candidates: In Whom Should Cardiac Scintigraphy Be 
Performed?## 841-7·110A
A Simple Additive Risk Score Discriminates Patients at 
Heightened Risk of Early Adverse Events During 
Medical Management Following Diagnostic Cardiac 
Catheterization##1020-166·390A
Accuracy of 64-Slice Computed Tomography for Evaluating 
Bypass Grafts and Corresponding Peripheral Coronary 
Arteries##917-229·175A
Accuracy of Fully Quantitative Cardiac Magnetic Resonance 
Myocardial Perfusion in Detection of Coronary Disease 
as Measured by Quantitative Coronary Angiography## 
824-6·105A
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Achieving High Cardiac Workload During Exercise Predicts 
Good Cardiac Function and a Low Risk of Abnormalities 
on Myocardial Perfusion Imaging in a Symptomatic 
Population With Significant Cardiac Risk Factors##918-
236·180A
Acute Coronary Angiographic Findings in Survivors of Out-of-
Hospital Cardiac Arrest##1013-197·219A
An Intravascular Ultrasound Simulator of Coronary Plaques 
Based on Histopathology##1006-189·275A
Anatomical Correlates of a Normal Perfusion Scan 
Using 64-Slice Computed Tomography Coronary 
Angiography##901-229·117A
Assessing Individual Response to Clopidogrel in Patients 
Undergoing Coronary Intervention##1014-121·365A
Assessment of Myocardial Perfusion and Coronary Flow 
Reserve in Children, Using 3-Tesla Cardiac Magnetic 
Resonance##1005-28·254A
Association Between Admission Neutrophil to Lymphocyte 
Ratio and 6-Month Mortality in Patients With Acute 
Coronary Syndrome##1012-148·278A
Association of MTHFD1 G1958A and MTHFR C677T 
Polymorphisms With Serum Homocysteine Concentration 
and Cardiovascular Disease: The Normative Aging 
Study##1025-69·236A
Atrial Fibrillation Is a Strong Predictor of Death and of Cardiac 
Events in Angiographied Coronary Patients##913-
237·30A
Bridging of Chronically Anticoagulated Patients With 
Low Molecular Weight Heparin Prior to Cardiac 
Catheterization: Experience in 203 Patients From the 
BRAVE Registry##1025-180·245A
Can the Burden of Coronary Atherosclerosis Be Predicted 
by a Patient’s Pretest Probability for Coronary Artery 
Disease?##903-229·124A
Cardiovascular Outcomes in Patients With Diabetes Mellitus, 
Metabolic Syndrome, or Neither Condition With New 
Diagnosis of Coronary Artery Disease##1020-120·368A
Chronic Obstructive Pulmonary Disease Was an Independent 
Predictor of Sudden Cardiac Death, Cardiac Death, 
and All-Cause Mortality After Percutaneous 
Coronary Intervention and Coronary Artery Bypass 
Grafting##1001-179·194A
Clinical Benefit of Antihypertensive Therapy on 
Cardiovascular Events in Obese Patients With Coronary 
Artery Disease: A CAMELOT Trial Subanalysis## 848-
4·417A
Clinical Impact of 64-Multi-Detector Computed Tomography 
on Percutaneous Coronary Intervention of Chronic Total 
Occlusion: Focus on Regional Calcium Score##916-
230·172A
Clinical Outcomes of Bifurcated Versus Nonbifurcated Lesions 
in Left Main Coronary Disease: Clinical Results of an 
European Retrospective Multicenter Study One Year 
After Elective Implantation of Sirolimus-Eluting Stents in 
Unprotected Left Main Coronary Arteries##1014-45·361A
Clinical Predictors of Presence of Left Main Coronary Artery 
Disease on Angiography in a Large Cohort##1013-
175·218A
Color-Coded Dual-Frequency Intravascular Ultrasound 
Imaging With Use of Radiofrequency Ultrasound Signals: 
A Novel Modality of Tissue Characterization of Coronary 
Plaque##916-227·171A
Comparison Between Coronary Anatomy and Physiology 
in Predicting Hard Events in Symptomatic Patients 
Undergoing Coronary Angiography##901-235·117A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography, Radionuclide Myocardial Perfusion 
Imaging, and Stress Echocardiogram in the Detection of 
Significant Coronary Artery Stenosis##908-229·142A
Comparison of 64-Slice Computed Tomography With 
Conventional Coronary Angiography for the Detection 
of In-Stent Restenosis in the Left Main Coronary 
Artery##906-230·135A
Comparison of Effects of Sirolimus-Eluting Stent, Bare 
Metal Stent, and Plain Only Balloon Angioplasty on 
Inflammatory Markers##1001-196·194A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery Among Patients With a Chronic Total 
Occlusion and Multi-Vessel Coronary Artery Disease in 
the Bare Metal Stent Era.##1019-176·229A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery in Patients With Multi-Vessel Coronary 
Artery Disease and Reduced Left Ventricular Function in 
the Bare Metal Stent Era.##1019-177·229A
Computed Tomography Angiography Should Be a 
Collaborative Effort Between Cardiologists and 
Radiologists##911-230·154A
Computed Tomography for Acute Chest Pain: Is It Time-and 
Cost-Effective?##902-229·121A
Coronary and Left Ventricular Angiographic Correlates of 
Chronic Kidney Disease Following Acute Myocardial 
Infarction: Data From the Survival and Ventricular 
Enlargement Trial## 805-7·353A
Coronary Artery Bypass Surgery Might Be Superior to 
Percutaneous Coronary Intervention With Drug-Eluting 
Stents for Unprotected Left Main Coronary Artery 
Disease##1007-200·207A
Coronary Artery Image Quality Using Multidetector Computed 
Tomography to Simultaneously Evaluate for Coronary 
Artery Stenosis, Aortic Dissection and Pulmonary 
Embolism##916-229·171A
Coronary Artery Plaque Composition Identified by 
Multidetector Computed Tomography Predicts Stress-
Induced Myocardial Ischemia##919-229·182A
Coronary Calcium Scanning Before Cardiac Computed 
Tomographic Angiography Reduces the Total Effective 
Radiation Dose##916-228·171A
Coronary Calcium Scores Add Incremental Diagnostic Value 
to Single-Photon Emission Computed Tomography 
Myocardial Perfusion Imaging for Detecting Significant 
Coronary Artery Disease##903-231·125A
Coronary Computed Tomography Angiography Decreases 
Need for Invasive Cardiac Catheterization in Patients 
With Indeterminate Stress Test##901-231·117A
Coronary Computed Tomography Angiography in Elderly 
High Risk Patients Presenting With Atypical Cardiac 
Symptoms##914-229·164A
Coronary Endothelial Dysfunction Associated With Depressive 
Mood in Patients Without Coronary Artery Disease## 
805-4·352A
Coronary Intervention Rates Following Coronary 
Angiography Without Prior Stress Testing: Results 
From the Investigation of National Coronary Disease 
Identification##1013-75·210A
Coronary Revascularization Procedure in Patients >80 Years 
Presenting With Acute Myocardial Infarction##1001-
116·188A
Culprit Coronary Lesions Requiring Percutaneous Coronary 
Intervention Following Vascular Surgery Often Arise 
From Non-Obstructive Disease##1013-159·217A
Cumulative Burden of Atherosclerotic Risk Genotypes and 
the Age at Onset of a First Myocardial Infarction##1002-
165·328A
Despite Increase in Diagnosis, Peripheral Artery Disease 
Patients Still Trail Coronary Artery Disease Patients 
in Statin and Aspirin Use: Results From a National 
Survey##1014-80·362A
Detection of Coronary Artery Disease Using Delayed Strain 
Imaging: Comparison With Conventional Exercise Stress 
Echocardiography##904-228·127A
Development of a Real-Time Fluorescence Imaging In Vivo 
Clot Lysis Method: Alcohol- and Polyphenol (Quercetin 
and Catechin)-Induced Effects##1020-85·385A
Diagnosis of Coronary Artery Disease by Detection of 
Post-Ischemic Diastolic Dyssynchrony After Treadmill 
Exercise Using Strain Image Derived From 2D Speckle 
Tracking##918-224·177A
Diagnostic accuracy of 64-Slice Computed Tomography 
Coronary Angiography in Patients With Unstable 
Angina and Non-ST-Segment Elevation Myocardial 
Infarction##915-230·168A
Diagnostic Accuracy of 64-Slice Computed Tomography 
Versus Conventional Coronary Angiography: Results of 
300 Consecutive Patients##904-229·128A
Diagnostic Accuracy of Coronary 64-Row Multi Detector 
Computed Tomography in Clinical Setting##905-
229·131A
Diagnostic Accuracy of Dual Source Coronary Tomography 
Coronary Angiography in Patients Referred for 
Conventional Angiography## 852-6·114A
Diagnostic Accuracy of Gated Myocardial Perfusion Single-
Photon Emission Computed Tomography for Detection of 
Left Main Coronary Artery Disease##917-233·176A
Diagnostic Accuracy of Global and Regional Left Ventricular 
Function Measured by 64-Slice Multi-Detector Computed 
Tomography for Acute Coronary Syndrome in Patients 
With Acute Chest Pain##912-230·157A
Diagnostic Accuracy of Noninvasive Coronary Angiography 
Using 64-Slice Multidetector Computed Tomography 
in the Evaluation of Significant Coronary Artery 
Disease##918-229·178A
Diagnostic Performance of the Modified Rush Score Across 
Risk Strata and Prespecified Clinical Subgroups, Is 
Superior to the TIMI Risk Score for Prediction of In-
Hospital Mortality in Acute Coronary Syndromes##1025-
112·239A
Diagnostic Value of Left Ventricular Function of Post-Stress 
and at Rest in the Detection of Multi-Vessel Coronary 
Artery Disease as Assessed by Electrocardiogram-Gated 
Single-Photon Emission Computed Tomography##912-
235·158A
Discharge Medications and 6-Month Outcomes in Acute 
Coronary Syndrome Patients With Minimal Versus 
Moderate to Severe Coronary Artery Disease##1012-
149·278A
Diverging Response of Stress-Induced Mitral Regurgitation to 
Exercise and Dobutamine##1015-20·305A
Do Drug-Eluting Stents Impact Survival in Patients With 
Chronic Renal Insufficiency?##1025-178·245A
Does C-Reactive Protein Measured at Admission, Discharge, 
or 1 Month Have Incremental Clinical Value to Predict 
Outcome in Acute Coronary Disease?##1007-95·199A
Does Progression of Coronary Artery Disease Differ in Patients 
With Stable and Acute Coronary Syndrome?##1007-
112·200A
Drug-Eluting Stents in the Elderly: Long-Term Clinical 
Outcomes of Octogenarians in the DESIRE 
Registry##1025-195·246A
Dynamic Responses of Proinflammatory Markers 
and Oxidative Stress Induced by Postchallenge 
Hyperglycemia Are Associated with Coronary Artery 
Disease in Patients Without Previous Diagnosis of Type 2 
Diabetes Mellitus##1002-43·320A
Economic Impact of Amlodipine in Normotensive Coronary 
Artery Disease Patients: Subgroup Analyses of 
Participants in the CAMELOT Trial##1026-168·413A
Effect of Patient Age on the Presence of Soft Plaque in Patients 
Without Evidence of Coronary Calcification on 64-
Detector Cardiac Computed Tomography##917-230·175A
Effect of Payer Status on Interventional Utilization Patterns: 
Current Results From the National Heart, Lung, and 
Blood Institute Dynamic Registry##1030-183·295A
Electromechanical Assessment of Percutaneous 
Intramyocardial Injection of Mesenchymal Versus 
Mononuclear Bone-Marrow Derived Stem Cells in the 
Chronic Ischemic Myocardium## 827-8·234A
End-Tidal PCO2 During Exercise Predicts Future 
Cardiovascular Events in Cardiac Patients##1002-
172·330A
Endothelial Dysfunction by Flow-Mediated Brachial Artery 
Dilatation Is a Marker of Ischemic Response During 
Stress Echocardiography##1002-84·323A
Erectile Dysfunction and Coronary Artery Disease Confer 
an Almost Similar Inflammatory and Endothelial/
Prothrombotic Activation##1020-78·383A
Evaluation of Coronary Artery Disease: Variations in Practice 
Patterns Across Six Countries##1014-129·367A
Fibrous Cap Thickness of Culprit Plaque in Subjects With 
Acute Coronary Syndromes Is Related to Individual 
Plaque Characteristics and Not to the Presence of 
Systemic Cardiovascular Risk Factors: An Intravascular 
Optical Coherence Tomography Study##1026-6·400A
Gadolinium-Enhanced Cardiac Magnetic Resonance Predicts 
Major Adverse Cardiac Events in Patients With Coronary 
Artery Disease and Preserved Left Ventricular Systolic 
Function: Results of a 4-year Prospective Study##914-
233·165A
Genetic Polymorphism C807T on Platelet Glycoprotein Ia 
Affects Platelet Activation Only in the Presence of High 
Von Willebrand Levels##1001-180·194A
Global and Regional Thoracic Aortic as Well as Coronary 
Calcification Are Inversely Related With Coronary 
Flow Reserve Measured by Rb-82 Positron Emission 
Tomography/Computed Tomography in Intermediate-Risk 
Patients## 811-4·101A
Global Outcomes of ST-Elevation Myocardial Infarction: 
Comparisons of the ExTRACT-TIMI 25 Registry and 
Trial##1001-94·186A
Heart Rate Recovery After Exercise Testing and Risk of 
Cardiovascular Events and Mortality in Stable Coronary 
Patients## 818-4·3A
High Urinary 8-Iso-Prostaglandin F2κ Concentration 
Reflects Plaque Instability in Early Stage Coronary 
Atherosclerosis: A 3-Dimensional Intravascular 
Ultrasound Study##1026-36·402A
High-Risk Patients Benefit Most From Angiotensin- 
Converting Enzyme Inhibition After an Acute Myocardial 
Infarction## 843-6·248A
How Long Does Sympathetic Activation Persist After 
Submaximal Exercise in Subjects With Coronary Artery 
Disease?##911-236·155A
How Long Does Sympathetic Activation Persist After 
Submaximal Exercise in Subjects With Coronary Artery 
Disease?## 406-7·420A
Impact of GP IIB/IIIA Receptor Inhibitors and Clopidogrel 
Treatment on 30-Day and 1-year All-Cause Mortality of 
Patients With ST-Elevation Myocardial Infarction Treated 
by Primary Percutaneous Coronary Intervention## 847-
5·251A
Impact of HMG-CoA Reductase Inhibitors (Statins) on 
New Cardiovascular Events Following Coronary 
Intervention and on the Progression-Regression of 
Coronary Atherosclerotic Plaque: A Three-Dimensional 
Intravascular Ultrasound Study##1002-123·325A
Impact of HMG-CoA Reductase Inhibitors on Progression 
of Coronary Atherosclerosis in Chronic Kidney 
Disease##1002-14·318A
Impact of Pharmacologic Management at Discharge for 
Complicated Risk Factors on Outcomes of Diabetic 
Patients Undergoing First Coronary Revascularization: 
Perspectives From CREDO-Kyoto Registry##1008-
168·348A
Impaired Aortic Distensibility as an Independent Marker of 
Coronary Artery Disease##1014-44·360A
Incidence of a Left Main Stenosis Among High-Risk Patients 
Presenting for Elective Vascular Surgery and Long-Term 
Outcomes## 814-6·374A
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Increased Risk of Incident Stroke Associated With the 
Cyclooxygenase 2 G-765C Polymorphism in African-
Americans: The Atherosclerosis Risk in Communities 
Study##1026-44·404A
Inflammatory Markers, Angiographic Severity of Coronary 
Artery Disease, and Patient Outcome##1008-42·338A
Influence of Statin Treatment on the Adenosine Diphosphate 
Responsiveness of Platelets During Clopidogrel 
Treatment: A Randomized Comparison of Rosuvastatin, 
Atorvastatin, and Simvastatin Co-Treatment## 804-
5·351A
Inhibition of Platelet Aggregation by Clopidogrel Is Unaffected 
by the CYP2C19 681G>A Polymorphism in Patients With 
Coronary Artery Disease## 815-4·375A
Intensive Lowering of the Low-Density Lipoprotein 
Cholesterol/High Density Lipoprotein Cholesterol Ratio 
With High-Dose Statin Therapy Promotes Regression 
of Obstructive Coronary Artery Disease: Insights From 
ASTEROID## 820-4·393A
Interleukin-17 Stimulates C-Reactive Protein Expression 
in Hepatocytes and Smooth Muscle Cells via P38 
MAPK and ERK1/2-Dependent NF-κB and C/EBPκ 
Activation##1008-7·335A
Joint Effects of Diabetes and Dialysis in Predicting Long- 
Term Outcomes Following Percutaneous Coronary 
Interventions##1007-157·204A
Left Ventricular Apical Ballooning Syndrome in an 
European Population: Results of a Multicenter Italian 
Registry##1013-112·213A
Levosimendan Echocardiography Allows Detection of 
Contractile Reserve in Post-Myocardial Infarction Patients 
That Do Not Improve Function With Dobutamine##917-
224·174A
Lipid Levels in Patients Hospitalized With Coronary Artery 
Disease: An Analysis of 136,905 Hospitalizations in Get 
With The Guidelines-Coronary Artery Disease##1206-
275·332A
Lipid-Independent Effects of Statins on Cardiovascular 
Events in the Japanese Coronary Artery Disease Study: 




 Is Especially 
Predictive of Coronary Artery Disease Among Patients 
With the Metabolic Syndrome##1008-46·339A
Location of Tendon Xanthomata and Prevalence of Coronary 
Artery Disease Among Heterozygous Familial 
Hypercholesterolemia Patients.##1026-118·408A
Long-Acting Calcium Channel Blockers in Patients With 
Coronary Artery Disease: A Meta-Analysis of 39,652 
Patients## 825-5·232A
Low Adiponectin Expression in Epicardial Adipose Tissue 
Is Associated With The Severity of Coronary Artery 
Disease##1014-88·364A
Low Calcium Score Predicts Absence of Significant Coronary 
Artery Disease in Patients With Indeterminate Single-
Photon Emission Computed Tomography Myocardial 
Perfusion Imaging##917-231·176A
Low Rates of Adverse Outcome Among Acute Coronary 
Syndrome Patients: Observations From the Australian 
Acute Coronary Syndromes Prospective Audit##1007-
92·199A
Macrophage Scavenger Receptor 1 Sequence Variations 
Are Associated With Atherosclerosis Susceptibility in 
Humans##1008-41·338A
Major Bleeding in Acute Coronary Syndrome Patients is 
Associated with a Marked Pro-Inflammatory Response: 
Results from the ACUITY Inflammatory Biomarker Sub-
Study## 615-5·209A
Manganese Superoxide Dismutase Polymorphism Is 
Associated With Acute Coronary Syndrome##1001-
73·185A
Mechanistic Insights From Serial Cardiac Magnetic Resonance 
Imaging at 3 and 15 Months After Application of 
Blood-Derived Progenitor Cells in Recanalized Chronic 
Coronary Total Occlusions## 824-3·104A
Metabolic Syndrome Is Independently Associated With 
Increased Coronary Atherosclerotic Plaque Burden##919-
230·182A
Microvascular Endothelial Function Is Impaired in the 
Cutaneous Circulation in Patients With Coronary Artery 
Disease##1025-115·240A
Multi-Detector Computed Tomography Coronary Angiography 
Detects a High Prevalence of Obstructive, Noncalcified 
Plaques in Symptomatic Patients and Zero Calcium 
Score##904-230·128A
N-3 Polyunsaturated Fatty Acids and Major Arrhythmic 
Events: A Meta-Analysis of Randomized Controlled 
Trials##918-239·38A
Nicotine Patches Are Safe to Use in Patients With Coronary 
Artery Disease and Stress-Induced Myocardial 
Ischemia##1013-70·209A
Noninvasive Assessment of the Low-Density Plaque in 
Culprit Lesion of Patients With Unstable Angina Pectoris 
by Multi-Slice Computed Tomographic Coronary 
Angiography##903-230·125A
Noninvasive Coronary Angiography With 64-Slice Multi -
Detector Computed Tomography Compared to 16-Slice in 
the Same Patients: Is the Benefit of More Slices Clinically 
Relevant?##911-229·154A
Noninvasive Coronary Angiography: 16-Slice Computed 
Tomography Versus 1.5 Tesla Magnetic Resonance 
Imaging Validated by Coronary Angiography##905-
230·131A
Noninvasive Diagnosis of Ischemic Cardiomyopathy Using 
64-Slice Computed Tomography## 852-8·114A
Normal Results on 64-Detector Coronary Computed 
Tomography Angiography Predict Excellent Outcomes at 
1-Year Follow-Up## 831-3·106A
Optimizing Transfusion in Cardiac Surgery: Deleterious 
Effects of Platelet Transfusion##1015-16·304A
Ottawa Heart Genomics Study: The First Genome-Wide Scan 
to Search for Coronary Artery Disease Genes Utilizing 
500,000 Markers##1002-9·316A
Patients With Acute Anginal Symptoms Frequently Do 
Not Receive Initial Electrocardiography: Results 
From the Investigation of National Coronary Disease 
Identification##1024-182·288A
Pioglitazone Increases Adiponectin Levels in Nondiabetic 
Patients With Coronary Artery Disease##1002-125·326A
Plaque Morphology in Coronary Arteries and Extent of 
Visceral Fat Mass as Assessed by 64-Row Multi-Detector 
Computed Tomography in Patients With Ischemic Heart 
Disease##907-229·139A
Plasma Levels of Arginine/(Ornithine + Citrulline), a Global 
Index of Functional Arginine Bioavailability, Predicts 
Future Risk for Major Adverse Cardiac Events##1008-
39·337A
Platelet Glycoprotein 1b Alpha T145M Dimorphism as a Risk 
Factor for the Recurrent Cardiac Events in Post-Infarction 
Patients With Claudication##1026-45·404A
Postsystolic Strain Index by Either Adenosine or Dobutamine: 
Correlations to Adequacy of Left Anterior Descending 
Flow Reserve##905-227·131A
Prediction of Long-Term Survival in Revascularized Coronary 
Artery Disease Patients##1024-191·290A
Predictive Value of Coronary CT Angiography for Late 
Adverse Cardiac Events in Patients With Chest Pain 
Syndromes## 831-5·106A
Predictive Value of Normal Adenosine-Stress Cardiac 
Magnetic Resonance Imaging Exams: A Prospective 
Follow-Up Study Over 12 Months After Diagnosis##909-
233·147A
Preoperative Statin Therapy Is Not Associated With Decrease 
Incidence of Postoperative Atrial Fibrillation in Patient 
Undergoing Coronary Artery Bypass Grafting##1015-
19·304A
Prognostic Significance of Dyspnea in Acute Coronary 
Syndromes##1030-146·293A
Prognostic Value and Clinical and Biochemical Correlates 
of Elevated Neutrophil to Lymphocyte Ratio Prior to 
Coronary Stenting##1001-157·192A
QRS Complex Fragmentation as Independent Risk Factor 
for Secondary Cardiac Event in Patients With Q-Wave 
Myocardial Infarction.##916-234·35A
Quantification Methods for Determination of Myocardial 
Blood Flow During Real-Time Dobutamine Perfusion 
Contrast Echocardiography: Is It Necessary to 
Normalize?##911-226·153A
Quantitative Evaluation of the Media in the Thoracic Aorta 
Using Integrated Backscatter by Transesophageal 
Echocardiography as a New Marker for Coronary Artery 
Disease##913-224·159A
Reducing Psychosocial Stress: A Novel Mechanism of 
Improving Survival From Exercise Training##916-
236·173A
Regression of Coronary Atherosclerosis During Treatment 
With Statins: Does Age Make a Difference?##1008-
12·336A
Relationship Between Insulin Resistance Features and 
Progression of Cardiac Allograft Vasculopathy##1010-
108·57A
Relationship Between Intensive Statin Therapy and 
Cardiovascular Outcomes in Patients With Stable 
Coronary Artery Disease: A Meta-Analysis of 
Randomized Clinical Trials##1025-179·245A
Relationship of Coronary Flow Reserve With Coronary Artery 
and Thoracic Aorta Calcium in Patients With End-Stage 
Renal Disease Compared to Controls With Intermediate 
Risk Using Rubidium-82 Positron Emission Tomography/
Computed Tomography##908-231·143A
Resting Myocardial Blood Flow Not Myocardial Flow Reserve 
Predicts Hibernating Myocardium: A Quantitative 
Myocardial Contrast Echocardiography Study##905-
226·131A
Restrictive Annuloplasty and Coronary Revascularization 
in Ischemic Mitral Regurgitation: Long-Term 
Results##1003-16·298A
Risk Factors and Associations of Coronary Artery Calcification 
in Hemodialysis Patients## 811-7·102A
Role of Gender in the Development of Coronary Artery 
Disease in Greek Cohort of Familial Combined 
Hyperlipidemia##1026-126·409A
Safety of Perioperative Use of Selective and Nonselective 
Cyclo-Oxygenase-2 Inhibitors: A Systematic Analysis 
on 6,829 Patients Undergoing Cardiac and Noncardiac 
Surgery##1015-18·304A
Serum Cystatin C Reflects the Presence and Severity 
of Coronary Artery Disease in Stable Angina 
Patients##1007-175·205A
Serum Myeloperoxidase Levels Are Associated With the 
Future Risk of Coronary Artery Disease in Apparently 
Healthy Individuals## 833-4·396A
Severity of Chronic Kidney Disease as a Risk Factor 
for Operative Mortality in the California Coronary 
Artery Bypass Graft Surgery Outcomes Reporting 
Program##1009-19·302A
Severity of Coronary Artery Disease in Obese Patients 
Undergoing Coronary Angiography and Intervention: 
Obesity Paradox Revisited##1013-111·212A
Sex, Prescribing Practices, and Guideline Recommended 
Treatment Goals at Baseline in the BARI 2D 
Study##1001-176·193A
Sirolimus-Eluting Stent Implantation for the Percutaneous 
Treatment of Unprotected Left Main Coronary Artery 
Disease: A Clinical Analysis Based on J-CYPHER 
Registry##1013-178·218A
ST2, a Novel Biomarker of Myocyte Mechanical Overload, 
Predicts Adverse Electrographic, Angiographic, and 
Clinical Outcomes in ST-Elevation Myocardial Infarction: 
Results From the CLARITY-TIMI 28 Biomarker 
Study##1019-95·223A
Strain Rate Is Superior to Peak Systolic Strain for the 
Detection of Ischemia During Dobutamine Stress 
Echocardiography##902-225·119A
Ten-Year Coronary Heart Disease Risk Cannot Predict 
Coronary Artery Plaques on Multi-Slice Computed 
Tomography##909-230·146A
The Actual Condition of Ulceration and Attenuation in Gray 
Scale Intravascular Ultrasound by Using Virtual Histology 
IVUS##907-223·137A
The Changing Profile of First Reoperative Coronary 
Artery Bypass Surgery: Trends Over 14 Years in 470 
Patients##1019-200·231A
The Comparison of Coronary Artery Bypass Surgery With 
Drug-Eluting Stent Implantation for the Treatment of 
Multivessel Coronary Artery Disease##1019-198·231A
The Influence of Oxidized Phospholipids and Lp(a) 
Lipoprotein on Coronary Artery Disease Is Conditional 
Upon Genotype at the Interleukin-1 Region##1026-
46·404A
The SIRIUS Study: 5-Year Outcomes##1025-159·244A
The Value of Repeat Single-Photon Emission Computed 
Tomography Testing After Initial Normal or Low-Risk 
SPECT in Patients With Coronary Artery Calcium##906-
235·136A
Three-Dimensional Quantification of Coronary Plaque Burden 
by 64-Slice Computed Tomography: A PROSPECT-
MSCT Substudy## 852-5·114A
Transition to an Unstable Coronary Syndrome Is Marked 
by Hypercoagulability, Platelet Activation, Heightened 
Platelet Reactivity and Inflammation: Results of the 
Thrombotic Risk Progression Study##1202-250·196A
Usefulness of 64-Slice Multi-Detector Computed Tomography 
as a First Diagnostic Approach in Acute Chest Pain 
Patients## 831-4·106A
Usefulness of 64-Slice Multi-Slice Computed Tomography 
Coronary Angiography to Assess In-Stent Restenosis## 
852-3·113A
Usefulness of Multidetector Computed Tomography for 
Noninvasive Evaluation of Coronary Arteries in 
Asymptomatic Patients With Type 2 Diabetes##913-
229·160A
Usefulness of Multiple Detector-Row Computed Tomography 
in Renal Transplant Candidates##913-230·161A
Waist-to-Hip Ratio Is a Superior Predictor of Atherosclerosis 
Compared With Body Mass Index in a Population-Based 
Sample: Observations From the Dallas Heart Study## 
812-3·372A
Warfarin Treatment in Patients With Giant Coronary 
Aneurysms Caused by Kawasaki Disease##1023-27·264A
Which Psychological Risk Factors Best Predict Mortality in 
Coronary Patients?##1020-131·389A
Whole-Body and Myocardial Insulin Resistance in Type 
2 Diabetes Mellitus and Established Coronary Artery 
Disease: A BARI 2D Positron Emission Tomography 
Substudy##909-235·147A
Coronary circulation
A New Approach to Noninvasive Coronary Angiography 
by Multidetector Computed Tomography: Preliminary 
Experience Using Gadolinium##915-229·168A
Angiographic Based Prevalence of Cardiovascular Disease in 
Pre-renal Transplant Patients##1019-180·230A
Anomalous Coronary Origin and Course in 1,682 Patients 
Undergoing Computed Tomography Angiography##906-
229·135A
Bare Metal Stent Implantation Is Independent Predictor of 
Cardiac Death After Percutaneous Interventions on 
Unprotected Left Main Coronary Artery##1025-156·243A
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Criteria for Defining Coronary Segments Using Computed 
Tomography: The Core-64 Trial## 852-4·113A
Is Soluble Lectin-Like Oxidized Low-Density 
Lipoprotein Receptor-1 A Good Indicator for Early 
Detection of Myocardial Fibrosis in Hypertrophic 
Cardiomyopathy?##1028-99·92A
Serial Observation of Shear Stress and Atherosclerotic Plaque 
Formation by a Newly-Developed Topographic Shear 
Stress Imaging System With Use of Three-Dimensional 
Intravascular Ultrasound##1020-11·379A
Three-Dimensional Quantification of Coronary Plaque Burden 
by 64-Slice Computed Tomography: A PROSPECT-
MSCT Substudy## 852-5·114A
TIMI Grade 3 After Successful Percutaneous Coronary 
Intervention Reduced Myocardial Infarction Volume 
Assessed by Delayed Enhancement Magnetic Resonance 
Imaging.##908-233·143A
Coronary heart disease
Angiographic Based Prevalence of Cardiovascular Disease in 
Pre-renal Transplant Patients##1019-180·230A
Association of High-Density Lipoprotein Cholesterol with 
Coronary Heart Disease Risk Across Categories of Low-
Density Lipoprotein Cholesterol: the ARIC Study##1002-
126·326A
Associations of Serum Uric Acid With Markers of 
Inflammation, Metabolic Syndrome, and Subclinical 
Coronary Atherosclerosis##1002-10·317A
Atorvastatin Exhibits Differential Effects on Circulating 
OxLDL Markers in Patients With Acute Coronary 
Syndromes in the MIRACL Trial According to 
the Severity of Underlying Cardiovascular Risk 
Factors##1008-37·337A
Balance Between Serum S100A12 and S100A8 Predicts 
Presence and Complications of Coronary Artery 
Disease##1014-37·359A
Cardiometabolic Risk Factor Profile of United States and 
Caribbean-born Blacks##1026-130·411A
Circulating Endothelium- and Platelet-Derived Microparticles 
in Healthy Subjects and Patients With Coronary Artery 
Disease##1008-10·335A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography With Computed Tomography Cardiac 
Function Analysis and Quantitative Catheter Angiography 
to Myocardial Perfusion Imaging for Predicting 
Functionally Relevant Coronary Artery Stenosis##907-
230·139A
Comparison of Drug-Eluting Versus Bare Metal Stents: Timing 
of Subacute Thrombosis up to 2 Years##1019-154·227A
Cost-Effectiveness and Clinical Outcomes of Coronary 
Computed Tomographic Angiography Compared to 
Myocardial Perfusion Imaging for the Diagnosis of 
Coronary Artery Disease## 831-7·107A
Daily Oral Administration of the Apolipoprotein A-I Mimetic 
Peptide D-4F in Patients With Coronary Heart Disease 
or Equivalent Risk Improves High-Density Lipoprotein 
Anti-Inflammatory Function##1014-123·366A
Demand Ischemia Is the Predominant Etiology of Perioperative 
Myocardial Infarction: Implications for Perioperative Risk 
Stratification##1025-111·239A
Elective Percutaneous Coronary Intervention Without 
On-Site Surgical Backup: A Community Hospital 
Experience##1012-193·281A
Genetic Variation in UDP-Glucuronosyltransferase One Family 
Polypeptide A7 and Coronary Heart Disease: The ARIC 
Study##1008-164·347A
Growth-Differentiation Factor-15 for Early Risk Stratification 
in Patients With Acute Chest Pain##1007-111·200A
Impact of Renal Function on Mortality Prediction in Patients 
Undergoing Stress Myocardial Perfusion SPECT## 
841-4·109A
Importance of Left Ventricular End-Systolic Volume as a 
Predictor of Heart Failure Hospitalization in Patients With 
Coronary Heart Disease: Data From the Heart and Soul 
Study##916-222·170A
In-Hospital Mortality Predictors in Patients With ST-Elevation 
Acute Myocardial Infarction: Substudy of RENASICA 
Mexican Registry## 843-8·248A
Incidence and Characteristics of Coronary Spasm and 
Myocardial Bridge in Patients With Acute Myocardial 
Infarction##1019-113·224A
Increased Myocardial Prevalence of C-Reactive Protein 
in Human Coronary Heart Disease: Relation to Local 
Endothelial Injury and Microvessel Rarefaction##1007-
72·198A
Increased Risk of Coronary Heart Disease After Recurrent 
Cerebrovascular Events: Findings From the SPARCL 
Study## 804-4·351A
Incremental Prognostic Value of Rubidium-82 Myocardial 
Perfusion Positron Emission Tomography-Computed 
Tomography Imaging in Patients With Known or 
Suspected Coronary Artery Disease## 841-3·109A
Left Ventricular Reconstruction Improves Left Ventricular 
Geometry and Systolic Function as Assessed by Cardiac 
Magnetic Resonance Imaging##1028-139·95A
Long-Term Adherence to the American College of Cardiology/
American Heart Association Class I Post-Discharge 
Medications and Recommendations Using Optimal 
Medical Therapy in 2,287 Patients With Established 
Coronary Heart Disease: Interim Data From the 
COURAGE Trial##1007-196·206A
Long-Term Effects of Cardiac Rehabilitation in Men and 
Women## 842-8·111A
Metabolic Syndrome Versus Diabetes Mellitus Type II and 
Global Risk Scores for Predicting Future Cardiovascular 
Events##1020-163·389A
Modular Secondary Prevention Based on Patient Choice 
Improves Risk Factor Profile and Knowledge After 
Acute Coronary Syndrome: A Randomized Controlled 
Trial##1008-167·347A
One-Year Outcome After Coronary Revascularization Among 
Patients With Left Anterior Descending Artery Disease 
and Diabetic Retinopathy: Sirolimus-Eluting Stent Versus 
Coronary Bypass Surgery##1001-200·195A
Predictors for Developing a New Significant Lesion After 
Percutaneous Coronary Intervention: The Impact of 
Clinical Syndrome and the Smokers Paradox##1014-
6·356A
Randomized Placebo-Controlled Trial of Nicotinic Acid in 
Patients With Coronary Heart Disease and Low High-
Density Lipoprotein Cholesterol Despite 6 Weeks of 
Statin Therapy (LOW Study)##1014-124·366A
Safety and Efficacy of Bivalirudin in High-Risk Patients 
With Acute Coronary Syndrome Admitted Through the 
Emergency Department: Implications for Upstream 
Management## 802-4·208A
Small Dense Low-Density Lipoprotein (LDL)-Cholesterol Is a 
Superior Marker Than LDL-Cholesterol in Determining 
Severe Coronary Atherosclerosis##1002-168·329A
Socially Vulnerable Myocardial Infarction Patients Have a 
Higher Risk of Dying or Suffering Reinfarction: Are 
Extended Rehabilitation Programs a Solution?##1014-
167·369A
Statins Decrease the Risk of Acute Myocardial Infarction and 
Coronary Heart Disease Mortality in Patients With Renal 
Failure: A Meta-Analysis##1001-117·188A
Stress Echocardiography Can Safely, Rapidly and Accurately 
Risk Stratify Patients With Suspected Non-ST Elevation 
Acute Coronary Syndrome and an Initial 12-Hour 
Negative Troponin: Implications for Early Use of Stress 
Echocardiography in the Emergency Department##903-
225·123A
The Association of Income With Cardiovascular Disease 
Burden##1014-164·369A
The Prevalence and Incidence of Coronary Heart Disease 
Are Significantly Increased in Periodontitis: A Meta-
Analysis##1002-160·327A
The Relationship Between Plasma Fatty Acid Composition 
And Coronary Artery Disease in Hypercholesterolemic 
Patients: Findings From JELIS##1008-123·344A
Trends in Low Density Lipoprotein and Treatments in the 
United States Over the Last Decade##1001-175·193A
Verapamil-SR Strategy Is Comparable to Atenolol Strategy 
at Reducing Cardiovascular Events in Patients With 
Prior Myocardial Infarction: An INVEST Substudy## 
825-4·232A
Waist Circumference Reduction, Not Body Mass Index, 
Improves Endothelial-Dependent Vasodilatation After 
Acute Coronary Syndrome## 840-3·415A
What Is the Best Measure for Rewarding Quality of Care: 
Defect-Free Versus Composite Scoring? An Analysis 
From the American Heart Association’s Get With The 
Guidelines-Coronary Artery Disease Program## 817-
7·291A
Coronary microcirculation
A Gender-Specific Difference in Vasodilating Capacity of 
Coronary Arteries: Comparison Between Postmenopausal 
Women and Age-Matched Men##1025-175·244A
Cardiomyocyte Engraftment in Human Gender-Mismatched 
Heart Transplantation Preserves Microvascular 
Function##1028-106·94A
Characteristics of the Coronary Velocity Profiles of Patients 
With Decreased Coronary Flow Velocity Reserve Despite 
Normal Thallium Stress Test##903-235·125A
Increased Myocardial Prevalence of C-Reactive Protein 
in Human Coronary Heart Disease: Relation to Local 
Endothelial Injury and Microvessel Rarefaction##1007-
72·198A
Increased Pulse Pressure Reduces Coronary Flow Reserve 
in Patients With Chronic Aortic Regurgitation##1008-
202·349A
Increased Red Blood Cell Aggregation and Blood Viscosity 
in Cardiac Syndrome X as a Cause of Microcirculatory 
Dysfunction## 825-8·233A
Independent Role of Necrosis and Microvascular Obstruction 
in Early and Late Left Ventricular Remodeling After 
Reperfused Myocardial Infarction##1007-71·197A
Predictors of Reduced Coronary Flow Reserve in Heart 
Transplant Recipients Without Cardiac Allograft 
Vasculopathy: A Contrast-Enhanced Echocardiographic 
Study##904-226·127A
Quantification Methods for Determination of Myocardial 
Blood Flow During Real-Time Dobutamine Perfusion 
Contrast Echocardiography: Is It Necessary to 
Normalize?##911-226·153A
Relationship Between Neutrophil Count on Admission, 
Microvascular Injury, and Long-Term Outcomes in 
Patients Treated With Primary Coronary Angioplasty for 
Acute Myocardial Infarction##1001-159·192A
Relationship of Inflammation With Endothelial Dysfunction 
and Coronary Flow Reserve in Patients With Cardiac 
Syndrome X##1019-175·229A
The Fate of Adipose Stromal Cells Following Intracoronary 
and Retrograde Venous Myocardial Delivery in a Swine 
Infarct Model##1025-154·243A
Uric Acid as a Mediator of Coronary Microvascular 
Dysfunction and Inflammation: A Gender-Specific 
Study##1008-5·334A
Coronary sinus
Co-Registration of Doppler Tissue Velocity Data With Multi-
Slice Computed Tomography of the Coronary Veins to 
Optimize Left Ventricular Lead Placement for Cardiac 
Resynchronization Therapy##901-241·11A
Noninvasive Evaluation of Coronary Sinus Anatomy and Its 
Relation to the Mitral Valve Annulus: Implications for 
Percutaneous Mitral Annuloplasty##1003-20·299A
Coronary vasospasm
Clinical Significance of Urinary 8-Iso-Prostaglandin F2κ 
Concentration in Patients With Coronary Vasospastic 
Angina Pectoris##1025-177·245A
Experience of 1,000 Acetylcholine Spasm Provocation Tests: 
What Have We Learned?##1013-176·218A
Incidence and Characteristics of Coronary Spasm and 
Myocardial Bridge in Patients With Acute Myocardial 
Infarction##1019-113·224A
Incidence of Coronary Artery Ectasia and Its Relationship 
With Coronary Endothelial Dysfunction in Asian 
Population##1026-8·406A
Left Ventricular Apical Ballooning Syndrome in an 
European Population: Results of a Multicenter Italian 
Registry##1013-112·213A
Coronary venous
Cardiac Venous Anatomy in Congenitally Corrected 
Transposition of the Great Arteries Provides Delivery 
Options for Device-Related Therapies##1011-54·261A
Noninvasive Evaluation of Coronary Sinus Anatomy and Its 
Relation to the Mitral Valve Annulus: Implications for 
Percutaneous Mitral Annuloplasty##1003-20·299A
The Fate of Adipose Stromal Cells Following Intracoronary 
and Retrograde Venous Myocardial Delivery in a Swine 
Infarct Model##1025-154·243A
Coronary vessels
Clinical Outcomes of Drug-Eluting Stents Versus Bare Metal 
Stents in Patients With Severe Renal Insufficiency##1025-
95·239A
Coronary Computed Tomography Angiography and 
Myocardial Perfusion Imaging in Patients With Known or 
Suspected Coronary Artery Disease##917-228·175A
Diagnostic Accuracy of Gated Myocardial Perfusion Single-
Photon Emission Computed Tomography for Detection of 
Left Main Coronary Artery Disease##917-233·176A
Early Left Ventricular Dysfunction Is Associated With 
Coronary Artery Dilation in Kawasaki Disease##1017-
30·261A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Converting-Enzyme 
Inhibitors: Final Results of Captopril Combined With 
Valsartan in Acute Myocardial Infarction Study##1002-
6·316A
Fate of Small-Sized Side Branches After Coronary Stent 
Implantation##1013-156·217A
Imaging and Quantification of Coronary Plaque 
Neovascularization With Contrast-Enhanced Intravascular 
Ultrasound and a New Computational Image Analysis 
Technique##905-228·131A
Incidence of Coronary Artery Ectasia and Its Relationship 
With Coronary Endothelial Dysfunction in Asian 
Population##1026-8·406A
Noninvasive Coronary Angiography: 16-Slice Computed 
Tomography Versus 1.5 Tesla Magnetic Resonance 
Imaging Validated by Coronary Angiography##905-
230·131A
Pioglitazone Reduces Neointimal Response by Suppression of 
the Early Inflammatory Reaction via NFkB Dependent 
MCP-1 Mediated Pathway in a Porcine Coronary Stent 
Model## 849-7·419A
Predisposition to Acute Angle Take-Off and Narrow 
Ostial Coronary Artery Orifice Areas in Patients With 
Anomalous Coronary Arteries Identified on 64-Detector 
Coronary Angiography##918-228·178A
Relationship Between the Coronary Artery Anatomy and 
the Subeustachian Isthmus, Coronary Sinus Os-Middle 
Cardiac Vein, and Floor of Coronary Sinus##910-238·25A
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Statins Inhibit Cholesterol Crystallization and Prevent 
Perforation of Biological Membranes and Intima in 
Human Coronary Arteries of Patients With Acute 
Coronary Syndrome##1014-13·358A
Strain Rate Is Superior to Peak Systolic Strain for the 
Detection of Ischemia During Dobutamine Stress 
Echocardiography##902-225·119A
Systemic and Coronary Hemodynamics of Intravenous 
Clevidipine in Normal Pigs: A Comparison With 
Nitroprusside and Nitroglycerin##1014-202·371A
Cost-effectiveness
A Cost-Effective Analysis of 64-Row Cardiac Computed 
Tomography for the Diagnosis of Coronary Artery 
Disease in the Intermediate-Risk Population: A Reflection 
on Recent ACC CCT Appropriateness Criteria## 831-
8·107A
Anemia and Its Impact on Use of Hospital Resources in Heart 
Failure: Results of the EuroHeart Failure Survey##1022-
98·76A
Computed Tomography for Acute Chest Pain: Is It Time-and 
Cost-Effective?##902-229·121A
Cost and Effectiveness Comparison of Very Early Treatment 
With Primary Percutaneous Coronary Intervention 
Facilitated With Abciximab or Thrombolytic Therapy 
for Acute ST-Elevation Myocardial Infarction##1013-
116·214A
Cost-Benefit Analysis of the Use of Coronary Artery 
Calcium Score and Positron Emission Tomography in 
the Evaluation of Subjects With Indeterminate Tc-99m 
Single- Phonton Emission Computed Tomography Stress 
Test##908-235·143A
Cost-Effectiveness and Clinical Outcomes of Coronary 
Computed Tomographic Angiography Compared to 
Myocardial Perfusion Imaging for the Diagnosis of 
Coronary Artery Disease## 831-7·107A
Economic Evaluation of Intensive Atorvastatin Compared to 
Standard Simvastatin in Patients With Acute Coronary 
Syndrome From the IDEAL Trial##1030-181·294A
Economic Evaluation of the Anglo-Scandinavian Cardiac 
Outcomes Trial Blood Pressure Lowering Arm: 
A Substudy on Incremental Cost-Effectiveness of 
Amlodipine-Based Regimen Versus Atenolol-Based 
Regimen in Primary Prevention Among Hypertensive 
Patients With Additional Risk Factors##1020-173·392A
Economic Impact of Amlodipine in Normotensive Coronary 
Artery Disease Patients: Subgroup Analyses of 
Participants in the CAMELOT Trial##1026-168·413A
Optimizing Use of Telemetry Resources in an Academic 
Medical Center##1024-190·290A
The Cardiovascular Disease Prevention Model: A Model That 
Predicts Future Incidences of Cardiovascular Disease in 
Any Given Population and Undertakes Cost-Effectiveness 
Analyses of Primary Preventive Interventions##1012-
194·281A
The Cost Effectiveness of Functional Cardiac Testing in the 
Diagnosis and Management of Coronary Artery Disease: 
Principal Results From the CECaT Trial## 817-4·291A
Creatine kinase
Cardiac Release of Urocortin Precedes the Occurrence of 
Irreversible Myocardial Damage in the Rat Heart Exposed 
to Ischemia/Reperfusion Injury##1013-90·211A
Creatinine Kinase-MB Enzyme Elevation in the Presence 
of Normal Troponin Is a Powerful Predictor of 
Cardiovascular Complications in Non-ST-Segment 
Elevation Acute Coronary Syndrome##1019-158·228A
Cytokines
Angiotensin-Receptor Blocker, Not Calcium Channel 
Blocker, Reduced Plasma Osteopontin Level in Essential 
Hypertensive Patients With no Cardiovascular Events## 
848-7·417A
Aortic Stiffness Is Increased in Patients With Hepatitis C Virus 
Seropositivity##1020-79·383A
Carbon Monoxide Donors or Heme Oxygenase-1 
Overexpression Block Interleukin-18-Mediated NF-
kB-PTEN-Dependent Human Cardiac Endothelial Cell 
Death##1020-8·378A
Cellular Basis for the Negative Inotropic Effects of High-
Mobility Group Box 1 in the Adult Mammalian Heart## 
829-7·86A
Chronic Stress Induces a Pro-Inflammatory Response: 
Implications for Cardiovascular Disease##1026-7·400A
Disruption of the Smad3 Signaling Pathway Attenuates Post-
Infarction Remodeling##1013-71·210A
Dynamic Responses of Proinflammatory Markers 
and Oxidative Stress Induced by Postchallenge 
Hyperglycemia Are Associated with Coronary Artery 
Disease in Patients Without Previous Diagnosis of Type 2 
Diabetes Mellitus##1002-43·320A
Effects of Ramipril on Endothelial Function and Inflammatory 
Process in Young Normotensive Patients With 
Successfully Repaired Coarctation of the Aorta## 837-
7·268A
Effects of SIV Infection and Immunostimulation on the 
Development of Myocarditis and Contractile Dysfunction 
in Rhesus Macaques## 801-8·61A
Endothelial Function, Inflammatory Process and Oxidative 
Stress in Chronic Atrial Fibrillation: The Impact of Left 
Atrium Distention##907-238·21A
Erectile Dysfunction and Coronary Artery Disease Confer 
an Almost Similar Inflammatory and Endothelial/
Prothrombotic Activation##1020-78·383A
Fibroblast Growth Factors Promote Proliferation of Sca-1+ 
Cardiac Stem Cells##1025-93·238A
G-CSF Inhibits Doxorubicin-Induced Cardiac Dysfunction 
by Suppressing of the Generation of Reactive Oxygen 
Species## 829-6·86A
Growth-Differentiation Factor-15 for Early Risk Stratification 
in Patients With Acute Chest Pain##1007-111·200A
In Patients With Heart Failure Elevated Soluble Tumor 
Necrosis Factor Receptor 1 Is Associated With Higher 
Risk of Depression##1004-61·43A
Inflammatory Markers, Angiographic Severity of Coronary 
Artery Disease, and Patient Outcome##1008-42·338A
Interleukin-17 Stimulates C-Reactive Protein Expression 
in Hepatocytes and Smooth Muscle Cells via P38 
MAPK and ERK1/2-Dependent NF-κB and C/EBPβ 
Activation##1008-7·335A
Interleukin-18 Suppresses Adiponectin Expression in 3T3L1 
Adipocytes via a Novel Signal Transduction Pathway 




 Inhibition Reduces 
Generation of Hydroxy-Fatty Acids##1014-87·364A
Low-Grade Inflammation and Hypoadiponectinemia Have 
an Additive Detrimental Effect on Aortic Stiffness in 
Essential Hypertensive Patients: A “Double-Edged 
Sword” of Vascular Damage##1002-36·318A
Pioglitazone Increases Adiponectin Levels in Nondiabetic 
Patients With Coronary Artery Disease##1002-125·326A
Pravastatin Increases Circulating Level of Adiponectin via 
Up-Regulation of Gene Expression of Adiponectin in 
Visceral Adipose Tissue but Not in Subcutaneous Adipose 
Tissue in Patients With Coronary Artery Disease##1020-
123·387A
Predictive Value of High-Sensitivity C-Reactive Protein 
in the Diagnosis and Prognosis of Acute Aortic 
Syndromes##1008-84·341A
Pro-Inflammatory Responses After Intracoronary Injections of 
Autologous Mononuclear Bone Marrow Cells in Patients 
With Acute Myocardial Infarction##1001-132·189A
Relationships Between Adiponectin and Markers of Oxidative 
Stress in High-Risk Patients for Coronary Artery 
Disease##1002-41·319A
Simvastatin Exerts Its Anti-Inflammatory Effect in 
Hypercholesterolemic Patients Mainly by Decreasing 
the Serum Levels of Monocyte Chemoattractant Protein-
1##1008-130·345A
Six-Minute Corridor Walking Performance Correlates With 
Subclinical Inflammation in Patients With Newly-
Diagnosed Systolic Heart Failure##915-236·169A
The Expression of Toll-Like Receptor2 in Patients With 
Nonvalvular Atrial Fibrillation##902-234·12A
The Novel Cytokine Interleukin-17 Stimulates MMP-1 
Expression In Primary Human Cardiac Fibroblasts via 
p38 MAPK And ERK-Dependent C/EBPκ, NF-κB, and 
AP-1 Activation##1010-56·52A
Thoracic Electric Impedance and Its Changes After Multiple 
Shocks for External Cardioversion of Atrial Fibrillation: A 
Role for Acute Inflammatory Response?##906-242·20A
Death, sudden
Blood Urea Nitrogen Levels and the Risk of Sustained 
Ventricular Arrhythmias and Sudden Cardiac Mortality 
in Patients With Left Ventricular Dysfunction.##917-
241·37A
Development of New Electrocardiographic Strain Pattern 
During Antihypertensive Therapy Is Associated With 
Increased Incidence of Sudden Cardiac Death: The LIFE 
Study##1002-202·331A
No Delay in Sudden Death but Contribution Diminishes in 
Advanced Heart Failure: Comparison From SCD-HeFT to 
ESCAPE##1016-142·71A
Post-Percutaneous Coronary Intervention Statin Usage and 
Long-Term Mortality: Is Statin Intolerance a Predictor of 
Adverse Outcome?## 804-3·350A
Sirolimus-Eluting Stent Implantation for the Percutaneous 
Treatment of Unprotected Left Main Coronary Artery 
Disease: A Clinical Analysis Based on J-CYPHER 
Registry##1013-178·218A
Smart ECG: Solution for Mobile Heart Work Analysis 
and Medical Interventions in Case of Heart Work 
Problems##1012-190·280A
Decision making, computer-assisted
Composite Measure Performance in Get With The Guidelines: 
Coronary Artery Disease, Stroke, Heart Failure##1006-
146·272A
Patient Refined Expectations Deciding Invasive Cardiac 
Treatment (PREDICT)##1018-193·286A
Defibrillation, atrial
Inadvertent Cardioversion During Routine Defibrillation 
Testing in Patients With Atrial Fibrillation Undergoing 
Defibrillator Implantation##908-241·23A
Thoracic Electric Impedance and Its Changes After Multiple 
Shocks for External Cardioversion of Atrial Fibrillation: A 
Role for Acute Inflammatory Response?##906-242·20A
Defibrillation, ventricular
Access to Implantable Cardioverter Defibrillator Therapy 
for Patients With MADIT-Like Criteria in Clinical 
Practice##910-241·26A
Achieving Sufficient Defibrillation Safety Margins With 
Fixed Duration Waveforms and the Use of Multiple Time 
Constants##907-241·21A
Delayed Time to Defibrillation and Mortality After In-Hospital 
Ventricular Tachyarrhythmic Cardiac Arrest##1001-
197·195A
Intraoperative Optimization of Cardiac Resynchynchronization 
Therapy Using Intracardiac Echocardiography Can 
Enhance Response and Outcomes in Refractory Heart 
Failure##1010-143·59A
Synchronizing Transthoracic Shocks for Ventricular 
Fibrillation to the Surface Electrocardiogram Does Not 
Improve Defibrillation Success##916-241·36A
Defibrillators, implantable
Arrhythmic Risk Stratification After Myocardial Infarction 
in the MADIT II Era: Should We Consider Infarct 
Localization?##901-240·11A
Blood Urea Nitrogen Levels and the Risk of Sustained 
Ventricular Arrhythmias and Sudden Cardiac Mortality 
in Patients With Left Ventricular Dysfunction.##917-
241·37A
Comparison of Complication Rates Between Outpatient and 
Inpatient Implantation of Cardiac Resynchronization 
Therapy Devices##918-241·39A
Complication Rate Following Device Implantation in Patients 
With Impaired Renal Function##903-242·15A
Composite Holter-Based Risk Stratifier Identifies Low-
Risk Postinfarction Patients With Left Ventricular 
Dysfunction##911-242·28A
Defibrillation Thresholds and Safety Profiles With Cardiac 
Resynchronization Therapy Devices Are Similar to 
Standard Implantable Cardiac Defibrillators##915-
241·34A
Devices in Heart Failure: A Systematic Review of the Efficacy, 
Effectiveness and Safety of Implantable Cardioverter 
Defibrillators and Cardiac Resynchronization Therapy in 
Left Ventricular Dysfunction## 830-7·7A
Fragmented QRS Complexes on 12-Lead ECG Predicts 
Arrhythmia Events in Patient With Ischemic 
Cardiomyopathy##912-241·30A
Gray Zone, Scar Size, and Ejection Fraction Are Determinants 
of Arrhythmic Risk in MADIT II Patients##914-232·165A
High Prevalance of Left Atrial Thrombus in Patients With 
Atrial Fibrillation Undergoing Defibrillator Implantation: 
A Case for Routine Transesophageal Echocardiographic 
Screening##915-224·167A
ICD Therapy and Outcomes in Survivors of Sudden Cardiac 
Arrest After High-Risk Myocardial Infarction: The 
VALsartan in Acute Myocardial INfarction Trial## 830-
5·6A
Impact of Race and Gender on Likelihood of Implant of 
Cardiac Defibrillators and Biventricular Pacemakers 
in Patients With Reduced Left Ventricular Systolic 
Function## 830-6·6A
Implantable Cardioverter Defibrillator Therapy Improves 
the Survival of Patients With Prior Coronary 
Revascularization: Data From the SCD-HeFT Trial##901-
242·12A
Inadvertent Cardioversion During Routine Defibrillation 
Testing in Patients With Atrial Fibrillation Undergoing 
Defibrillator Implantation##908-241·23A
Influence of Lead Location on Clinical Outcomes With Cardiac 
Resynchronization: Experience From the DECREASE-HF 
Study##902-242·13A
Is Outpatient Implantation of Biventricular Devices 
Safe?##905-242·18A
Isolated Left Ventricular Diastolic Dysfunction Immediately 
After Defibrillation Threshold Testing in Patients With 
Implantable Cardioverter Defibrillator##909-221·144A
Microvolt T-Wave Alternans Does Not Predict Appropriate 
Implantable Defibrillator Discharges or Correlate 
With Traditional Risk Factors for Sudden Cardiac 
Death in Patients With Hypertrophic Obstructive 
Cardiomyopathy##912-242·30A
Morbidity and Mortality Associated With Device Generator 
Replacement##911-241·28A
Mortality of Heart Failure Patients After Cardiac 
Resynchronization Therapy: Choice of Device and 
Identification of Predictors## 830-8·7A
No Delay in Sudden Death but Contribution Diminishes in 
Advanced Heart Failure: Comparison From SCD-HeFT to 
ESCAPE##1016-142·71A
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Programming Ventricular Tachycardia Therapy in Patients 
With a Primary Prevention Implantable Cardioverter 
Defibrillator Indication: Preliminary Results From the 
PROVE Trial## 830-4·6A
Quantitative Tagged Magnetic Resonance Imaging Strain 
Assessment of Mechanical Dyssynchrony in Patients With 
Narrow and Wide QRS Complexes##906-233·136A
Real-Time Three-Dimensional Echocardiography Is Superior 
to Inducibility on Electrophysiological Testing for 
Predicting Adverse Clinical Outcomes Among Post-
Myocardial Infarction MADIT-II Patients## 813-8·104A
Shock-Free Survival in Patients With Hypertrophic Obstructive 
Cardiomyopathy and Implantable Defibrillators Following 
Alcohol Septal Ablation##919-241·40A
Single Center Experience With Complications due to Two 
Manufacturers’ Recent Device Advisories##914-241·32A
Use of Implantable Cardioverter Defibrillators in Patients With 
Left Ventricular Assist Devices##909-241·24A
Utility of Lead and Generator Cultures in Managing Cardiac 
Device Infections##913-241·31A
Diabetes mellitus
Are Fatness and Fitness Related to Microvascular Reactivity in 
Hypertensive Diabetics?## 840-8·416A
Association Between Baseline Low-Density Lipoprotein 
Cholesterol, Triglycerides, and High-Density Lipoprotein 
Cholesterol Levels and the Lipid-Altering and hs-C-
Reactive Protein Efficacy of Ezetimibe/Simvastatin 
Versus Atorvastatin in Patients With Type 2 Diabetes 
and Hypercholesterolemia: The VYTAL Study##1008-
127·345A
Atherogenic Vascular and Lipid Phenotypes in Juvenile Type 
One Diabetes Are Influenced by HLA-Related Diabetes 
Susceptibility##1026-11·401A
Cardiac Structure and Function in Diabetics With Acute 
Myocardial Infarction Complicated by Heart Failure, Left 
Ventricular Dysfunction, or Both: The VALIANT Echo 
Study##903-222·122A
Cardiovascular Outcomes in Patients With Diabetes Mellitus, 
Metabolic Syndrome, or Neither Condition With New 
Diagnosis of Coronary Artery Disease##1020-120·368A
Comparison of Statin Treatment of Hypercholesterolemic 
Patients in Ethnically Diverse Populations With and 
Without Diabetes##1002-130·327A
Comparison of the Risk Associated With Diabetes Mellitus in 
Patients With Preserved and Low Ejection Fraction Heart 
Failure: An Analysis of the Candesartan in Heart Failure 
Assessment of Reduction in Mortality and Morbidity 
(CHARM) Program## 614-5·61A
Coronary Artery Calcium Score and Noninvasive Angiography 
With Multi-Slice Computed Tomography: Comparison 
to Myocardial Perfusion Imaging in Asymptomatic 
Diabetics##919-233·183A
Do Thiazolidinediones Worsen Heart Failure in Patients With 
Type 2 Diabetes Mellitus and Structural Heart Disease? 
Study With Doppler Echocardiography##1010-99·56A
Dynamic Responses of Proinflammatory Markers 
and Oxidative Stress Induced by Postchallenge 
Hyperglycemia Are Associated with Coronary Artery 
Disease in Patients Without Previous Diagnosis of Type 2 
Diabetes Mellitus##1002-43·320A
Effect of Amlodipine on the Clinical Outcome in Diabetic 
Patients With Coronary Artery Disease After Angioplasty: 
Results From the Cardiovascular Events Follow-Up Trial 
in Kokura##1007-176·205A
Effect of Atorvastatin in Patients With Metabolic Syndrome 
and Type 2 Diabetes: Subgroup Analysis of the 
Collaborative Diabetes Study##1020-118·368A
Effect of Beta-Blockade on the Association Between Cardiac 
Autonomic Dysfunction and Inflammation in Type 1 
Diabetic Patients##918-242·39A
Effect of Diabetes and Glomerular Filtration Rate on 6-
Month Outcomes in Patients Undergoing Cardiac 
Catheterization##1012-147·278A
Effect of Glycemic Control in a Canine Model of Diabetes 
and Left Ventricular Dysfunction on Left Ventricular 
Performance: Utility of the Index of Myocardial 
Performance## 807-6·62A
Effect of Statins on Thermal Heterogeneity of Atherosclerotic 
Plaques in Patients With Diabetes Mellitus##1020-
35·380A
Effects of Acute Hyperglycemia on Endothelial Function and 
Inflammatory Process in Newly Diagnosed Diabetes 
Mellitus Type 2: The Impact of Diet and Metformin 
Treatment##1008-89·343A
Effects of Candesartan Versus Losartan on Insulin Levels, 
Lipid Profile and Blood Pressure in Patients With Mild 
Hypertension, Hyperinsulinism and Dyslipidemia## 
848-6·417A
Efonidipine Simultaneously Improves Endothelial 
Function and Metabolic Parameters In Patients With 
Hypertension##1002-5·316A
Endothelial Dysfunction and Circulating Endothelial 
Progenitor Cells in Young People With Type 1 
Diabetes##1025-117·241A
Favorable Effect of Statins on Local Inflammatory Activation 
in Nonculprit Lesions of Patients With Multivessel 
Coronary Artery Disease##1019-94·223A
Glycemic Control and the Length of Hospital Stay in Patients 
With Diabetes and Heart Failure: A Prospective Cohort 
Study##1022-65·75A
Glycemic Control Associated With Reductions in Myocardial 
Infarction and Coronary Artery Bypass Graft## 833-
3·396A
Impact of Diabetes Mellitus on Local Inflammatory Activity 
in Nonculprit Lesions: An Additional Inflammatory 
Trigger?##1020-127·388A
Impact of High Clopidogrel Maintenance Dosing on Thrombin 
Generation in Patients With Diabetes Mellitus##1026-
4·403A
Impact of Renal Dysfunction, Glucometabolic Status, and 
Quality of Care on One Month Mortality After Acute 
Myocardial Infarction##1020-128·388A
Impaired Therapeutic Potential of Bone Marrow-Derived 
Endothelial Progenitor Cells in the Metabolic Syndrome 
and Diabetes Mellitus##1026-39·403A
Is Diabetes a Significant Risk Factor in Contemporary 
Percutaneous Coronary Intervention (PCI)?##1007-
178·205A
Lack of Clinical Response in Diabetic Patients After 
Transendocardial Injection of Bone Marrow Mononuclear 
Cells##1016-139·71A
Mechanisms of Platelet Hyperreactivity in Type One and Type 
Two Diabetes##1026-2·399A
Metabolic Syndrome Predicts Cardiovascular Outcome 
Independently of Left Ventricular Hypertrophy: The 
Strong Heart Study## 812-5·373A
Metabolic Syndrome Versus Diabetes Mellitus Type II and 
Global Risk Scores for Predicting Future Cardiovascular 
Events##1020-163·389A
Mortality After Serious Heart Failure: Results From 
PROactive##1016-65·66A
Nifedipine Added to the Combination With Pravastatin and 
Olmesartan Shows Preventive Effect on Hypoxia-Induced 
Left Ventricular Remodeling in Diabetes Mellitus##1008-
205·349A
One-Year Outcome After Coronary Revascularization Among 
Patients With Left Anterior Descending Artery Disease 
and Diabetic Retinopathy: Sirolimus-Eluting Stent Versus 
Coronary Bypass Surgery##1001-200·195A
Outcomes After Acute Myocardial Infarction in Systemic 
Lupus Erythematosus as Compared to Diabetes 
Mellitus## 843-7·248A
Phosphorylation of 5-Lipoxygenase by Protein Kinase A 
Determines Whether Cardiomyocytes Will Produce 15-
Epi-Lipoxin A4 or Leukotriene B
4
 When Incubated With 
Atorvastatin and Pioglitazone##1002-8·316A
Postchallenge Plasma Glucose Is Associated With Arterial 
Stiffness in Nondiabetic Healthy Men##1002-85·323A
Preserving Systolic Function: Two Studies Demonstrate Safety 
of Pioglitazone in Patients With Type 2 Diabetes Mellitus 
and Heart Failure##1016-64·66A
Prognostic Value of Stress Gated SPECT Imaging in Diabetics: 
Contribution of Perfusion and Function for Prediction of 
Adverse Cardiac Outcome## 841-8·110A
Race/Ethnicity and Incident Congestive Heart Failure: The 
Multi-Ethnic Study of Atherosclerosis## 835-5·87A
Sex, Prescribing Practices, and Guideline Recommended 
Treatment Goals at Baseline in the BARI 2D 
Study##1001-176·193A
Sustained Release of Prostaglandin E1 Ameliorates 
the Impaired Therapeutic Angiogenesis by Basic 
Fibroblast Growth Factor in Diabetic Murine Hindlimb 
Ischemia##1014-39·359A
The Association Between Adherence to the Mediterranean 
Diet and Fasting Indices of Glucose Homoeostasis: The 
ATTICA Study##1020-126·388A
The Benefits of the Fixed-Dose Combination of Isosorbide 
Dinitrate and Hydralazine in A-HeFT Are Not Influenced 
by the Absence or Presence of Diabetes##1004-65·44A
The Effects of Rosiglitazone Versus Glyburide on Endothelial 
Function and Oxidative Stress in Patients With Type Two 
Diabetes##1026-10·401A
The Long-Term Safety and Efficacy of Combined Simvastatin 
and Fenofibrate Therapy in Diabetic Patients With 
Dyslipidemia: The DIACOR Study##1008-125·344A
Tissue-Specific Angiotensin-Converting Enzyme (ACE) 
Inhibitors in Prevention of Cardiovascular Disease 
in Patients with Diabetes Mellitus and Preserved 
Left Ventricular Function: A Pooled Bayesian Meta-
Analysis##1026-173·414A
Transplantation of Bone Marrow Mesenchymal Stem Cells 
Induces Angiogenesis and Attenuates the Remodeling of 
Diabetic Cardiomyopathy## 807-5·62A
Urotensin II Is a Major Risk Biomarker for Stroke in Type 2 
Diabetes##1002-46·320A
Usefulness of Multidetector Computed Tomography for 
Noninvasive Evaluation of Coronary Arteries in 
Asymptomatic Patients With Type 2 Diabetes##913-
229·160A
Whole-Body and Myocardial Insulin Resistance in Type 
2 Diabetes Mellitus and Established Coronary Artery 
Disease: A BARI 2D Positron Emission Tomography 
Substudy##909-235·147A
Diagnosis, computer-assisted
Accuracy of Three-Dimensional Quantititive Coronary 
Analysis by Comparison With Intravascular 
Ultrasound and Two-Dimensional Quantitive Coronary 
Analysis##1013-179·219A
Determination of Optimal Viewing Angles for X-Ray Coronary 
Angiography Based on a Quantitative Analysis of 3D 
Reconstructed Models##1030-188·296A
Diagnostic accuracy of 64-Slice Computed Tomography 
Coronary Angiography in Patients With Unstable 
Angina and Non-ST-Segment Elevation Myocardial 
Infarction##915-230·168A
Diagnostic Accuracy of 64-Slice Computed Tomography 
Versus Conventional Coronary Angiography: Results of 
300 Consecutive Patients##904-229·128A
Quantitative Assessment of Mechanical Valve Using Multi-
Detector Computed Tompgraphy##1027-21·313A
Smart ECG: Solution for Mobile Heart Work Analysis 
and Medical Interventions in Case of Heart Work 
Problems##1012-190·280A
Strain and Strain Rate by Velocity Vector Imaging 
in Diagnosing Acute Rejection After Heart 
Transplantation##1010-107·57A
Diagnostic techniques
A Biomarker for Diagnosing Acute Aortic Dissection: 
Preliminary Experience With the Smooth Muscle 
Troponin-Like Protein, Calponin## 814-3·374A
A Combination of Multislice Computed Tomography 
and Coronary Flow Reserve Measured by Doppler 
Echocardiography Improves the Diagnostic Accuracy in 
the Left Anterior Descending Coronary Artery Stenosis 
With Severe Calcification##919-228·182A
A Cost-Effective Analysis of 64-Row Cardiac Computed 
Tomography for the Diagnosis of Coronary Artery 
Disease in the Intermediate-Risk Population: A Reflection 
on Recent ACC CCT Appropriateness Criteria## 831-
8·107A
A Novel Clinical Indicator Using Tc-99m Sestamibi for 
Evaluating Cardiac Mitochondrial Function in Patients 
With Cardiomyopathies## 807-3·61A
Accuracy of Fully Quantitative Cardiac Magnetic Resonance 
Myocardial Perfusion in Detection of Coronary Disease 
as Measured by Quantitative Coronary Angiography## 
824-6·105A
Anatomic Evaluation of the Right Atrial Cavo-Tricuspid 
Isthmus by Multi-Detector Computed Tomography##903-
237·14A
Atherosclerotic Plaque Inflammation and Calcification: A 
Negative Relationship Imaged Using Fluorodeoxyglucose 
Positron Emission Tomography and Computed 
Tomography##1014-35·358A
Can the Burden of Coronary Atherosclerosis Be Predicted 
by a Patient’s Pretest Probability for Coronary Artery 
Disease?##903-229·124A
Combined Positron Emission Tomography and Tagging 
Magnetic Resonance Imaging Reveal Altered Patterns 
of Regional Function and Metabolism in Ventricular 
Dyssynchrony##901-236·117A
Comparison of Five Different Cardiac Troponin Assays in 
Patients With End-Stage Renal Disease on Chronic 
Hemodialysis##1013-69·209A
Coronary Intervention Rates Following Coronary 
Angiography Without Prior Stress Testing: Results 
From the Investigation of National Coronary Disease 
Identification##1013-75·210A
Determination of Optimal Viewing Angles for X-Ray Coronary 
Angiography Based on a Quantitative Analysis of 3D 
Reconstructed Models##1030-188·296A
Diagnostic Accuracy of Global and Regional Left Ventricular 
Function Measured by 64-Slice Multi-Detector Computed 
Tomography for Acute Coronary Syndrome in Patients 
With Acute Chest Pain##912-230·157A
Diagnostic Accuracy of Multidetector 64-Slice Computed 
Tomography Coronary Angiography in Assessing Patency 
of Coronary Artery Bypass Grafts##910-230·150A
Effect of Patient Age on the Presence of Soft Plaque in Patients 
Without Evidence of Coronary Calcification on 64-
Detector Cardiac Computed Tomography##917-230·175A
Fragmented QRS on 12-Lead ECG Is a Sign of Recent Non-ST 
Elevation Myocardial Infarction in Patients With Acute 
Coronary Syndrome##1001-114·188A
Impact of a Cardiovascular Limited Ultrasound Examination 
Using a Hand-Carried Ultrasound Device: Changes 
in Clinical Management Outcomes in a Primary-Care 
Clinic##1008-162·346A
Improved Detection of Stress-Induced Ischemia Using 
Analysis of High-Frequency ECG Components## 842-
3·110A
Is Elastin Really Useful for Marker of Acute Aortic 
Dissection?##1002-76·321A
Left Ventricular Volumes and Regional Wall Motion by 
Multislice Computed Tomography as Compared to 
Magnetic Resonance Imaging Using the Tagging 
Technique##901-232·117A
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Liver Function Test Abnormalities and Outcome in Patients 
With Chronic Heart Failure: Data From the Candesartan 
in Heart Failure Assessment of Reduction in Mortality and 
Morbidity (CHARM) Program##1004-66·44A
Lung Echo and Cardiac Doppler Study Can Diagnose the 
Etiologies of Acute Respiratory Distress in the Emergency 
Room##1204-266·277A
Microvolt T-Wave Alternans Does Not Predict Appropriate 
Implantable Defibrillator Discharges or Correlate 
With Traditional Risk Factors for Sudden Cardiac 
Death in Patients With Hypertrophic Obstructive 
Cardiomyopathy##912-242·30A
Molecular Imaging of Post-Ischemic Inflammation With 
Contrast Ultrasound and Microbubbles Bearing Dimeric 
P-Selectin Glycoprotein Ligand-1##910-226·149A
Normal Results on 64-Detector Coronary Computed 
Tomography Angiography Predict Excellent Outcomes at 
1-Year Follow-Up## 831-3·106A
Normal Values Differ Between Right Ventricular and Left 
Ventricular Measurements of Doppler-Derived Velocity, 
Displacement, Strain Rate, and Strain##906-224·134A
Novel Assessment of Aortic Stenosis Using Real-Time 
Three-Dimensional Echocardiography: Comparison of 
Continuity Equation-Derived Aortic Valve Area With 
Planimetry##908-223·141A
Patients With Acute Anginal Symptoms Frequently Do 
Not Receive Initial Electrocardiography: Results 
From the Investigation of National Coronary Disease 
Identification##1024-182·288A
Predictive Value of Coronary CT Angiography for Late 
Adverse Cardiac Events in Patients With Chest Pain 
Syndromes## 831-5·106A
Preload Independence of Diastolic Torsional Dynamics 
Evaluated by Two-Dimensional Ultrasound Speckle 
Tracking Imaging##910-227·149A
Real-Time Three-Dimensional Echocardiography and Its 
Potential Role in Cardiac Resynchronization Therapy 
Patient Selection: Ready for Prime Time?##907-224·137A
Red Cell Distribution Width as a Novel Prognostic Marker in 
Heart Failure: Data From the CHARM Program and the 
Duke Databank## 835-6·88A
Simvastatin Attenuates Plaque Inflammation Evaluation 
by 18F-Fluoro-2-Deoxyglucose Positron Emission 
Tomography##1026-47·405A
Strain and Strain Rate by Velocity Vector Imaging 
in Diagnosing Acute Rejection After Heart 
Transplantation##1010-107·57A
Transesophageal Echocardiographic Direct Measurement of 
Left Ventricular Outflow Tract Area Improves Accuracy 
of Aortic Valve Area Determination by the Continuity 
Equation in Aortic Stenosis##909-224·145A
Ultrasound Lung Comet Is Useful and Specific Sign of Lung 
Disease: Importance of Doppler Study to Diagnose Lung 
Congestion##1018-190·285A
Use of Multidetector Computer Tomography Angiography 
Following Abnormal Myocardial Perfusion Stress Testing 
in a Large Single-Specialty Cardiology Practice## 831-
6·106A
Use of Positron Emission Tomography and Computed 
Tomography to Discriminate Between Ischemic and 
Nonischemic Dilated Cardiomyopathy##913-228·160A
Usefulness of 64-Slice Multi-Detector Computed Tomography 
as a First Diagnostic Approach in Acute Chest Pain 
Patients## 831-4·106A
Usefulness of 64-Slice Multi-Slice Computed Tomography 
Coronary Angiography to Assess In-Stent Restenosis## 
852-3·113A
Utility of Magnetic Resonance Imaging-Derived End-Diastolic 
Volume Ratio in Diagnosis of Arrhythmogenic Right 
Ventricular Dysplasia##1028-103·93A
Variation of Coronary Artery Size With End-Systolic to 
Mid-Diastolic Triggering With Computed Tomography 
Angiography##912-229·157A
Vascular Inflammation Evaluated by 18F-Fluorodeoxyglucose 
Positron Emission Tomography Is Associated With the 
Metabolic Syndrome##1014-5·356A
Volume and Mix of Cardiac Diagnostic Procedures Before and 
After the Introduction of a Multidetector Computered 
Tomography Angiography in a Large Single-Specialty 
Cardiology Practice##914-230·165A
Diastole
β-adrenergic Stimulation Acutely Increases Myocardial 
Distensibility - A PKA, PKC And Na+/H+ Exchanger 
Mediated Effect##1026-88·407A
Alterations in Perioperative Doppler Indices of Diastolic 
Function Predict Postoperative Course in Children 
Undergoing Congenital Heart Surgery##1023-49·265A
Analysis of End-Systolic Intraventricular Pressure Gradients 
Improves the Noninvasive Assessment of Left Ventricular 
Relaxation## 834-3·107A
Angiotensin II-Induced Increase in Myocardial Distensibility Is 
Modulated by the Endocardial Endothelium, Endothelin-1 
and Nitric Oxide##1010-57·53A
Brain Natriuretic Peptide and Severity of Diastolic 
Dysfunction: Interaction With Left Ventricular Geometry 
and Function in Mild-Moderate Heart Failure: The 
AREA-IN-CHF Study##1010-68·55A
Calculation of Peak Filling Rate by Real-Time Three-
Dimensional Echocardiography for Detection of Diastolic 
Abnormalities During Adenosine Stress Nuclear Perfusion 
Imaging##908-225·141A
Changes in Diastolic Function Induced by Surgical 
Ventricular Restoration in Patients With Ischemic Dilated 
Cardiomyopathy##1016-145·72A
Chronic Therapy With Cardiac Contractility Modulation 
Electric Signals Normalizes mRNA and Protein 
Expression of Titin and Tubulin in Dogs With Heart 
Failure##1004-142·49A
Coronary Endothelial Dysfunction and Hyperlipidemia Are 
Independently Associated With Diastolic Dysfunction in 
Humans##1014-9·357A
Diagnosis of Coronary Artery Disease by Detection of 
Post-Ischemic Diastolic Dyssynchrony After Treadmill 
Exercise Using Strain Image Derived From 2D Speckle 
Tracking##918-224·177A
Diastolic and Systolic Asynchrony in Patients With Diastolic 
Heart Failure: A Common but Ignored Condition##918-
227·178A
Diastolic Function Analysis by Echocardiography Predicts 
Mortality Incremental to Clinical Risk and Ejection 
Fraction##910-221·148A
Diastolic Function in Primary Aldosteronism: A Tissue Doppler 
Imaging Approach##1002-206·332A
Diastolic Index of Color Kinesis Can Noninvasively Detect 
Therapeutic Effects of Angiotensin II Receptor Blocker 
on Left Ventricular Diastolic Function In Hypertensive 
Diastolic Heart Failure Model.##911-228·153A
Diverse Cardiac Geometry and Cardiorenal Interaction in 
Diastolic Heart Failure##1201-245·51A
Do Statins Improve Survival in Patients With Diastolic 
Dysfunction?##1020-121·368A
Doppler Restrictive Filling Pattern Is an Independent Predictor 
of Survival in Patients With Heart Failure of Both 
Ischemic and Nonischemic Etiology: Results From an 
Individual Patient Meta-Analysis##905-221·129A
Effect of Intramyocardial Bone Marrow Cell Injection on 
Diastolic Function in Patients With Chronic Myocardial 
Ischemia##912-222·155A
Elevated Pro-Inflammatory High Density Lipoprotein in 
Primary Systemic Amyloidosis: Potential Role of 
Oxidative Stress in Cardiac Injury##1004-101·46A
Endogenous Methylated Arginine Derivatives in Patients 
With Chronic Systolic Heart Failure: Relationship With 
Echocardiographic Indices and Clinical Outcomes## 
835-7·88A
Excessive Inotropic Response During Exercise Testing Is 
Associated With Left Ventricular Diastolic Dysfunction 
Detected by Tissue Doppler Imaging: Understanding 
the Prognostic Role of Blood Pressure Elevation at Peak 
Exercise in Hypertensives##913-236·162A
Heterogeneity of Diastolic Characteristics by the Same Level 
of Systolic Dysfunction in Mild Heart Failure: The 
AREA-IN-CHF Study##1004-100·46A
High-Resolution Echocardiography Indicates Diastolic 
Dysfunction Without Hypertrophy in a Novel Murine 
Model of Hypertrophic Cardiomyopathy##1022-59·74A
Incremental Value of Measuring Systolic Mitral Annular 
Velocity and Time Difference Between Onset of Mitral 
Inflow and Onset of Early Diastolic Mitral Annular 
Velocity for Differentiating Constrictive Pericarditis From 
Restrictive Cardiomyopathy##1010-101·56A
Is Rhythm Control Superior to Rate Control in Patients With 
Atrial Fibrillation and Diastolic Heart Failure?## 819-
5·5A
Is Vascular Dysfunction the Forerunner of Paroxysmal Atrial 
Fibrillation in Hypertensive Subjects?##1002-34·318A
Lateral Versus Septal E/E’ by Tissue Doppler Imaging to 
Assess Left Ventricular Filling Pressures in Patients With 
Regional Wall Motion Abnormalities After Myocardial 
Infarction: Which Should We Use?##901-228·117A
Left Atrial Volume and Ventricular Filling Pattern in Mild 
Heart Failure: The AREA-IN-CHF Study##1004-67·44A
Major Weight Loss Prevents Long-Term Left Atrial 
Enlargement in Patients With Morbid Obesity##1008-
170·348A
N-Terminal Pro-BNP Is Associated With Cardiac Structure 
and Function in Elderly Patients With Heart Failure 
and Preserved Systolic Function: The iPRESERVE 
Study##1010-63·54A
New Physiological Classification for Surgical Management of 
Hypoplastic Right Ventricle in Pulmonary Atresia With 
Intact Ventricular Septum##1011-50·260A
Oxidative Stress, Not Iron Overload, Is Associated With 
Systolic and Diastolic Strain Rate in Asymptomatic 
Subjects With Hereditary Hemochromatosis##904-
221·126A
Preload Independence of Diastolic Torsional Dynamics 
Evaluated by Two-Dimensional Ultrasound Speckle 
Tracking Imaging##910-227·149A
Quantification of Global Left Ventricular Early Diastolic 
Expansion and Its Coupling to Systolic Contraction 
in Normal and Hypertrophic Myocardium by Speckle 
Tracking Global Strain and Strain Rate Imaging##910-
228·150A
Regional Mechanical Dyssynchrony: A Determinant of 
Degenerative Mitral Regurgitation in Hypertensive 
Patients With Isolated Diastolic Dysfunction##901-
227·116A
Relation Between the Type of Connective Tissue Disease and 
Diastolic Dysfunction##1028-104·93A
Relationship Between the Ratio of Peak Early Diastolic 
Transmitral Flow and Mitral Annular Velocities and 
the Plasma B-Type Natriuretic Peptide Concentration 
in Patients With Atrial Fibrillation: Assessment by 
Simultaneous Recording of Transmitral Flow and Mitral 
Annular Velocity##907-221·137A
Reversal of Left Atrial Remodeling in Patients With “Isolated” 
Left Ventricular Diastolic Dysfunction##1028-64·91A
Segmental Diastolic Functional Change due to Myocardial 
Ischemia and Its Persistence: 2-D Strain Analysis##908-
221·140A
The Effect of Nesiritide on Left Ventricular Diastolic 
Function##1010-98·55A
The Mitral L Wave: A Marker of Advanced Diastolic 
Dysfunction in Patients With Atrial Fibrillation##901-
222·115A
The Ratio of Mitral Deceleration Time to E-Wave Velocity 
Outperforms Its Individual Components in Predicting 
Cardiovascular Outcomes: The Strong Heart Study## 
834-8·108A
Two-Dimensional Ultrasound Speckle Tracking Imaging Is 
Useful in Assessing Left Ventricular Early Diastolic 
Function: Comparison With Invasive Parameters##912-
226·156A
Velocity Vector Imaging Characterizes Systolic and Diastolic 
Augmentation of the Failing Heart During Nonblood 
Contacting Ventricular Actuation##1016-109·70A
Diet
Dietary Fat and Subclinical Atherosclerosis as Detected by 
Coronary Artery Calcium##902-231·121A
Effect of Gender and Ethnicity on Effectiveness of 
Therapeutic Lifestyle Changes in Patients With 
Prehypertension##1020-203·392A
Involvement of the Interaction Between Mediterranean 
Diet and Methylenetetrahydrofolate Reductase C677T 
Mutation on Oxidized Low-Density Lipoprotein 
Concentrations: The ATTICA Study##1014-8·357A
Long-Term Fish Consumption Offers Cardiovascular 
Protection in Healthy People due to its Antiarrhythmic 
and Anti-Inflammatory Properties: The ATTICA 
Study##1014-127·367A
Low Carbohydrate Diet Reduces Myocardial Glycogen Stores 
and Impairs Cardiac Function During Ischemia##1025-
72·237A
The Association Between Adherence to the Mediterranean 
Diet and Fasting Indices of Glucose Homoeostasis: The 
ATTICA Study##1020-126·388A
The Association between the Prevalence of Obesity and 
Adherence to the Mediterranean Diet; the ATTICA 
study.##1026-162·411A
The J-Shape Relationship of Alcohol Consumption With Lipid 
Levels, Inflammatory and Hemostatic Factors, in General 
Population: The ATTICA Study##1020-164·390A
Weight Loss and Changes in Cardiovascular Risk Markers 
With a Low Glycemic Load Diet Compared With 
a Conventional Low Fat Recommended Diet: A 
Randomized Trial##1008-169·348A
Diuretics
Did Blood Pressure Medication Withdrawal Prior to 
Randomization Influence Subsequent Rates of Heart 
Failure in the Antihypertensive and Lipid-Lowering 
Treatment to Prevent Heart Attack Trial?##1008-
206·350A
Effect of Spironolactone Use on the Benefit of Fixed-Dose 
Combination of Isosorbide Dinitrate/Hydralazine in the 
African-American Heart Failure Trial## 808-3·63A
Renin System Suppression With the Oral Direct Renin 
Inhibitor Aliskiren Administered Alone or in 
Combination: A Pooled Analysis of 1,093 Patients With 
Hypertension##1014-170·370A
Ultrafiltration Is Associated With Fewer Re-Hospitalizations 
Than Continuous Diuretic Infusion in Patients With 
Decompensated Heart Failure: Results From UNLOAD## 
808-5·63A
Doppler ultrasound
2D Speckle Tracking Strain Analysis Compared With 
Sonomicrometry in a New In Vitro Pig Heart 
Model Which Rotates, Expands, and Contracts 
Synchronously##917-227·175A
2D Strain Quantification Varies With Size and Location of 
Region of Interest## 806-6·99A
A Gender-Specific Difference in Vasodilating Capacity of 
Coronary Arteries: Comparison Between Postmenopausal 
Women and Age-Matched Men##1025-175·244A
A Novel Method for Visualization of Vortex in Left Ventricle 
Using Flow Velocity Vector Estimated From Color 
Doppler Velocity Data##907-222·137A
A Novel Noninvasive Quantification Method of Left 
Ventricular Diastolic Function##909-223·144A
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Accuracy of Cuff and Echo Doppler Blood Pressure Gradients 
to Detect Recurrent Aortic Arch Obstruction in Infants 
After the Norwood Stage I Palliation##1005-33·255A
Characteristics of the Coronary Velocity Profiles of Patients 
With Decreased Coronary Flow Velocity Reserve Despite 
Normal Thallium Stress Test##903-235·125A
Clinical and Echocardiographic Characterization of 
Nonresponders to Cardiac Resynchronization Therapy## 
821-5·81A
Clinical and Echocardiographic Predictors of Significant 
Improvement in Ejection Fraction After Cardiac 
Resynchronization Therapy##1010-145·59A
Co-Registration of Doppler Tissue Velocity Data With Multi-
Slice Computed Tomography of the Coronary Veins to 
Optimize Left Ventricular Lead Placement for Cardiac 
Resynchronization Therapy##901-241·11A
Comparison of the Tissue Doppler Yu Index to the Opposing 
Wall Delay Method to Predict Response to Cardiac 
Resynchronization Therapy: Impact of Post-Systolic Peak 
Velocities## 850-4·112A
Diastolic and Systolic Asynchrony in Patients With Diastolic 
Heart Failure: A Common but Ignored Condition##918-
227·178A
Do Thiazolidinediones Worsen Heart Failure in Patients With 
Type 2 Diabetes Mellitus and Structural Heart Disease? 
Study With Doppler Echocardiography##1010-99·56A
Failure of Doppler Echocardiography to Accurately 
Estimate Left Ventricular Filling Pressures in Healthy 
Volunteers##910-222·148A
Incremental Value of Measuring Systolic Mitral Annular 
Velocity and Time Difference Between Onset of Mitral 
Inflow and Onset of Early Diastolic Mitral Annular 
Velocity for Differentiating Constrictive Pericarditis From 
Restrictive Cardiomyopathy##1010-101·56A
Nasal Continuous Positive Airway Pressure Can Improve 
Global Left Ventricular Dysfunction Assessed by Tei-
Index in Obstructive Sleep Apnea Syndrome##1022-
140·79A
Noncoronary Atherosclerosis by Carotid Ultrasound for 
Predicting Future Cardiovascular Events##1014-83·363A
Noninvasive Evaluation of Right Ventricular Dysfunction and 
Disease Severity in Patients With Chronic Pulmonary 
Arterial Hypertension Using Tissue Doppler and Strain 
Rate Imaging##1002-88·324A
Novel Assessment of Aortic Stenosis Using Real-Time 
Three-Dimensional Echocardiography: Comparison of 
Continuity Equation-Derived Aortic Valve Area With 
Planimetry##908-223·141A
Prediction of Myocardial Viability With Tissue Doppler 
Imaging in Patients With Acute Anterior Myocardial 
Infarction After Primary Reperfusion Therapy##918-
226·178A
Prediction of Transition to Chronic Atrial Fibrillation in Elderly 
Patients With Nonvalvular Paroxysmal Atrial Fibrillation 
by Transthoracic Doppler Echocardiography##918-
221·177A
Predictive Value of Combined Longitudinal and Radial 
Dyssynchrony for Response to Cardiac Resynchronization 
Therapy## 810-3·1A
Presence of Mechanical Dyssynchrony Predicts Response to 
Cardiac Resynchronization in Heart Failure Patients With 
Narrow QRS##903-228·124A
Systolic Tissue Doppler Velocity of the Ascending Aorta is 
an Index of Vascular Remodeling and Stiffness##1026-
81·406A
The Effect of Echocardiographic Contrast on Velocity Vector 
Imaging Myocardial Tracking##909-226·145A
Tissue Doppler Echocardiographic Evidence of Primary 
Atrial Mechanical Dysfunction in Hypertrophic 
Cardiomyopathy##907-227·138A
Utility of Real-Time Three-Dimensional Echocardiography 
for Optimizing Cardiac Resynchronization Therapy: 
Comparison With Tissue Doppler Imaging## 813-6·103A
Utility of Transthoracic Three-Dimensional Color Doppler 
Echocardiography for Diagnosis of Congenital Aortic 
Arch Anomalies##1005-31·255A
Dose-response relationship, drug
Increased Bleeding Risk Among Asians With Non-ST-Segment 
Elevation Acute Coronary Syndromes: Insights From the 
CRUSADE Quality Improvement Initiative## 802-6·208A
Initial Aspirin Dose for the Treatment of ST-Elevation 
Myocardial Infarction##1007-135·202A
The Primary In Vivo Metabolic Activation of Clopidogrel Is 
by Hepatic and Not Enterocytic Cytochrome P450 3A4 
Isoenzyme##1008-119·343A
Drug administration
Enoxaparin Versus Unfractionated Heparin With Fibrinolysis 
for ST-Elevation Myocardial Infarction In Patients ≥75 
Years Compared With <75 Years## 844-5·249A
Immunotargeting of Vascular Inflammation##1014-7·356A
Multi-Functional Echogenic Liposomes for Image-Guided and 
Ultrasound-Controlled PPAR Agonist Delivery##1014-
89·365A
Nebulized Delivery of Nano-Scale All-Trans Retinoic Acid 
Particles Inhibited Monocrotaline-Induced Pulmonary 
Hypertension in Rats##1008-88·342A
Periprocedural Aprotinin Use is Associated With an 
Increase in Adverse Events: An Analysis of 2,761 
Patients Undergoing Coronary Artery Bypass Graft 
Surgery##1026-122·409A
Slowly Release a Synthetic Small Molecule: PGI2 Agonist 
Up-Regulate Endogenous Growth Factors Expression and 
Augment Collateral Growth in Swine Chronic Cardiac 
Ischemia Model##1013-74·210A
Synthesis ad Acoustic Characterization of a Novel Ultrasound 
Controlled Drug Delivery System Based on Echogenic 
Liposomes##902-226·120A
Drug interactions
Saint John’s Wort Enhances Clopidogrel Responsiveness 
in Clopidogrel Resistant Volunteers and Patients by 
Induction of CYP3A4 Isoenzyme##1008-121·343A
The Pharmacokinetics of Torcetrapib/Atorvastatin Are 
Unaffected by Coadministration of Fenofibrate in Healthy 
Adult Subjects##1014-118·365A
Drug therapy
A Novel Next Generation Natriuretic Peptide: CD-NP##1008-
120·343A
Activated Partial Thromboplastin Time Measurement Is Not 
Associated With Clinical Outcomes in Patients With 
High-Risk Non-ST-Segment Elevation Acute Coronary 
Syndromes Treated With Unfractionated Heparin##1001-
93·186A
Activation of Peroxisome Proliferator-Activated Receptor κ 




Adjusted Clopidogrel Dosing in Patients With Insufficient 
Platelet Inhibition After Elective Coronary Stenting 
Caused a More Robust and Consistent Platelet Inhibition 
in the Entire Cohort##1020-9·378A
Assessing Individual Response to Clopidogrel in Patients 
Undergoing Coronary Intervention##1014-121·365A
Black Patients With Symptomatic Heart Failure Have Similar 
Outcomes and Response to Angiotensin Receptor 
Blockade as White Patients##1022-62·75A
Blood Pressure Lowering And cGMP Activating Actions Of 
Oral Human BNP In Experimental Hypertension##1026-
170·413A
Comparison of Thrombotic Cardiovascular Event Rates 
Following Long-Term Treatment of Arthritis Patients 
at Elevated Cardiovascular Risk With Etoricoxib 
and Diclofenac: Results of the Etoricoxib MEDAL 
Program##1002-2·315A
Discharge Medications and 6-Month Outcomes in Acute 
Coronary Syndrome Patients With Minimal Versus 
Moderate to Severe Coronary Artery Disease##1012-
149·278A
Do Thiazolidinediones Worsen Heart Failure in Patients With 
Type 2 Diabetes Mellitus and Structural Heart Disease? 
Study With Doppler Echocardiography##1010-99·56A
Economic Impact of Amlodipine in Normotensive Coronary 
Artery Disease Patients: Subgroup Analyses of 
Participants in the CAMELOT Trial##1026-168·413A
Evidence for Cholesterol Hyperabsorbers and Hyperproducers 
Based on Comparative Low-Density Lipoprotein 
Reductions Achieved by Ezetimibe Versus Statins## 
820-6·393A
Glucagon-Like-Peptide-1 Fused to Transferrin: A Novel 
Approach to Myocardial Reperfusion Injury## 803-
7·236A
Long-Term Intravenous and Subcutaneous Prostaglandin 
Therapy Outperforms Oral Endothelin Antagonism in 
Patients With Eisenmenger Syndrome##1011-52·260A
Negative Impact of Nesiritide in Combination With Inotropic 
Therapy Among Patients Admited With Acute Heart 
Failure##1022-66·76A
Nesiritide Does Not Cause Renal Dysfunction in Acute 
Decompensated Heart Failure: A Randomized, Double-
Blind, Placebo-Controlled Clinical Trial## 808-4·63A
Percutaneous Coronary Intervention: It Is Safe for Women as 
Long as They Receive the Right Medications##1012-
186·280A
Simvastatin Attenuates Plaque Inflammation Evaluation 
by 18F-Fluoro-2-Deoxyglucose Positron Emission 
Tomography##1026-47·405A
Simvastatin Enhances Endothelial Differentiation of Peripheral 
Blood Mononuclear Cells in Lone Hypercholesterolemic 
Patients and Induces Proangiogenic Cytokine Il-8 
Secretion From Monocytes: More Evidence of Statin 
Pleiotropism##1014-46·361A
Synthesis ad Acoustic Characterization of a Novel Ultrasound 
Controlled Drug Delivery System Based on Echogenic 
Liposomes##902-226·120A
Ventricular Rate Control in the Goat Model of Atrial 
Fibrillation: Synergistic Effects of Metoprolol and 
Adenosine Receptor Agonist##910-234·25A
Echocardiography, contrast
Cardiac Structure and Function in Diabetics With Acute 
Myocardial Infarction Complicated by Heart Failure, Left 
Ventricular Dysfunction, or Both: The VALIANT Echo 
Study##903-222·122A
Characterization of Intraventricular Blood Flow Vorticity In 
Health and Disease By Contrast Echocardiography Using 
Vector Particle Image Velocitimetry## 824-5·105A
Gene Delivery for Therapeutic Angiogenesis Is More 
Effective by Ultrasound-Mediated Destruction of 
Carrier Microbubbles Than by Direct Intramuscular 
Injection##918-225·178A
Is Framingham Risk Score a Good Predictor of Coronary 
Artery Disease in Early Menopausal Women Referred for 
Stress Echocardiography? A Contrast Echocardiography, 
Cardiac Computed Tomography, and Serum Biomarker 
Study##908-226·141A
Molecular Imaging of Post-Ischemic Inflammation With 
Contrast Ultrasound and Microbubbles Bearing Dimeric 
P-Selectin Glycoprotein Ligand-1##910-226·149A
Prediction of Function Recovery by Myocardial Contrast 
Echocardiography in Patients With Chronic Coronary 
Artery Disease Undergoing Bypass Surgery: Comparison 
With Late Gadolinium-Enhanced Cardiovascular 
Magnetic Resonance##901-226·116A
Predictors of Reduced Coronary Flow Reserve in Heart 
Transplant Recipients Without Cardiac Allograft 
Vasculopathy: A Contrast-Enhanced Echocardiographic 
Study##904-226·127A
Quantification Methods for Determination of Myocardial 
Blood Flow During Real-Time Dobutamine Perfusion 
Contrast Echocardiography: Is It Necessary to 
Normalize?##911-226·153A
Real-Time 3D Myocardial Perfusion: Is It Feasible?##906-
226·134A
Relative Value of Electrocardiogram, Magnetic Resonance 
Imaging, Angiography, and Contrast Echocardiography 
for Analyzing Microcirculation After Reperfused 
Myocardial Infarction##917-225·174A
Resting Myocardial Blood Flow Not Myocardial Flow Reserve 
Predicts Hibernating Myocardium: A Quantitative 
Myocardial Contrast Echocardiography Study##905-
226·131A
Synthesis ad Acoustic Characterization of a Novel Ultrasound 
Controlled Drug Delivery System Based on Echogenic 
Liposomes##902-226·120A
The Extent of Residual Contrast Perfusion and Not Left 
Ventricular Function Predicts Late Recovery of Global 
Contractile Function After Acute Myocardial Infarction 
and Reperfusion Therapy##919-225·181A
Echocardiography, stress
18F-Fluoromisonidazole Is Selectively Retained in Ischemic 
Human Myocardium During Dobutamine Stress: A Pilot 
Study##913-235·162A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography, Radionuclide Myocardial Perfusion 
Imaging, and Stress Echocardiogram in the Detection of 
Significant Coronary Artery Stenosis##908-229·142A
Detection of Coronary Artery Disease Using Delayed Strain 
Imaging: Comparison With Conventional Exercise Stress 
Echocardiography##904-228·127A
Diagnosis of Coronary Artery Disease by Detection of 
Post-Ischemic Diastolic Dyssynchrony After Treadmill 
Exercise Using Strain Image Derived From 2D Speckle 
Tracking##918-224·177A
Diverging Response of Stress-Induced Mitral Regurgitation to 
Exercise and Dobutamine##1015-20·305A
Dobutamine Stress Echo Adds Incremental Prognostic 
Information in the Long-Term Risk Stratification 
of Medically Treated Patients With Ischemic 
Cardiomyopathy##909-225·145A
Dobutamine Stress Echocardiography Is Feasible, Efficacious, 
and Safe in the Estimation of Right Ventricular Reserve 
in Patients With Repaired Tetralogy of Fallot##1011-
49·259A
Endothelial Dysfunction by Flow-Mediated Brachial Artery 
Dilatation Is a Marker of Ischemic Response During 
Stress Echocardiography##1002-84·323A
Exercise-Induced Changes in the Severity of Mitral 
Regurgitation Among Patients With Chronic Left 
Ventricular Ischemic Dysfunction: Prevalence and 
Clinical Significance##919-224·181A
Feasibility of Myocardial Perfusion and Wall Motion Analysis 
With Real-Time Perfusion Echocardiography During 
Treadmill Exercise Stress##916-225·171A
Incremental Benefit of Strain Rate Imaging to the Accuracy 
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Novel Muscarinic Bronchodilators Afford Customized 
Management of Chronic Heart Failure Complicated by 
Chronic Obstructive Pulmonary Disease in Ambulatory 
Elderly Patients##1004-98·45A
Percutaneous Transluminal Septal Ablation Therapy for 
Hypertrophic Obstructive Cardiomyopathy: Procedural 
Success and In-Hospital Complications From the Emory 
University Experience##1022-145·81A
Pooled Mortality for the First 31 Days Following Treatment 
With Levosimendan Is Similar to Comparator 
Therapies##1016-63·66A
Predicting Long-Term Effect of Cardiac Resynchronization 
Therapy: Comparison Between Tissue Doppler Imaging 
and Speckle Tracking Imaging##916-226·171A
Predictive Value of Combined Longitudinal and Radial 
Dyssynchrony for Response to Cardiac Resynchronization 
Therapy## 810-3·1A
Predictors of Pump Failure Death in Heart Failure Patients in 
the CARE-HF Study## 845-3·97A
Protective Effects of a Novel Long-Acting Calcium Channel 
Blocker Azelnidipine Against Cardiac Hypertrophy and 
Failure in Dahl Salt-Sensitive Rats##1002-205·331A
Quality of Veterans Administration Heart Failure Care, 2004-
2005##1030-184·295A
Real-Time Three-Dimensional Echocardiography and Its 
Potential Role in Cardiac Resynchronization Therapy 
Patient Selection: Ready for Prime Time?##907-224·137A
Rosuvastatin Regulates Extracellular Matrix by Reducing 
MMP-2 and -9 and Increasing TIMP-2 Levels in Patients 
With Heart Failure##1020-160·389A
Systolic Blood Pressure at Baseline Predicts Efficacy of 
Intravenous Atrial Natriuretic Peptide Anole Therapy for 
Acute Exacerbation of Chronic Heart Failure in Patients 
With Dilated Cardiomyopathy##1004-99·45A
The Administration of Subcutaneous Erythropoietin in Anemic 
Elderly Patients With Heart Failure and Normal Ejection 
Fraction Over 3 Months Is Associated With Improvement 
in Exercise Capacity and Quality of Life##1016-97·67A
The Benefits of the Fixed-Dose Combination of Isosorbide 
Dinitrate and Hydralazine in A-HeFT Are Not Influenced 
by the Absence or Presence of Diabetes##1004-65·44A
The Effect of Nesiritide on Left Ventricular Diastolic 
Function##1010-98·55A
The V-HeFT Paradox, Identical Doses of Different 
Formulations of Isosorbide Dinitrate and Hydralazine Are 
Not Bioequivalent and Neither Is Bioequivalent to the 
Fixed-Dose Combination of ISDN/Hydralazine Used in 
A-HeFT## 808-8·64A
Ultrafiltration Is Associated With Fewer Re-Hospitalizations 
Than Continuous Diuretic Infusion in Patients With 
Decompensated Heart Failure: Results From UNLOAD## 
808-5·63A
Use of Perioperative Nesiritide Improves Clinical Outcomes 
and Decreases Resource Utilization in Heart Failure 
Patients Undergoing Cardiac Surgery##1009-15·301A
Velocity Vector Imaging Characterizes Systolic and Diastolic 
Augmentation of the Failing Heart During Nonblood 
Contacting Ventricular Actuation##1016-109·70A
Heart function tests
2D Speckle Tracking Strain Analysis Compared With 
Sonomicrometry in a New In Vitro Pig Heart 
Model Which Rotates, Expands, and Contracts 
Synchronously##917-227·175A
2D Strain Quantification Varies With Size and Location of 
Region of Interest## 806-6·99A
A New Method for Strain Determination in Adjacent Slices of 
the Left Ventricle on the Same Beat##915-227·167A
A Study in Ventricular-Ventricular Interaction: Left Ventricular 
Diastolic Biomechanics and Exercise Tolerance in 
Tetralogy of Fallot Utilizing Cardiac Magnetic Resonance 
Tagging##1023-31·265A
Accurate and Reproducible Quantification of Global and 
Regional Left Ventricular Function Using Tissue Tracking 
Based Automated Function Imaging##912-227·156A
Arterial-Ventricular Interaction Assessment on the Basis of 
Noninvasive Wave Intensity Parameters Most Precisely 
Predicts Risk of Death in Cardiomyopathy Patients 
Referred for Transplantation##1026-13·401A
Bedside Prediction of Elevated Filling Pressures With Acoustic 
Cardiography in Dyspneic Patients##1022-144·80A
Earlier Detection of Doxorubicin-Induced Cardiomyopathy 
in Rats Using Radial Strain Obtained by 2D Strain 
Echocardiography##1004-57·42A
Evaluation of Left Ventricular Dyssynchrony Indices in 
Heart Failure Patients With Narrow and Wide QRS 
Durations##1010-144·59A
Isolated Left Ventricular Diastolic Dysfunction Immediately 
After Defibrillation Threshold Testing in Patients With 
Implantable Cardioverter Defibrillator##909-221·144A
Left Ventricular Twist Is an Important and Sensitive Marker of 
Cardiac Performance During Cardiac Resynchronization 
Therapy## 821-7·82A
Normal Values Differ Between Right Ventricular and Left 
Ventricular Measurements of Doppler-Derived Velocity, 
Displacement, Strain Rate, and Strain##906-224·134A
Red Cell Distribution Width as a Novel Prognostic Marker in 
Heart Failure: Data From the CHARM Program and the 
Duke Databank## 835-6·88A
The Predictive Value of Elevated Amino Terminal Pro-B-Type 
Natriuretic Peptide and B-Type Natriuretic Peptide for 
Mortality in the Absence of Cardiovascular Risk Factors 
or Structural Cardiac Abnormalities in the General 
Community##1002-163·328A
Twisting Motion Within the Septum Using High Frequency 
Ultrasound: Studies on Piglets## 834-6·108A
Two-Dimensional Ultrasound Speckle Tracking Imaging Is 
Useful in Assessing Left Ventricular Early Diastolic 
Function: Comparison With Invasive Parameters##912-
226·156A
Velocity Vector Imaging of the Mitral Annulus: A Novel 
Method to Quantify Global Ventricular Function##906-
222·133A
Heart rate
Algal Docosahexaenoic Acid Lowers Diastolic Blood Pressure 
and Reduces Heart Rate in a Statin-Treated Cardiac Risk 
Population##1008-207·350A
Assessment of Exercise Heart Rate Parameters for Predicting 
Mortality and Sudden Death## 842-7·111A
Beta 1-Adrenergic Receptor Gene Modulates the Effect of 
Heart Rate on Arterial Stiffness: The Bogalusa Heart 
Study## 838-6·398A
Circadian Variability of Deceleration Capacity of Heart 
Rate##910-242·26A
Deceleration Capacity In Post-MI Patients on and off Beta-
Blockers## 818-7·3A
Heart Rate Variability Is Significantly Increased by Ivabradine 
Compared With Amlodipine in Patients With Chronic 
Stable Angina: A Prospective Randomized Double-Blind 
Controlled Study##908-242·23A
Higher Resting Heart Rate Is Associated With Metabolic 
Syndrome and Lower Ejection Fraction in Patients With 
Diabetes and Known Coronary Artery Disease in Bypass 
Angioplasty Revascularization Investigation 2 Diabetes 
Trial##1206-277·333A
How Long Does Sympathetic Activation Persist After 
Submaximal Exercise in Subjects With Coronary Artery 
Disease?##911-236·155A
How Long Does Sympathetic Activation Persist After 
Submaximal Exercise in Subjects With Coronary Artery 
Disease?## 406-7·420A
Low Incidence of Significant Bradycardia During Therapy 
With an I
f
 Current Inhibitor Ivabradine: Heart Rate 
Reduction Depends on Baseline Heart Rate##1007-
195·206A
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Morning Hypertension and Sympathetic Overactivity Among 
Patients With Obstructive Sleep Apnea##1014-203·372A
Nonlinear Analysis of Heart Rate Variability During Recovery 
From Treadmill Testing Predicts Cardiovascular 
Prognosis##917-242·37A
Heart septal defects
Clinical Significance of Mitral Valve Prolapse in Adult Patients 
With Atrial Septal Defect##1023-50·266A
Transnasal Omniplane Echocardiography: First Clinical 
Application for Guiding Catheter-Based Interventions in 
Nonsedated Patients##915-223·167A
Heart surgery
An Endocardial to Epicardial Myocardial Contraction Gradient 
Is Present in Severe Compensated Aortic Stenosis: Does 
It Reverse After Aortic Valve Replacement?##1003-
18·298A
Can Improvements in Dyssynchrony Occur via Nonpacemaker 
Techniques--Utilization of a Minimally Invasive Left 
Ventricular Wrap: Detection of Dyssynchrony by Cardiac 
Magnetic Resonance##919-232·183A
Comparison of Stentless Valve Implantation Techniques 
in Large Cohort of Patients From the Freestyle Valve 
Registry##1027-15·401A
Left Ventricular Reconstruction Improves Left Ventricular 
Geometry and Systolic Function as Assessed by Cardiac 
Magnetic Resonance Imaging##1028-139·95A
One-Year Outcome After Coronary Revascularization Among 
Patients With Left Anterior Descending Artery Disease 
and Diabetic Retinopathy: Sirolimus-Eluting Stent Versus 
Coronary Bypass Surgery##1001-200·195A
Persistent Pulmonary Hypertension of the Newborn in Patients 
With Transposition of the Great Arteries: A 10-Year, 
Single-Centre Experience in the Nitric Oxide Era##1005-
48·255A
Preoperative Statin Therapy Is Not Associated With Decrease 
Incidence of Postoperative Atrial Fibrillation in Patient 
Undergoing Coronary Artery Bypass Grafting##1015-
19·304A
Radiofrequency Ablation of Atypical Atrial Flutter Following 
Cardiac Surgery or Atrial Fibrillation Ablation: 
Comparison of Open Irrigation-Tip Versus 8-mm-Tip 
Catheters##912-238·29A
Safe Use of Clopidogrel and Aspirin Antiplatelet Therapy After 
Off-Pump Coronary Artery Bypass Graft Surgery##1027-
18·312A
Use of Perioperative Nesiritide Improves Clinical Outcomes 
and Decreases Resource Utilization in Heart Failure 
Patients Undergoing Cardiac Surgery##1009-15·301A
Valve Competence One-Year After Percutaneous Pulmonary 
Valve Implantation or Surgical Homograft Implantation 
Assessed by Magnetic Resonance Imaging##1203-
260·258A
Ventricular Wall Motion Abnormality After Right Ventricle to 
Pulmonary Artery Shunt Does Not Cause Hemodynamic 
Impairment in Patients With Hypoplastic Left Heart 
Syndrome##1029-48·270A
Heart valve prosthesis
An Atherosclerotic Process Is Involved in the Structural Valve 
Deterioration of Bioprostheses## 839-8·311A
Cardiac Computed Tomography Measurement of Aortic 
Annular Diameter: Implications for Percutaneous Aortic 
Valve Implantation##907-231·139A
Early North American Experience With Percutaneous Aortic 
Valve Replacement in Patients Unsuitable for Surgical 
Aortic Valve Replacement## 816-5·309A
Multi-Slice Cardiac Computed Tomography Imaging 
of Patients Undergoing Percutaneous Aortic Valve 
Replacement##904-231·128A
Patient-Prosthesis Mismatch Following Mechanical Mitral 
Valve Replacement##1027-25·314A
Patient-Prosthesis Mismatch in Aortic Valve Replacement: Is 
Its Clinical Relevance Currently Overestimated?##1015-
22·305A
Prosthesis-Patient Mismatch Is an Independent Predictor 
of Mortality After Mitral Valve Replacement##1015-
24·306A
Quantitative Assessment of Mechanical Valve Using Multi-
Detector Computed Tompgraphy##1027-21·313A
Heart valves
An Atherosclerotic Process Is Involved in the Structural Valve 
Deterioration of Bioprostheses## 839-8·311A
In-Hospital and 30-Day Outcomes Following Retrograde 
Trans-Femoral Aortic Valve Replacement in High-Risk 
Patients: A Report From the REVIVAL-II Trial## 816-
4·309A
Is There an Alternative Explanation for Post-Myocardial 
Infaction Mitral Regurgitation? Insights From Cardiac 
Magnetic Resonance##1205-268·300A
LRP5 Stem Cell-Mediated Prosthetic Valve 
Calcification##1003-17·298A
Metabolic Profile of the Elderly With a Calcific Aortic Stenosis 
and Its Relation With the Valvular Calcium Content## 
839-3·310A
Phase Velocity Magnetic Resonance Imaging Is 
Fundamentally Flawed When Compared With Doppler 
Echocardiography##912-232·158A
Transesophageal Echocardiographic Direct Measurement of 
Left Ventricular Outflow Tract Area Improves Accuracy 
of Aortic Valve Area Determination by the Continuity 
Equation in Aortic Stenosis##909-224·145A
Hemodynamics
A Novel Method for Visualization of Vortex in Left Ventricle 
Using Flow Velocity Vector Estimated From Color 
Doppler Velocity Data##907-222·137A
Acoustic Cardiography Correlates With Invasive and 
Echocardiographic Systolic and Diastolic Hemodynamic 
Parameters##1016-98·68A
Apelin Improves Myocardial Performance in MCT-Induced 
Pulmonary Hypertension##1022-61·74A
Characterization of Ventricular Myocardial Performance in the 
Fetus by Tissue Doppler Imaging##903-227·124A
Comparison of Baseline Dyssynchrony and Acute 
Hemodynamic Effects of Cardiac Resynchronization 
Therapy in Patients With Right and Left Bundle Branch 
Block##910-240·26A
Dual-Specific A Kinase-Anchoring Protein 2 Polymorphism Is 
Associated With Increased Left Ventricular End-Systolic 
Elastance in Caucasians: Data From the Heart and Soul 
Study##1010-55·52A
Extracardiac Fontan Demonstrates Lower Power Loss 
Compared to Intracardiac Fontan: A Computational Fluid 
Dynamics Study##1011-28·258A
Functional Characterization of Epicardial Beating Heart 
Radiofrequency Left Atrial Maze##901-237·10A
Intravenous Nesiritide Decreases Contractility in Humans: 
Observations From Pressure-Volume Analysis##1022-
63·75A
Is Invasive Hemodynamic Assessment Essential Prior to the 
Fontan Operation?##1005-49·255A
Low Endothelial Shear Stress Leads to Expansive Remodeling 
of Atherosclerotic Coronary Subsegments: An In-Vivo 
Follow-Up Intravascular Ultrasound Study##1008-9·335A
Low Endothelial Shear Stress Predicts the Development 
of High-Risk Coronary Atherosclerotic Plaques: A 
Correlative Intravascular Ultrasound and Histopathology 
Natural History Study##1008-3·334A
New Physiological Classification for Surgical Management of 
Hypoplastic Right Ventricle in Pulmonary Atresia With 
Intact Ventricular Septum##1011-50·260A
Prehypertension Is Associated With Increased Aortic Stiffness 
but Not Muscular Artery Stiffness: A Population-Based 
Study## 838-4·398A
Preload Independence of Diastolic Torsional Dynamics 
Evaluated by Two-Dimensional Ultrasound Speckle 
Tracking Imaging##910-227·149A
Prosthesis-Patient Mismatch Is an Independent Predictor 
of Mortality After Mitral Valve Replacement##1015-
24·306A
Radiofrequency Based Wireless Pressure Sensor Is a Reliable 
Method for Hemodynamic Assessment in Ambulatory 
Chronic Heart Failure Patients: Comparison to Swan-
Ganz Catheter and Echocardiography##1004-140·48A
Reappraisal of the Use of Inferior Vena Cava for Estimating 
Right Atrial Pressure##916-221·169A
Serum Tenascin-C Levels Predict Hospitalization for 
Decompensated Heart Failure in Patients With Dilated 
Cardiomyopathy## 845-5·97A
Stent Implantation in Left Main Lesion Without Routine Intra-
Aortic Balloon Pump Support: Risk Factors Related to 
Hemodynamic Instability##1025-96·239A
Systemic and Coronary Hemodynamics of Intravenous 
Clevidipine in Normal Pigs: A Comparison With 
Nitroprusside and Nitroglycerin##1014-202·371A
Systolic Blood Pressure at Baseline Predicts Efficacy of 
Intravenous Atrial Natriuretic Peptide Anole Therapy for 
Acute Exacerbation of Chronic Heart Failure in Patients 
With Dilated Cardiomyopathy##1004-99·45A
The Effect of Nesiritide on Left Ventricular Diastolic 
Function##1010-98·55A
The Effects of QRS Duration and Atrial Pacing 
on Atrioventricular Optimization of Cardiac 
Resynchronization Therapy## 810-7·2A
Ventricular Wall Motion Abnormality After Right Ventricle to 
Pulmonary Artery Shunt Does Not Cause Hemodynamic 
Impairment in Patients With Hypoplastic Left Heart 
Syndrome##1029-48·270A
Hemostasis
An Evaluation of the Safety of Aprotinin Use: The REACTS 
Study##1007-201·207A
Influence of Statin Treatment on the Adenosine Diphosphate 
Responsiveness of Platelets During Clopidogrel 
Treatment: A Randomized Comparison of Rosuvastatin, 
Atorvastatin, and Simvastatin Co-Treatment## 804-
5·351A
Platelet Aggregometry and Receptor Binding to Predict the 
Magnitude of Antithrombotic and Bleeding Time Effects 
of Clopidogrel in Rabbits## 815-8·376A
Hormones
Angiotensin II Production During Exercise Is Augmented 
in Patients With a Hypertensive Response to 
Exercise##1014-171·371A
Combined Measurements of Cardiac Troponin T and Brain 
Natriuretic Peptide in Patients With Congestive Heart 
Failure From Various Etiology##1201-244·51A
Erythropoietin Predicts the Presence of Coronary Artery 
Collaterals in ST-Segment Elevation Myocardial 
Infarction## 851-8·253A
Impact of Subclinical Hypothyroidism on Coronary Heart 
Disease, Cardiovascular, and All-Cause Mortality: A 
Meta-Analysis##1002-173·330A
Low Adiponectin Expression in Epicardial Adipose Tissue 
Is Associated With The Severity of Coronary Artery 
Disease##1014-88·364A
Nasal Continuous Positive Airway Pressure Can Improve 
Global Left Ventricular Dysfunction Assessed by Tei-
Index in Obstructive Sleep Apnea Syndrome##1022-
140·79A
Role of Adiponectin in the Development of Chronic Heart 
Failure## 409-9·422A
Status of Estrogen Receptors in Menopause: Active or 
Not?##1020-10·378A
The Atrial Vulnerability Parameters in Lone Atrial Fibrillation 
Patients With Subclinical Hypothyroidism: A New Entity 
in Idiopathic Atrial Fibrillation?##916-237·35A
Hyperlipoproteinemia
Enhanced External Counterpulstion Inhibits Intimal 
Hyperplasia by Downregulating Proliferative Signaling 
Proteins##1001-90·185A
Role of Gender in the Development of Coronary Artery 
Disease in Greek Cohort of Familial Combined 
Hyperlipidemia##1026-126·409A
Small Dense Low-Density Lipoprotein (LDL)-Cholesterol Is a 
Superior Marker Than LDL-Cholesterol in Determining 
Severe Coronary Atherosclerosis##1002-168·329A
Hypertension, pulmonary
A Simple Measurement of Time to Maximum Tricuspid 
Regurgitant Jet Identifies Right Ventricular Dysfunction in 
Pulmonary Hypertension##1020-84·384A
Apelin Improves Myocardial Performance in MCT-Induced 
Pulmonary Hypertension##1022-61·74A
Atrial Septal Defects Versus Ventricular Septal Defects in 
BREATHE-5, a Placebo-Controlled Study of Pulmonary 
Arterial Hypertension Associated With Eisenmenger 
Syndrome: A Subgroup Analysis##1203-259·257A
Echocardiography Provides Important Prognostic Information 
in Patients With Advanced Pulmonary Hypertension, Even 
After Initiation of Vasodilator Therapy##913-222·159A
Elevated Pulmonary Arterial Pressures Predict Mortality and 
Heart Failure Admission in Cardiac Resynchronization 
Therapy-Defibrillator Recipients##1016-110·70A
Gene Transfer of Human Extracellular Superoxide Dismutase 
Ameliorates Monocrotaline-Induced Pulmonary Arterial 
Hypertension in Rats##1002-86·323A
Long-Term Intravenous and Subcutaneous Prostaglandin 
Therapy Outperforms Oral Endothelin Antagonism in 
Patients With Eisenmenger Syndrome##1011-52·260A
Normalization of Fixed Pulmonary Hypertension in Severe 
Heart Failure Patients With Placement of Left Ventricular 
Assist Device##1010-109·58A
Pulmonary Hypertension In Patients With Long Term 
Arteriovenous Access For Hemodialysis##1026-85·407A
Right Ventricular Function in Patients With Eisenmenger 
Physiology: Insights From Two-Dimensional Strain 
Echocardiography##1011-51·260A
Strain Analysis Identifies Regional Right Ventricular 
Contractile Inhomogeneity After Pulmonary 
Endarterectomy: 2-Dimensional Strain Echocardiographic 
Study##1026-86·407A
The French Registry of Pulmonary Arterial Hypertension in 
Children: Characteristics at Diagnosis##1008-87·342A
Hypertension, renal
Is Renal Magnetic Resonance Imaging/Magnetic Resonance 
Angiography an Appropriate Screening Tool in the 
Workup of Patients With Suspected Renovascular 
Hypertension?##1008-208·350A
The Effects of Two Different Blood Pressure Control Strategies 
on Cardiac Structures and Functions in Hemodialysis 
Patients##1020-171·391A
The Influence of Renal Magnetic Resonance Imaging/Magnetic 
Resonance Angiography Diagnosed Renal Artery Stenosis 
on Glomerular Filtration Rate and Renal Parenchymal 
Volume in Patients With Atherosclerotic Renovascular 
Hypertension##1020-82·384A
Hypertension, systemic
A Polymorphism in Promoter Region of Cytochrome 
P450 4A11 Gene is Associated with a New Onset of 
Hypertension: the Tanno and Sobetsu Study##1026-
203·414A
A Unifying Explanation of the Aortic Pulse Waveform in 
Humans## 838-3·397A
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Accelerated Vascular Damage in Hypertensive Subjects 
With Obstructive Sleep Apnea Syndrome: An Adverse 
Nocturnal Stimulus on Arterial Properties##1002-45·320A
Aliskiren-Based Therapy Lowers Blood Pressure More 
Effectively Than Ramipril-Based Therapy in Patients 
With Hypertension: A 6-Month, Randomized, Double-
Blind Trial##1014-173·371A
Aliskiren-Based Therapy Provides Long-Term Suppression 
of Plasma Renin Activity That Persists After Treatment 
Withdrawal in Patients With Hypertension##1020-
168·390A
Ambulatory Blood Pressure Monitoring Improves the 
Prediction of On-Treatment Risk in The Anglo-
Scandinavian Cardiac Outcomes Trial##1020-202·392A
Angiotensin II Production During Exercise Is Augmented 
in Patients With a Hypertensive Response to 
Exercise##1014-171·371A
Angiotensin-Receptor Blocker, Not Calcium Channel 
Blocker, Reduced Plasma Osteopontin Level in Essential 
Hypertensive Patients With no Cardiovascular Events## 
848-7·417A
Antihypertensive Efficacy of the Direct Renin Inhibitor 
Aliskiren When Added to Hydrochlorothiazide 
Treatment in Patients With Extreme Obesity and 
Hypertension##1014-169·370A
Are Coronary Revascularization and Myocardial Infarction a 
Logical Combined Endpoint in Hypertension Trials? The 
LIFE Study##1026-169·413A
Are Fatness and Fitness Related to Microvascular Reactivity in 
Hypertensive Diabetics?## 840-8·416A
Associations of Serum Uric Acid With Markers of 
Inflammation, Metabolic Syndrome, and Subclinical 
Coronary Atherosclerosis##1002-10·317A
Beneficial Effect of Angiotensin-II Type 1 Receptor Blocker 
Antihypertensive Treatment on Arterial Stiffness. The 
Role of Smoking##1026-171·413A
Benefits of Candesartan Are Consistent Regardless of 
Pretreatment Systolic Blood Pressure in the CHARM 
Program##1002-204·331A
Blood Pressure Control With Clevidipine Compared 
to Nitroglycerin in the Treatment of Perioperative 
Hypertension: Primary Results From the Randomized 
ECLIPSE Trial##1020-169·391A
Blood Pressure Lowering And cGMP Activating Actions Of 
Oral Human BNP In Experimental Hypertension##1026-
170·413A
Blood Pressure Lowering Effects Persist Following the Last 
Dose of Long-Term Therapy With Aliskiren, an Oral 
Direct Renin Inhibitor##1014-204·372A
Can an Outpatient, Physician-Driven Approach to Weight 
Loss Work in an Overweight, Dyslipidemic Pediatric 
Population With Characteristics of Metabolic 
Syndrome?##1011-48·259A
Changes in Left Atrial Volumes With Mild Hypertension##915-
222·166A
Cornell Voltage Product in ECG Relates to Left Ventricular 
Mass in Subjects Prone to Develop Hypertension Over 20 
Years## 818-6·3A
Cross-Sectional Relations of Pregnancy-Associated Plasma 
Protein-A Levels With C-Reactive Protein and Urinary 
Albumin Excretion Rate in Essential Hypertensive 
Subjects: A Novel Approach to Diffuse Atherosclerosis## 
805-8·353A
Cross-Sectional Relationships of Urinary Albumin Excretion 
With Arterial Stiffness and Left Ventricular Mass 
in Essential Hypertensive Subjects: Data From the 
Hippokration Hellenic Hypertension (3H) Study##1008-
204·349A
Depression, Anxiety and Quality of Life in Patients With Atrial 
Fibrillation##904-238·16A
Development of New Electrocardiographic Strain Pattern 
During Antihypertensive Therapy Is Associated With 
Increased Incidence of Sudden Cardiac Death: The LIFE 
Study##1002-202·331A
Diastolic Function in Primary Aldosteronism: A Tissue Doppler 
Imaging Approach##1002-206·332A
Diastolic Index of Color Kinesis Can Noninvasively Detect 
Therapeutic Effects of Angiotensin II Receptor Blocker 
on Left Ventricular Diastolic Function In Hypertensive 
Diastolic Heart Failure Model.##911-228·153A
Effect of Gender and Ethnicity on Effectiveness of 
Therapeutic Lifestyle Changes in Patients With 
Prehypertension##1020-203·392A
Efonidipine Simultaneously Improves Endothelial 
Function and Metabolic Parameters In Patients With 
Hypertension##1002-5·316A
Endothelial Dysfunction Increases Hypertensive Evolution and 
Mortality##1014-2·355A
Enhanced Subclinical Inflammation in Middle-Aged 
Hypertensive Subjects With Obstructive Sleep Apnea: 
A Molecular Insight of Atherogenic Load in Restless 
Sleep##1002-203·331A
Ethnic Differences in Plasma Adiponectin Levels Among 
Hypertensive Adults##1019-74·222A
Exaggerated Exercise Blood Pressure Response Is Related to 
a State of Pronounced Inflammatory Activation, Impaired 
Thrombosis/Fibrinolysis System, and Arterial Stiffening 
in Essential Hypertensive Subjects##1002-37·318A
Excessive Inotropic Response During Exercise Testing Is 
Associated With Left Ventricular Diastolic Dysfunction 
Detected by Tissue Doppler Imaging: Understanding 
the Prognostic Role of Blood Pressure Elevation at Peak 
Exercise in Hypertensives##913-236·162A
Gender Difference in the Association Between Leptinemia 
and Blood Pressure in the United States Population: 
The Third National Health and Nutrition Examination 
Survey##1002-208·332A
Graded Relationship Between Adiponectin Levels and Arterial 
Stiffening in Newly Diagnosed Essential Hypertensive 
Subjects## 840-7·416A
Immunolocalization of Platelet Glycoprotein IIb/IIIIa and 
P-selectin, and Neutrophil-Platelet Association in Human 
Carotid Unstable Plaques##1026-79·405A
Importance of Pain and Hypertension in Acute Type B Aortic 
Dissection: Insights From the International Registry of 
Acute Aortic Dissection##1018-184·284A
Increased Oxidative Stress via Activation of NADPH Oxidase 
Mediates Angiotensin II-Induced Skeletal Muscle 
Wasting: Potential Mechanism of Cachexia in Congestive 
Heart Failure## 845-7·98A
Is Vascular Dysfunction the Forerunner of Paroxysmal Atrial 
Fibrillation in Hypertensive Subjects?##1002-34·318A
Left Atrial Volume and Booster Pump Function Assessed 
With Tissue Doppler Imaging Predict Paroxysmal 
Atrial Fibrillation Occurrence in Patients With 
Hypertension##912-228·157A
Left Ventricular Geometric Patterns in the African American 
Study of Kidney Disease and Hypertension Cohort## 
838-8·399A
Left Ventricular Hypertrophy Is Associated With Exercise 
Induced Intraventricular Dyssynchrony in Hypertensive 
Patients##913-225·160A
Left Ventricular Longitudinal Contractile Reserve Is 
Abnormal in Hypertensive Patients With Left Ventricular 
Hypertrophy##911-225·153A
Long-Term Effects (up to 18 Years) of Balloon Angioplasty 
of Coarctation of the Aorta on Systemic Hypertension 
and Left Ventricular Hypertrophy in Adolescents and 
Adults##1005-52·256A
Longitudinal Strain and Torsion Assessed by 2-D Speckle 
Tracking Correlates With the Serum Level of Tissue 
Inhibitor of Matrix Metalloproteinase-1a: A Marker of 
Myocardial Fibrosis in Patients With Hypertension## 
806-7·100A
Low-Grade Inflammation and Hypoadiponectinemia Have 
an Additive Detrimental Effect on Aortic Stiffness in 
Essential Hypertensive Patients: A “Double-Edged 
Sword” of Vascular Damage##1002-36·318A
Microalbuminuria Is Correlated With Endothelin-1, 
Adiponectin, C-Reactive Protein, and Arterial Stiffness 
in Essential Hypertension: Reflections Beyond the 
Glomerulus##1002-79·322A
Morning Hypertension and Sympathetic Overactivity Among 
Patients With Obstructive Sleep Apnea##1014-203·372A
Pregnancy-Associated Plasma Protein-A Levels Are Related 
to Urinary Albumin Excretion Rate: A Novel Pathway 
Linking Atherosclerotic Processes With Microalbuminuria 
in Essential Hypertension##1002-4·315A
Prehypertension Is Associated With Increased Aortic Stiffness 
but Not Muscular Artery Stiffness: A Population-Based 
Study## 838-4·398A
Prevalence and Correlates of Microalbuminuria in Essential 
Hypertensive Subjects: Insights From The Hippokration 
Hellenic Hypertension (3H) Study##1008-203·349A
Prevalence and Correlates of Mitral Annular Calcification in 
Hypertensive Adults With Left Ventricular Hypertrophy: 
The LIFE Study##1002-207·332A
Prevalence, Treatment, and Control of Hypertension and/or 
Dyslipidemia Among Hispanic Adults in United States 
Communities##1012-185·279A
Protective Effects of a Novel Long-Acting Calcium Channel 
Blocker Azelnidipine Against Cardiac Hypertrophy and 
Failure in Dahl Salt-Sensitive Rats##1002-205·331A
QRS Duration Predicts Sudden Cardiac Death in Hypertensive 
Patients: The LIFE Study##907-239·21A
Race/Ethnicity and Incident Congestive Heart Failure: The 
Multi-Ethnic Study of Atherosclerosis## 835-5·87A
Regional Differences in the Prevalence of Hypertension 
and Dyslipidemia in United States Urban Hispanic 
Populations##1014-161·368A
Relationship of Increasing QRS Duration to Worsening 
Systolic Function in Hypertensive Patients With ECG 
Left Ventricular Hypertrophy: The LIFE Study##1010-
140·58A
Renin System Suppression With the Oral Direct Renin 
Inhibitor Aliskiren Administered Alone or in 
Combination: A Pooled Analysis of 1,093 Patients With 
Hypertension##1014-170·370A
Role of Metabolic Syndrome, Independent of Its Components, 
in Prediction of Cardiovascular Outcomes in Hypertensive 
Patients of ASCOT- BPLA## 848-5 ·417A
Synergistic Effects of Systolic Hypertension and Female 
Sex on the Arterial-Ventricular Coupling Ratio##904-
236·129A
The Association of Income With Cardiovascular Disease 
Burden##1014-164·369A
The Effect of Valsartan Compared to Valsartan/
Hydrochlorothiazide on Plasma Levels of Cellular 
Adhesion Molecules: The Val-MARC Trial## 848-8·418A
The Expression of Cardiac Ankyrin Repeat Protein in Animal 
Model of Adriamycin-Induced Cardiomyopathy##1022-
60·74A
The Presence or Development of New Electrocardiographic 
Strain Pattern Is Associated With an Increased Risk of 
New Heart Failure During Antihypertensive Treatment: 
The LIFE Study##1004-63·43A
Unfavorable Structural and Functional Cardiac Adaptations in 
Hypertensive Subjects With Metabolic Syndrome: Data 
From the 3H Study##915-221·166A
Verapamil-SR Strategy Is Comparable to Atenolol Strategy 
at Reducing Cardiovascular Events in Patients With 
Prior Myocardial Infarction: An INVEST Substudy## 
825-4·232A
Hypertrophy
AKT Kinase Overexpression Prevents Heart Failure 
Development Modulating Cardiac Contractility in 
Pressure Overload Animal Model##1010-59·53A
Circulating Osteoprotegerin Levels in the General Population: 
Relation to Left Ventricular Structure and Function## 
845-6·98A
Development of New Electrocardiographic Strain Pattern 
During Antihypertensive Therapy Is Associated With 
Increased Incidence of Sudden Cardiac Death: The LIFE 
Study##1002-202·331A
Diverse Cardiac Geometry and Cardiorenal Interaction in 
Diastolic Heart Failure##1201-245·51A
Effect of Anemia Treatment With Epoetin Alfa or Darbepoetin 
Alfa on Left Ventricular Mass in Patients With Chronic 
Kidney Disease Not on Dialysis in Japan##1016-67·67A
Estrogen Induces Weight Loss and Improves Systolic Function 
in a Mouse Model of Obesity## 829-3·85A
Gender and Severity of Left Ventricular Hypertrophy Predict 
Long-Term Survival##911-223·152A
Gender Differences in the Cardiac Response to Pressure 
Overload in Mice##1016-60·65A
Hemodynamic Load-Dependent Activation of Cardiac Stem 
Cells and Myocyte Turnover in Mitral Regurgitation## 
822-8·84A
Intersital Fibrosis in Human Hypertrophic Cardiomyopathy 
and the TIEG Male Null Mouse Is Associated With an 
Osteoblast Phenotype##1004-103·46A
Left Ventricular Hypertrophy Is Associated With Exercise 
Induced Intraventricular Dyssynchrony in Hypertensive 
Patients##913-225·160A
Long-Term Effects (up to 18 Years) of Balloon Angioplasty 
of Coarctation of the Aorta on Systemic Hypertension 
and Left Ventricular Hypertrophy in Adolescents and 
Adults##1005-52·256A
Long-Term Therapy With Ranolazine Decreases mRNA and 
Protein Expression of the Transcriptional Repressor Nab1 
and the Transcription Factor Egr1 in Dogs With Chronic 
Heart Failure##1004-58·42A
Quantification of Global Left Ventricular Early Diastolic 
Expansion and Its Coupling to Systolic Contraction 
in Normal and Hypertrophic Myocardium by Speckle 
Tracking Global Strain and Strain Rate Imaging##910-
228·150A
Ranolazine Normalizes Action Potential Duration of 
Hypertrophied Ventricular Cardiomyocytes##909-
234·24A
Relationship of Increasing QRS Duration to Worsening 
Systolic Function in Hypertensive Patients With ECG 
Left Ventricular Hypertrophy: The LIFE Study##1010-
140·58A
Successful In Vivo Imaging of the Enhanced Transcriptional 
Activity of GATA in the Heart During the Progression 
of Angiotensin II-Induced Hypertrophy in Mice##1010-
62·54A
The Presence or Development of New Electrocardiographic 
Strain Pattern Is Associated With an Increased Risk of 
New Heart Failure During Antihypertensive Treatment: 
The LIFE Study##1004-63·43A
Tissue Doppler Echocardiographic Evidence of Primary 
Atrial Mechanical Dysfunction in Hypertrophic 
Cardiomyopathy##907-227·138A
Hypoxia
Central Aortic Stiffness Is Increased in Stable Heart Transplant 
Patients and Is Associated With Higher Mortality## 
828-4·84A
Hypoxic Preconditioning Promotes Bone Marrow 
Mesenchymal Stem Cells Survival by Enhancing Stem 
Cell Autocrine Action## 827-7·234A
Nifedipine Added to the Combination With Pravastatin and 
Olmesartan Shows Preventive Effect on Hypoxia-Induced 
Left Ventricular Remodeling in Diabetes Mellitus##1008-
205·349A
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Opening of Mitochondria Permeability Transition Pores Is a 
Key Factor in Increased Hypoxia-Induced Susceptibility 
of Failing Cardiomyocytes to Undergo Apoptosis##1010-
58·53A
Resuscitation With Liposome-Encapsulated Hemoglobin 
From Lethal Hemorrhage and Its Protective Effect 
on Myocardium During Hemorrhagic Shock##1001-
199·195A
The Interventricular Relationship in Eisenmenger Syndrome: 
Findings With Cardiac Magnetic Resonance and Late 
Gadolinium Enhancement##1017-52·263A
Image processing, computer-assisted
64 Multi-Detector Computed Tomography Coronary 
Angiography: Effect of Sublingual Nitroglycerin on 
Coronary Luminal Diameter and Image Quality##918-
230·179A
A New Automated Method for Quantitative Computed 
Tomography Coronary Angiography: An In Vivo 
Validation Study With Intracoronary Ultrasound as a 
Reference##909-229·146A
A New Automated Method for Quantitative Coronary Plaque 
Compositional Imaging by Multislice Computed 
Tomography: An Ex Vivo Feasibility Study##1006-
190·275A
A Novel Acquisition and Analysis Technique for Accurate 
Myocardial Perfusion Measurement During Helical 
Multi-Detector Computed Tomography Imaging##902-
232·121A
A Novel Noninvasive Technique for Pulse-Wave Imaging and 
Characterization of Vascular Mechanical Properties In 
Vivo##906-228·135A
An Intravascular Ultrasound Simulator of Coronary Plaques 
Based on Histopathology##1006-189·275A
Analysis of End-Systolic Intraventricular Pressure Gradients 
Improves the Noninvasive Assessment of Left Ventricular 
Relaxation## 834-3·107A
Anatomically Oriented Measurement of Right Ventricular 
(RV) Volumes and Function by 4D Semi-Automated 
RV Reconstruction of Cardiac Magnetic Resonance 
Images##1029-49·270A
Characterization of Intraventricular Blood Flow Vorticity In 
Health and Disease By Contrast Echocardiography Using 
Vector Particle Image Velocitimetry## 824-5·105A
Clinical Relevance of Fat Replacement of the Right Ventricular 
Myocardium Determined by Multislice Computed 
Tomography: Relationship With Aging, Obesity, and the 
Occurrence of Ventricular Arrhythmia##1010-106·57A
Coronary Computed Tomography Angiography in Elderly 
High Risk Patients Presenting With Atypical Cardiac 
Symptoms##914-229·164A
Left Ventricular Volumes and Regional Wall Motion by 
Multislice Computed Tomography as Compared to 
Magnetic Resonance Imaging Using the Tagging 
Technique##901-232·117A
Location on Left Atrial 3-D Computer Tomography of Lesions 
Delivered Through Balloon-Based Ablation Systems## 
846-4·9A
Logistic Regression Models to Identify Negative Predictors 
of Agreement of Findings of 64-Slice Computed 
Tomography and Conventional Coronary Angiogram for 
Evaluation of Patency of Drug-Eluting Stents and Bare 
Metal Stents in Coronary Arteries##1013-177·218A
Multi-Detector Computed Tomography Quantitatively 
Distinguishes Grades of Left Atrial Appendage 
Spontaneous Echo Contrast and Thrombus in Patients 
Undergoing Evaluation for Radiofrequency Pulmonary 
Vein Antral Isolation##915-231·168A
Noncardiac Findings in Patients Undergoing Coronary 
Multislice Computed Tomography: Preliminary Results 
From the Core64 International Multicenter Trial##916-
231·172A
Noninvasive Coronary Angiography With 64-Slice Multi -
Detector Computed Tomography Compared to 16-Slice in 
the Same Patients: Is the Benefit of More Slices Clinically 
Relevant?##911-229·154A
Prediction of Impairment Factors for Evaluation of Patency of 
Drug-Eluting Stent and Bare Metal Stents in Coronary 
Arteries Using 64-Slice Computed Tomography in 
Logistic Regression Models##1020-14·379A
Prognostic Value of Stress Gated SPECT Imaging in Diabetics: 
Contribution of Perfusion and Function for Prediction of 
Adverse Cardiac Outcome## 841-8·110A
Strain Rate Is Superior to Peak Systolic Strain for the 
Detection of Ischemia During Dobutamine Stress 
Echocardiography##902-225·119A
Usefulness of Computed Tomography Angiography in 
the Follow-Up of Abdominal Aortic Aneurysm 
Treatment##911-231·154A
Validation of Novel Echocardiographic Speckle Tracking 
Radial Strain to Assess Ventricular Dyssynchorny: 
Comparison With Angle Corrected Tissue Doppler Strain 
Imaging## 806-8·100A
Immune suppression
Clinical Characteristics and Outcomes of Behcet’s Disease 
With Cardiovascular Involvement##1014-81·362A
Immune system
Differential Regulatory Network Patterns During Rejection and 
Quiescence in Peripheral Blood Mononuclear Cell Gene 
Signatures##1004-139·48A
Peripheral Blood Leukocyte Gene Expression Signatures of 
Antibody Mediated Cardiac Allograft Rejection##1028-
107·94A
Presence of C-Reactive Protein in Left Atrium Is Associated 
With Atrial Fibrillation Irrespective of Serum CRP##908-
234·22A
Prevalence of Organ-Specific Autoantibodies and Coeliac 
Disease in Patients With Sporadic and Inherited Dilated 
Cardiomyopathy and Their Relatives## 801-5·60A
Widespread Coronary and Myocardial Activated 
T Lymphocytic Infiltrate in Acute Myocardial 
Infarction##1020-42·381A
Immunologic factors
Balance Between Serum S100A12 and S100A8 Predicts 
Presence and Complications of Coronary Artery 
Disease##1014-37·359A
Peripheral Arterial Disease Is Associated With Increased Serum 
Myeloperoxidase Levels Independently of the Presence of 
Severity of Coronary Artery Disease##1002-81·322A
Perivascular Adipose Tissue With Chlamydophyla Pneumoniae 
Antigens Is Associated With Positive Remodeling In 
Severe Abdominal Aortic Atherosclerosis.##1026-
82·406A
Reverse Remodeling of Failing Myocardium Is Associated 
With Decreased Deposition of Anti-Cardiac 
Antibodies: Observations in Patients Following Cardiac 
Resynchronization Therapy##1022-58·73A
Serum Myeloperoxidase Levels Are Associated With the 
Future Risk of Coronary Artery Disease in Apparently 
Healthy Individuals## 833-4·396A
Widespread Coronary and Myocardial Activated 
T Lymphocytic Infiltrate in Acute Myocardial 
Infarction##1020-42·381A
Immunologic techniques
Peripheral Blood Leukocyte Gene Expression Correlates With 
Cardiac Allograft Function## 828-6·85A
Peripheral Blood Leukocyte Gene Expression Signatures of 
Antibody Mediated Cardiac Allograft Rejection##1028-
107·94A
Implants, artificial
Stent Implantation for the Treatment of Adult Aortic 
Coarctation: Initial and 5-Year Results##1005-51·256A
Stroke Prevention Technology for Patients with Non-Valvular 
AF: Worldwide Experience with the WATCHMAN LAA 
System## 623-5·2A
Utility of Lead and Generator Cultures in Managing Cardiac 
Device Infections##913-241·31A
Infarct size
Acute Metformin Therapy Protects Against Myocardial 
Ischemia-Reperfusion Injury##1019-90·222A
Angiographic Estimates of Myocardium at Risk During Acute 
Myocardial Infarction: A Validation Study Using Cardiac 
Magnetic Resonance Imaging## 824-8·105A
Cardioprotective Effect of Cannabidiol, a Nonpsychoactive 
Cannabis Constituent, in Ischemic Reperfusion 
Injury##1001-91·186A
Comparison of Positron Emission Tomography and Magnetic 
Resonance Imaging for the Evaluation of Infarct Size in 
Acute Myocardial Infarction Patients##911-232·154A
Does Erythropoietin Reduce Enzymatic Infarct Size in Non-
STE ACS? Results From a Pilot Trial## 847-4·250A
Effect of Slice Thickness on Quantitative Chronic Myocardial 
Scar Imaging by Multidetector Computed Tomography: 
Comparison to Magnetic Resonance Imaging and 
Pathology##910-231·150A
Glucagon-Like-Peptide-1 Fused to Transferrin: A Novel 
Approach to Myocardial Reperfusion Injury## 803-
7·236A
Gray Zone, Scar Size, and Ejection Fraction Are Determinants 
of Arrhythmic Risk in MADIT II Patients##914-232·165A
Hydrogen Sulfide Donor Confers Protection Against Acute 
Myocardial Ischemia-Reperfusion Injury##1019-92·222A
Infarct Size, Viability, and Correlates in Patients Presenting 
With a Persistent Total Occlusion of the Infarct-Related 
Artery 3-28 Days Post-Myocardial Infarction: An OAT 
Substudy##1007-94·199A
Infarct Transmurality and Infarct Size Assessed by Delayed 
Enhancement Magnetic Resonance Imaging: Association 
With Time-to-Treatment, St-Segment Resolution, and 
Timi-Flow Grades##1001-137·190A
Intracoronary Stem Cell Therapy Improves Left Ventricular 
Function and Decreases Infarct Size Following Acute 
Myocardial Infarction: A Meta-Analysis##1001-135·189A
Intramyocardial Allogeneic Mesenchymal Stem Cells Reduce 
Infarct Size in a Porcine Model of Chronic Ischemic 
Cardiomyopathy##907-233·140A
Persistent Reduction in Myocardial Infarct Size After a Brief 




Rapamycin (Sirolimus) Administration In Vivo Limits Post-
Ischemic Myocardial Injury by MAPK Signaling in the 
Mouse Heart##1025-92·238A
Reperfusion BURST Arrhythmias as a Biomarker of 
Myocellular Damage Despite TIMI 3 Epicardial 
Flow##1019-96·223A
Time Is Muscle: Delay in Primary Percutaneous Coronary 
Intervention Results in Larger Infarct Size by Delayed 
Enhancement Cardiac Magnetic Resonance: Results From 
the APEX-AMI Study##903-232·125A
TIMI Grade 3 After Successful Percutaneous Coronary 
Intervention Reduced Myocardial Infarction Volume 
Assessed by Delayed Enhancement Magnetic Resonance 
Imaging.##908-233·143A
Total Scar Burden on Contrast-Enhanced Magnetic 
Resonance Imaging Determines Response to Cardiac 
Resynchronization Therapy##905-233·132A
Troponin Is as Accurate as Creatine Kinase and Creatine 
Kinase MB for Estimation of Infarct Size##1013-
138·216A
Information technology
i-Trial: An Innovative Internet System for the Complete 
Management and Monitoring of International Multicenter 
Clinical Studies##1018-188·285A
The Blog Web Site: A New Educational Tool for 
Cardiology##1006-192·275A
Inotropic agents
Correlation Between Troponin Elevation and Vasoactive 
Medication Use in Patients With Septic Shock##1001-
112·187A
Use of Inotropic Drugs on First-Day Hospitalization for Acute 
Heart Failure Is Associated With Higher In-Hospital All 
Cause Mortality##1022-64·75A
Insulin
National Patterns of Glucose Control Among Patients 
Hospitalized With Acute Myocardial Infarction##1018-
183·283A
RANTES and T Cell Modulation of Adipocyte 
Function##1026-14·402A
Variability in the Hospital Use of Insulin to Control Sustained 
Hyperglycemia Among Acute Myocardial Infarction 
Patients##1018-186·284A
Integrated delivery systems
An Integrated Approach to the Treatment of Sudden Cardiac 
Death Improves Survival in an Urban Setting##1019-
196·230A
Impact of Coordinated Process of Care on Individual 
Components of Treatment Delays Among ST-Elevation 
Myocardial Infarction Patients Treated With Primary 
Percutaneous Coronary Intervention##1018-147·282A
Intravascular ultrasound/doppler
Accuracy of Three-Dimensional Quantititive Coronary 
Analysis by Comparison With Intravascular 
Ultrasound and Two-Dimensional Quantitive Coronary 
Analysis##1013-179·219A
An Intravascular Ultrasound Simulator of Coronary Plaques 
Based on Histopathology##1006-189·275A
Baseline Lipid Status Does Not Influence the Promotion 
of Coronary Atheroma Regression in Response to 
Use of High-Dose Statin Therapy: Insights From 
ASTEROID##1014-119·365A
Can C-Reactive Protein Levels Be a Predictor of Intravascular 
Ultrasound Intimal Hyperplasia Obstruction After 
Zotarolimus-Eluting Stent implantation?##1019-69·221A
Color-Coded Dual-Frequency Intravascular Ultrasound 
Imaging With Use of Radiofrequency Ultrasound Signals: 
A Novel Modality of Tissue Characterization of Coronary 
Plaque##916-227·171A
Effect of Increasing Metabolic Syndrome Score on 
Atherosclerotic Plaque Burden in Coronary Artery 
Disease: Volumetric Assessment by Intravascular 
Ultrasound##1013-195·219A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Converting-Enzyme 
Inhibitors: Final Results of Captopril Combined With 
Valsartan in Acute Myocardial Infarction Study##1002-
6·316A
Effects of Balloon Angioplasty on the Tissue Composition of 
Acute Coronary Lesions: In Vivo Spectral Analysis of 
Intravascular Ultrasound Radiofrequency Data##1019-
116·225A
Ethnic and Geographic Differences in Coronary 
Atherosclerotic Plaque Composition: A Report From 
the Global Virtual Histology Intravascular Ultrasound 
Registry##1026-41·403A
High Urinary 8-Iso-Prostaglandin F2κ Concentration 
Reflects Plaque Instability in Early Stage Coronary 
Atherosclerosis: A 3-Dimensional Intravascular 
Ultrasound Study##1026-36·402A
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Impact of HMG-CoA Reductase Inhibitors (Statins) on 
New Cardiovascular Events Following Coronary 
Intervention and on the Progression-Regression of 
Coronary Atherosclerotic Plaque: A Three-Dimensional 
Intravascular Ultrasound Study##1002-123·325A
Impact of Low-Density Lipoprotein Cholesterol and C-
Reactive Protein on the Tissue Characteristics of 
Coronary Plaques Determined by Integrated Backscatter 
Intravascular Ultrasound##1008-47·339A
In Vivo Intravascular Ultrasound Derived Cardiac Allograft 
Vasculopathy Characterization Using Ultrasound 
Radiofrequency Analysis## 828-3·84A
Intracardiac Echocardiography for Conservative Aortic Valve 
Surgery: A New Investigative Tool##914-224·163A
Intracoronary Sinus Echocardiography: A New Approach to 
Guide Cardiac Interventional Procedures##906-223·133A
Low Endothelial Shear Stress Leads to Expansive Remodeling 
of Atherosclerotic Coronary Subsegments: An In-Vivo 
Follow-Up Intravascular Ultrasound Study##1008-9·335A
Low Endothelial Shear Stress Predicts the Development 
of High-Risk Coronary Atherosclerotic Plaques: A 
Correlative Intravascular Ultrasound and Histopathology 
Natural History Study##1008-3·334A
Regression of Coronary Atherosclerosis During Treatment 
With Statins: Does Age Make a Difference?##1008-
12·336A
Relationship Between Insulin Resistance Features and 
Progression of Cardiac Allograft Vasculopathy##1010-
108·57A
Relationship Between Neutrophil Count on Admission, 
Microvascular Injury, and Long-Term Outcomes in 
Patients Treated With Primary Coronary Angioplasty for 
Acute Myocardial Infarction##1001-159·192A
Relationship of Mild Renal Insufficiency to C-Reactive 
Protein and Coronary Plaque Morphology as Determined 
by Intravascular Ultrasound-Virtual Histology##1013-
180·219A
Role of Multimodality Imaging in the Evalution of Patients 
Undergoing Pulmonary Vein Antral Isolation for Atrial 
Fibrillation: The ROTEA Study##915-237·33A
Safety and Efficacy of IVUS-guided Lumen Re-entry Devices 
for the Percutaneous Revascularization of Chronic Total 
Occlusions of the Superficial Femoral Artery##1026-
80·400A
Serial Observation of Shear Stress and Atherosclerotic Plaque 
Formation by a Newly-Developed Topographic Shear 
Stress Imaging System With Use of Three-Dimensional 
Intravascular Ultrasound##1020-11·379A
Statin-Mediated Increases in High-Density Lipoprotein 
Cholesterol Promote Regression of Coronary 
Atherosclerosis: Insights From Intravascular 
Ultrasound##1014-120·365A
The Actual Condition of Ulceration and Attenuation in Gray 
Scale Intravascular Ultrasound by Using Virtual Histology 
IVUS##907-223·137A
Investigational devices
Accurate Non-Invasive Calibration of an Implantable Left 
Atrial Pressure Monitoring System in Heart Failure 
Patients During Long-Term Follow-Up##1028-110·95A
Fibrous Cap Thickness of Culprit Plaque in Subjects With 
Acute Coronary Syndromes Is Related to Individual 
Plaque Characteristics and Not to the Presence of 
Systemic Cardiovascular Risk Factors: An Intravascular 
Optical Coherence Tomography Study##1026-6·400A
First Experience With Remote Left Ventricular Mapping and 
Cell Injection Utilizing a Novel Integrated NOGA XP/
Stereotaxis Platform##1016-141·71A
Lower Plasma Adiponectin Levels and Higher Oxidative Stress 
Are Associated With In Vivo Thin-Cap Fibroatheroma in 
Patients With Stable Angina Pectoris##1020-45·382A
New Generation Axial-Flow Left Ventricular Assist Device 
Can Support Patients With Various Degrees of Right 
Ventricular Dysfunction##1022-108·78A
Radiofrequency Based Wireless Pressure Sensor Is a Reliable 
Method for Hemodynamic Assessment in Ambulatory 
Chronic Heart Failure Patients: Comparison to Swan-
Ganz Catheter and Echocardiography##1004-140·48A
Stroke Prevention Technology for Patients with Non-Valvular 
AF: Worldwide Experience with the WATCHMAN LAA 
System## 623-5·2A
Investigational drugs
A Novel, Rationally Engineered Heparin (M118) Prevents 
Thrombosis More Effectively Than Unfractionated 
Heparin in a Canine Model of Deep Arterial 
Injury##1020-34·379A
AZD6140 Suppresses Platelet Aggregation in Clopidogrel-
Treated Patients Even in Those With High Aggregation 
Levels## 802-7·208A
Daily Oral Administration of the Apolipoprotein A-I Mimetic 
Peptide D-4F in Patients With Coronary Heart Disease 




 Inhibition Reduces 
Generation of Hydroxy-Fatty Acids##1014-87·364A
LXR Agonist T1317 Inhibits the Aortic Valve Calcification in 
ApoE-/- Mice##1021-23·308A
Safety and Tolerability of a Novel Tissue Factor/Factor VIIa 
Inhibitor rNAPc2 in Patients With Non-ST Elevation 
Acute Coronary Syndrome Managed Invasively: Results 
From the ANTHEM-TIMI 32 Trial##1202-252·196A
Synthesis ad Acoustic Characterization of a Novel Ultrasound 
Controlled Drug Delivery System Based on Echogenic 
Liposomes##902-226·120A
Ion channels
A Constitutively Activating Mutation of Gα
s
 in Outflow 
Tract Tachycardia Increases L-Type Ca2+ Channel 
Activity##918-234·38A
A Novel KCNH2 Mutation Associated With the Short QT 




Aging-Related Myocardial Intolerence to Stress: Recapitulated 
in Adults by K
ATP




Analysis of Action Potentials in the Canine Interventricular 
Septum: No Evidence of M Cells##901-234·10A
Calcium Activated Potassium Channels Contribute to Protease 
Activated Receptor Type One Induced Vasodilatation in 
Humans##1026-3·415A
Characterization of Ion Channels in Human Adipose Tissue-
Derived Stem Cells##904-234·15A
Electrocardiogram Characteristics Prior to the Onset of 
Ventricular Tachycardia/Fibrillation in Patients With 
Brugada Syndrome##919-242·41A
Glucagon-Like Peptide-1 Decreases Myocardial Contractility 




Inhibition of HERG Channel by Aspirin: pH or Direct 
Effect##1002-119·324A
Is the pH-Induced Change in IK
r
 Inhibition by Ibutilide 
Arrhythmogenic?##1002-118·324A
Mechanism of Fever-Aggravation of ST-Elevation and 
Arrhythmogenesis in a Canine Tissue Model of Brugada 
Syndrome##919-234·39A
Mechanisms of Differential Patterns of Survival Between 
Andersen-Tawil and Timothy Syndromes## 836-5·8A
Phenotypic Expression of the Congenital Long QT Syndrome 
in Caucasian and Japanese Patients With Matched 
KCNQ1 Genotypes##905-234·17A
Prevalence of Long QT Syndrome and Identification of Genetic 
Alterations in a Population of Japanese Children##903-
239·14A
The Characteristic Vectorcardiographic Changes in Patients 
With Brugada Syndrome##913-242·31A
Variable Genetic Backgrounds Between Congenital and 
Acquired Long QT Syndromes## 836-7·8A
Ion currents
Inhibition of HERG Channel by Aspirin: pH or Direct 
Effect##1002-119·324A
Ischemia
18F-Fluoromisonidazole Is Selectively Retained in Ischemic 
Human Myocardium During Dobutamine Stress: A Pilot 
Study##913-235·162A
A New Technique for Detecting Stress-Induced Ischemia 
Using Analysis of the Electrocardiogram Depolarization 
Phase##907-242·21A
A Novel Acquisition and Analysis Technique for Accurate 
Myocardial Perfusion Measurement During Helical 
Multi-Detector Computed Tomography Imaging##902-
232·121A
Adverse Cardiovascular Effects of Air Pollution in Patients 
With Coronary Heart Disease## 805-5·352A
Angiotensin Converting Enzyme Inhibitors Beneficially 
Modify Vascular Endothelial Growth factor gene 
expression and protein levels in Stable Coronary Artery 
Disease##1007-180·206A
Association Between Recurrent Ischemia on Continuous ECG 
Holter Monitoring and Short- and Long-Term Mortality 
in Patients With Non-ST-Elevation Acute Coronary 
Syndrome in the MERLIN-TIMI 36 Trial##1019-
155·227A
C-Reactive Protein and B-Type Natriuretic Peptide 
Independently Predict Hospitalization for Heart Failure 
After Acute Coronary Syndromes and Identify Patients 
Who Benefit From Intensive Statin Therapy in the 
PROVE IT-TIMI 22 Trial##1007-174·204A
Can Myocardial Perfusion Imaging Predict Response to 
Cardiac Resynchronization Therapy?##1028-144·96A
Cardiac Release of Urocortin Precedes the Occurrence of 
Irreversible Myocardial Damage in the Rat Heart Exposed 
to Ischemia/Reperfusion Injury##1013-90·211A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography With Computed Tomography Cardiac 
Function Analysis and Quantitative Catheter Angiography 
to Myocardial Perfusion Imaging for Predicting 
Functionally Relevant Coronary Artery Stenosis##907-
230·139A
Coronary Artery Calcium Score and Noninvasive Angiography 
With Multi-Slice Computed Tomography: Comparison 
to Myocardial Perfusion Imaging in Asymptomatic 
Diabetics##919-233·183A
Correlation Between Coronary Calcium Score and Presence of 
Ischemia on Rubidium-82 Positron Emission Tomography 
Stress Test## 811-5·101A
Cost-Benefit Analysis of the Use of Coronary Artery 
Calcium Score and Positron Emission Tomography in 
the Evaluation of Subjects With Indeterminate Tc-99m 
Single- Phonton Emission Computed Tomography Stress 
Test##908-235·143A
Creatinine Kinase-MB Enzyme Elevation in the Presence 
of Normal Troponin Is a Powerful Predictor of 
Cardiovascular Complications in Non-ST-Segment 
Elevation Acute Coronary Syndrome##1019-158·228A
Diagnostic Accuracy of Gated Myocardial Perfusion Single-
Photon Emission Computed Tomography for Detection of 
Left Main Coronary Artery Disease##917-233·176A
Exercise-Induced Changes in the Severity of Mitral 
Regurgitation Among Patients With Chronic Left 
Ventricular Ischemic Dysfunction: Prevalence and 
Clinical Significance##919-224·181A
Hepatocyte Growth Factor Is a Key Paracrine Molecule 
Mediating the Angiogenic and Therapeutic Effects of 
Adipose Stromal Cells##1020-39·381A
Household Passive Smoking Exposure on the Risk of Ischemic 
Heart Disease in Female Never-Smoker Patients##1002-
171·330A
In-Hospital Mortality Predictors in Patients With ST-Elevation 
Acute Myocardial Infarction: Substudy of RENASICA 
Mexican Registry## 843-8·248A
Increased Glucose Uptake by Amphiphysin SH3 Reduces 
Hypoxia-Induced Apoptosis in Cultured Neonatal Rat 
Cardiomyocytes##1007-75·198A
Incremental Benefit of Strain Rate Imaging to the Accuracy 
of Novice and Expert Interpreters of Dobutamine Stress 
Echocardiography##906-225·134A
Inflammatory Markers, Angiographic Severity of Coronary 
Artery Disease, and Patient Outcome##1008-42·338A
Is the pH-Induced Change in IK
r
 Inhibition by Ibutilide 
Arrhythmogenic?##1002-118·324A
Low Carbohydrate Diet Reduces Myocardial Glycogen Stores 
and Impairs Cardiac Function During Ischemia##1025-
72·237A
Myocardial Ischemia and Open Coronary Arteries in Women: 
Etiological Mechanisms##1001-195·194A
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Stress Echocardiography##905-225·130A
Outcome of Patients After Successful Cardiopulmonary 
Resuscitation and Suspected Acute Coronary Syndrome 
Treated With an Early Invasive Strategy##1019-156·228A
Prediction of Cardiac Events in Patients With Reduced 
Left Ventricular Ejection Fraction Using Dobutamine 
Cardiovascular Magnetic Resonance Assessment of Wall 
Motion Score Index##1007-158·204A
Predictive Value of Normal Adenosine-Stress Cardiac 
Magnetic Resonance Imaging Exams: A Prospective 
Follow-Up Study Over 12 Months After Diagnosis##909-
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Prevalence and Prognosis of Silent Ischemia in Outpatients 
With Stable Coronary Heart Disease: The Heart and Soul 
Study## 825-7·233A
Role of Nox2-Containing NADPH Oxidase in Cigarette 
Smoke-Induced Impairment of Angiogenesis##1002-
39·319A
Segmental Diastolic Functional Change due to Myocardial 
Ischemia and Its Persistence: 2-D Strain Analysis##908-
221·140A
Strain Rate Analysis and Levosimendan Improve Detection of 
Myocardial Viability by Dobutamine Echocardiography 
in Patients With Post-Infarction Left Ventricular 
Dysfunction##919-226·181A
Subendocardial Perfusion Deficits Predict the Functional 
Significance of Coronary Stenoses During Adenosine 
Stress Multi-Detector Computed Tomography in Patients 
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Effect of Atorvastatin##1001-69·184A
Preconditioning-Like Cardioprotection by Regular Ethanol 
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Is Associated With eNOS Upregulation## 803-5·235A
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Bloodborne Factor That Allows Interspecies Protection## 
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Acute Metformin Therapy Protects Against Myocardial 
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Direct (Ambulance-Based) Referral to Coronary Care Unit for 
Primary Percutaneous Coronary Intervention Improves 
Door-to-Catheterization Time and Final TIMI Flow: 
Should We Bypass the Emergency Room?##1025-
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Disruption of the Smad3 Signaling Pathway Attenuates Post-
Infarction Remodeling##1013-71·210A
Hydrogen Sulfide Donor Confers Protection Against Acute 
Myocardial Ischemia-Reperfusion Injury##1019-92·222A
Inhibition of κ-Protein Kinase C to Ameliorate Reperfusion 
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Intervention for Acute ST-Elevation Myocardial 
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Preconditioning-Like Cardioprotection by Regular Ethanol 
Consumption Lasts at Least 7 Days After Abstention and 
Is Associated With eNOS Upregulation## 803-5·235A
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Remote Ischemic Preconditioning Is Induced by a Transferable 
Bloodborne Factor That Allows Interspecies Protection## 
803-3·235A
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Warfarin Treatment in Patients With Giant Coronary 
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Kidney
Comparison of Five Different Cardiac Troponin Assays in 
Patients With End-Stage Renal Disease on Chronic 
Hemodialysis##1013-69·209A
Cross-Sectional Relations of Pregnancy-Associated Plasma 
Protein-A Levels With C-Reactive Protein and Urinary 
Albumin Excretion Rate in Essential Hypertensive 
Subjects: A Novel Approach to Diffuse Atherosclerosis## 
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Cross-Sectional Relationships of Urinary Albumin Excretion 
With Arterial Stiffness and Left Ventricular Mass 
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Effect of Anemia Treatment With Epoetin Alfa or Darbepoetin 
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Progression of Calcific Aortic Stenosis##1021-22·308A
Impact of HMG-CoA Reductase Inhibitors on Progression 
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Disease##1002-14·318A
Impact of Hospital Performance on Underuse of Therapies 
Among Patients With Chronic Kidney Disease 
and Non-ST-Segment Elevation Acute Coronary 
Syndromes##1024-187·289A
Infective Endocarditis: Mortality Can Be Predicted by Kidney 
Function at Time of Admission##1015-21·305A
Joint Effects of Diabetes and Dialysis in Predicting Long- 
Term Outcomes Following Percutaneous Coronary 
Interventions##1007-157·204A
Left Ventricular Geometric Patterns in the African American 
Study of Kidney Disease and Hypertension Cohort## 
838-8·399A
Microalbuminuria Is Correlated With Endothelin-1, 
Adiponectin, C-Reactive Protein, and Arterial Stiffness 
in Essential Hypertension: Reflections Beyond the 
Glomerulus##1002-79·322A
Poor Outcomes in Patients With Chronic Kidney Disease 
With and Without Reperfusion After Presentation With 
ST Elevation Myocardial Infarction/Left Bundle Branch 
Block## 826-6·292A
Pregnancy-Associated Plasma Protein-A Levels Are Related 
to Urinary Albumin Excretion Rate: A Novel Pathway 
Linking Atherosclerotic Processes With Microalbuminuria 
in Essential Hypertension##1002-4·315A
Prevalence and Correlates of Microalbuminuria in Essential 
Hypertensive Subjects: Insights From The Hippokration 
Hellenic Hypertension (3H) Study##1008-203·349A
Usefulness of Multiple Detector-Row Computed Tomography 
in Renal Transplant Candidates##913-230·161A
Laser
Novel Laser Doppler Assessment of Microvascular Endothelial 
Function Correlates With Body Mass Index##1026-
37·402A
Leukocytes
Peripheral Arterial Disease Is Associated With Increased Serum 
Myeloperoxidase Levels Independently of the Presence of 
Severity of Coronary Artery Disease##1002-81·322A
Prediction of Future Cardiovascular Disease by Monocyte 
Count in an Asymptomatic Population##1008-160·346A
Prognostic Value and Clinical and Biochemical Correlates 
of Elevated Neutrophil to Lymphocyte Ratio Prior to 
Coronary Stenting##1001-157·192A
RANTES and T Cell Modulation of Adipocyte 
Function##1026-14·402A
Relationship Between Neutrophil Count on Admission, 
Microvascular Injury, and Long-Term Outcomes in 
Patients Treated With Primary Coronary Angioplasty for 
Acute Myocardial Infarction##1001-159·192A
Leukotrienes
Phosphorylation of 5-Lipoxygenase by Protein Kinase A 
Determines Whether Cardiomyocytes Will Produce 15-
Epi-Lipoxin A4 or Leukotriene B
4
 When Incubated With 
Atorvastatin and Pioglitazone##1002-8·316A
Lipid modifying agents
Activation of Peroxisome Proliferator-Activated Receptor γ 




Active Atorvastatin Metabolite Preferentially Inhibits 
Oxidation of Small Dense Low-Density Lipoproteins: A 
Comparative Analysis##1008-13·336A
Association Between Baseline Low-Density Lipoprotein 
Cholesterol, Triglycerides, and High-Density Lipoprotein 
Cholesterol Levels and the Lipid-Altering and hs-C-
Reactive Protein Efficacy of Ezetimibe/Simvastatin 
Versus Atorvastatin in Patients With Type 2 Diabetes 
and Hypercholesterolemia: The VYTAL Study##1008-
127·345A
Baseline Lipid Status Does Not Influence the Promotion 
of Coronary Atheroma Regression in Response to 
Use of High-Dose Statin Therapy: Insights From 
ASTEROID##1014-119·365A
Combination of Amlodipine and Atorvastatin Reverses Age-
Dependent Endothelial Dysfunction in Rat Aorta##1002-
7·316A
Despite Increase in Diagnosis, Peripheral Artery Disease 
Patients Still Trail Coronary Artery Disease Patients 
in Statin and Aspirin Use: Results From a National 
Survey##1014-80·362A
Differential Effects of Inhibition of Cholesterol Absorption 
by Plant Sterols Compared to Ezetimibe on 
Atherogenesis##1008-34·336A
Do Plant Sterols Provide Additional Cholesterol 
Reduction When Added to Statin-Based Combination 
Therapy?##1014-125·366A
Does Preoperative Statin Therapy Improve Outcomes in 
Patients Undergoing Cardiac Valve Surgery?##1021-
19·307A
Economic Evaluation of Intensive Atorvastatin Compared to 
Standard Simvastatin in Patients With Acute Coronary 
Syndrome From the IDEAL Trial##1030-181·294A
Effect of Preoperative Statins in Cardiac Valve Surgery 
Without Coronary Artery Disease##1003-15·298A
Effect of Statins on Thermal Heterogeneity of Atherosclerotic 
Plaques in Patients With Diabetes Mellitus##1020-
35·380A
Effects of Intensive vs. Standard Statin Therapy on Lipids and 
Inflammation in Racial/Ethnic Groups. An Analysis from 
PROVE IT-TIMI 22##1026-120·408A
Evidence for Cholesterol Hyperabsorbers and Hyperproducers 
Based on Comparative Low-Density Lipoprotein 
Reductions Achieved by Ezetimibe Versus Statins## 
820-6·393A
Favorable Effect of Statins on Local Inflammatory Activation 
in Nonculprit Lesions of Patients With Multivessel 
Coronary Artery Disease##1019-94·223A
Fenofibrate Reduces Lipoprotein-Associated Phospholipase 
A2 Mass and Oxidative Stress in Hypertriglyceridemia 
Subjects With the Metabolic Syndrome## 809-5·354A
Fibrates in the Prevention of Cardiovascular Events in 
Dyslipidemic Patients: A Meta-Analysis of Randomized 
Placebo-Controlled Clinical Trials##1002-127·326A
Flushing Experience and Discontinuation With Niacin in 
Clinical Practice##1006-149·273A
Impact of HMG-CoA Reductase Inhibitors (Statins) on 
New Cardiovascular Events Following Coronary 
Intervention and on the Progression-Regression of 
Coronary Atherosclerotic Plaque: A Three-Dimensional 
Intravascular Ultrasound Study##1002-123·325A
Impact of HMG-CoA Reductase Inhibitors on Progression 
of Coronary Atherosclerosis in Chronic Kidney 
Disease##1002-14·318A
Intensive Lowering of the Low-Density Lipoprotein 
Cholesterol/High Density Lipoprotein Cholesterol Ratio 
With High-Dose Statin Therapy Promotes Regression 
of Obstructive Coronary Artery Disease: Insights From 
ASTEROID## 820-4·393A
ISIS 301012, an Antisense Inhibitor of Apolipoprotein B, 
Produces Significant Additional Reduction of Low-
Density Lipoprotein Cholesterol and Apolipoprotein B in 
Hypercholesterolemic Subjects on Statins Not Meeting 
Target## 820-7·393A
Long-Term Effects of Niacin-Simvastatin Combination 
Compared to High-Dose Simvastatin on Lipids, 
Apolipoproteins, Lipoprotein Particles and Inflammatory 
Markers in Patients With Carotid Atherosclerosis## 
820-8·394A
Long-Term Rosuvastatin Treatment Improves Renal Function 
in National Cholesterol Education Program Adult 
Treatment Panel III High Risk Patients##1002-131·327A
N-3 Polyunsaturated Fatty Acids and Major Arrhythmic 
Events: A Meta-Analysis of Randomized Controlled 
Trials##918-239·38A
Phosphorylation of 5-Lipoxygenase by Protein Kinase A 
Determines Whether Cardiomyocytes Will Produce 15-
Epi-Lipoxin A4 or Leukotriene B
4
 When Incubated With 
Atorvastatin and Pioglitazone##1002-8·316A
Post-Percutaneous Coronary Intervention Statin Usage and 
Long-Term Mortality: Is Statin Intolerance a Predictor of 
Adverse Outcome?## 804-3·350A
Pravastatin Increases Circulating Level of Adiponectin via 
Up-Regulation of Gene Expression of Adiponectin in 
Visceral Adipose Tissue but Not in Subcutaneous Adipose 
Tissue in Patients With Coronary Artery Disease##1020-
123·387A
Preoperative Statin Therapy Is Not Associated With Decrease 
Incidence of Postoperative Atrial Fibrillation in Patient 
Undergoing Coronary Artery Bypass Grafting##1015-
19·304A
Relationship Between Intensive Statin Therapy and 
Cardiovascular Outcomes in Patients With Stable 
Coronary Artery Disease: A Meta-Analysis of 
Randomized Clinical Trials##1025-179·245A
Short-Term Statin Therapy Is Associated With Marked 
Reduction of C-Jun N-Terminal Kinase of Aortic Wall 
in Patients With Abdominal Aortic Aneurysm##1008-
44·339A
Statin Therapy Decreases Contrast-Induced Nephropathy in 
Patients Undergoing Cardiac Catheterization##1014-
126·367A
Statin-Like, Dose-Dependent Reductions in LDL-C and 
Apolipoprotein B With ISIS 301012, an Antisense 
Inhibitor of Apolipoprotein B, in Subjects With Polygenic 
Hypercholesterolemia##1206-278·333A
Statin-Mediated Increases in High-Density Lipoprotein 
Cholesterol Promote Regression of Coronary 
Atherosclerosis: Insights From Intravascular 
Ultrasound##1014-120·365A
Statins Reduce the Risk of Death and the Occurrence of 
Adverse Cardiovascular Events in Patients With 
Dyslipidemia and Renal Dysfunction: A Meta-Analysis of 
Randomized Placebo-Controlled Clinical Trials##1008-
124·344A
The Long-Term Safety and Efficacy of Combined Simvastatin 
and Fenofibrate Therapy in Diabetic Patients With 
Dyslipidemia: The DIACOR Study##1008-125·344A
The Role of Adenosine in Activation of Endothelial Nitric 
Oxide Synthase by Atorvastatin: Adenosine, Generated by 
Ecto-5’-Nucleotidase, Is Needed for Akt Phosphorylation 
by Phosphorylated 3-Phosphoinositide-Dependent Kinase 
1##1001-70·184A
Lipoproteins
Association Between the TaqIB Polymorphism of the 
Cholesteryl Ester Transfer Protein Gene and Postprandial 
Triglyceride Levels in Patients With Familial 
Hypercholesterolemia##1002-121·325A
Can an Outpatient, Physician-Driven Approach to Weight 
Loss Work in an Overweight, Dyslipidemic Pediatric 
Population With Characteristics of Metabolic 
Syndrome?##1011-48·259A
Chronic Stress Induces a Pro-Inflammatory Response: 
Implications for Cardiovascular Disease##1026-7·400A
Lipoprotein-associated phospholipase A2 (Lp-PLA2) 
is Associated with CHD Mortality in a High Risk 
Cohort##1026-124·409A
Long-Term Effects of Niacin-Simvastatin Combination 
Compared to High-Dose Simvastatin on Lipids, 
Apolipoproteins, Lipoprotein Particles and Inflammatory 
Markers in Patients With Carotid Atherosclerosis## 
820-8·394A
The Influence of Oxidized Phospholipids and Lp(a) 
Lipoprotein on Coronary Artery Disease Is Conditional 
Upon Genotype at the Interleukin-1 Region##1026-
46·404A
Triglycerides Predict Acute Myocardial Infarction Mortality in 
Older Persons: Findings From the EPESE Study##1020-
124·387A
Lipoproteins, HDL
Association Between Baseline Low-Density Lipoprotein 
Cholesterol, Triglycerides, and High-Density Lipoprotein 
Cholesterol Levels and the Lipid-Altering and hs-C-
Reactive Protein Efficacy of Ezetimibe/Simvastatin 
Versus Atorvastatin in Patients With Type 2 Diabetes 
and Hypercholesterolemia: The VYTAL Study##1008-
127·345A
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Daily Oral Administration of the Apolipoprotein A-I Mimetic 
Peptide D-4F in Patients With Coronary Heart Disease 
or Equivalent Risk Improves High-Density Lipoprotein 
Anti-Inflammatory Function##1014-123·366A
Dose-Dependent Effect of Rosuvastatin on High-Density 
Lipoprotein Kinetics in the Metabolic Syndrome##1020-
119·368A
Elevated Pro-Inflammatory High Density Lipoprotein in 
Primary Systemic Amyloidosis: Potential Role of 
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Flushing Experience and Discontinuation With Niacin in 
Clinical Practice##1006-149·273A
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Cholesterol/High Density Lipoprotein Cholesterol Ratio 
With High-Dose Statin Therapy Promotes Regression 
of Obstructive Coronary Artery Disease: Insights From 
ASTEROID## 820-4·393A
Lipid Levels in Patients Hospitalized With Coronary Artery 
Disease: An Analysis of 136,905 Hospitalizations in Get 
With The Guidelines-Coronary Artery Disease##1206-
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Low Levels of Paraoxonase Activity are Associated with 
Systemic Oxidative Stress, Extensive Coronary Artery 
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651-5·394A
Multiple Splice Defects in ABCA1 Cause Low High-Density 
Lipoprotein Cholesterol in a Family With Premature 
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Patterns of High-Density Lipoprotein Levels in Patients With 
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122·366A
Prevalence of Low High-Density Lipoprotein Cholesterol in 
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Lipoproteins, LDL
Association Between Baseline Low-Density Lipoprotein 
Cholesterol, Triglycerides, and High-Density Lipoprotein 
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Reactive Protein Efficacy of Ezetimibe/Simvastatin 
Versus Atorvastatin in Patients With Type 2 Diabetes 
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Association Between Plasma Low-Density Lipoprotein Particle 
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Lipoprotein and Inflammation in Patients With Severe 
Aortic Stenosis## 839-5·311A
Atorvastatin Exhibits Differential Effects on Circulating 
OxLDL Markers in Patients With Acute Coronary 
Syndromes in the MIRACL Trial According to 
the Severity of Underlying Cardiovascular Risk 
Factors##1008-37·337A
Chronic Stress Induces a Pro-Inflammatory Response: 
Implications for Cardiovascular Disease##1026-7·400A
Comparison of Statin Treatment of Hypercholesterolemic 
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Do Plant Sterols Provide Additional Cholesterol 
Reduction When Added to Statin-Based Combination 
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Endothelial Function, Inflammatory Process and Oxidative 
Stress in Chronic Atrial Fibrillation: The Impact of Left 
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Evidence for Cholesterol Hyperabsorbers and Hyperproducers 
Based on Comparative Low-Density Lipoprotein 
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ISIS 301012, an Antisense Inhibitor of Apolipoprotein B, 
Produces Significant Additional Reduction of Low-
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Target## 820-7·393A
Lipid Levels in Patients Hospitalized With Coronary Artery 
Disease: An Analysis of 136,905 Hospitalizations in Get 
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Lipid-Independent Effects of Statins on Cardiovascular 
Events in the Japanese Coronary Artery Disease Study: 
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Generation of Hydroxy-Fatty Acids##1014-87·364A
Lipoprotein-Associated Phospholipase A
2
 Is Especially 
Predictive of Coronary Artery Disease Among Patients 
With the Metabolic Syndrome##1008-46·339A
LY518674, a Potent and Selective Peroxisome Proliferator 
Activated Receptor Alpha Agonist, Reduces Triglycerides, 
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and Apolipoproteins B and C3##1026-5·405A
Small Dense Low-Density Lipoprotein (LDL)-Cholesterol Is a 
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Statin-Like, Dose-Dependent Reductions in LDL-C and 
Apolipoprotein B With ISIS 301012, an Antisense 
Inhibitor of Apolipoprotein B, in Subjects With Polygenic 
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Longitudinal studies
Gender Differences in 1-Year Outcomes Following Acute 
Myocardial Infarction: Results From the PREMIER 
Study##1024-185·288A
Long-Term Clinical Outcome After Coronary Balloon 
Angioplasty: A 25-Year Follow-Up Study##1001-
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Longitudinal Changes in Chronotropic Response to Exercise 
and Heart Rate Recovery in Pediatric Heart Transplant 
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Trends in Profile and Mortality of Patients With Acute 
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Macrophages
Apolipoprotein E Derived Peptide Containing Gadolinium 
Mixed Micelles for Macrophage Imaging in 
Atherosclerotic Plaque of Apoe -/- Mice##910-232·150A
Arterial-Ventricular Interaction Assessment on the Basis of 
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Broad Spectrum Adenoviral CC-Chemokine Blockade 
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Atherosclerosis in ApoE-Knockout Mice##1013-
200·220A
Circulating Human Monocytes Express a Characteristic 
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Syndrome##1001-72·184A
Extracellular Matrix Protein, Fibulin-2, Enhances Acute 
Wound Healing After Experimental Myocardial Infarction 
in Mice##1025-75·237A
Galectin-3, a Novel Marker of Macrophage Activity, Predicts 
Outcome in Patients With Stable Chronic Heart Failure## 
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Improved Ex-Vivo MR Imaging of Human Aortic 
Atherosclerosis with Macrophage-Specific 
Immunomicelles##1026-78·405A
Magnesium
Magnesium Therapy for the Acute Management of Atrial 
Fibrillation: A Meta-Analysis##918-237·38A
Magnetic resonance imaging
24-Month Outcome Following Negative Adenosine Stress 
Magnetic Resonance Imaging Perfusion Imaging in 92 
Patients Presenting With Chest Pain##915-233·169A
30-Day Results of a Novel, Balloon Expandable Endovascular 
Stent With an Integrated Resonance Circuit for Active 
Visualization in Magnetic Resonance Imaging in a 
Porcine Model##916-233·172A
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Diastolic Biomechanics and Exercise Tolerance in 
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Tagging##1023-31·265A
Abnormal Papillary Muscle Morphology Is Independently 
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The Shrinking Heart: Normal Right Ventricular Structure and 
Function##904-232·128A
Time Is Muscle: Delay in Primary Percutaneous Coronary 
Intervention Results in Larger Infarct Size by Delayed 
Enhancement Cardiac Magnetic Resonance: Results From 
the APEX-AMI Study##903-232·125A
TIMI Grade 3 After Successful Percutaneous Coronary 
Intervention Reduced Myocardial Infarction Volume 
Assessed by Delayed Enhancement Magnetic Resonance 
Imaging.##908-233·143A
Tissue Characterization in Hypertrophic Cardiomyopathy: 
Typical Focal Hyperintensities in T2-Weighted Images 
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and Diabetes Mellitus##1026-39·403A
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230·182A
Metabolic Syndrome Versus Diabetes Mellitus Type II and 
Global Risk Scores for Predicting Future Cardiovascular 
Events##1020-163·389A
Parental Coronary Heart Disease Increases Vulnerability of 
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With Duchenne Muscular Dystrophy -Inhibitory Effect of 
Carvedilol on Cardiac Myolysis##1028-102·93A
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Predicts Long-Term Cardiac Events: A Real-Time 3D 
Echo Study##1025-157·243A
Left Ventricular End-Diastolic Pressure Is a Predictor 
of Suboptimal Myocardial Reperfusion in Patients 
Undergoing Percutaneous Coronary Intervention for ST-
Elevation Myocardial Infarction##1013-93·211A
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Relationship Between the Coronary Artery Anatomy and 
the Subeustachian Isthmus, Coronary Sinus Os-Middle 
Cardiac Vein, and Floor of Coronary Sinus##910-238·25A
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Blind, Multi-Center Dose-Escalation Study to 
Evaluate Tolerability, Safety, Pharmacokinetics, 
and Pharmacodynamics of a Single Intravenous 
Administration of INO-1001 in Subjects With ST-
Elevation Myocardial Infarction Undergoing Primary 
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Randomized, Double-Blind, Placebo-Controlled Study to 
Assess the Safety and Efficacy of Nitric Oxide Synthase 
Inhibition With Tilarginine Acetate Injection in Patients 
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Access to Implantable Cardioverter Defibrillator Therapy 
for Patients With MADIT-Like Criteria in Clinical 
Practice##910-241·26A
Acute Coronary Angiographic Findings in Survivors of Out-of-
Hospital Cardiac Arrest##1013-197·219A
Acute Myocardial Infarction and Pregnancy: Clinical Profile, 
Treatment and Outcome## 844-7·250A
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Risk of Stroke## 410-7·422A
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Door-to-Balloon Time and Mortality in Patients 
Hospitalized With ST-Elevation Myocardial Infarction: 
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Differentiation Potential##1025-70·236A
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Clinical Presentation and Outcomes##1007-198·207A
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Ventricular Reconstruction in Patients With Ischemic 
Heart Failure##1004-143·49A
Characterization of Ion Channels in Human Adipose Tissue-
Derived Stem Cells##904-234·15A
Clinical Factors Associated With Thrombolysis Failure in 
Patients Transferred to an Interventional Cardiac Unit for 
Myocardial Infarction: Data From RICO Survey##1001-
153·191A
Comparison of Hospital Door-to-Balloon Times Reported 
by Centers for Medicare and Medicaid Services and the 
American College of Cardiology-National Cardiovascular 
Data Registry: Apples and Oranges?##1204-264·277A
Cool It: Therapeutic Hypothermia for Anoxic Encephalopathy 
in a High-Risk Transfer Population of Cardiac Arrest 
Patients: Initial Results##1013-196·219A
Coronary Revascularization Procedure in Patients >80 Years 
Presenting With Acute Myocardial Infarction##1001-
116·188A
Cost and Effectiveness Comparison of Very Early Treatment 
With Primary Percutaneous Coronary Intervention 
Facilitated With Abciximab or Thrombolytic Therapy 
for Acute ST-Elevation Myocardial Infarction##1013-
116·214A
Diagnostic Performance of the Modified Rush Score Across 
Risk Strata and Prespecified Clinical Subgroups, Is 
Superior to the TIMI Risk Score for Prediction of In-
Hospital Mortality in Acute Coronary Syndromes##1025-
112·239A
Differences in Invasive Therapies and In-Hospital Mortality 
Between Patients With and Without ST-Segment 
Elevation Myocardial Infarction Complicated by 
Cardiogenic Shock##1025-197·246A
Differences in Medical Care in Patients Presenting With Acute 
Myocardial Infarction During Holidays and Weekends vs. 
Weekdays##1030-185·295A
Direct (Ambulance-Based) Referral to Coronary Care Unit for 
Primary Percutaneous Coronary Intervention Improves 
Door-to-Catheterization Time and Final TIMI Flow: 
Should We Bypass the Emergency Room?##1025-
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Direct Collagen Injection to Thicken the Infarct Scar: Collagen 
Density Determines Angiogenesis##1001-75·185A
Direct Transport of Patients With Acute Myocardial 
Infarction to Interventional Cardiology Center 
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Intervention##1013-133·214A
Do Core Measures and Other Evidence-Based Practices 
Reduce Risk-Adjusted In-Hospital Mortality for Acute 
Myocardial Infarction in Community Practice?## 826-
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Does Early Invasive Strategy Provide a Clinically Important 
Advantage Over Early Conservative Strategy in the 
Management of Acute Coronary Syndromes?##1025-
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Does Erythropoietin Reduce Enzymatic Infarct Size in Non-
STE ACS? Results From a Pilot Trial## 847-4·250A
Does NT-proBNP Predict and Explain Poor Outcomes in ST-
Elevated Myocardial Infarction Patients? Insights From 
ASSENT-4 PCI##1019-133·226A
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Cautionary Results##1022-142·80A
Effect of Cell Based Intercellular Delivery of GATA-4 on 
Ischemic Cardiomyopathy## 409-7·421A
Effect of Cell-Based Intercellular Delivery of GATA-4 on 
Ischemic Cardiomyopathy## 822-3·82A
Effect of Early Versus Late In-Hospital Initiation of Statin 
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Infarction: Results From 5,866 Patients From the ACOS 
Registry##1025-158·244A
Impact of Coordinated Process of Care on Individual 
Components of Treatment Delays Among ST-Elevation 
Myocardial Infarction Patients Treated With Primary 
Percutaneous Coronary Intervention##1018-147·282A
Impact of Exercise Training in the Cardiac and Autonomic 
Dysfunctions After Myocardial Infarction in an 
Experimental Menopause Model##907-236·140A
Impact of GP IIB/IIIA Receptor Inhibitors and Clopidogrel 
Treatment on 30-Day and 1-year All-Cause Mortality of 
Patients With ST-Elevation Myocardial Infarction Treated 
by Primary Percutaneous Coronary Intervention## 847-
5·251A
Impact of Guidelines-Based Protocol on Timeliness of 
Reperfusion for Patients Presenting During Regular-Hours 
and Off-Hours##1024-147·286A
Impact of Hospital Performance on Underuse of Therapies 
Among Patients With Chronic Kidney Disease 
and Non-ST-Segment Elevation Acute Coronary 
Syndromes##1024-187·289A
Impact of Obesity on Prognosis of High-Risk Patients After 
Myocardial Infarction or Chronic Heart Failure: A Meta-
Analysis of Individual Patient Data##1004-150·50A
Impact of Renal Dysfunction on Prognosis After Acute 
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Percutaneous Coronary Intervention After Early 
Prehospital Thrombolysis: Reasonable, Useless, or 
Dangerous?##1013-137·215A
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ST Elevation Myocardial Infarction/Left Bundle Branch 
Block## 826-6·292A
Potent Mitochondria-Targeted Peptides Reduce Myocardial 
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With Acute Coronary Syndrome Admitted Through the 
Emergency Department: Implications for Upstream 
Management## 802-4·208A
Safety and Efficacy of the Use of Endothelial Progenitor 
Cell Capture Stent Genous® Bio-Engineered R Stent in 
the Setting of Acute Myocardial Infarction: A Clinico-
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to Men##1019-93·223A
The Fate of Adipose Stromal Cells Following Intracoronary 
and Retrograde Venous Myocardial Delivery in a Swine 
Infarct Model##1025-154·243A
The Impact of Aspirin Resistance on Long-Term 
Cardiovascular Mortality in Patients With Non-ST 
Elevation Acute Coronary Syndromes##1025-116·240A
The Impact of Different Aerobic Exercise Intensity on 
Endothelial Function in Patients Post-Myocardial 
Infarction##1002-170·330A
The Prognostic Value of the 12-Lead Electrocardiogram (ECG) 
in Patients Presenting With Acute Coronary Syndromes: 
Insights From the GRACE ECG Substudy##1001-
95·187A
Towards Reduced Symptoms-to-Balloon Times in Primary 
Percutaneous Coronary Intervention: Effects of 
Prehospital Triage and Off-Site PCI##1001-136·190A
Transradial Approach In Percutaneous Coronary Intervention 
Following Prehospital Fibrinolysis Reduces Vascular 
Access Site Complication: Data From the French National 
OPTIMAL Study##1001-74·185A
Trends in Profile and Mortality of Patients With Acute 
Myocardial Infarction From 1987 to 2002: A New Jersey 
Statewide Study## 817-6·291A
Tumor Necrosis Factor-κ Enhances the Engraftment of 
Mesenchymal Stem Cells Onto Infarcted Myocardium via 
Bone Morphogenetic Protein-2##1007-73·198A
Type of Glycoprotein IIb/IIIa Inhibitor and In-Hospital 
Outcome in STEMI Patients Treated With Primary 
Percutaneous Coronary Intervention: Results From the 
Nationwide French FAST-MI Registry##1019-114·224A
Use of Low Molecular Weight Heparin Is Associated 
With Improved In-Hospital Survival of ST-Elevation 
Myocardial Infarction Patients Who Receive Reperfusion 
Therapy: Results From the Nationwide French FAST-MI 
Registry##1025-94·238A
Utilization of Emergency Medical Services for Hospital 
Transport in Patients With ST-Elevation Myocardial 
Infarction Results in a Shorter Door-to-Balloon 
Time##1019-138·227A
Variability in the Hospital Use of Insulin to Control Sustained 
Hyperglycemia Among Acute Myocardial Infarction 
Patients##1018-186·284A
Myocardial stunning
Diagnostic Value of Left Ventricular Function of Post-Stress 
and at Rest in the Detection of Multi-Vessel Coronary 
Artery Disease as Assessed by Electrocardiogram-Gated 
Single-Photon Emission Computed Tomography##912-
235·158A
Tako-Tsubo Syndrome and Acute Coronary Syndrome: Are 
They Really Different Entities? Electrocardiogram 
Analysis##914-242·33A
Washout Ratio of 123I-BMIPP Myocardial Scintigraphy Predicts 
Negative Cardiac Remodeling After Acute Myocardial 
Infarction: Comparison With Three-Dimensional 
Echocardiography##908-224·141A
Myocarditis
Differential Activation of JAK-STAT Signaling in 
Cardiac Dysfunction due to Myocarditis vs. Pressure 
Overload##1016-58·65A
Effects of SIV Infection and Immunostimulation on the 
Development of Myocarditis and Contractile Dysfunction 
in Rhesus Macaques## 801-8·61A
Natural History of Patients With Biopsy-Proved Myocarditis 
According to Different Clinical Presentations## 801-
4·60A
Predictors of Mortality in Patients With Acute 
Myocarditis##1016-104·69A
Serum Proteomic Profiles in Giant Cell Myocarditis: Altered 
Expression of Immune Response and Lipid Metabolism 
Proteins## 801-3·60A
Myocardium
A Novel Acquisition and Analysis Technique for Accurate 
Myocardial Perfusion Measurement During Helical 
Multi-Detector Computed Tomography Imaging##902-
232·121A
Activation of Peroxisome Proliferator-Activated Receptor κ 




Aortic Regurgitation: Role of Proteoglycans in Myocardial 
Fibrosis?##1021-20·307A
Clinical Relevance of Fat Replacement of the Right Ventricular 
Myocardium Determined by Multislice Computed 
Tomography: Relationship With Aging, Obesity, and the 
Occurrence of Ventricular Arrhythmia##1010-106·57A
Desmin Content in Right and Left Ventricle in Congenital 
Heart Disease: An Indicator of Heart Failure##1016-
61·65A
Early Impairment of Left Atrial Kinetic Energy in Transfusion-
Dependent Beta-Thalassemic Patients With Preserved 
Ventricular Function##1016-103·69A
Global Diastolic Strain Rate for the Assessment of Left 
Ventricular Relaxation and Filling Pressures##902-
227·120A
Glucagon-Like Peptide-1 Decreases Myocardial Contractility 




Hemodynamic Load-Dependent Activation of Cardiac Stem 
Cells and Myocyte Turnover in Mitral Regurgitation## 
822-8·84A
Myogenic Development of Adipose Tissue-Derived 
Mesenchymal Stem Cells: Co-Expression and Interaction 
of Telemerase and Myocardin-A##1028-57·89A
Strain Analysis Identifies Regional Right Ventricular 
Contractile Inhomogeneity After Pulmonary 
Endarterectomy: 2-Dimensional Strain Echocardiographic 
Study##1026-86·407A
Subendocardial Perfusion Deficits Predict the Functional 
Significance of Coronary Stenoses During Adenosine 
Stress Multi-Detector Computed Tomography in Patients 
With Chest Pain##913-231·161A
Tissue Doppler Diastolic Variables Can Differentiate 
Hibernating Myocardium##901-223·115A
Vector Velocity Imaging Yields Accurate Measures of 
Left Ventricular Torsional Mechanics: Comparison to 
Magnetic Resonance Imaging## 806-3·99A
Myosin
Desmin Content in Right and Left Ventricle in Congenital 
Heart Disease: An Indicator of Heart Failure##1016-
61·65A
Natriuretic peptides, atrial
A Novel Next Generation Natriuretic Peptide: CD-NP##1008-
120·343A
Associations of Left Atrium Volume With Aortic Stiffness and 
Neurohumoral Factors in the Early Stages of Essential 
Hypertension##912-221·155A
B-Type Natriuretic Peptide and Recurrence of Atrial 
Fibrillation After Electrical Cardioversion: A Prospective 
Study With 1-year Follow-Up##917-238·37A
Blood Pressure Lowering And cGMP Activating Actions Of 
Oral Human BNP In Experimental Hypertension##1026-
170·413A
BNP Inhibits Cardiac Fibroblast Proliferation via the 
Natriuretic Peptide C Receptor and Modulates FAK 
Signaling and p21 and Cyclin D1 Expression##1022-
57·73A
Brain Natriuretic Peptide and Severity of Diastolic 
Dysfunction: Interaction With Left Ventricular Geometry 
and Function in Mild-Moderate Heart Failure: The 
AREA-IN-CHF Study##1010-68·55A
Des-Serine-Proline B-Type Natriuretic Peptide (BNP 3-32), 
Which Is Produced From Mature BNP 1-32 by Dipeptidyl 
Peptidase IV, Has Reduced Bioactivity##1008-118·343A
Factors Associated With Serum Brain Natriuretic Peptide 
Levels in Patients After the Fontan Procedure## 823-
6·267A
Higher Percent Brain Natriuretic Peptide Reduction Is 
Required in Blacks Than Whites to Reduce Event-Free 
Survival in Heart Failure##1028-67·91A
Influence of Cardiac Resynchronization Therapy on the 
Prognostic Power of NT-Brain Natriuretic Pepetide in 
Patients With Heart Failure Characterized by Cardiac 
Dyssynchrony: A Substudy of the CARE-HF Trial##914-
240·32A
Is B-Type Natriuretic Peptide Superior to Contractile Reserve 
in Predicting Outcome in Low-Flow Aortic Stenosis? 
Results From the Multicenter TOPAS Study##1205-
269·300A
Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) 
Predicts Survival in Patients with Mild to Moderate 
Chronic Heart Failure## 625-5·73A
N-Terminal Pro-BNP Is Associated With Cardiac Structure 
and Function in Elderly Patients With Heart Failure 
and Preserved Systolic Function: The iPRESERVE 
Study##1010-63·54A
Negative Impact of Nesiritide in Combination With Inotropic 
Therapy Among Patients Admited With Acute Heart 
Failure##1022-66·76A
Predicting Value of Early Period B-Type Natriuretic Peptide 
for Left Ventricular Remodeling Following Prompt 
Reperfusion Therapy in Patients With Acute Myocardial 
Infarction##1025-74·237A
Prognostic Role of Left Atrial Volume in Elderly Patients With 
Symptomatic Stable Chronic Heart Failure: Comparison 
With Left Ventricular Diastolic Dysfunction and B-Type 
Natriuretic Peptide##1022-67·76A
Relationship Between the Ratio of Peak Early Diastolic 
Transmitral Flow and Mitral Annular Velocities and 
the Plasma B-Type Natriuretic Peptide Concentration 
in Patients With Atrial Fibrillation: Assessment by 
Simultaneous Recording of Transmitral Flow and Mitral 
Annular Velocity##907-221·137A
Similar Unfavorable Effects of Diabetes Mellitus and 
Metabolic Syndrome on Hypertensive Target Organ 
Damage: Data From the 3H Study##902-222·119A
Systolic Blood Pressure at Baseline Predicts Efficacy of 
Intravenous Atrial Natriuretic Peptide Anole Therapy for 
Acute Exacerbation of Chronic Heart Failure in Patients 
With Dilated Cardiomyopathy##1004-99·45A
The Predictive Value of Elevated Amino Terminal Pro-B-Type 
Natriuretic Peptide and B-Type Natriuretic Peptide for 
Mortality in the Absence of Cardiovascular Risk Factors 
or Structural Cardiac Abnormalities in the General 
Community##1002-163·328A
Nitrates/Nitroglycerin
Dissociation of Aldehyde Dehydrogenase Activity From 
Nitrate Effect, Bioconversion and Tolerance in Humans## 
406-6·420A
Nitric oxide
Asymmetric Dimethylarginine and Reduced Nitric Oxide 
Bioavailability in Young Black African Men## 805-
6·353A
Asymmetric Dimethylarginine as a Mediator of Inflammation 
and Coronary Microvascular Endothelial Dysfunction In 
Postmenopausal Women##1014-14·358A
Chronic Baroreflex Activation Therapy Normalizes Gene 
Expression of Nitric Oxide Synthase in Left Ventricular 
Myocardium of Dogs With Chronic Heart Failure## 
829-5·86A
Circulating Levels of Endogenous Nitric Oxide Synthase 
Inhibitors Independently Predict Carotid Intima-Media 
Thickness: A Population-Based Study##1002-12·317A
Combination of Amlodipine and Atorvastatin Reverses Age-
Dependent Endothelial Dysfunction in Rat Aorta##1002-
7·316A
Effect of Spironolactone Use on the Benefit of Fixed-Dose 
Combination of Isosorbide Dinitrate/Hydralazine in the 
African-American Heart Failure Trial## 808-3·63A
Effects of Ramipril on Endothelial Function and Inflammatory 
Process in Young Normotensive Patients With 
Successfully Repaired Coarctation of the Aorta## 837-
7·268A
Endogenous Methylated Arginine Derivatives in Patients 
With Chronic Systolic Heart Failure: Relationship With 
Echocardiographic Indices and Clinical Outcomes## 
835-7·88A
Exogenous Nitric Oxide Increases the Expression of Oct-4 and 
May Modify Bone Marrow Stem Cell Differentiation Into 
Endothelial Cells In Vitro##1026-9·408A
Genetic Polymorphism G894T on eNOS Gene Increases the 
Smoking-Associated Risk for Premature Myocardial 
Infarction: A Gene-Environment Interaction##1008-
11·336A
L-Methylfolate Enhances Flow-Mediated Dilation in Patients 
With Abnormal Endothelial Function##1014-1·355A
Neuronal Nitric Oxide Synthase Deficiency Increases Calcium 
Leakage From the Sarcoplasmic Reticulum in Ventricular 
Myocytes##1022-55·73A
Obesity Is Associated With Impaired Human Coronary 
Endothelial Function##1020-4·377A
Oxidized Low-Density Lipoprotein Downregulates Insulin-
Like Growth Factor-1 Receptor via Enhanced Generation 
of Nitric Oxide and Reactive Oxygen Species in Human 
Aortic Smooth Muscle Cells##1008-35·337A
Plasma Levels of Arginine/(Ornithine + Citrulline), a Global 
Index of Functional Arginine Bioavailability, Predicts 
Future Risk for Major Adverse Cardiac Events##1008-
39·337A
Pure HNO Donors Increase Myofilament Ca2+ Responsiveness 
in Cardiac Muscle##1004-62·43A
Quantification of Endothelial Cell Activation in Ambulatory 
Patients With Compensated Heart Failure by a Novel 
Methodology: Human Endothelial Biopsy Coupled With 
Analysis of Protein Expression##1014-47·361A
Sildenafil Exerts Direct Cardioprotective Effects on HL-1 Cells 
Inducing Nitric Oxide-Mediated Opening of MitoKATP 
Channels##1019-70·221A
Sodium Nitrite Is a Potent Venodilator##1020-5·377A
The Heart-Kidney Connection: Myocardial Infarction 
Accelerates Glomerular Dysfunction, Hypertrophy, 
and Proteinuria in Experimental Mild Renal 
Insufficiency##1019-73·221A
The Role of Adenosine in Activation of Endothelial Nitric 
Oxide Synthase by Atorvastatin: Adenosine, Generated by 
Ecto-5’-Nucleotidase, Is Needed for Akt Phosphorylation 
by Phosphorylated 3-Phosphoinositide-Dependent Kinase 
1##1001-70·184A
The V-HeFT Paradox, Identical Doses of Different 
Formulations of Isosorbide Dinitrate and Hydralazine Are 
Not Bioequivalent and Neither Is Bioequivalent to the 
Fixed-Dose Combination of ISDN/Hydralazine Used in 
A-HeFT## 808-8·64A
Norepinephrine
Biochemical Evidence of Resensitization of the Failing Left 
Ventricular Myocardium to κ-Adrenergic Stimulation 
Following Extended Therapy With the Orqis Medical 
Cardiac Recovery System## 828-5·84A
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Central Sleep Apnea Promotes Increased Endothelin-1 and 
Norepinephrine Serum Concentration and Pulmonary 
Hypertension in Patients With Congestive Heart 
Failure##1201-246·51A
Neurohormonal Features of Stress-Induced (Takotsubo) 
Cardiomyopathy Versus Acute Myocardial Infarction## 
670-5·96A
Nutrition
A School-Based Health Education Program Identifies Children 
at Risk for Cardiovascular Disease and Diabetes: Baseline 
Data From the Project Healthy Schools 2005-06 Pilot 
Program## 817-5·291A
Association of MTHFD1 G1958A and MTHFR C677T 
Polymorphisms With Serum Homocysteine Concentration 
and Cardiovascular Disease: The Normative Aging 
Study##1025-69·236A
Cytoplasmic Serine Hydroxymethyltransferase and Methylene-
Tetrahydrofolate Reductase Polymorphisms and Coronary 
Heart Disease Risk in US Women##1025-71·237A
Differential Effects of Inhibition of Cholesterol Absorption 
by Plant Sterols Compared to Ezetimibe on 
Atherogenesis##1008-34·336A
Evidence Does Not Support Obesity as a Relative 
Contraindication to Heart Transplantation##1016-
108·70A
Obesity
A School-Based Health Education Program Identifies Children 
at Risk for Cardiovascular Disease and Diabetes: Baseline 
Data From the Project Healthy Schools 2005-06 Pilot 
Program## 817-5·291A
A Simple Additive Risk Score Discriminates Patients at 
Heightened Risk of Early Adverse Events During 
Medical Management Following Diagnostic Cardiac 
Catheterization##1020-166·390A
Antihypertensive Efficacy of the Direct Renin Inhibitor 
Aliskiren When Added to Hydrochlorothiazide 
Treatment in Patients With Extreme Obesity and 
Hypertension##1014-169·370A
Are Fatness and Fitness Related to Microvascular Reactivity in 
Hypertensive Diabetics?## 840-8·416A
Body Fat Related to Risk Factors for Cardiovascular Disease in 
Young Children##1002-166·329A
Can an Outpatient, Physician-Driven Approach to Weight 
Loss Work in an Overweight, Dyslipidemic Pediatric 
Population With Characteristics of Metabolic 
Syndrome?##1011-48·259A
Cardiovascular Determinants of Improved Exercise Capacity 
After Marked Weight Loss From Gastric Bypass 
Surgery##1026-167·413A
Cardiovascular Risk, Obesity and Myocardial Blood Flow in 
Postmenopausal Women## 840-4·415A
Clinical Benefit of Antihypertensive Therapy on 
Cardiovascular Events in Obese Patients With Coronary 
Artery Disease: A CAMELOT Trial Subanalysis## 848-
4·417A
Does Subcutaneous Adiposity Protect Women Against 
Coronary Disease?##910-229·150A
Dose-Dependent Effect of Rosuvastatin on High-Density 
Lipoprotein Kinetics in the Metabolic Syndrome##1020-
119·368A
Effects of Diet-Induced Weight Loss in Obese Males on 
Cardiac and Vascular Function##1020-1·377A
Effects of Metabolic Syndrome on Pattern of Acute Coronary 
Syndromes##1013-115·213A
Epidemiology of Valvular Regurgitation in the Large Middle-
Aged African American Cohort of the Atherosclerosis 
Risk in Communities Study##1003-21·299A
Estrogen Induces Weight Loss and Improves Systolic Function 
in a Mouse Model of Obesity## 829-3·85A
Gender Difference in the Association Between Leptinemia 
and Blood Pressure in the United States Population: 
The Third National Health and Nutrition Examination 
Survey##1002-208·332A
Impact of Obesity on Prognosis of High-Risk Patients After 
Myocardial Infarction or Chronic Heart Failure: A Meta-
Analysis of Individual Patient Data##1004-150·50A
Is There a Relationship Between Weight and Mortality Risk in 
Optimally Managed Heart Failure Patients? Observations 
From the Sudden Cardiac Death in Heart Failure 
Trial##1004-145·49A
Low Carbohydrate Diet Reduces Myocardial Glycogen Stores 
and Impairs Cardiac Function During Ischemia##1025-
72·237A
Major Weight Loss Prevents Long-Term Left Atrial 
Enlargement in Patients With Morbid Obesity##1008-
170·348A
Metabolic Syndrome Predicts Cardiovascular Outcome 
Independently of Left Ventricular Hypertrophy: The 
Strong Heart Study## 812-5·373A
Nifedipine Added to the Combination With Pravastatin and 
Olmesartan Shows Preventive Effect on Hypoxia-Induced 
Left Ventricular Remodeling in Diabetes Mellitus##1008-
205·349A
Obesity and Atrial Fibrillation: A Meta-Analysis##1020-
130·388A
Obesity Is Associated With Impaired Human Coronary 
Endothelial Function##1020-4·377A
Obesity Paradox in Risk Stratification and Prognosis of 
Patients Undergoing Stress Echocardiography##914-
225·163A
Objectively Measured Daily Physical Activity in Relation 
to Fitness and Fatness in an Urban Sample of 
Children##914-236·166A
Preserved Endothelial Function in Subjects With Morbid 
Obesity: A New Obesity Paradox?##1026-1·399A
RANTES and T Cell Modulation of Adipocyte 
Function##1026-14·402A
Reduction in Left Atrial Size 2 Years After Marked Weight 
Loss Achieved With Bariatric Surgery##1026-163·412A
Rimonabant Improves Body Weight and Cardiometabolic Risk 
Factors in Older Adults##1002-124·325A
Safety and Efficacy of Bariatric Surgery in Morbid Obese 
Patients With Severe Heart Failure## 807-8·62A
Serum Adiponectin as a Surrogate Marker of Metabolic 
Syndrome: A Prospective Cohort Study##1020-129·388A
Severity of Coronary Artery Disease in Obese Patients 
Undergoing Coronary Angiography and Intervention: 
Obesity Paradox Revisited##1013-111·212A
The Association between the Prevalence of Obesity and 
Adherence to the Mediterranean Diet; the ATTICA 
study.##1026-162·411A
The Impact of Body Mass Index on Mortality in 35,607 
Patients With Preserved Systolic Function: The Obesity 
Paradox Revisited## 812-7·373A
The Implication of Obesity on Total Antioxidant Capacity and 
Inflammatory Process in Apparently Healthy Men and 
Women: The ATTICA Study## 812-4·372A
The Role of Quinapril in the Presence of a Weight Loss 
Regimen: Endothelial Function and Markers of Obesity in 
Patients with the Metabolic Syndrome##1026-202·414A
Ventricular Vascular Coupling in Obesity Is Affected by an 
Adverse Temporal Profile of Wave Reflections and 
Ventricular Ejection: A Population-Based Study## 840-
5·415A
Waist Circumference and the Risk of Heart Failure## 812-
8·373A
Waist Circumference Reduction, Not Body Mass Index, 
Improves Endothelial-Dependent Vasodilatation After 
Acute Coronary Syndrome## 840-3·415A
Waist-Hip Ratio Is the Strongest Measure of Abdominal 
Obesity in the Prediction of Subclinical Atherosclerosis 
as Measured by Coronary Artery Calcium in Persons 
Without Multiple Metabolic Syndrome Risk Factors## 
811-8·102A
Waist-to-Hip Ratio Is a Superior Predictor of Atherosclerosis 
Compared With Body Mass Index in a Population-Based 
Sample: Observations From the Dallas Heart Study## 
812-3·372A
We Are Getting Fatter - But Are Our Cath Labs 
Ready?##1006-186·274A
Outcomes assessment
A 15-Year Study on Pacemaker-Related Infections: A Claim for 
Using Postoperative Antibiotics##904-241·16A
Abciximab or Eptifibatide: Differences in Outcomes of Patients 
Treated With Abciximab Versus Eptifibatide as Adjunct 
Therapy for Primary Percutaneous Coronary Interventions 
for ST-Elevation Myocardial Infarction## 826-3·292A
Are There Any Differences in the Clinical and Angiographic 
Correlates of Short- and Long-Term Mortality in Patients 
Undergoing Coronary Artery Bypass Surgery?##1013-
198·220A
Aristotle Comprehensive Complexity Score Is Not Better Than 
Analysis of Variance in Predicting Hospital Length of 
Stay After Congenital Heart Surgery##1023-48·265A
Association Between Admission Neutrophil to Lymphocyte 
Ratio and 6-Month Mortality in Patients With Acute 
Coronary Syndrome##1012-148·278A
Association of Peripheral Vascular Disease and All-Cause 
Mortality in Patients With Rheumatoid Arthritis## 814-
7·375A
Can Myocardial Perfusion Imaging Predict Response to 
Cardiac Resynchronization Therapy?##1028-144·96A
Candesartan Benefits and Safety Observed Regardless of Age- 
Insights From CHARM Program##1010-97·55A
Carotid Stenting in Patients With Prior Carotid Endarterectomy 
Is Associated With Favorable Outcomes in Community 
Practice: Insights From the Large German Multicenter 
ALKK CAS Registry## 814-5·374A
Comparing Early and Delayed Enalapril Therapy on Long-
Term Cardiovascular Morbidity and Mortality in Patients 
With Reduced Ejection Fractions From SOLVD##1016-
68·67A
Complication Rate Following Device Implantation in Patients 
With Impaired Renal Function##903-242·15A
Coronary Artery Calcium Percentiles and Absolute Scores: 
Which Is a Stronger Predictor of Mortality?##912-
231·157A
Despite Increase in Diagnosis, Peripheral Artery Disease 
Patients Still Trail Coronary Artery Disease Patients 
in Statin and Aspirin Use: Results From a National 
Survey##1014-80·362A
Diastolic Function Analysis by Echocardiography Predicts 
Mortality Incremental to Clinical Risk and Ejection 
Fraction##910-221·148A
Differences in Early Mortality, Treatment and Procedures 
by Age and Race for Women With Acute Myocardial 
Infarction, 2000 Through 2006## 847-8·251A
Discharge Medications and 6-Month Outcomes in Acute 
Coronary Syndrome Patients With Minimal Versus 
Moderate to Severe Coronary Artery Disease##1012-
149·278A
Do Core Measures and Other Evidence-Based Practices 
Reduce Risk-Adjusted In-Hospital Mortality for Acute 
Myocardial Infarction in Community Practice?## 826-
8·293A
Do Statins Improve Survival in Patients With Diastolic 
Dysfunction?##1020-121·368A
Do the Results of the Arterial Revascularization Therapies 
Study Trial Generalize to Current Revascularization 
Practices in Northern New England?##1018-146·282A
Dual Antiplatelet Agent Failure: A New Syndrome or a Clinical 
Non-Entity?##1024-186·289A
Echocardiography Provides Important Prognostic Information 
in Patients With Advanced Pulmonary Hypertension, Even 
After Initiation of Vasodilator Therapy##913-222·159A
Effect of Diabetes and Glomerular Filtration Rate on 6-
Month Outcomes in Patients Undergoing Cardiac 
Catheterization##1012-147·278A
Effect of Preoperative Statins in Cardiac Valve Surgery 
Without Coronary Artery Disease##1003-15·298A
Effects of Drug-Eluting Stents on Hospital Readmission Rates 
and Long-Term Repeat Revascularization: Outcomes 
From a Large Clinical Registry##1024-181·287A
Emergency Treatment of Acute Type B Dissection: Is Surgery 
Still Justified? Results From the International Registry of 
Aortic Dissection## 814-4·374A
Evaluation of the Appropriateness Criteria for Myocardial 
Perfusion Imaging: A Clinical Appropriateness Score 
Stratifies Perfusion Findings##910-235·151A
Evaluation of the Clinical Composite Endpoint: Results From 
the COMPANION Study##1028-141·95A
Evidence Does Not Support Obesity as a Relative 
Contraindication to Heart Transplantation##1016-
108·70A
Evidence Does Support Glomerular Filtration Rate <40 
ml/min as a Relative Contraindication to Heart 
Transplantation##1016-107·70A
Gender Differences in 1-Year Outcomes Following Acute 
Myocardial Infarction: Results From the PREMIER 
Study##1024-185·288A
Global Outcomes of ST-Elevation Myocardial Infarction: 
Comparisons of the ExTRACT-TIMI 25 Registry and 
Trial##1001-94·186A
High-Dose Atorvastatin - Better Value for Money: The Treating 
to New Targets Trial United States Economic Substudy 
in 5,308 Stable Coronary Heart Disease Patients## 817-
3·290A
Higher Percent Brain Natriuretic Peptide Reduction Is 
Required in Blacks Than Whites to Reduce Event-Free 
Survival in Heart Failure##1028-67·91A
ICD Therapy and Outcomes in Survivors of Sudden Cardiac 
Arrest After High-Risk Myocardial Infarction: The 
VALsartan in Acute Myocardial INfarction Trial## 830-
5·6A
Immediate- and Long-Term Outcomes Related to 
Retroperitoneal Bleeding Following Percutaneous 
Coronary Intervention##1006-185·274A
Impact of a Cardiovascular Limited Ultrasound Examination 
Using a Hand-Carried Ultrasound Device: Changes 
in Clinical Management Outcomes in a Primary-Care 
Clinic##1008-162·346A
Impact of Body Mass Index on Mortality in Patients Presenting 
With Acute ST-Elevation Myocardial Infarctions##1006-
183·273A
Impact of Coordinated Process of Care on Individual 
Components of Treatment Delays Among ST-Elevation 
Myocardial Infarction Patients Treated With Primary 
Percutaneous Coronary Intervention##1018-147·282A
Impact of Depression, Anxiety, and Social Support on Risk of 
Hospitalization in Patients With Cardiac Disease##1014-
160·368A
Impact of Subclinical Hypothyroidism on Coronary Heart 
Disease, Cardiovascular, and All-Cause Mortality: A 
Meta-Analysis##1002-173·330A
Improved Prognosis in Isolated Left Ventricular 
Noncompaction: Follow-Up Study of 39 Patients##1028-
100·93A
In-Hospital Mortality May Not Be a Valid Predictor of 
Overall Quality of Care in Patients With Myocardial 
Infarction##1024-183·288A
Incidence, Predictors, and Outcomes of Ventricular 
Arrhythmias During Angioplasty for Acute Myocardial 
Infarction##910-239·26A
Increased Mortality With Early Surgical Revascularization 
in Acute ST-Elevation Myocardial Infarction After 
Fibrinolysis: An Analysis of the GUSTO V Study##1202-
251·196A
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Increased Risk of Incident Stroke Associated with the 
Cyclooxygenase 2 G-765C Polymorphism in African-
Americans: The Atherosclerosis Risk in Communities 
Study## 406-8·420A
Influence of Lead Location on Clinical Outcomes With Cardiac 
Resynchronization: Experience From the DECREASE-HF 
Study##902-242·13A
Interaction Between Social Support, Marital Status, and 
Gender After Acute Myocardial Infarction##1018-
149·282A
Lipoprotein-associated phospholipase A2 (Lp-PLA2) 
is Associated with CHD Mortality in a High Risk 
Cohort##1026-124·409A
Long-Term Follow-Up of Patients With ST-Segment Elevation 
Myocardial Infarction Treated With Sirolimus-Eluting 
Stents##1025-153·243A
Long-Term Mortality Benefits From Early Enalapril Therapy 
in Patients With Left Ventricular Systolic Dysfunction: A 
20-Year Follow-Up of SOLVD##1018-181·283A
Low Rates of Adverse Outcome Among Acute Coronary 
Syndrome Patients: Observations From the Australian 
Acute Coronary Syndromes Prospective Audit##1007-
92·199A
Marriage and 1-Year Post-Myocardial Infarction Mortality: 
Better for Men Than Women##1013-154·216A
Meta-Analysis of Randomized Controlled Trials Found No 
Benefit of Fish Oil or Omega-3 Fatty Acids on Sudden 
Cardiac Death or Ventricular Arrhythmias##1018-
185·284A
Mid-Term Follow-Up of Cryoballoon Technique in Drug 
Resistant Atrial Fibrillation##913-238·31A
Myocardial Infarction After Age 90: Outcomes in 10,213 
Nonagenarians##1007-74·198A
Noncoronary Atherosclerosis by Carotid Ultrasound for 
Predicting Future Cardiovascular Events##1014-83·363A
Normal Results on 64-Detector Coronary Computed 
Tomography Angiography Predict Excellent Outcomes at 
1-Year Follow-Up## 831-3·106A
One-Year Outcome in Different Types and Subclasses of Acute 
Heart Failure: Results From Euro Heart Failure Survey 
II## 835-8·88A
Outcome in Acute Coronary Syndrome Patients Managed 
Surgically Based on Clopidogrel Exposure and Delay to 
Surgery: A Report From the ACUITY Trial## 851-5·252A
Outcome of Patients After Successful Cardiopulmonary 
Resuscitation and Suspected Acute Coronary Syndrome 
Treated With an Early Invasive Strategy##1019-156·228A
Outcomes After Acute Myocardial Infarction in Systemic 
Lupus Erythematosus as Compared to Diabetes 
Mellitus## 843-7·248A
Patients Transferred for Primary Percutaneous Coronary 
Intervention (PCI) in the APEX-AMI Trial Have Only 
Modest Symptom Onset to PCI Delays and Good 
Outcomes##1025-132·241A
Patients Treated With Clopidogrel Before Coronary Artery 
Bypass Grafting Surgery: Detrimental or Merely a 
Bother?##1025-198·246A
Prediction of Long-Term Survival in Revascularized Coronary 
Artery Disease Patients##1024-191·290A
Predictive Value of Coronary CT Angiography for Late 
Adverse Cardiac Events in Patients With Chest Pain 
Syndromes## 831-5·106A
Prevalence of and Recovery From Hospital-Acquired Anemia 
in Patients With Myocardial Infarction##1012-183·279A
Prognostic Significance of Dyspnea in Acute Coronary 
Syndromes##1030-146·293A
Prognostic Significance of Dyspnea in Patients Referred for 
Stress Echocardiography##912-225·156A
Prognostic Value and Clinical and Biochemical Correlates 
of Elevated Neutrophil to Lymphocyte Ratio Prior to 
Coronary Stenting##1001-157·192A
Protective Effect of Chronic Statin Use Against Post-Discharge 
Stroke After Coronary Artery Bypass Grafting in Patients 
With Acute Coronary Syndromes##1006-188·275A
Relationship Between Intensive Statin Therapy and 
Cardiovascular Outcomes in Patients With Stable 
Coronary Artery Disease: A Meta-Analysis of 
Randomized Clinical Trials##1025-179·245A
Retroperitoneal Hematoma After Percutaneous Coronary 
Intervention: Prevalence, Risk Factors, Predictors, 
Management, and Outcomes. Results From the Blue Cross 
Blue Shield of Michigan Cardiovascular Consortium 
Registry##1024-146·286A
Risk Factors for Stroke Complicating Coronary 
Angioplasty##1012-182·279A
Risk-Adjusted Hospital Mortality Is Similar Between 
Patients Undergoing Coronary Artery Bypass Grafting 
or Percutaneous Coronary Intervention for Residual 
Multi-Vessel Disease Following Primary Percutaneous 
Revascularization##1001-201·195A
Secondhand Smoke Exposure Is Associated With Lower 
Quality of Life in a Population With Heart Failure##1028-
140·95A
Short-Term Clinical Outcomes of Compensated Heart 
Failure Patients Undergoing Elective Major Noncardiac 
Surgery##1006-181·273A
Systolic Dysfunction Is Frequent and Has a Similar Prevalence 
in Patients With ST and Non-ST Elevation Myocardial 
Infarction##1007-113·200A
The Adoption of the 2000 European Society of Cardiology and 
American College of Cardiology Guidelines on Acute 
Coronary Syndrome Eliminated the Gender Difference in 
First Year Survival##1026-131·411A
The Changing Profile of First Reoperative Coronary 
Artery Bypass Surgery: Trends Over 14 Years in 470 
Patients##1019-200·231A
The Impact of Renal Insufficiency on Long-Term Outcomes 
in Patients Undergoing Cardiac Resynchronization 
Therapy##908-240·23A
The Impact of Right Heart Abnormalities on Survival in 
Neonates With Hypoplastic Left Heart Syndrome 
Undergoing Single Ventricle Palliation##1029-33·270A
The Predictive Value of Elevated Amino Terminal Pro-B-Type 
Natriuretic Peptide and B-Type Natriuretic Peptide for 
Mortality in the Absence of Cardiovascular Risk Factors 
or Structural Cardiac Abnormalities in the General 
Community##1002-163·328A
The Prognostic Value of the 12-Lead Electrocardiogram (ECG) 
in Patients Presenting With Acute Coronary Syndromes: 
Insights From the GRACE ECG Substudy##1001-
95·187A
The Relationship Between Change in Hematocrit and Change 
in Health Status in Patients With Heart Failure After 
Myocardial Infarction##1018-187·284A
The Utility of Measuring Heart Rate Recovery After Exercise 
Testing to Risk Stratify Adults With Congenital Heart 
Disease##1023-51·266A
Use of an Automated Monitoring Tool in the Evaluation of 
Retroperitoneal Hemorrhage Following the Use of a 
Vascular Closure Device in Percutaneous Coronary 
Intervention##1018-189·285A
Use of Inotropic Drugs on First-Day Hospitalization for Acute 
Heart Failure Is Associated With Higher In-Hospital All 
Cause Mortality##1022-64·75A
Use of Low Molecular Weight Heparin Is Associated 
With Improved In-Hospital Survival of ST-Elevation 
Myocardial Infarction Patients Who Receive Reperfusion 
Therapy: Results From the Nationwide French FAST-MI 
Registry##1025-94·238A
Use of Perioperative Nesiritide Improves Clinical Outcomes 
and Decreases Resource Utilization in Heart Failure 
Patients Undergoing Cardiac Surgery##1009-15·301A
Utilization and Impact of Angiotensin-Converting Enzyme 
Inhibitors on Recurrent Ischemic Events Following 
Coronary Artery Bypass Graft Surgery## 804-7·351A
Variation in Coronary Artery Bypass Grafting and 
Percutaneous Coronary Intervention Outcomes Across 
Four Revascularization Centers in Northern New England 
and Its Relation to Community Survival##1030-186·296A
Vascular Complications Following Cardiac Catheterization 
and Coronary Intervention 1998-2005: Influence of 
Gender##1001-177·193A
Vascular Disease Burden and In-Hospital Outcomes Among 
Patients With Coronary Artery Disease Undergoing 
Percutaneous Coronary Intervention##1008-85·341A
Ventricular Wall Motion Abnormality After Right Ventricle to 
Pulmonary Artery Shunt Does Not Cause Hemodynamic 
Impairment in Patients With Hypoplastic Left Heart 
Syndrome##1029-48·270A
Women and Men Have Differences in Outcomes and 
Potentially Response to Antithrombin Therapy: 
Preliminary Results From Subgroup Analyses in 
SYNERGY##1001-154·191A
Oxygen consumption
Enhanced External Counterpulsation Treatment Decreases 
Arterial Stiffness and Myocardial Oxygen Demand in 
Patients With Refractory Angina## 842-4·110A
Evaluation of Exercise Tolerance by Cardiopulmonary 
Exercise Test in Patients With Heart Failure After Cardiac 
Resynchronization Therapy##908-236·144A
Is O2-Pulse Obtained From Respiratory Gas Analysis Useful 
for Estimating the Stroke Volume During Exercise in 
Patients With Left Ventricular Dysfunction?##910-
236·151A
Reducing Psychosocial Stress: A Novel Mechanism of 
Improving Survival From Exercise Training##916-
236·173A
The Minute Ventilation/Carbon Dioxide Production Slope 
Prognostically Outperforms the Oxygen Uptake 
Efficiency Slope##905-236·133A
Pacemaker, artificial
Adverse Clinical Events Associated With Normal Pacemaker 
Pulse Generator End-of-Service Life Behavior##904-
240·16A
Clinical and Echocardiographic Characterization of 
Nonresponders to Cardiac Resynchronization Therapy## 
821-5·81A
Complication Rate Following Device Implantation in Patients 
With Impaired Renal Function##903-242·15A
Fragmented QRS and Dyssynchrony in Heart Failure 
Patients##1022-139·79A
Is Outpatient Implantation of Biventricular Devices 
Safe?##905-242·18A
Morbidity and Mortality Associated With Device Generator 
Replacement##911-241·28A
Predictive Value of Combined Longitudinal and Radial 
Dyssynchrony for Response to Cardiac Resynchronization 
Therapy## 810-3·1A
Reverse-Polarity Pacing: The Hemodynamic Benefit of Anodal 
Versus Cathodal Currents in Cardiac Resynchronization 
Therapy##905-241·18A
Single Center Experience With Complications due to Two 
Manufacturers’ Recent Device Advisories##914-241·32A
Temporary Cardiac Resynchronization Therapy for Post 
Operative CABG Patients With Left Ventricular 
Dysfunction## 410-8·423A
Utility of Lead and Generator Cultures in Managing Cardiac 
Device Infections##913-241·31A
Pacing
A 15-Year Study on Pacemaker-Related Infections: A Claim for 
Using Postoperative Antibiotics##904-241·16A
A Dedicated Left Atrial Pacing and Sensing Lead Improves the 
Outcome of Atrial Resynchronization Pacing for Atrial 
Fibrillation##911-240·28A
Acute and Chronic Additive Beneficial Effects of Dual-
Chamber Pacing Combined With Disopyramide 
in Patients With Obstructive Hypertrophic 
Cardiomyopathy##1016-102·69A
Adverse Clinical Events Associated With Normal Pacemaker 
Pulse Generator End-of-Service Life Behavior##904-
240·16A
Assessment of Left Ventricular Torsion by Speckle Tracking 
Echocardiography in Patients With Ventricular Pacing## 
834-5·108A
Atrial Pacing Induces Atrial Mechanical Dyssynchrony 
Resulting in Reduced Left Ventricular Performance in 
Heart Failure Patients on Cardiac Resynchronization 
Therapy##917-226·174A
Cardiac Involvement and Evolution in Familial Amyloidosis 
According to the Mutation Type##1004-107·47A
Clinical and Echocardiographic Predictors of Significant 
Improvement in Ejection Fraction After Cardiac 
Resynchronization Therapy##1010-145·59A
Comparison of Complication Rates Between Outpatient and 
Inpatient Implantation of Cardiac Resynchronization 
Therapy Devices##918-241·39A
Comparison of Coupled and Paired Pacing for Rapid Rate-
Control During Atrial Fibrillation##902-241·13A
Comparison of the Tissue Doppler Yu Index to the Opposing 
Wall Delay Method to Predict Response to Cardiac 
Resynchronization Therapy: Impact of Post-Systolic Peak 
Velocities## 850-4·112A
Contraction Front Mapping: A Novel Tool in Evaluating Acute 
Response to Cardiac Resynchronization Therapy##903-
240·14A
Electromechanical Property in Heart Failure and Its Implication 
to Cardiac Resynchronization Therapy##1010-141·58A
Interobserver Variability in Identifying the Location of 
Coronary Venous Leads##906-241·20A
Left Ventricular Twist Is an Important and Sensitive Marker of 
Cardiac Performance During Cardiac Resynchronization 
Therapy## 821-7·82A
Predicting Long-Term Effect of Cardiac Resynchronization 
Therapy: Comparison Between Tissue Doppler Imaging 
and Speckle Tracking Imaging##916-226·171A
Predictors of Pump Failure Death in Heart Failure Patients in 
the CARE-HF Study## 845-3·97A
Right Ventricular Apical Pacing Impairs Left Ventricular 
Torsion as Well as Synchrony##913-227·160A
Speckle Tracking Radial Strain Reveals Left Ventricular 
Dyssynchrony in Patients With Permanent Right 
Ventricular Pacing## 850-6·112A
Validation of Novel Echocardiographic Speckle Tracking 
Radial Strain to Assess Ventricular Dyssynchorny: 
Comparison With Angle Corrected Tissue Doppler Strain 
Imaging## 806-8·100A
What Programmed Atrioventricular Delay Is Needed to 
Minimize Pacing for Any Given Baseline PR Interval: 
How Much Longer Is Long Enough?##919-240·40A
Patent foramen ovale
Can Morphology on Transesophageal Echocardiography 
Differentiate an Asymptomatic From Symptomatic Patent 
Foramen Ovale?## 813-3·102A
Early Transesophageal Echocardiography After Transcathether 
Occlusion of Interatrial Communications Allows Timely 
Detection and Treatment of Intracardiac Thrombus 
Formation##1005-53·256A
The Association of Cryptogenic Arterial Emboli and 
Nonsteroidal Anti-Inflammatory Medications in Patients 
With and Without Atrial Septal Defect and Patent 
Foramen Ovale##1014-78·362A
Pathology
A New Automated Method for Quantitative Coronary Plaque 
Compositional Imaging by Multislice Computed 
Tomography: An Ex Vivo Feasibility Study##1006-
190·275A
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Effect of Iron Supplementation on Cardiomyocyte 
Apoptosis Involves Modulation of Tissue Inhibitor of 
Metalloproteinases and Matrix Metalloproteinase in a 
Model of Doxorubicin-Induced Cardiomyopathy##1004-
104·46A
Effect of Slice Thickness on Quantitative Chronic Myocardial 
Scar Imaging by Multidetector Computed Tomography: 
Comparison to Magnetic Resonance Imaging and 
Pathology##910-231·150A
Ethnic and Geographic Differences in Coronary 
Atherosclerotic Plaque Composition: A Report From 
the Global Virtual Histology Intravascular Ultrasound 
Registry##1026-41·403A
Is Soluble Lectin-Like Oxidized Low-Density 
Lipoprotein Receptor-1 A Good Indicator for Early 
Detection of Myocardial Fibrosis in Hypertrophic 
Cardiomyopathy?##1028-99·92A
Left Atrium Volume Index Related With Pathological Findings 
as a Predictor of the Success of Sinus Conversion With 
the Maze Procedure in Patients With Chronic and Valvular 
Atrial Fibrillation##1027-17·312A
Presence of C-Reactive Protein in Left Atrium Is Associated 
With Atrial Fibrillation Irrespective of Serum CRP##908-
234·22A
Trace Element Deficiency in Patients With Dilated 
Cardiomyopathy Enhances the Oxidative Stress and 
Aggravates the Impairment of Cardiac Function##1004-
102·46A
Ultrasound Biomicroscopy of Rat Carotid Intima and Wall 
Thicknesses##1026-83·406A
Patient care
A Gender and Racial Gap in Implantable Cardioverter 
Defibrillator Use Among Hospitalized Heart Failure 
Patients: Data From the American Heart Association’s Get 
With The Guidelines Heart Failure Program## 830-3 ·6A
Bleeding Is Common Among Patients Treated With 
Heparin Experiencing Thrombocytopenia and Confers 
a High Mortality Risk: Report From the CATCH 
Registry##1008-77·340A
Clinically Significant Noncardiac Findings Are Common in 
64-Slice Multi-Detector Computed Tomography of the 
Heart##906-231·135A
Continuation of Warfarin at Hospital Discharge in Patients 
With Acute Coronary Syndromes on Chronic Warfarin 
Anticoagulation## 847-6·251A
Differences in Early Mortality, Treatment and Procedures 
by Age and Race for Women With Acute Myocardial 
Infarction, 2000 Through 2006## 847-8·251A
Impact of Hospital Performance on Underuse of Therapies 
Among Patients With Chronic Kidney Disease 
and Non-ST-Segment Elevation Acute Coronary 
Syndromes##1024-187·289A
Increased Bleeding Risk Among Asians With Non-ST-Segment 
Elevation Acute Coronary Syndromes: Insights From the 
CRUSADE Quality Improvement Initiative## 802-6·208A
Late Effects of a Disease Program Management on Mortality, 
Hospitalization, and Quality of Life in Heart Failure 
Patients Followed by Cardiologists With Experience 
in Heart Failure: A Randomized and Prospective 
Trial##1022-143·80A
Non-ST-Segment Elevation Acute Coronary Syndrome 
Patients on Chronic Warfarin Anticoagulation: Care and 
Outcomes##1013-114·213A
Paging the Worldwide Cardiology Consultant: The Army 
Knowledge Online Telemedicine Consultation Program in 
Cardiology##1030-191·297A
Patient Refined Expectations Deciding Invasive Cardiac 
Treatment (PREDICT)##1018-193·286A
Patterns of High-Density Lipoprotein Levels in Patients With 
Non-ST-Segment Elevation Acute Coronary Syndromes 
and Association With Clinical Outcomes##1014-
122·366A
Projecting an Impending General Cardiology Workforce 
Shortage##1204-265·277A
Trends in the Treatment and Outcomes of Patients 
With Non-ST-Segment Elevation Acute Coronary 
Syndromes Managed Medically Without Cardiac 
Catheterization##1202-253·196A
Use and Outcomes of Acute Clopidogrel Therapy in Non-ST-
Segment Elevation Myocardial Infarction in Community 
Practice: Results From CRUSADE## 802-3·207A
Using Waist Circumference to Screen for Metabolic Syndrome 
in an Inpatient Population##1008-131·345A
Patterns of care in population
A Gender and Racial Gap in Implantable Cardioverter 
Defibrillator Use Among Hospitalized Heart Failure 
Patients: Data From the American Heart Association’s Get 
With The Guidelines Heart Failure Program## 830-3 ·6A
Association of Primary Percutaneous Coronary Intervention 
Door-to-Balloon Time and Mortality in Patients 
Hospitalized With ST-Elevation Myocardial Infarction: 
Findings From the American College of Cardiology-
National Cadiovascular Data Registry CathPCI 
Registry##1202-254·197A
Beta-Blocker Dose Adjustment Upon Hospitalization for Acute 
Decompensated Heart Failure##1028-66·91A
Cardiovascular Emergencies in Cruise Ship Passengers: 
Clinical Presentation and Outcomes##1007-198·207A
Children and Adults With Congenital Heart Disease Lost to 
Follow-Up: Who and When? A Population-Based Study## 
837-5·268A
Computed Tomography Angiography Should Be a 
Collaborative Effort Between Cardiologists and 
Radiologists##911-230·154A
Differences in Medical Care in Patients Presenting With Acute 
Myocardial Infarction During Holidays and Weekends vs. 
Weekdays##1030-185·295A
Effect of Payer Status on Interventional Utilization Patterns: 
Current Results From the National Heart, Lung, and 
Blood Institute Dynamic Registry##1030-183·295A
Outcomes in Patients with a Previous Vascular Intervention 
Enrolled in the REduction of Atherothrombosis for 
Continued Health (REACH) Registry in the United 
States##1026-127·410A
Statin Undertreatment and Its Predictors: Results From a Large 
Community Survey##1030-182·295A
Ten-Year Secular Trends and Characteristics Associated With 
Patient Delay From Symptom Onset to First Hospital 
Arrival in ST-Elevation Myocardial Infarction##1024-
148·287A
Use of Aspirin Among Patients with Atherothrombotic Disease 
in the United States: The REduction of Atherothrombosis 
for Continued Health (REACH) Registry##1026-
123·409A
Pediatric cardiac surgery
Age at Bidirectional Glenn Procedure and Mortality: A Multi-
Center, International Registry## 823-8·267A
Alterations in Perioperative Doppler Indices of Diastolic 
Function Predict Postoperative Course in Children 
Undergoing Congenital Heart Surgery##1023-49·265A
Aristotle Comprehensive Complexity Score Is Not Better Than 
Analysis of Variance in Predicting Hospital Length of 
Stay After Congenital Heart Surgery##1023-48·265A
Discrete Subaortic Membrane: Echo Does Not Reliably Predict 
Aortic Valve Impingement##1017-49·263A
Extracardiac Fontan Demonstrates Lower Power Loss 
Compared to Intracardiac Fontan: A Computational Fluid 
Dynamics Study##1011-28·258A
Factors Associated With Serum Brain Natriuretic Peptide 
Levels in Patients After the Fontan Procedure## 823-
6·267A
Home Surveillance Is Warranted in Patients With Systemic to 
Pulmonary Artery Shunts##1023-33·265A
Impact of Fontan Type on Blood Flow Distribution in a Large 
Series of Single Ventricle Patients: A Cardiac Magnetic 
Resonance Velocity Mapping Study##1029-32·270A
Minimal Interstage Mortality With the Hybrid Procedure for 
Hypoplastic Left Heart Patients##1203-257·257A
New Physiological Classification for Surgical Management of 
Hypoplastic Right Ventricle in Pulmonary Atresia With 
Intact Ventricular Septum##1011-50·260A
Survival Through Fontan Completion After Stage One 
Palliation With Either a Right Ventricle to Pulmonary 
Artery Conduit or Modified Blalock-Taussig 
Shunt##1203-258·257A
Pediatric cardiology
Acute Changes in Exercise Performance After Relief of 
Unfavorable Right Ventricular Loading Condition##1017-
33·262A
Age at Bidirectional Glenn Procedure and Mortality: A Multi-
Center, International Registry## 823-8·267A
Alterations in Calcium Cycling Proteins in Pediatric vs. Adult 
Heart Failure##1029-29·269A
Alterations in Systemic Vascular Properties in Young Patients 
With Single Ventricle Physiology##1029-30·269A
Aspirin and Coumadin Are Safe and Effective Therapies After 
the Fontan Operation##1023-29·264A
Assessment of Myocardial Perfusion and Coronary Flow 
Reserve in Children, Using 3-Tesla Cardiac Magnetic 
Resonance##1005-28·254A
Body Fat Related to Risk Factors for Cardiovascular Disease in 
Young Children##1002-166·329A
Congenital Vascular Rings and Slings Are a Significantly 
Underdiagnosed Cause of Childhood Diseases: 
Screening of 186,213 School-Aged Children by 
Echocardiography##1005-32·255A
Cytomegalovirus Replication Is Associated With 
Endothelial Dysfunction in Pediatric Heart Transplant 
Recipients##1023-30·264A
Developmental Changes in the Modulation of Contractility in 
the Human Ventricle##1011-33·259A
Discrete Subaortic Membrane: Echo Does Not Reliably Predict 
Aortic Valve Impingement##1017-49·263A
Early Experience of Cryoablation for Accessory Pathways in 
Children##1017-29·261A
Factors Associated With Serum Brain Natriuretic Peptide 
Levels in Patients After the Fontan Procedure## 823-
6·267A
Fetal Hemodynamic Instability During Prenatal Cardiac 
Intervention: Risk Factors, Management, and Outcome## 
823-3·266A
Heparin Therapy in Protein Losing Enteropathy Associated 
With Single Ventricle Palliation##1011-32·259A
Impact of Stent Implantation on Pulmonary Artery 
Growth##1017-32·262A
Left Ventricular Dysfunction Is Associated With 
Intraventricular Dyssynchrony in Children##1017-
31·262A
Longitudinal Changes in Chronotropic Response to Exercise 
and Heart Rate Recovery in Pediatric Heart Transplant 
Recipients##1023-32·265A
Medium-Term Renal Outcome of Pediatric Heart Transplant 
Patients on Reduced Calcineurin Inhibitor and 
Rapamycin##1004-109·48A
Minimal Interstage Mortality With the Hybrid Procedure for 
Hypoplastic Left Heart Patients##1203-257·257A
Near Infrared Spectroscopy Predicts Hyperlactatemia in 
Children Following Cardiac Surgery##1029-31·270A
Novel NKX2.5 Mutations in Sporadic Cardiac Septal 
Defects##1017-28·261A
PRISM-III Predicts Death Among Medical Admissions to a 
Pediatric Cardiac Intensive Care Unit##1005-30·254A
Radiation Risks Related to Pediatric Catheter Ablation##1011-
27·258A
Secular Trends of Cardiovascular Risk Factors in Children 
According to Left Ventricular Mass and Body Mass 
Index: A Twenty Year Echocardiographic Study##1026-
204·415A
Simulation-Based Crisis Resource Management Program 
in a Pediatric Cardiac Intensive Care Unit Improves 
Participant’s Self-Perception of Resuscitation 
Skills##1030-190·297A
Survival Through Fontan Completion After Stage One 
Palliation With Either a Right Ventricle to Pulmonary 
Artery Conduit or Modified Blalock-Taussig 
Shunt##1203-258·257A
The French Registry of Pulmonary Arterial Hypertension in 
Children: Characteristics at Diagnosis##1008-87·342A
The United Kingdom, Ireland and Sweden Collaborative Study 
of Pulmonary Vein Stenosis: Spectrum of Morphology## 
823-5·267A
Treatment of Severe Metabolic Syndrome With Gemfibrozil in 
a Pediatric Population##1005-27·254A
Utility of Transthoracic Three-Dimensional Color Doppler 
Echocardiography for Diagnosis of Congenital Aortic 
Arch Anomalies##1005-31·255A
Peptides
Apelin Improves Myocardial Performance in MCT-Induced 
Pulmonary Hypertension##1022-61·74A
Chromogranin A Is an Independent Prognostic Indicator Across 
the Spectrum of Acute Coronary Syndromes##1019-
159·228A
Could Antipeptides for Vascular Endothelial Growth Factor 
and Receptor Reduce the Neointima Formation in 
Balloon-Injury Carotid Model in Rats?## 832-8·395A
Mid-Regional Pro-Atrial Natriuretic Peptide Predicts Risk of 
Death or Heart Failure in Patients With Acute Myocardial 
Infarction: Leicester Acute Myocardial Infarction Peptide 
Study##1013-155·216A
Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide 
Predicts Angiographic No-Reflow Phenomenon During 
Stent Implantation in Patients With Acute Myocardial 
Infarction##1007-134·202A
Urinary B-Type Natriuretic Peptide Levels in the Diagnosis 
and Prognosis of Heart Failure Patients##1004-64·44A
Urotensin II Is a Major Risk Biomarker for Stroke in Type 2 
Diabetes##1002-46·320A
Percutaneous valve repair/replacement
Cardiac Computed Tomography Measurement of Aortic 
Annular Diameter: Implications for Percutaneous Aortic 
Valve Implantation##907-231·139A
Early Improvement in Left Ventricular Systolic Function 
Following Retrograde Transfemoral Aortic Valve 
Implantation## 816-3·309A
Early North American Experience With Percutaneous Aortic 
Valve Replacement in Patients Unsuitable for Surgical 
Aortic Valve Replacement## 816-5·309A
In-Hospital and 30-Day Outcomes Following Retrograde 
Trans-Femoral Aortic Valve Replacement in High-Risk 
Patients: A Report From the REVIVAL-II Trial## 816-
4·309A
Multi-Slice Cardiac Computed Tomography Imaging 
of Patients Undergoing Percutaneous Aortic Valve 
Replacement##904-231·128A
Noninvasive Evaluation of Coronary Sinus Anatomy and Its 
Relation to the Mitral Valve Annulus: Implications for 
Percutaneous Mitral Annuloplasty##1003-20·299A
Significant Reduction in Mitral Regurgitation 6 Months 
Following Percutaneous Mitral Valve Repair With the 
MitraClip™## 816-7·310A
Six Years’ Experience of Outcome After Percutaneous 
Pulmonary Valve Implantation## 823-4·266A
Valve Competence One-Year After Percutaneous Pulmonary 
Valve Implantation or Surgical Homograft Implantation 
Assessed by Magnetic Resonance Imaging##1203-
260·258A
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Pericarditis
Impact of Pericardiectomy in Quality of Life of Patients With 
Recurrent Pericarditis##1022-101·77A
Incremental Value of Measuring Systolic Mitral Annular 
Velocity and Time Difference Between Onset of Mitral 
Inflow and Onset of Early Diastolic Mitral Annular 
Velocity for Differentiating Constrictive Pericarditis From 
Restrictive Cardiomyopathy##1010-101·56A
Pericardium
Characteristic Findings of Constrictive Pericarditis by 
Magnetic Resonance Imaging##903-233·125A
Total Absence of the Left Pericardium Brings Lack of Left 
Ventricular Torsion but No Impairment of Regional 
Myocardial Function##909-227·145A
Peripheral vasculature
A High Ankle Brachial Index Is Associated With Increased 
Cardiovascular Disease Morbidity And Worse Quality Of 
Life##1026-77·405A
A History of Stroke or Peripheral Arterial Disease Is 
Common in Patients With Acute Myocardial Infarction 
and Is Associated With Less Aggressive Therapy and 
Worse In-Hospital Outcome: Insights From the RICO 
Survey##1007-117·201A
Analysis of Multiple Methylation Derivatives of Amino Acids 
Suggests That Factors Independent of Nitric Oxide 
Synthase Inhibition Are Responsible for Their Prognostic 
Value for Cardiovascular Risk Prediction## 809-4·354A
Despite Increase in Diagnosis, Peripheral Artery Disease 
Patients Still Trail Coronary Artery Disease Patients 
in Statin and Aspirin Use: Results From a National 
Survey##1014-80·362A
Differences in Responsiveness of Platelets to Shear in Patients 
With Peripheral Artery Disease and Coronary Artery 
Disease in the Effect of Lipid Modification on Peripheral 
Arterial Disease After Endovascular Intervention Trial## 
814-8·375A
Enhanced External Counterpulsation Treatment Decreases 
Arterial Stiffness and Myocardial Oxygen Demand in 
Patients With Refractory Angina## 842-4·110A
Feasibility of Magnetic Resonance Imaging to Quantify Blood 
Flow Reserve in Lower Extremities##1020-77·382A
Functional Status in Peripheral Artery Disease Is Predicted 
by Both Abnormal and Low-Normal Ankle-Brachial 
Index: The National Health and Nutrition Examination 
Survey##1020-81·384A
Glomerular Filtration Rate and N-Terminal Pro-Brain 
Natriuretic Peptide as Predictors of Cardiovascular 
Mortality in Vascular Patients##1026-160·411A
Hepatocyte Growth Factor Generated in the Distal Segment 
of the Occlusive Lesions Enhances the Collateral 
Development in Peripheral Artery Disease##1008-
82·341A
Hospitalizations and Associated Costs in Patients With 
Peripheral Arterial Disease: Results From the REACH 
Registry##1002-80·322A
Impact of Stent Fractures After Femoropopliteal 
Stenting##1008-81·341A
Influence of Serum Gamma Glutamyl Transferase on Vascular 
Compliance in Young Adults: The Bogalusa Heart 
Study##1026-76·400A
Long-Term Clinical Outcome of Supervised Exercise 
Rehabilitation Among Patients With Peripheral Arterial 
Disease## 804-6·351A
Long-Term Outcome of Autologous Transplantation of 
Bone Marrow Mononuclear Cells in Patients With 
Thromboangiitis Obliterans##1008-40·338A
Magnitude of the Improvement in Skin Perfusion Pressure 
Is as Important as Skin Perfusion Pressure Immediately 
Following Intervention for Predicting Limb Salvage in 
Critical Limb Ischemia##1008-79·340A
Peripheral Arterial Disease Is Associated With Increased Serum 
Myeloperoxidase Levels Independently of the Presence of 
Severity of Coronary Artery Disease##1002-81·322A
Platelet Glycoprotein 1b Alpha T145M Dimorphism as a Risk 
Factor for the Recurrent Cardiac Events in Post-Infarction 
Patients With Claudication##1026-45·404A
Pressure Recovery, as Assessed by Cardiovascular Magnetic 
Resonance Imaging, Is Most Related to Aortic Impedance 
Rather Than Proximal Aortic Area##1003-24·300A
Safety and Efficacy of IVUS-guided Lumen Re-entry Devices 
for the Percutaneous Revascularization of Chronic Total 
Occlusions of the Superficial Femoral Artery##1026-
80·400A
Successful Revascularization of at Least a Branch of the Tibial 
Artery to the Pedal Arch Contributes Limb Salvage in 
Critical Limb Ischemia##1008-78·340A
Ultrasound-Guided Thrombin Injection for the Treatment of 
Iatrogenic Upper Extremity Pseudoaneurysm##1014-
79·362A
Vascular Disease Burden and In-Hospital Outcomes Among 
Patients With Coronary Artery Disease Undergoing 
Percutaneous Coronary Intervention##1008-85·341A
Pharmacokinetics
“First in Human” Experience With PRT060128, A New Direct-
Acting, Reversible, P2Y
12
 Inhibitor for Intravenous and 
Oral Use##1002-128·326A
Pharmacology
A Novel Next Generation Natriuretic Peptide: CD-NP##1008-
120·343A
A Rapid Genotyping Assay for Polymorphisms Affecting the 
Dose-Response to Warfarin Therapy##1020-89·385A
Acute and Chronic Additive Beneficial Effects of Dual-
Chamber Pacing Combined With Disopyramide 
in Patients With Obstructive Hypertrophic 
Cardiomyopathy##1016-102·69A
An Evaluation of the Safety of Aprotinin Use: The REACTS 
Study##1007-201·207A
Des-Serine-Proline B-Type Natriuretic Peptide (BNP 3-32), 
Which Is Produced From Mature BNP 1-32 by Dipeptidyl 
Peptidase IV, Has Reduced Bioactivity##1008-118·343A
Dissociation of Aldehyde Dehydrogenase Activity From 
Nitrate Effect, Bioconversion and Tolerance in Humans## 
406-6·420A
Effect of Increased Maintenance Dose of Clopidogrel on 
Platelet Aggregation## 815-7·376A
Effect of Iron Supplementation on Cardiomyocyte 
Apoptosis Involves Modulation of Tissue Inhibitor of 
Metalloproteinases and Matrix Metalloproteinase in a 
Model of Doxorubicin-Induced Cardiomyopathy##1004-
104·46A
Influence of Statin Treatment on the Adenosine Diphosphate 
Responsiveness of Platelets During Clopidogrel 
Treatment: A Randomized Comparison of Rosuvastatin, 
Atorvastatin, and Simvastatin Co-Treatment## 804-
5·351A
Inhibition of HERG Channel by Aspirin: pH or Direct 
Effect##1002-119·324A
Is the pH-Induced Change in IK
r
 Inhibition by Ibutilide 
Arrhythmogenic?##1002-118·324A
Long-Term Therapy With Ranolazine Decreases mRNA and 
Protein Expression of the Transcriptional Repressor Nab1 
and the Transcription Factor Egr1 in Dogs With Chronic 
Heart Failure##1004-58·42A
LY518674, a Potent and Selective Peroxisome Proliferator 
Activated Receptor Alpha Agonist, Reduces Triglycerides, 
Total Cholesterol, Low-Density Lipoprotein Cholesterol, 
and Apolipoproteins B and C3##1026-5·405A
Nebulized Delivery of Nano-Scale All-Trans Retinoic Acid 
Particles Inhibited Monocrotaline-Induced Pulmonary 
Hypertension in Rats##1008-88·342A
Non-Steroidal Anti-Inflammatory Drugs Antagonize the 
Irreversible Antiplatelet Effect of Aspirin##1008-
129·345A
Orally Administered Vanoxerine, a Cardiac Multichannel 
Blocker, Terminates Atrial Flutter and Prevents Its 
Reinducibility in the Canine Sterile Pericarditis 
Model##918-238·38A
Phosphorylated Akt Is Critical to the Differentiation of Bone 
Marrow Stem Cells Into Endothelial Cells##1020-
87·385A
Platelet Aggregometry and Receptor Binding to Predict the 
Magnitude of Antithrombotic and Bleeding Time Effects 
of Clopidogrel in Rabbits## 815-8·376A
Randomized Placebo-Controlled Trial of Nicotinic Acid in 
Patients With Coronary Heart Disease and Low High-
Density Lipoprotein Cholesterol Despite 6 Weeks of 
Statin Therapy (LOW Study)##1014-124·366A
Rifalazil Prevents Chlamydia Pneumoniae Induced 
Acceleration of Atherosclerosis and Eradicates 
the Organism in a Rabbit Model Better Than 
Azithromycin##1002-120·324A
The Effect of Nesiritide on Left Ventricular Diastolic 
Function##1010-98·55A
The Long-Term Safety and Efficacy of Combined Simvastatin 
and Fenofibrate Therapy in Diabetic Patients With 
Dyslipidemia: The DIACOR Study##1008-125·344A
Variability of Antiaggregant Response to Clopidogrel in 
Healthy Subjects: First Correlation to Platelet P2Y
12
 ADP-
Receptor Occupancy in Three Selected Platelet-Response 
Groups## 815-5·376A
Women and Men Have Differences in Outcomes and 
Potentially Response to Antithrombin Therapy: 
Preliminary Results From Subgroup Analyses in 
SYNERGY##1001-154·191A
Phonocardiography
Acoustic Cardiography Correlates With Invasive and 
Echocardiographic Systolic and Diastolic Hemodynamic 
Parameters##1016-98·68A
Physiology
A Common Limb Involved in Bi-Atrial Mechanics: Insights 
From 3D Motion Tracking##913-240·31A
Abnormal Papillary Muscle Morphology Is Independently 
Associated With Increased Left Ventricular Outflow Tract 
Obstruction in Hypertrophic Cardiomyopathy##913-
233·161A
Accurate Non-Invasive Calibration of an Implantable Left 
Atrial Pressure Monitoring System in Heart Failure 
Patients During Long-Term Follow-Up##1028-110·95A
Aggressive Prophylaxis Against Cytomegalovirus Plays a Key 
Role in Preserving Epicardial Artery Flow Early After 
Cardiac Transplantation##1022-106·78A
Cardiac Resynchronization Therapy Normalizes Suction 
Filling in Heart Failure Patients## 821-6·82A
Des-Serine-Proline B-Type Natriuretic Peptide (BNP 3-32), 
Which Is Produced From Mature BNP 1-32 by Dipeptidyl 
Peptidase IV, Has Reduced Bioactivity##1008-118·343A
Effect of Statin Therapy on Central Aortic Pressures and 
Hemodynamics: Principal Results of the Lipid Lowering 
Arm of the Conduit Artery Function Evaluation 
Study##1026-43·404A
Increased Local Inflammatory Activation in Stenotic 
Nonrheumatic Aortic Valves: New Implications of 
Inflammation##1009-23·303A
Low Congestion Score 1-Month After Hospitalization Predicts 
Better Function and Survival##1004-106·47A
Tear Size and Location Impacts False Lumen Pressure in an Ex 
Vivo Model of Chronic Type B Aortic Dissection##1020-
80·383A
Transition to an Unstable Coronary Syndrome Is Marked 
by Hypercoagulability, Platelet Activation, Heightened 
Platelet Reactivity and Inflammation: Results of the 
Thrombotic Risk Progression Study##1202-250·196A
Plaque
An Abbreviated Carotid Intima-Media Thickness Scanning 
Protocol to Facilitate Clinical Screening for Subclinical 
Atherosclerosis##1002-78·321A
Blood Rheology in Stable Angina and Acute Coronary 
Syndrome: A Logical Basis for the Transition?##1007-
96·200A
Color-Coded Dual-Frequency Intravascular Ultrasound 
Imaging With Use of Radiofrequency Ultrasound Signals: 
A Novel Modality of Tissue Characterization of Coronary 
Plaque##916-227·171A
Coronary Artery Plaque Composition Identified by 
Multidetector Computed Tomography Predicts Stress-
Induced Myocardial Ischemia##919-229·182A
Effects of Balloon Angioplasty on the Tissue Composition of 
Acute Coronary Lesions: In Vivo Spectral Analysis of 
Intravascular Ultrasound Radiofrequency Data##1019-
116·225A
High Urinary 8-Iso-Prostaglandin F2κ Concentration 
Reflects Plaque Instability in Early Stage Coronary 
Atherosclerosis: A 3-Dimensional Intravascular 
Ultrasound Study##1026-36·402A
Impact of Low-Density Lipoprotein Cholesterol and C-
Reactive Protein on the Tissue Characteristics of 
Coronary Plaques Determined by Integrated Backscatter 
Intravascular Ultrasound##1008-47·339A
Lower Plasma Adiponectin Levels and Higher Oxidative Stress 
Are Associated With In Vivo Thin-Cap Fibroatheroma in 
Patients With Stable Angina Pectoris##1020-45·382A
Metabolic Syndrome Is Independently Associated With 
Increased Coronary Atherosclerotic Plaque Burden##919-
230·182A
Noninvasive Assessment of the Low-Density Plaque in 
Culprit Lesion of Patients With Unstable Angina Pectoris 
by Multi-Slice Computed Tomographic Coronary 
Angiography##903-230·125A
Segmental Coronary Endothelial Dysfunction in Humans Is 
Associated With Necrotic Core Plaques##1014-10·357A
Serial Observation of Shear Stress and Atherosclerotic Plaque 
Formation by a Newly-Developed Topographic Shear 
Stress Imaging System With Use of Three-Dimensional 
Intravascular Ultrasound##1020-11·379A
Short-Term Treatment With ApoAI Milano Induces 
Atherosclerotic Plaque Regression and Signs of Plaque 
Stabilization: In Vivo MRI Study## 832-5·395A
Simvastatin Attenuates Plaque Inflammation Evaluation 
by 18F-Fluoro-2-Deoxyglucose Positron Emission 
Tomography##1026-47·405A
The Actual Condition of Ulceration and Attenuation in Gray 
Scale Intravascular Ultrasound by Using Virtual Histology 
IVUS##907-223·137A
Variants in Genes Associated With Inflammation and 
Vascular Cell Function Are Associated With Vulnerable 
Plaque##1007-91·199A
Platelet inhibitors
“First in Human” Experience With PRT060128, A New Direct-
Acting, Reversible, P2Y
12
 Inhibitor for Intravenous and 
Oral Use##1002-128·326A
Abciximab or Eptifibatide: Differences in Outcomes of Patients 
Treated With Abciximab Versus Eptifibatide as Adjunct 
Therapy for Primary Percutaneous Coronary Interventions 
for ST-Elevation Myocardial Infarction## 826-3·292A
Adjusted Clopidogrel Dosing in Patients With Insufficient 
Platelet Inhibition After Elective Coronary Stenting 
Caused a More Robust and Consistent Platelet Inhibition 
in the Entire Cohort##1020-9·378A
Antiplatelet Therapy Attenuates Subcellular Cardiac 
Remodeling by Modifying Ca2+ Dynamics in Ischemic 
Heart Failure## 829-8·87A
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Assessing Individual Response to Clopidogrel in Patients 
Undergoing Coronary Intervention##1014-121·365A
Assessment of Inter- and Intraindividual Variability of Platelet 
Function Profiles in Patients on Standard and High 
Clopidogrel Maintenance Doses##1020-86·385A
AZD6140 Suppresses Platelet Aggregation in Clopidogrel-
Treated Patients Even in Those With High Aggregation 
Levels## 802-7·208A
Clopidogrel Resistance Overcome by Reloading## 644-5·231A
Dual Antiplatelet Agent Failure: A New Syndrome or a Clinical 
Non-Entity?##1024-186·289A
Effect of Increased Maintenance Dose of Clopidogrel on 
Platelet Aggregation## 815-7·376A
Elevated Fibrinogen, Higher Body Mass Index, and Diabetes 
Mellitus Are Associated With Lower Platelet Inhibition in 
Patients Treated With Clopidogrel##1020-122·387A
How Likely Are Therapeutic Interventions Recommended 
by the 2002 American College of Cardiology/American 
Heart Association Clinical Guidelines for Acute Coronary 
Syndromes to Be Clinically Worthwhile?##1013-92·211A
Impact of GP IIB/IIIA Receptor Inhibitors and Clopidogrel 
Treatment on 30-Day and 1-year All-Cause Mortality of 
Patients With ST-Elevation Myocardial Infarction Treated 
by Primary Percutaneous Coronary Intervention## 847-
5·251A
Impact of High Clopidogrel Maintenance Dosing on Thrombin 
Generation in Patients With Diabetes Mellitus##1026-
4·403A
Impact of Higher Clopidogrel Loading and Maintenance Dose 
on Platelet Function and Antithrombosis in Patients 
Undergoing Percutaneous Coronary Intervention 
Measured by Thromboelastogram## 815-6·376A
Influence of Statin Treatment on the Adenosine Diphosphate 
Responsiveness of Platelets During Clopidogrel 
Treatment: A Randomized Comparison of Rosuvastatin, 
Atorvastatin, and Simvastatin Co-Treatment## 804-
5·351A
Inhibition of Platelet Aggregation by Clopidogrel Is Unaffected 
by the CYP2C19 681G>A Polymorphism in Patients With 
Coronary Artery Disease## 815-4·375A
Inhibition of Platelet Aggregation: A Novel Effect of C-
Reactive Protein##1020-36·380A
Optimizing Transfusion in Cardiac Surgery: Deleterious 
Effects of Platelet Transfusion##1015-16·304A
Patients Treated With Clopidogrel Before Coronary Artery 
Bypass Grafting Surgery: Detrimental or Merely a 
Bother?##1025-198·246A
Platelet Aggregometry and Receptor Binding to Predict the 
Magnitude of Antithrombotic and Bleeding Time Effects 
of Clopidogrel in Rabbits## 815-8·376A
Platelet Function in Clopidogrel-Treated Patients With Acute 
Coronary Syndrome## 851-6·253A
Safe Use of Clopidogrel and Aspirin Antiplatelet Therapy After 
Off-Pump Coronary Artery Bypass Graft Surgery##1027-
18·312A
Saint John’s Wort Enhances Clopidogrel Responsiveness 
in Clopidogrel Resistant Volunteers and Patients by 
Induction of CYP3A4 Isoenzyme##1008-121·343A
Sticky Platelet Syndrome: Platelet Hyperfunction, Alone or 
With Other Recognized Thrombophilias, Is Strongly 
Associated With Venous and Arterial Thrombosis##1014-
11·357A
The Primary In Vivo Metabolic Activation of Clopidogrel Is 
by Hepatic and Not Enterocytic Cytochrome P450 3A4 
Isoenzyme##1008-119·343A
Type of Glycoprotein IIb/IIIa Inhibitor and In-Hospital 
Outcome in STEMI Patients Treated With Primary 
Percutaneous Coronary Intervention: Results From the 
Nationwide French FAST-MI Registry##1019-114·224A
Variability of Antiaggregant Response to Clopidogrel in 
Healthy Subjects: First Correlation to Platelet P2Y
12
 ADP-
Receptor Occupancy in Three Selected Platelet-Response 
Groups## 815-5·376A
Platelets
Activated Platelets Can Be Imaged by Activation-Specific 
Glycoprotein IIb/IIIa Antibodies Conjugated to Iron 
Oxide Microparticles in an Ex Vivo Magnetic Resonance 
Imaging Mouse Model##907-232·139A
Adjusted Clopidogrel Dosing in Patients With Insufficient 
Platelet Inhibition After Elective Coronary Stenting 
Caused a More Robust and Consistent Platelet Inhibition 
in the Entire Cohort##1020-9·378A
Bleeding Is Common Among Patients Treated With 
Heparin Experiencing Thrombocytopenia and Confers 
a High Mortality Risk: Report From the CATCH 
Registry##1008-77·340A
Comparison of Four Commercial Platelet Function Assays 
Abilities to Detect Response to Aspirin at 81 and 325 mg 
Doses##1002-35·318A
Differences in Responsiveness of Platelets to Shear in Patients 
With Peripheral Artery Disease and Coronary Artery 
Disease in the Effect of Lipid Modification on Peripheral 
Arterial Disease After Endovascular Intervention Trial## 
814-8·375A
Effect of Increased Maintenance Dose of Clopidogrel on 
Platelet Aggregation## 815-7·376A
Effects of Diabetes on the Prevalence of Aspirin Resistance 
During Low Dose Aspirin Therapy##1019-179·230A
Elevated Fibrinogen, Higher Body Mass Index, and Diabetes 
Mellitus Are Associated With Lower Platelet Inhibition in 
Patients Treated With Clopidogrel##1020-122·387A
Genetic Polymorphism C242T on the P22-Phox Subunit 
of NADPH Oxidase, as a Risk Factor for Myocardial 
Infarction: Effects on Platelet Activation and Oxidized 
Low-Density Lipoprotein Levels##1008-76·339A
Genetic Polymorphism C807T on Platelet Glycoprotein Ia 
Affects Platelet Activation Only in the Presence of High 
Von Willebrand Levels##1001-180·194A
Genetic Polymorphisms on Alpha
2





, Modify Platelets’ Activation Only in the 
Presence of Advanced Atherosclerosis or Endothelial 
Dysfunction: Effects on the Risk for Myocardial 
Infarction in Young Individuals## 815-3·375A
Genetic Variability of P22 Phox Subunit of NADPH 
Oxidase, and Risk for Myocardial Infarction in Young 
Individuals##1002-169·329A
Impact of Higher Clopidogrel Loading and Maintenance Dose 
on Platelet Function and Antithrombosis in Patients 
Undergoing Percutaneous Coronary Intervention 
Measured by Thromboelastogram## 815-6·376A
Mechanisms of Platelet Hyperreactivity in Type One and Type 
Two Diabetes##1026-2·399A
Non-Steroidal Anti-Inflammatory Drugs Antagonize the 
Irreversible Antiplatelet Effect of Aspirin##1008-
129·345A
Omega-3 Fatty Acids Cause Blood Cells to Become Insensitive 
to Mechanical Stress in Patients With Cardiac Assist 
Devices## 828-7·85A
Optimizing Transfusion in Cardiac Surgery: Deleterious 
Effects of Platelet Transfusion##1015-16·304A
Platelet Activity and Aspirin Efficacy After Off-Pump 
Compared to On-Pump Coronary Artery Bypass 
Surgery##1013-201·220A
Platelet Function in Clopidogrel-Treated Patients With Acute 
Coronary Syndrome## 851-6·253A
Saint John’s Wort Enhances Clopidogrel Responsiveness 
in Clopidogrel Resistant Volunteers and Patients by 
Induction of CYP3A4 Isoenzyme##1008-121·343A
Sticky Platelet Syndrome: Platelet Hyperfunction, Alone or 
With Other Recognized Thrombophilias, Is Strongly 
Associated With Venous and Arterial Thrombosis##1014-
11·357A
The Combination of Diabetes Mellitus and 
Hypercholesterolemia in Swine Leads to the Development 
of Complex, Human-Like Atherosclerosis##1002-1·315A
Variability of Antiaggregant Response to Clopidogrel in 
Healthy Subjects: First Correlation to Platelet P2Y
12
 ADP-
Receptor Occupancy in Three Selected Platelet-Response 
Groups## 815-5·376A
Point-of-services
Elevated Fibrinogen, Higher Body Mass Index, and Diabetes 
Mellitus Are Associated With Lower Platelet Inhibition in 
Patients Treated With Clopidogrel##1020-122·387A
Impact of a Cardiovascular Limited Ultrasound Examination 
Using a Hand-Carried Ultrasound Device: Changes 
in Clinical Management Outcomes in a Primary-Care 
Clinic##1008-162·346A
Population studies
Changing Age Distribution of Death in Congenital Heart 
Disease From 1988 to 2005: A Population-Based Study## 
837-6·268A
Congenital Vascular Rings and Slings Are a Significantly 
Underdiagnosed Cause of Childhood Diseases: 
Screening of 186,213 School-Aged Children by 
Echocardiography##1005-32·255A
Current Imaging Recommendations Minimally Change the 
Distribution of Cardiovascular Risk in Dallas County: 
Findings From the Dallas Heart Study## 833-7·397A
Gender Difference in the Association Between Leptinemia 
and Blood Pressure in the United States Population: 
The Third National Health and Nutrition Examination 
Survey##1002-208·332A
Low Rates of Adverse Outcome Among Acute Coronary 
Syndrome Patients: Observations From the Australian 
Acute Coronary Syndromes Prospective Audit##1007-
92·199A
Ottawa Heart Genomics Study: The First Genome-Wide Scan 
to Search for Coronary Artery Disease Genes Utilizing 
500,000 Markers##1002-9·316A
Peripartum Cardiomyopathy: Differences in Clinical Profile 
and Presentation in African Americans## 801-7·61A
Prehypertension Is Associated With Increased Aortic Stiffness 
but Not Muscular Artery Stiffness: A Population-Based 
Study## 838-4·398A
Prevalence, Treatment, and Control of Hypertension and/or 
Dyslipidemia Among Hispanic Adults in United States 
Communities##1012-185·279A
Rethinking Ethnic Cardiovascular Disease Risk: Urban 
Caucasian Risk Profile Shows Greater Similarity to Urban 
Minorities Than to Rural Caucasians##1014-165·369A
Secular Trends and Mortality Causes in Women Over the Last 
24 Years in Argentina##1008-165·347A
Secular Trends of Cardiovascular Risk Factors in Children 
According to Left Ventricular Mass and Body Mass 
Index: A Twenty Year Echocardiographic Study##1026-
204·415A
Statin Undertreatment and Its Predictors: Results From a Large 
Community Survey##1030-182·295A
Sticky Platelet Syndrome: Platelet Hyperfunction, Alone or 
With Other Recognized Thrombophilias, Is Strongly 
Associated With Venous and Arterial Thrombosis##1014-
11·357A
The Metabolic Syndrome Is Associated With Increased 
Stiffness of Large Arteries but Not of Muscular Arteries: 
A Population-Based Study## 840-6·416A
Trends in Profile and Mortality of Patients With Acute 
Myocardial Infarction From 1987 to 2002: A New Jersey 
Statewide Study## 817-6·291A
Ventricular Vascular Coupling in Obesity Is Affected by an 
Adverse Temporal Profile of Wave Reflections and 
Ventricular Ejection: A Population-Based Study## 840-
5·415A
Potassium
Calcium Activated Potassium Channels Contribute to Protease 
Activated Receptor Type One Induced Vasodilatation in 
Humans##1026-3·415A
Practice management
Aspirin and Coumadin Are Safe and Effective Therapies After 
the Fontan Operation##1023-29·264A
Evaluation of Coronary Artery Disease: Variations in Practice 
Patterns Across Six Countries##1014-129·367A
The Shifting Paradigm of Single-Photon Emission Computed 
Tomography Myocardial Perfusion Imaging Utilization: 
Comparative Analysis of Clinical Practice Guidelines 
Versus Appropriateness Criteria##916-235·173A
Pregnancy
Acute Myocardial Infarction and Pregnancy: Clinical Profile, 
Treatment and Outcome## 844-7·250A
Calcium Cycling Proteins in Peripartum 
Cardiomyopathy##1028-55·89A
Effect of Pulmonic Stenosis on Pregnancy: A Case Control 
Study##1021-24·308A
Peripartum Cardiomyopathy: Differences in Clinical Profile 
and Presentation in African Americans## 801-7·61A
Peripartum Cardiomyopathy: Incidence, Mortality, and Race in 
a Large Community-Based Cohort## 801-6·60A
Web-Based Recruitment Facilitates Collection of Patients With 
Peripartum Cardiomyopathy##1006-194·276A
Pressure-volume relation
Cardiac Resynchronization Therapy Normalizes Suction 
Filling in Heart Failure Patients## 821-6·82A
Failure of Doppler Echocardiography to Accurately 
Estimate Left Ventricular Filling Pressures in Healthy 
Volunteers##910-222·148A
Prevention
Double Trouble for 1,934 Hospitalized Medical Patients 
Who Developed Deep Venous Thrombosis: Prophylaxis 
Omitted More Often and Pulmonary Embolism More 
Frequent##1002-87·323A
A 15-Year Study on Pacemaker-Related Infections: A Claim for 
Using Postoperative Antibiotics##904-241·16A
A Meta-Analysis of Smoking Cessation Behavioral 
Interventions##1006-148·272A
Abdominal Obesity, Body Mass Index, and Physical Activity: 
How Do They Modify the Framingham Risk Score?## 
812-6·373A
Angiotensin-Converting Enzymel inhibitors Did Not Prevent 
Atrial Fibrillation in the Pacemaker Mode Selection 
Trial##902-237·12A
Composite Measure Performance in Get With The Guidelines: 
Coronary Artery Disease, Stroke, Heart Failure##1006-
146·272A
Impact of Population-Based Primary Prevention Strategies on 
Cardiovascular Risk Factors in India: A Demonstration 
Project in Indian Industrial Population##1014-168·370A
Modular Secondary Prevention Based on Patient Choice 
Improves Risk Factor Profile and Knowledge After 
Acute Coronary Syndrome: A Randomized Controlled 
Trial##1008-167·347A
Nicorandil Prevents Initial and Recurrent Events in Patients 
With Stable Angina Pectoris##1025-91·238A
Pharmacological Venous Thromboembolism Prophylaxis 
in Hospitalized Medical Patients: A Meta-Analysis of 
Randomized Controlled Trials##1002-89·324A
Secular Trends of Cardiovascular Risk Factors in Children 
According to Left Ventricular Mass and Body Mass 
Index: A Twenty Year Echocardiographic Study##1026-
204·415A
Simplified Scoring System to Predict Atrial Fibrillation After 
Coronary Artery Bypass Surgery##1020-167·390A
The Cardiovascular Disease Prevention Model: A Model That 
Predicts Future Incidences of Cardiovascular Disease in 
Any Given Population and Undertakes Cost-Effectiveness 
Analyses of Primary Preventive Interventions##1012-
194·281A
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The Impact of Body Mass Index on Mortality in 35,607 
Patients With Preserved Systolic Function: The Obesity 
Paradox Revisited## 812-7·373A
The Role of Quinapril in the Presence of a Weight Loss 
Regimen: Endothelial Function and Markers of Obesity in 
Patients with the Metabolic Syndrome##1026-202·414A
Treatment of Severe Metabolic Syndrome With Gemfibrozil in 
a Pediatric Population##1005-27·254A
Professional issues
Rapid Rise in Cardiac Auscultation Skill After a Single 
90-Minute Intervention: A Quality Improvement 
Study##1006-193·276A
Prognosis
A Novel Clinical Indicator Using Tc-99m Sestamibi for 
Evaluating Cardiac Mitochondrial Function in Patients 
With Cardiomyopathies## 807-3·61A
Adult Treatment Panel III 2001 but Not International Diabetes 
Federation 2005 Criteria of the Metabolic Syndrome 
Predict Future Vascular Events Among Women 
Undergoing Coronary Angiography##1025-176·245A
Are Coronary Revascularization and Myocardial Infarction a 
Logical Combined Endpoint in Hypertension Trials? The 
LIFE Study##1026-169·413A
Artificial Neural Networks Are a Potential Tool for Estimating 
Prognosis in Coronary Artery Disease: Are Standard 
Algorithms Sufficient?##1012-189·280A
Association Between Recurrent Ischemia on Continuous ECG 
Holter Monitoring and Short- and Long-Term Mortality 
in Patients With Non-ST-Elevation Acute Coronary 
Syndrome in the MERLIN-TIMI 36 Trial##1019-
155·227A
Atrial Fibrillation Is a Strong Predictor of Death and of Cardiac 
Events in Angiographied Coronary Patients##913-
237·30A
Baseline Hemoglobin and White Blood Cell Composite 
Complete Blood Count Index Improves Risk Stratification 
in ST-Elevation Myocardial Infarction Patients##1019-
111·224A
C-Reactive Protein and B-Type Natriuretic Peptide 
Independently Predict Hospitalization for Heart Failure 
After Acute Coronary Syndromes and Identify Patients 
Who Benefit From Intensive Statin Therapy in the 
PROVE IT-TIMI 22 Trial##1007-174·204A
C-Reactive Protein Predicts Mortality in Patients With Atrial 
Fibrillation##911-238·27A
Cardiac Computed Tomographic Angiography in an Outpatient 
Setting: An Analysis of Patient Outcomes Over a 30-
Month Period## 852-7·114A
Cardiopulmonary Exercise Function Predicts Long-Term 
Prognosis in Adults With Repaired Tetralogy of Fallot## 
837-3·267A
Carotid Artery Stenosis: Is It a Marker of Poor 
Prognosis?##1014-43·360A
Circulating Endothelium- and Platelet-Derived Microparticles 
in Healthy Subjects and Patients With Coronary Artery 
Disease##1008-10·335A
Clinical Characteristics and Outcomes of Behcet’s Disease 
With Cardiovascular Involvement##1014-81·362A
Combined Measurements of Cardiac Troponin T and Brain 
Natriuretic Peptide in Patients With Congestive Heart 
Failure From Various Etiology##1201-244·51A
Comparison of Five Different Cardiac Troponin Assays in 
Patients With End-Stage Renal Disease on Chronic 
Hemodialysis##1013-69·209A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery Among Patients With a Chronic Total 
Occlusion and Multi-Vessel Coronary Artery Disease in 
the Bare Metal Stent Era.##1019-176·229A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery in Patients With Multi-Vessel Coronary 
Artery Disease and Reduced Left Ventricular Function in 
the Bare Metal Stent Era.##1019-177·229A
Comparison of the Risk Associated With Diabetes Mellitus in 
Patients With Preserved and Low Ejection Fraction Heart 
Failure: An Analysis of the Candesartan in Heart Failure 
Assessment of Reduction in Mortality and Morbidity 
(CHARM) Program## 614-5·61A
Coronary Artery Calcium Percentiles and Absolute Scores: 
Which Is a Stronger Predictor of Mortality?##912-
231·157A
Coronary Artery Plaque Composition Identified by 
Multidetector Computed Tomography Predicts Stress-
Induced Myocardial Ischemia##919-229·182A
Coronary Calcium Predicts Near-Term Coronary Heart Disease 
Events in Major American Ethnic Groups: The Multi-
Ethnic Study of Atherosclerosis## 811-3·101A
Dobutamine Stress Echo Adds Incremental Prognostic 
Information in the Long-Term Risk Stratification 
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Population With Significant Cardiac Risk Factors##918-
236·180A
Adherence to the American College of Cardiology/ American 
Society of Nuclear Cardiology Appropriateness Criteria 
for Single-Photon Emission Computed Tomography 
Myocardial Perfusion Imaging##911-235·155A
Aortic Valve Calcifications Are Associated With an Ischemic 
Perfusion Study in Individuals With Minimal Coronary 
Calcifications##1020-76·382A
Atherosclerotic Plaque Inflammation and Calcification: A 
Negative Relationship Imaged Using Fluorodeoxyglucose 
Positron Emission Tomography and Computed 
Tomography##1014-35·358A
Calculation of Peak Filling Rate by Real-Time Three-
Dimensional Echocardiography for Detection of Diastolic 
Abnormalities During Adenosine Stress Nuclear Perfusion 
Imaging##908-225·141A
Can Myocardial Perfusion Imaging Predict Response to 
Cardiac Resynchronization Therapy?##1028-144·96A
Characteristics of the Coronary Velocity Profiles of Patients 
With Decreased Coronary Flow Velocity Reserve Despite 
Normal Thallium Stress Test##903-235·125A
Combined Positron Emission Tomography and Tagging 
Magnetic Resonance Imaging Reveal Altered Patterns 
of Regional Function and Metabolism in Ventricular 
Dyssynchrony##901-236·117A
Comparison of 64-Slice Computed Tomography Coronary 
Angiography, Radionuclide Myocardial Perfusion 
Imaging, and Stress Echocardiogram in the Detection of 
Significant Coronary Artery Stenosis##908-229·142A
Comparison of Delayed Enhanced MRI With F 18-FDG-
Positron Emission Tomography and Te-99m SPECT for 
Detection of Cardiac Sarcoidosis##1022-105·78A
Coronary Computed Tomography Angiography and 
Myocardial Perfusion Imaging in Patients With Known or 
Suspected Coronary Artery Disease##917-228·175A
Correlation Between Coronary Calcium Score and Presence of 
Ischemia on Rubidium-82 Positron Emission Tomography 
Stress Test## 811-5·101A
Cost-Benefit Analysis of the Use of Coronary Artery 
Calcium Score and Positron Emission Tomography in 
the Evaluation of Subjects With Indeterminate Tc-99m 
Single- Phonton Emission Computed Tomography Stress 
Test##908-235·143A
Determinants of the Impact of Guideline-Based Review on 
Utilization of Myocardial Stress Perfusion Imaging: Roles 
of Self-Referral, Physician Specialty, Patient Age and 
Type of Insurance## 817-8·292A
Diagnostic Accuracy of Gated Myocardial Perfusion Single-
Photon Emission Computed Tomography for Detection of 
Left Main Coronary Artery Disease##917-233·176A
Evaluation of the Appropriateness Criteria for Myocardial 
Perfusion Imaging: A Clinical Appropriateness Score 
Stratifies Perfusion Findings##910-235·151A
FDG PET-guided Therapy Versus Standard Care In Severe LV 
Dysfunction (The PARR-2 Trial)## 620-5·100A
Gender Differences in the Application of the Appropriateness 
Criteria for Single-Photon Emission Computed 
Tomography Myocardial Perfusion Imaging##904-
235·129A
Gender Normal Limits for Dipyridamole-Induced Changes 
in Left Ventricular Volumes and Transient Dilatation 
With Rubidium-82 Positron Emission Tomography 
Imaging##907-235·140A
Infarct Size, Viability, and Correlates in Patients Presenting 
With a Persistent Total Occlusion of the Infarct-Related 
Artery 3-28 Days Post-Myocardial Infarction: An OAT 
Substudy##1007-94·199A
Intramyocardial Injection of Autologous Bone Marrow 
Mononuclear Cells in Patients With Severe Post-
Infarction Heart Failure Is Safe, Reduces Heart Failure 
Symptoms, Improves Exercise Capacity and Increases 
Left Ventricular Function##1004-144·49A
Low Calcium Score Predicts Absence of Significant Coronary 
Artery Disease in Patients With Indeterminate Single-
Photon Emission Computed Tomography Myocardial 
Perfusion Imaging##917-231·176A
Nicotine Patches Are Safe to Use in Patients With Coronary 
Artery Disease and Stress-Induced Myocardial 
Ischemia##1013-70·209A
Phase Analysis of Gated Myocardial Perfusion Single-Photon 
Emission Computed Tomography Compared to Tissue 
Doppler Imaging for the Assessment of Left Ventricular 
Dyssynchrony##905-235·132A
Predictors of All-Cause Mortality and Impact of Medical 
Therapy on Long-Term Prognosis in Patients Undergoing 
Myocardial Perfusion Single Photon Emission Computed 
Tomography: Results of 10-Year Follow-Up##902-
236·122A
Scintigraphic Abnormalities by Myocardial Perfusion 
Imaging Predict Echocardiographic Response to 
Cardiac Resynchronization Therapy in Nonischemic 
Cardiomyopathy## 821-4·81A
Sympathetic Nerve Activation Predicts Origin of 
Tachyarrhythmia in Patients With a History Taking 
Paroxysmal Palpitation##902-235·122A
The Shifting Paradigm of Single-Photon Emission Computed 
Tomography Myocardial Perfusion Imaging Utilization: 
Comparative Analysis of Clinical Practice Guidelines 
Versus Appropriateness Criteria##916-235·173A
The Value of Repeat Single-Photon Emission Computed 
Tomography Testing After Initial Normal or Low-Risk 
SPECT in Patients With Coronary Artery Calcium##906-
235·136A
Wall Thickness in Human Carotid Arteries Correlates 
Negatively With Plaque Inflammation Measured 
by Fluorodeoxyglucose Positron Emission 
Tomography##914-235·166A
Washout Ratio of 123I-BMIPP Myocardial Scintigraphy Predicts 
Negative Cardiac Remodeling After Acute Myocardial 
Infarction: Comparison With Three-Dimensional 
Echocardiography##908-224·141A
Where Is Best Pacing Site to Decrease Dyssynchrony 
for Complete Atrioventricular Block? Study of 
Electrocardiographically Gated Myocardial Single 
Photon-Emission Computed Tomography##919-235·183A
Worsening Left Ventricular Function Per Se Is a Predictor of 
Left Ventricular Dyssynchrony Independently of QRS 





-Adrenergic Receptors Agonists: A New Therapeutic 
Strategy for the Treatment of Chronic Heart 
Failure##1004-60·43A
Receptors, endogenous substances
BNP Inhibits Cardiac Fibroblast Proliferation via the 
Natriuretic Peptide C Receptor and Modulates FAK 
Signaling and p21 and Cyclin D1 Expression##1022-
57·73A
Soluble CXCL16 Independently Predicts Long-Term Mortality 
in Acute Coronary Syndromes##1025-155·243A
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Referral guidelines
Adherence to the American College of Cardiology/ American 
Society of Nuclear Cardiology Appropriateness Criteria 
for Single-Photon Emission Computed Tomography 
Myocardial Perfusion Imaging##911-235·155A
Paging the Worldwide Cardiology Consultant: The Army 
Knowledge Online Telemedicine Consultation Program in 
Cardiology##1030-191·297A
The Shifting Paradigm of Single-Photon Emission Computed 
Tomography Myocardial Perfusion Imaging Utilization: 
Comparative Analysis of Clinical Practice Guidelines 
Versus Appropriateness Criteria##916-235·173A
Rehabilitation
Long-Term Clinical Outcome of Supervised Exercise 
Rehabilitation Among Patients With Peripheral Arterial 
Disease## 804-6·351A
Modular Secondary Prevention Based on Patient Choice 
Improves Risk Factor Profile and Knowledge After 
Acute Coronary Syndrome: A Randomized Controlled 
Trial##1008-167·347A
Prevalence of the Metabolic Syndrome in Cardiac 
Rehabilitation Patients##1020-161·389A
Racial Differences in Access and Utilization of Cardiac 
Rehabilitation##1026-165·412A
Self-Reported Depression Is Associated With Decreased 
but Considerable Benefit From Phase 2 Cardiac 
Rehabilitation##1020-165·390A
Sex, Work, Exercise, and Driving Following an ST-Elevation 
Myocardial Infarction: A GAP in the Guidelines##1008-
173·348A
Socially Vulnerable Myocardial Infarction Patients Have a 
Higher Risk of Dying or Suffering Reinfarction: Are 
Extended Rehabilitation Programs a Solution?##1014-
167·369A
The Impact of Different Aerobic Exercise Intensity on 
Endothelial Function in Patients Post-Myocardial 
Infarction##1002-170·330A
Weight Loss and Changes in Cardiovascular Risk Markers 
With a Low Glycemic Load Diet Compared With 
a Conventional Low Fat Recommended Diet: A 
Randomized Trial##1008-169·348A
Reimbursement
Impact of Payer Type on the Utilization of Drug-Eluting 
Stents for Patients With and Without Acute Myocardial 
Infarction##1030-147·294A
Renal circulation
Anemia in Chronic Heart Failure Is Not Only Related to 
Impaired Renal Perfusion and Blunted Epo Production, 
But to Fluid Retention and Impaired Survival as Well## 
835-3·87A
Is Renal Magnetic Resonance Imaging/Magnetic Resonance 
Angiography an Appropriate Screening Tool in the 
Workup of Patients With Suspected Renovascular 
Hypertension?##1008-208·350A
The Influence of Renal Magnetic Resonance Imaging/Magnetic 
Resonance Angiography Diagnosed Renal Artery Stenosis 
on Glomerular Filtration Rate and Renal Parenchymal 
Volume in Patients With Atherosclerotic Renovascular 
Hypertension##1020-82·384A
Renal function
A Novel Next Generation Natriuretic Peptide: CD-NP##1008-
120·343A
A Prospective Study Comparing Two Different Algorithms 
for Predicting Cardiovascular Events in Renal Transplant 
Candidates: In Whom Should Cardiac Scintigraphy Be 
Performed?## 841-7·110A
A Unique Animal Model of Aortic Valve Calcification Using 
High Adenine Diet##1012-192·281A
Angiographic Based Prevalence of Cardiovascular Disease in 
Pre-renal Transplant Patients##1019-180·230A
Blood Urea Nitrogen Levels and the Risk of Sustained 
Ventricular Arrhythmias and Sudden Cardiac Mortality 
in Patients With Left Ventricular Dysfunction.##917-
241·37A
Clinical Outcomes of Drug-Eluting Stents Versus Bare Metal 
Stents in Patients With Severe Renal Insufficiency##1025-
95·239A
Complication Rate Following Device Implantation in Patients 
With Impaired Renal Function##903-242·15A
Coronary and Left Ventricular Angiographic Correlates of 
Chronic Kidney Disease Following Acute Myocardial 
Infarction: Data From the Survival and Ventricular 
Enlargement Trial## 805-7·353A
Cystatin C Is an Independent Predictor of Recurrent 
Spontaneous Myocardial Infarction or Death in High 
Risk Non-ST-Elevation Acute Coronary Syndrome 
Patients##1013-174·217A
Cystatin C Is Lower in Acute Coronary Syndrome Than in 
Stable Angina and Nonischemic Chest Pain: An Apparent 
Paradox?##1019-157·228A
Diverse Cardiac Geometry and Cardiorenal Interaction in 
Diastolic Heart Failure##1201-245·51A
Do Drug-Eluting Stents Impact Survival in Patients With 
Chronic Renal Insufficiency?##1025-178·245A
Effect of Diabetes and Glomerular Filtration Rate on 6-
Month Outcomes in Patients Undergoing Cardiac 
Catheterization##1012-147·278A
Effect of Nesiritide on Renal Functions in Patients With Acute 
Decompensated Congestive Heart Failure##1004-68·45A
Evidence Does Support Glomerular Filtration Rate <40 
ml/min as a Relative Contraindication to Heart 
Transplantation##1016-107·70A
Glomerular Filtration Rate and N-Terminal Pro-Brain 
Natriuretic Peptide as Predictors of Cardiovascular 
Mortality in Vascular Patients##1026-160·411A
Impact of Renal Dysfunction on Prognosis After Acute 
Myocardial Infarction##1002-161·328A
Impact of Renal Dysfunction, Glucometabolic Status, and 
Quality of Care on One Month Mortality After Acute 
Myocardial Infarction##1020-128·388A
Impact of Renal Function on Mortality Prediction in Patients 
Undergoing Stress Myocardial Perfusion SPECT## 
841-4·109A
Joint Effects of Diabetes and Dialysis in Predicting Long- 
Term Outcomes Following Percutaneous Coronary 
Interventions##1007-157·204A
Left Ventricular Function Rather Than Coronary Anatomy 
Predicts Survival in Patients With End-Stage Renal 
Disease##1014-128·367A
Levosimendan Does Not Adversely Impact Mortality in 
Patients With Increased Serum Creatinine: REVIVE 
II##1016-62·66A
Long-Term Rosuvastatin Treatment Improves Renal Function 
in National Cholesterol Education Program Adult 
Treatment Panel III High Risk Patients##1002-131·327A
Medium-Term Renal Outcome of Pediatric Heart Transplant 
Patients on Reduced Calcineurin Inhibitor and 
Rapamycin##1004-109·48A
Metabolic Syndrome Is an Independent Predictor of 
Postoperative Renal Failure After Coronary Artery Bypass 
Surgery##1021-15·306A
Microalbuminuria in Chronic Heart Failure: Prevalence and 
Determinants in More Than 2,000 Patients Enrolled in the 
GISSI-HF Trial## 845-4·97A
Nesiritide Does Not Cause Renal Dysfunction in Acute 
Decompensated Heart Failure: A Randomized, Double-
Blind, Placebo-Controlled Clinical Trial## 808-4·63A
Prognostic Significance of Renal Function in Patients 
Undergoing Dobutamine Stress Echocardiography for 
Detection of Coronary Artery Disease##907-225·138A
Relationship of Coronary Flow Reserve With Coronary Artery 
and Thoracic Aorta Calcium in Patients With End-Stage 
Renal Disease Compared to Controls With Intermediate 
Risk Using Rubidium-82 Positron Emission Tomography/
Computed Tomography##908-231·143A
Renal Failure Independently Predicts Hospital Mortality in 
Consecutive Patients With Non-ST-Elevation Myocardial 
Infarction in Clinical Practice: Results of the ACOS-
Registry##1007-114·200A
Risk Factors and Associations of Coronary Artery Calcification 
in Hemodialysis Patients## 811-7·102A
Severity of Chronic Kidney Disease as a Risk Factor 
for Operative Mortality in the California Coronary 
Artery Bypass Graft Surgery Outcomes Reporting 
Program##1009-19·302A
Stabilization of Renal Function With Intra-Aortic Balloon 
Counterpulsation Therapy in Acute Myocardial 
Infarction Patients Undergoing Percutaneous Coronary 
Intervention##1025-135·242A
Statin Therapy Decreases Contrast-Induced Nephropathy in 
Patients Undergoing Cardiac Catheterization##1014-
126·367A
Statins Decrease the Risk of Acute Myocardial Infarction and 
Coronary Heart Disease Mortality in Patients With Renal 
Failure: A Meta-Analysis##1001-117·188A
Statins Reduce the Risk of Death and the Occurrence of 
Adverse Cardiovascular Events in Patients With 
Dyslipidemia and Renal Dysfunction: A Meta-Analysis of 
Randomized Placebo-Controlled Clinical Trials##1008-
124·344A
The Effect of Sodium Bicarbonate on Short- and Long-Term 
Renal Outcomes in Patients Undergoing an Emergent 
Cardiac Catheterization: A Prospective Randomized 
Controlled Trial##1001-113·187A
The Heart-Kidney Connection: Myocardial Infarction 
Accelerates Glomerular Dysfunction, Hypertrophy, 
and Proteinuria in Experimental Mild Renal 
Insufficiency##1019-73·221A
The Impact of Renal Insufficiency on Long-Term Outcomes 
in Patients Undergoing Cardiac Resynchronization 
Therapy##908-240·23A
The Influence of Renal Magnetic Resonance Imaging/Magnetic 
Resonance Angiography Diagnosed Renal Artery Stenosis 
on Glomerular Filtration Rate and Renal Parenchymal 
Volume in Patients With Atherosclerotic Renovascular 
Hypertension##1020-82·384A
Use of Perioperative Nesiritide Improves Clinical Outcomes 
and Decreases Resource Utilization in Heart Failure 
Patients Undergoing Cardiac Surgery##1009-15·301A
Renin
Aliskiren-Based Therapy Lowers Blood Pressure More 
Effectively Than Ramipril-Based Therapy in Patients 
With Hypertension: A 6-Month, Randomized, Double-
Blind Trial##1014-173·371A
Aliskiren-Based Therapy Provides Long-Term Suppression 
of Plasma Renin Activity That Persists After Treatment 
Withdrawal in Patients With Hypertension##1020-
168·390A
Antihypertensive Efficacy of the Direct Renin Inhibitor 
Aliskiren When Added to Hydrochlorothiazide 
Treatment in Patients With Extreme Obesity and 
Hypertension##1014-169·370A
Blood Pressure Lowering Effects Persist Following the Last 
Dose of Long-Term Therapy With Aliskiren, an Oral 
Direct Renin Inhibitor##1014-204·372A
Renin System Suppression With the Oral Direct Renin 
Inhibitor Aliskiren Administered Alone or in 
Combination: A Pooled Analysis of 1,093 Patients With 
Hypertension##1014-170·370A
Reperfusion
A Phase II Randomized, Placebo-Controlled, Single-
Blind, Multi-Center Dose-Escalation Study to 
Evaluate Tolerability, Safety, Pharmacokinetics, 
and Pharmacodynamics of a Single Intravenous 
Administration of INO-1001 in Subjects With ST-
Elevation Myocardial Infarction Undergoing Primary 
Percutaneous Coronary Intervention: Results of the TIMI 
37A Trial##1007-133·202A
A Rapid Response Trauma Approach Drops Reperfusion Time 
in ST-Elevation Myocardial Infarction##1019-135·226A
Cost and Effectiveness Comparison of Very Early Treatment 
With Primary Percutaneous Coronary Intervention 
Facilitated With Abciximab or Thrombolytic Therapy 
for Acute ST-Elevation Myocardial Infarction##1013-
116·214A
Excess Endothelin-1 Results in Fatal Calcium Overload 
in Porcine Myocardial Infarction and Isolated Rabbit 
Myocytes##1019-75·222A
Glucagon-Like-Peptide-1 Fused to Transferrin: A Novel 
Approach to Myocardial Reperfusion Injury## 803-
7·236A
Impact of a Guidelines Based Protocol to Improve 
Timeliness of Reperfusion Therapy and In-Hospital 
Outcomes##1013-95·212A
Impact of Guidelines-Based Protocol on Timeliness of 
Reperfusion for Patients Presenting During Regular-Hours 
and Off-Hours##1024-147·286A
Is It Possible to Predict Which Patients Need Distal 
Protection During Primary Percutaneous Coronary 
Intervention?##1001-133·189A
Left Ventricular End-Diastolic Pressure Is a Predictor 
of Suboptimal Myocardial Reperfusion in Patients 
Undergoing Percutaneous Coronary Intervention for ST-
Elevation Myocardial Infarction##1013-93·211A
Myocardial Perfusion in ST-Elevation Myocardial Infarction 
Patients Following Primary Percutaneous Coronary 
Intervention: Insights From the Electrocardiography/
Angiography Substudy of APEX AMI## 844-4·249A
Patients Transferred for Primary Percutaneous Coronary 
Intervention (PCI) in the APEX-AMI Trial Have Only 
Modest Symptom Onset to PCI Delays and Good 
Outcomes##1025-132·241A
Persistent Reduction in Myocardial Infarct Size After a Brief 




Potent Mitochondria-Targeted Peptides Reduce Myocardial 
Infarction in Rats##1001-71·184A
Rapamycin (Sirolimus) Administration In Vivo Limits Post-
Ischemic Myocardial Injury by MAPK Signaling in the 
Mouse Heart##1025-92·238A
Remote Periconditioning Reduces Myocardial No-Reflow by 
Decreasing Rho-Kinase Activity##1019-134·226A
Reperfusion BURST Arrhythmias as a Biomarker of 
Myocellular Damage Despite TIMI 3 Epicardial 
Flow##1019-96·223A
Risk-Adjusted Hospital Mortality Is Similar Between 
Patients Undergoing Coronary Artery Bypass Grafting 
or Percutaneous Coronary Intervention for Residual 
Multi-Vessel Disease Following Primary Percutaneous 
Revascularization##1001-201·195A
ST Resolution After Primary Percutaneous Coronary Infarction 
for ST-Elevation Myocardial Infarction Is a Strong 
Predictor of Outcome##1001-134·189A
Survival and Maturation of Human Embryonic Stem Cell-
Derived Cardiomyocytes Implanted Into Rat Hearts 
Exposed to Ischemia## 827-4·233A
Ten-Year Secular Trends and Characteristics Associated With 
Patient Delay From Symptom Onset to First Hospital 
Arrival in ST-Elevation Myocardial Infarction##1024-
148·287A
Utilization of Emergency Medical Services for Hospital 
Transport in Patients With ST-Elevation Myocardial 
Infarction Results in a Shorter Door-to-Balloon 
Time##1019-138·227A
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Ventricular Arrhythmia Bursts in the Setting of Acute Anterior 
Infarct Artery Recanalization: A Re-Definition of 
Reperfusion Arrhythmias##905-239·17A
Resource utilization
Bleeding Complications Are a Major Driver of Resource Use 
Among Patients With Acute Coronary Syndromes## 
851-4·252A
Children and Adults With Congenital Heart Disease Lost to 
Follow-Up: Who and When? A Population-Based Study## 
837-5·268A
Effect of Payer Status on Interventional Utilization Patterns: 
Current Results From the National Heart, Lung, and 
Blood Institute Dynamic Registry##1030-183·295A
Projecting an Impending General Cardiology Workforce 
Shortage##1204-265·277A
Restenosis
12/15-Lipoxygenase Transgenic Mice Have More Neointimal 
Formation Than C57BL/6 Mice in Response to Wire 
Endothelial Denudation## 849-5·418A
ALOX5AP Genetic Variants Are Associated With In-
Stent Restenosis After Percutaneous Coronary 
Intervention##1013-91·211A
Baseline C-Reactive Protein Levels and Angiographic 
Restenosis After Coronary Stenting: A Meta-
Analysis##1020-6·377A
Can C-Reactive Protein Levels Be a Predictor of Intravascular 
Ultrasound Intimal Hyperplasia Obstruction After 
Zotarolimus-Eluting Stent implantation?##1019-69·221A
Clinical Outcomes of Drug-Eluting Stents Versus Bare Metal 
Stents in Patients With Severe Renal Insufficiency##1025-
95·239A
Comparison of 64-Slice Computed Tomography With 
Conventional Coronary Angiography for the Detection 
of In-Stent Restenosis in the Left Main Coronary 
Artery##906-230·135A
Could Antipeptides for Vascular Endothelial Growth Factor 
and Receptor Reduce the Neointima Formation in 
Balloon-Injury Carotid Model in Rats?## 832-8·395A
Endothelial Layer Restoration After Vascular Injury Is Delayed 
With Aging Bone Marrow While the Inflammatory 
Response and Intimal Formation are Increased##1002-
38·319A
Glucose Suppresses Endothelial Cell Proliferation by Inhibiting 
Adenosine-Stimulated Erk1/2 Activation##1014-12·358A
Increased Neointimal Formation After Vascular Injury in the 
Thrombospondin-2 Knockout Mice Is Not Mediated by 
Cd36 Pathway## 849-4·418A
Involvement of Epigenetic Variation in Restenosis After 
Percutaneous Coronary Intervention##1014-4·356A
Is Diabetes a Significant Risk Factor in Contemporary 
Percutaneous Coronary Intervention (PCI)?##1007-
178·205A
Is In-Stent Late Loss Related to the Risk of Drug-Eluting Stent 
Thrombosis? A Meta-Regression From 21 Randomized 
Trials##1001-156·191A
Pioglitazone Reduces Neointimal Response by Suppression of 
the Early Inflammatory Reaction via NFkB Dependent 
MCP-1 Mediated Pathway in a Porcine Coronary Stent 
Model## 849-7·419A
Rapamycin (Sirolimus) Administration In Vivo Limits Post-
Ischemic Myocardial Injury by MAPK Signaling in the 
Mouse Heart##1025-92·238A
Two-Year Results From the TAXUS-V ISR Trial: A 
Randomized Trial of Paclitaxel-Eluting Coronary 
Stents Versus Vascular Brachytherapy for Treatment of 
Restenosis in Bare Metal Stents##1007-159·204A
Vascular Stenosis Response to Balloon-Injury Is Inhibited 
Following Local Intramural Delivery of Rapamycin With 
avb3-Integrin-Targeted Perfluorocarbon Nanoparticles## 
849-6·418A
Revascularization
Activated Partial Thromboplastin Time Measurement Is Not 
Associated With Clinical Outcomes in Patients With 
High-Risk Non-ST-Segment Elevation Acute Coronary 
Syndromes Treated With Unfractionated Heparin##1001-
93·186A
Clinical Impact of 64-Multi-Detector Computed Tomography 
on Percutaneous Coronary Intervention of Chronic Total 
Occlusion: Focus on Regional Calcium Score##916-
230·172A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery Among Patients With a Chronic Total 
Occlusion and Multi-Vessel Coronary Artery Disease in 
the Bare Metal Stent Era.##1019-176·229A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery in Patients With Multi-Vessel Coronary 
Artery Disease and Reduced Left Ventricular Function in 
the Bare Metal Stent Era.##1019-177·229A
Differences in Invasive Therapies and In-Hospital Mortality 
Between Patients With and Without ST-Segment 
Elevation Myocardial Infarction Complicated by 
Cardiogenic Shock##1025-197·246A
Effects of Drug-Eluting Stents on Hospital Readmission Rates 
and Long-Term Repeat Revascularization: Outcomes 
From a Large Clinical Registry##1024-181·287A
FDG PET-guided Therapy Versus Standard Care In Severe LV 
Dysfunction (The PARR-2 Trial)## 620-5·100A
Growth-Differentiation Factor-15 for Risk Stratification and 
Selection of Patients for an Early Invasive Treatment 
Strategy in Non-ST-Elevation Acute Coronary 
Syndrome##1025-136·242A
Human Cord Blood Endothelial Progenitors Decrease 
Neointimal Hyperplasia in SCID Mouse Vein Grafts## 
849-8·419A
Impact of Pharmacologic Management at Discharge for 
Complicated Risk Factors on Outcomes of Diabetic 
Patients Undergoing First Coronary Revascularization: 
Perspectives From CREDO-Kyoto Registry##1008-
168·348A
Implantable Cardioverter Defibrillator Therapy Improves 
the Survival of Patients With Prior Coronary 
Revascularization: Data From the SCD-HeFT Trial##901-
242·12A
Incidence of a Left Main Stenosis Among High-Risk Patients 
Presenting for Elective Vascular Surgery and Long-Term 
Outcomes## 814-6·374A
Increased Mortality With Early Surgical Revascularization 
in Acute ST-Elevation Myocardial Infarction After 
Fibrinolysis: An Analysis of the GUSTO V Study##1202-
251·196A
Invasive Treatment in Non-ST Elevation Acute Coronary 
Syndrome Promotes Long-Term Health-Related Quality 
of Life: Results From the FRISC II Trial## 802-8·209A
Mortality and Repeat Coronary Interventions 30 Years After 
Venous Coronary Bypass Surgery: A Follow-Up Study of 
1,041 Patients##1007-154·203A
Outcomes in Patients with a Previous Vascular Intervention 
Enrolled in the REduction of Atherothrombosis for 
Continued Health (REACH) Registry in the United 
States##1026-127·410A
Outcomes of Coronary Artery Bypass Surgery Compared to 
Percutaneous Coronary Intervention With Drug-Eluting 
Stents for Unprotected Left Main Coronary Artery 
Disease##1025-200·247A
Prediction of Improvement in Cardiac Function After 
Revascularization Using Myocardial Deformation 
Imaging##913-221·159A
Safety and Efficacy of IVUS-guided Lumen Re-entry Devices 
for the Percutaneous Revascularization of Chronic Total 
Occlusions of the Superficial Femoral Artery##1026-
80·400A
Short- and Long-Term Health-Related Quality of Life and 
Anginal Status After Randomization to Coronary Stenting 
Versus Bypass Surgery for the Treatment of Multivessel 
Disease: Results of the ARTS-1 Study##1012-188·280A
Strain Rate Analysis and Levosimendan Improve Detection of 
Myocardial Viability by Dobutamine Echocardiography 
in Patients With Post-Infarction Left Ventricular 
Dysfunction##919-226·181A
The Changing Profile of First Reoperative Coronary 
Artery Bypass Surgery: Trends Over 14 Years in 470 
Patients##1019-200·231A
Three-Year Gain in Life Expectancy of Smoking Cessation 
After Coronary Bypass Surgery: A 30-Year Follow-Up 
Study## 804-8·351A
Variation in Coronary Artery Bypass Grafting and 
Percutaneous Coronary Intervention Outcomes Across 
Four Revascularization Centers in Northern New England 
and Its Relation to Community Survival##1030-186·296A
Rhythm disorders
Remote Magnetic Navigation to Map and Ablate Arrhythmias 
in the Pericardial Space##912-239·29A
Smart ECG: Solution for Mobile Heart Work Analysis 
and Medical Interventions in Case of Heart Work 
Problems##1012-190·280A
The Efficacy of Ablation Techniques for the Treatment of 
Atrial Fibrillation: Is Pulmonary Vein Isolation Adequate 
as Lone Ablation Therapy?##904-237·15A
Risk factors
A Meta-Analysis of Smoking Cessation Behavioral 
Interventions##1006-148·272A
A Risk Score to Predict Sudden Cardiac Death in Patients With 
ST-Elevation Myocardial Infarction##1013-94·212A
A School-Based Health Education Program Identifies Children 
at Risk for Cardiovascular Disease and Diabetes: Baseline 
Data From the Project Healthy Schools 2005-06 Pilot 
Program## 817-5·291A
Abdominal Obesity, Body Mass Index, and Physical Activity: 
How Do They Modify the Framingham Risk Score?## 
812-6·373A
Access to Implantable Cardioverter Defibrillator Therapy 
for Patients With MADIT-Like Criteria in Clinical 
Practice##910-241·26A
Adverse Cardiovascular Effects of Air Pollution in Patients 
With Coronary Heart Disease## 805-5·352A
Aggressive Prophylaxis Against Cytomegalovirus Plays a Key 
Role in Preserving Epicardial Artery Flow Early After 
Cardiac Transplantation##1022-106·78A
ALOX5AP Genetic Variants Are Associated With In-
Stent Restenosis After Percutaneous Coronary 
Intervention##1013-91·211A
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Association Between Recurrent Ischemia on Continuous ECG 
Holter Monitoring and Short- and Long-Term Mortality 
in Patients With Non-ST-Elevation Acute Coronary 
Syndrome in the MERLIN-TIMI 36 Trial##1019-
155·227A
C-Reactive Protein and B-Type Natriuretic Peptide 
Independently Predict Hospitalization for Heart Failure 
After Acute Coronary Syndromes and Identify Patients 
Who Benefit From Intensive Statin Therapy in the 
PROVE IT-TIMI 22 Trial##1007-174·204A
Mechanism of Fever-Aggravation of ST-Elevation and 
Arrhythmogenesis in a Canine Tissue Model of Brugada 
Syndrome##919-234·39A
Myocardial Perfusion in ST-Elevation Myocardial Infarction 
Patients Following Primary Percutaneous Coronary 
Intervention: Insights From the Electrocardiography/
Angiography Substudy of APEX AMI## 844-4·249A
ST Resolution After Primary Percutaneous Coronary Infarction 
for ST-Elevation Myocardial Infarction Is a Strong 
Predictor of Outcome##1001-134·189A
Value of Serial Measurements of C-Reactive Protein 
in Non-ST-Segment Elevation Acute Coronary 
Syndromes##1001-92·186A
Stent
30-Day Results of a Novel, Balloon Expandable Endovascular 
Stent With an Integrated Resonance Circuit for Active 
Visualization in Magnetic Resonance Imaging in a 
Porcine Model##916-233·172A
A Meta-Analysis of Drug-Eluting Stents for the Treatment of 
Acute Myocardial Infarction##1019-132·225A
Adjusted Clopidogrel Dosing in Patients With Insufficient 
Platelet Inhibition After Elective Coronary Stenting 
Caused a More Robust and Consistent Platelet Inhibition 
in the Entire Cohort##1020-9·378A
Aspirin Resistance and Long-Term Prognosis After Successful 
Coronary Stenting##1025-174·244A
Baseline C-Reactive Protein Levels and Angiographic 
Restenosis After Coronary Stenting: A Meta-
Analysis##1020-6·377A
Clinical Outcomes of Drug-Eluting Stents Versus Bare Metal 
Stents in Patients With Severe Renal Insufficiency##1025-
95·239A
Comparison of 64-Slice Computed Tomography With 
Conventional Coronary Angiography for the Detection 
of In-Stent Restenosis in the Left Main Coronary 
Artery##906-230·135A
Comparison Of Angiopoietin-1 And Angiopoietin-2 Gene 
Expression Levels Among Patients Treated With 
Sirolimus-eluting Versus Bare Metal Stents##1007-
179·205A
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Comparison of Drug-Eluting Versus Bare Metal Stents: Timing 
of Subacute Thrombosis up to 2 Years##1019-154·227A
Comparison of Effects of Sirolimus-Eluting Stent, Bare 
Metal Stent, and Plain Only Balloon Angioplasty on 
Inflammatory Markers##1001-196·194A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery Among Patients With a Chronic Total 
Occlusion and Multi-Vessel Coronary Artery Disease in 
the Bare Metal Stent Era.##1019-176·229A
Comparison of Percutaneous Coronary Intervention and 
Bypass Surgery in Patients With Multi-Vessel Coronary 
Artery Disease and Reduced Left Ventricular Function in 
the Bare Metal Stent Era.##1019-177·229A
Coronary Artery Bypass Surgery Might Be Superior to 
Percutaneous Coronary Intervention With Drug-Eluting 
Stents for Unprotected Left Main Coronary Artery 
Disease##1007-200·207A
Differential Predictors for Subacute, Late and Very Late Drug-
Eluting Stent Thrombosis: Results From the Multicenter 
ESTROFA Study## 847-3·250A
Do Drug-Eluting Stents Impact Survival in Patients With 
Chronic Renal Insufficiency?##1025-178·245A
Do the Results of the Arterial Revascularization Therapies 
Study Trial Generalize to Current Revascularization 
Practices in Northern New England?##1018-146·282A
Effects of Drug-Eluting Stents on Hospital Readmission Rates 
and Long-Term Repeat Revascularization: Outcomes 
From a Large Clinical Registry##1024-181·287A
Elective Percutaneous Coronary Intervention Without 
On-Site Surgical Backup: A Community Hospital 
Experience##1012-193·281A
Fate of Small-Sized Side Branches After Coronary Stent 
Implantation##1013-156·217A
Impact of Payer Type on the Utilization of Drug-Eluting 
Stents for Patients With and Without Acute Myocardial 
Infarction##1030-147·294A
Impact of Stent Fractures After Femoropopliteal 
Stenting##1008-81·341A
Impact of Stent Implantation on Pulmonary Artery 
Growth##1017-32·262A
Intraoperative Monitoring by Transesophageal 
Echocardiography of Surgical Implantation of a Novel 
Prosthesis-Stent Combination in Aortic Dissection 
Involving Arch and Descending Aorta##910-224·149A
Is In-Stent Late Loss Related to the Risk of Drug-Eluting Stent 
Thrombosis? A Meta-Regression From 21 Randomized 
Trials##1001-156·191A
Logistic Regression Models to Identify Negative Predictors 
of Agreement of Findings of 64-Slice Computed 
Tomography and Conventional Coronary Angiogram for 
Evaluation of Patency of Drug-Eluting Stents and Bare 
Metal Stents in Coronary Arteries##1013-177·218A
Meta-Analysis of 1,193 Patients Shows That Late Percutaneous 
Coronary Intervention for the Occluded Infarct-Related 
Artery Improves Survival## 844-3·249A
One-Year Outcome After Coronary Revascularization Among 
Patients With Left Anterior Descending Artery Disease 
and Diabetic Retinopathy: Sirolimus-Eluting Stent Versus 
Coronary Bypass Surgery##1001-200·195A
Paclitaxel-Eluting Stents Compared to Bare Metal Stents in an 
Underserved Hispanic Population Presenting With Acute 
ST-Segment Myocardial Infarction##1019-115·225A
Pioglitazone Reduces Neointimal Response by Suppression of 
the Early Inflammatory Reaction via NFkB Dependent 
MCP-1 Mediated Pathway in a Porcine Coronary Stent 
Model## 849-7·419A
Prediction of Impairment Factors for Evaluation of Patency of 
Drug-Eluting Stent and Bare Metal Stents in Coronary 
Arteries Using 64-Slice Computed Tomography in 
Logistic Regression Models##1020-14·379A
Prognostic Value and Clinical and Biochemical Correlates 
of Elevated Neutrophil to Lymphocyte Ratio Prior to 
Coronary Stenting##1001-157·192A
Safety and Efficacy of IVUS-guided Lumen Re-entry Devices 
for the Percutaneous Revascularization of Chronic Total 
Occlusions of the Superficial Femoral Artery##1026-
80·400A
Sirolimus-Eluting Stent Implantation for the Percutaneous 
Treatment of Unprotected Left Main Coronary Artery 
Disease: A Clinical Analysis Based on J-CYPHER 
Registry##1013-178·218A
Stent Implantation in Left Main Lesion Without Routine Intra-
Aortic Balloon Pump Support: Risk Factors Related to 
Hemodynamic Instability##1025-96·239A
Systemic Inflammation 12-Months After Stent Implantation: 
Comparison Between Sirolimus-Eluting Stent and Bare-
Metal Stent##1001-178·193A
The Comparison of Coronary Artery Bypass Surgery With 
Drug-Eluting Stent Implantation for the Treatment of 
Multivessel Coronary Artery Disease##1019-198·231A
The Effectiveness of Improvement on Activities of Daily 
Living in Intermediate-Term With Percutaneous 
Peripheral Intervention of Lower Limbs in Hemodialysis 
Patients##1008-83·341A
The SIRIUS Study: 5-Year Outcomes##1025-159·244A
Timing of Stent Thrombosis in the Real World: Comparison 
of Bare Metal Stents Versus Drug-Eluting Stents## 802-
5·208A
Two-Year Results From the TAXUS-V ISR Trial: A 
Randomized Trial of Paclitaxel-Eluting Coronary 
Stents Versus Vascular Brachytherapy for Treatment of 
Restenosis in Bare Metal Stents##1007-159·204A
Usefulness of 64-Slice Multi-Slice Computed Tomography 
Coronary Angiography to Assess In-Stent Restenosis## 
852-3·113A
Stress testing
24-Month Outcome Following Negative Adenosine Stress 
Magnetic Resonance Imaging Perfusion Imaging in 92 
Patients Presenting With Chest Pain##915-233·169A
A New Technique for Detecting Stress-Induced Ischemia 
Using Analysis of the Electrocardiogram Depolarization 
Phase##907-242·21A
A Prospective Study Comparing Two Different Algorithms 
for Predicting Cardiovascular Events in Renal Transplant 
Candidates: In Whom Should Cardiac Scintigraphy Be 
Performed?## 841-7·110A
Abnormal Myocardial Perfusion Imaging Predicts Decreased 
Survival in Patients With a Negative Coronary 
Angiogram## 841-6·109A
Accuracy of Fully Quantitative Cardiac Magnetic Resonance 
Myocardial Perfusion in Detection of Coronary Disease 
as Measured by Quantitative Coronary Angiography## 
824-6·105A
Adherence to the American College of Cardiology/ American 
Society of Nuclear Cardiology Appropriateness Criteria 
for Single-Photon Emission Computed Tomography 
Myocardial Perfusion Imaging##911-235·155A
Cardiac Magnetic Resonance Imaging During Dobutamine 
Stress Test to Detect Myocardial Perfusion Defects in 
Cardiac Syndrome X##1019-174·228A
Comparison Between Coronary Anatomy and Physiology 
in Predicting Hard Events in Symptomatic Patients 
Undergoing Coronary Angiography##901-235·117A
Coronary Computed Tomography Angiography and 
Myocardial Perfusion Imaging in Patients With Known or 
Suspected Coronary Artery Disease##917-228·175A
Coronary Computed Tomography Angiography Decreases 
Need for Invasive Cardiac Catheterization in Patients 
With Indeterminate Stress Test##901-231·117A
Determinants of the Impact of Guideline-Based Review on 
Utilization of Myocardial Stress Perfusion Imaging: Roles 
of Self-Referral, Physician Specialty, Patient Age and 
Type of Insurance## 817-8·292A
Do Myocardial Perfusion Abnormalities Predict Survival in 
Patients Who Develop Myocardial Infarction Late After 
Stress Testing?##1013-157·217A
Evaluation of Coronary Artery Disease: Variations in Practice 
Patterns Across Six Countries##1014-129·367A
Evaluation of the Appropriateness Criteria for Myocardial 
Perfusion Imaging: A Clinical Appropriateness Score 
Stratifies Perfusion Findings##910-235·151A
External Prognostic Validations and Comparisons of Age- and 
Gender-Adjusted Exercise Capacity Predictions## 410-
9·423A
Impact of Renal Function on Mortality Prediction in Patients 
Undergoing Stress Myocardial Perfusion SPECT## 
841-4·109A
Left Ventricular Function Rather Than Coronary Anatomy 
Predicts Survival in Patients With End-Stage Renal 
Disease##1014-128·367A
Low Calcium Score Predicts Absence of Significant Coronary 
Artery Disease in Patients With Indeterminate Single-
Photon Emission Computed Tomography Myocardial 
Perfusion Imaging##917-231·176A
Myocardial Perfusion Imaging in Patients With New-Onset 
Atrial Fibrillation: Cardiac Risk Factors and Coronary 
Artery Disease Predict Perfusion Findings##917-
235·176A
Obesity Paradox in Risk Stratification and Prognosis of 
Patients Undergoing Stress Echocardiography##914-
225·163A
Prediction of Cardiac Events in Patients With Reduced 
Left Ventricular Ejection Fraction Using Dobutamine 
Cardiovascular Magnetic Resonance Assessment of Wall 
Motion Score Index##1007-158·204A
Predictors of Long-Term All-Cause Mortality in Patients 
With Normal Exercise Echocardiography Study##904-
225·127A
Prognostic Significance of Dyspnea in Patients Referred for 
Stress Echocardiography##912-225·156A
Prognostic Value of Stress Gated SPECT Imaging in Diabetics: 
Contribution of Perfusion and Function for Prediction of 
Adverse Cardiac Outcome## 841-8·110A
Safety and Efficacy of Intermediate Dobutamine Stress 
Imaging With Real-Time Perfusion Echocardiography in 
the Elderly##907-226·138A
Serial Observation of Shear Stress and Atherosclerotic Plaque 
Formation by a Newly-Developed Topographic Shear 
Stress Imaging System With Use of Three-Dimensional 
Intravascular Ultrasound##1020-11·379A
Strain Rate Is Superior to Peak Systolic Strain for the 
Detection of Ischemia During Dobutamine Stress 
Echocardiography##902-225·119A
The Cost Effectiveness of Functional Cardiac Testing in the 
Diagnosis and Management of Coronary Artery Disease: 
Principal Results From the CECaT Trial## 817-4·291A
The Effect of Metabolic Syndrome on Myocardial Contractile 
Reserve During Exercise in Nondiabetic Hypertensive 
Patients##901-225·116A
The Oral Adenosine A1 Receptor Agonist, BAY 68-4986, 
Reduces Heart Rate at Peak Exercise in Patients With 
Chronic Stable Angina## 825-6·232A
Stroke
A History of Stroke or Peripheral Arterial Disease Is 
Common in Patients With Acute Myocardial Infarction 
and Is Associated With Less Aggressive Therapy and 
Worse In-Hospital Outcome: Insights From the RICO 
Survey##1007-117·201A
Anticoagulation After Anterior Myocardial Infarction and the 
Risk of Stroke## 410-7·422A
Can Morphology on Transesophageal Echocardiography 
Differentiate an Asymptomatic From Symptomatic Patent 
Foramen Ovale?## 813-3·102A
Carotid Stenting in Patients With Prior Carotid Endarterectomy 
Is Associated With Favorable Outcomes in Community 
Practice: Insights From the Large German Multicenter 
ALKK CAS Registry## 814-5·374A
Celecoxib Increases the Risk of Myocardial Infarction but 
Not of Death or Stroke: A Meta-Analysis of Randomized 
Controlled Trials##1030-148·294A
Clinical and Echocardiographic Measures Governing Embolic 
Destination in Atrial Fibrillation##919-238·40A
Early Assessment of Transesophageal Echocardiography in the 
Definition of Ischemic Stroke Subtypes in the Emergency 
Department: Implications on Clinical and Therapeutic 
Decision Making##903-223·123A
Efficacy of Intravenous Prothrombin Complex Concentrate for 
Emergent Reversal of Oral Anticoagulation in Patients 
With Left Ventricular Assist System##1028-108·94A
Immunolocalization of Platelet Glycoprotein IIb/IIIIa and 
P-selectin, and Neutrophil-Platelet Association in Human 
Carotid Unstable Plaques##1026-79·405A
Increased Risk of Coronary Heart Disease After Recurrent 
Cerebrovascular Events: Findings From the SPARCL 
Study## 804-4·351A
Increased Risk of Incident Stroke Associated With the 
Cyclooxygenase 2 G-765C Polymorphism in African-
Americans: The Atherosclerosis Risk in Communities 
Study##1026-44·404A
Protective Effect of Chronic Statin Use Against Post-Discharge 
Stroke After Coronary Artery Bypass Grafting in Patients 
With Acute Coronary Syndromes##1006-188·275A
Risk Factors for Stroke Complicating Coronary 
Angioplasty##1012-182·279A
Stroke Prevention Technology for Patients with Non-Valvular 
AF: Worldwide Experience with the WATCHMAN LAA 
System## 623-5·2A
The Association of Cryptogenic Arterial Emboli and 
Nonsteroidal Anti-Inflammatory Medications in Patients 
With and Without Atrial Septal Defect and Patent 
Foramen Ovale##1014-78·362A
Three-Month Cumulative Incidence of Thromboembolism 
and Bleeding After Periprocedural Anticoagulation 
Management of Nonvalvular Atrial Fibrillation Patients: A 
Single Center Retrospective Cohort Study##915-238·33A
Urotensin II Is a Major Risk Biomarker for Stroke in Type 2 
Diabetes##1002-46·320A
Use of Warfarin and Performance of Stroke Risk Stratification 
Models in Atrial Fibrillation## 819-8·5A
Stroke volume
Is O2-Pulse Obtained From Respiratory Gas Analysis Useful 
for Estimating the Stroke Volume During Exercise in 
Patients With Left Ventricular Dysfunction?##910-
236·151A
Noninvasive Left Ventricular Stroke Work Index in Severe 
Mitral Regurgitation as a Parameter of True Left 
Ventricular Performance##1009-21·303A
Sudden death
A Risk Score to Predict Sudden Cardiac Death in Patients With 
ST-Elevation Myocardial Infarction##1013-94·212A
Access to Implantable Cardioverter Defibrillator Therapy 
for Patients With MADIT-Like Criteria in Clinical 
Practice##910-241·26A
An Integrated Approach to the Treatment of Sudden Cardiac 
Death Improves Survival in an Urban Setting##1019-
196·230A
Arrhythmic Risk Stratification After Myocardial Infarction 
in the MADIT II Era: Should We Consider Infarct 
Localization?##901-240·11A
Assessment of Exercise Heart Rate Parameters for Predicting 
Mortality and Sudden Death## 842-7·111A
Electrically Induced Chest Constrictions During Ventricular 
Fibrillation Produce Blood Flow##1019-195·230A
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Electrocardiogram Characteristics Prior to the Onset of 
Ventricular Tachycardia/Fibrillation in Patients With 
Brugada Syndrome##919-242·41A
Evidence for Mechanically-Induced Ion-Channel Dysfunction 
as a Mechanism in Chest Blow-Induced Ventricular 
Fibrillation## 836-3·7A
Features of Ventricular Tachyarrhythmias in Patients With 
Brugada Syndrome##919-239·40A
Genotype-Phenotype Aspects of Type-2 Long-QT 
Syndrome##917-239·37A
Hibernating Myocardium Leads to an Upregulation in Nerve 
Growth Factor and Partial Subendocardial Sympathetic 
Denervation##915-239·34A
Home Surveillance Is Warranted in Patients With Systemic to 
Pulmonary Artery Shunts##1023-33·265A
Impact of Object Shape and Resultant Left Ventricular Pressure 
Is Critically Important in the Generation of Ventricular 
Fibrillation From Chest Wall Impact##904-239·16A
Mechanism of Ventricular Fibrillation in the Aged Hearts 
Expsoed to Glycolytic Inhibition: A New Model of 
Sudden Cardiac Death## 406-5·420A
Mechanisms of Differential Patterns of Survival Between 
Andersen-Tawil and Timothy Syndromes## 836-5·8A
Microvolt T-Wave Alternans Does Not Predict Appropriate 
Implantable Defibrillator Discharges or Correlate 
With Traditional Risk Factors for Sudden Cardiac 
Death in Patients With Hypertrophic Obstructive 
Cardiomyopathy##912-242·30A
N-3 Polyunsaturated Fatty Acids and Major Arrhythmic 
Events: A Meta-Analysis of Randomized Controlled 
Trials##918-239·38A
New ECG Pattern in Young Patients With Polymorphic 
Catecholaminergic Ventricular Tachycardia##916-
242·36A
Predisposition to Acute Angle Take-Off and Narrow 
Ostial Coronary Artery Orifice Areas in Patients With 
Anomalous Coronary Arteries Identified on 64-Detector 
Coronary Angiography##918-228·178A
Prevalence and Significance of an Isolated Long-QT Interval 
on a 12-Lead Electrocardiogram in Elite Athletes##915-
242·34A
Programming Ventricular Tachycardia Therapy in Patients 
With a Primary Prevention Implantable Cardioverter 
Defibrillator Indication: Preliminary Results From the 
PROVE Trial## 830-4·6A
QRS Duration Predicts Sudden Cardiac Death in Hypertensive 
Patients: The LIFE Study##907-239·21A
Sleep Apnea Predicts Lethal Arrhythmic Events in Patients 
With Chronic Heart Failure##1010-65·54A
Soluble Lectin-Like Oxidized-Low Density Lipoprotein 
Receptor-1: Is a Prognostic Biomarker for Acute Coronary 
Syndrome to Predict Recurrence or Death##1001-
155·191A
Steadiness of Left Ventricular Ejection Fraction After 
Revascularization in Patients Post-Myocardial Infarction: 
Impact on Primary Prevention With Implantable 
Cardioverter Defibrillators##904-242·16A
The Characteristic Vectorcardiographic Changes in Patients 
With Brugada Syndrome##913-242·31A
Therapeutic Hypothermia for Out-of-Hospital Cardiac 
Arrest May Not Improve Survival When Utilized in an 
Unselected Population##1025-196·246A
Superoxide dismutase
Gene Transfer of Human Extracellular Superoxide Dismutase 
Ameliorates Monocrotaline-Induced Pulmonary Arterial 
Hypertension in Rats##1002-86·323A
Oxidative Stress, Not Iron Overload, Is Associated With 
Systolic and Diastolic Strain Rate in Asymptomatic 
Subjects With Hereditary Hemochromatosis##904-
221·126A
Relationships Between Adiponectin and Markers of Oxidative 
Stress in High-Risk Patients for Coronary Artery 
Disease##1002-41·319A
Supraventricular tachycardia
Anatomic Evaluation of the Right Atrial Cavo-Tricuspid 
Isthmus by Multi-Detector Computed Tomography##903-
237·14A
Delineation of Reentrant Circuit in Atypical Atrioventricular 
Nodal Reentrant Tachycardia With Eccentric Coronary 
Sinus Activation##905-237·17A
Early Experience of Cryoablation for Accessory Pathways in 
Children##1017-29·261A
Relationship Between the Coronary Artery Anatomy and 
the Subeustachian Isthmus, Coronary Sinus Os-Middle 
Cardiac Vein, and Floor of Coronary Sinus##910-238·25A
Sympathetic Nerve Activation Predicts Origin of 
Tachyarrhythmia in Patients With a History Taking 
Paroxysmal Palpitation##902-235·122A
Unique Electrophysiological Characteristics of Irregular 
Atypical Atrioventricular Nodal Reentrant 
Tachycardia##914-238·32A
Syncope
Different Biological Pattern in Adenosine Sensitive Syncope 
and Tilt-Induced Vasovagal Syncope## 818-5·3A
Systole
Abnormalities in Left Ventricular Systolic Function Predict 
Heart Failure Events Despite Normal Baseline Ejection 
Fraction: Data From the Heart and Soul Study##903-
221·122A
Siemens Velocity Vector Imaging Versus GE 2-D Speckle 
Tracking: Are We Measuring the Same Thing?## 834-
4·107A
Tachycardia
Tachycardiomyopathy in Patients With Persistent Atrial 
Flutter##919-237·40A
Tech assessment
Cardiac Velocity, Strain and Strain Rate Using Velocity Vector 
Imaging in Normal Adults##914-222·162A
Siemens Velocity Vector Imaging Versus GE 2-D Speckle 
Tracking: Are We Measuring the Same Thing?## 834-
4·107A
Tetralogy of fallot
Accuracy and Importance of Phase Contrast Magnetic 
Resonance for Measurement of Blood Flows in Branch 
Pulmonary Arteries With and Without Stenosis in the 
Presence of Pulmonary Regurgitation: Comparison 
With Radionuclide Lung Perfusion Scintigraphy##906-
232·136A
Cardiopulmonary Exercise Function Predicts Long-Term 
Prognosis in Adults With Repaired Tetralogy of Fallot## 
837-3·267A
Dobutamine Stress Echocardiography Is Feasible, Efficacious, 
and Safe in the Estimation of Right Ventricular Reserve 
in Patients With Repaired Tetralogy of Fallot##1011-
49·259A
Early Evidence of Adverse Left Ventricular Mechanics in 
Patients With Repaired Tetralogy of Fallot##1029-
52·271A
Home Surveillance Is Warranted in Patients With Systemic to 
Pulmonary Artery Shunts##1023-33·265A
Prediction of Right Ventricular Ejection Fraction From 
Color Doppler Tissue Indices in Patients With Repaired 
Tetralogy of Fallot##1029-27·269A
Right Ventricular Mechanics and QRS Duration After Repair 
of Tetralogy of Fallot: Implications of Infundibular 
Disease##1029-50·271A
Thrombin inhibitors
“Virtual Superiority”: A New Composite Score for Grading 
the Quality of Noninferiority Cardiovascular Clinical 
Trials##1024-149·287A
Major Bleeding in Acute Coronary Syndrome Patients is 
Associated with a Marked Pro-Inflammatory Response: 
Results from the ACUITY Inflammatory Biomarker Sub-
Study## 615-5·209A
Thromboembolism
Bridging of Chronically Anticoagulated Patients With 
Low Molecular Weight Heparin Prior to Cardiac 
Catheterization: Experience in 203 Patients From the 
BRAVE Registry##1025-180·245A
Clinical and Echocardiographic Measures Governing Embolic 
Destination in Atrial Fibrillation##919-238·40A
High Frequency of Intracardiac Thrombosis and Embolic 
Events in 116 Autopsy or Explant Cases of Cardiac 
Amyloidosis##1010-102·56A
Inadvertent Cardioversion During Routine Defibrillation 
Testing in Patients With Atrial Fibrillation Undergoing 
Defibrillator Implantation##908-241·23A
Is It Possible to Predict Which Patients Need Distal 
Protection During Primary Percutaneous Coronary 
Intervention?##1001-133·189A
Mechanism of Coagulum Formation in Radiofrequency 
Ablation and a Novel Method to Prevent it## 410-6·422A
Multidetector Computed Tomography for the Detection of Left 
Atrial Appendage Thrombus: A Comparative Study With 
Transesophageal Echocardiography##919-231·182A
Pharmacological Venous Thromboembolism Prophylaxis 
in Hospitalized Medical Patients: A Meta-Analysis of 
Randomized Controlled Trials##1002-89·324A
Platelet Function in Clopidogrel-Treated Patients With Acute 
Coronary Syndrome## 851-6·253A
The Association of Cryptogenic Arterial Emboli and 
Nonsteroidal Anti-Inflammatory Medications in Patients 
With and Without Atrial Septal Defect and Patent 
Foramen Ovale##1014-78·362A
Thrombolysis
Clinical Factors Associated With Thrombolysis Failure in 
Patients Transferred to an Interventional Cardiac Unit for 
Myocardial Infarction: Data From RICO Survey##1001-
153·191A
Development of a Real-Time Fluorescence Imaging In Vivo 
Clot Lysis Method: Alcohol- and Polyphenol (Quercetin 
and Catechin)-Induced Effects##1020-85·385A
Does NT-proBNP Predict and Explain Poor Outcomes in ST-
Elevated Myocardial Infarction Patients? Insights From 
ASSENT-4 PCI##1019-133·226A
Early Transesophageal Echocardiography After Transcathether 
Occlusion of Interatrial Communications Allows Timely 
Detection and Treatment of Intracardiac Thrombus 
Formation##1005-53·256A
Enoxaparin Versus Unfractionated Heparin With Fibrinolysis 
for ST-Elevation Myocardial Infarction In Patients ≥75 
Years Compared With <75 Years## 844-5·249A
Fibrinolysis With Planned Early Percutaneous Coronary 
Intervention Versus Primary PCI Alone: One-
Year Follow-Up Results From the ASSENT-4 PCI 
Study##1019-117·225A
Infarct Transmurality and Infarct Size Assessed by Delayed 
Enhancement Magnetic Resonance Imaging: Association 
With Time-to-Treatment, St-Segment Resolution, and 
Timi-Flow Grades##1001-137·190A
Percutaneous Coronary Intervention After Early 
Prehospital Thrombolysis: Reasonable, Useless, or 
Dangerous?##1013-137·215A
Should Clinical Guidelines Emphasize Statistical Significance 
Over Clinical Importance? A Reappraisal of the 2004 
American College of Cardiology /American Heart 
Association Treatment Guidelines for ST-Elevation 
Myocardial Infarction##1007-153·203A
Tenecteplase-Pretreated ST-Elevated Myocardial Infarction 
Patients With TIMI 0-2 Flow Before Percutaneous 
Coronary Infarction Are Less Likely to Have TIMI 3 Flow 
After PCI##1019-153·227A
Transradial Approach In Percutaneous Coronary Intervention 
Following Prehospital Fibrinolysis Reduces Vascular 
Access Site Complication: Data From the French National 
OPTIMAL Study##1001-74·185A
Thrombosis
“First in Human” Experience With PRT060128, A New Direct-
Acting, Reversible, P2Y
12
 Inhibitor for Intravenous and 
Oral Use##1002-128·326A
Double Trouble for 1,934 Hospitalized Medical Patients Who Developed Deep Venous Thrombosis: 
Prophylaxis Omitted More Often and Pulmonary Embolism More Frequent##1002-
87·323A
A Novel, Rationally Engineered Heparin (M118) Prevents 
Thrombosis More Effectively Than Unfractionated 
Heparin in a Canine Model of Deep Arterial 
Injury##1020-34·379A
Assessment of Inter- and Intraindividual Variability of Platelet 
Function Profiles in Patients on Standard and High 
Clopidogrel Maintenance Doses##1020-86·385A
Clinical Characteristics and Outcomes of Behcet’s Disease 
With Cardiovascular Involvement##1014-81·362A
Comparison of Drug-Eluting Versus Bare Metal Stents: Timing 
of Subacute Thrombosis up to 2 Years##1019-154·227A
Comparison Of Outcomes In Patients Randomized To Warfarin 
According To Anticoagulant Control: Results From 
Sportif III And V.##1026-121·408A
Differential Predictors for Subacute, Late and Very Late Drug-
Eluting Stent Thrombosis: Results From the Multicenter 
ESTROFA Study## 847-3·250A
Early Transesophageal Echocardiography After Transcathether 
Occlusion of Interatrial Communications Allows Timely 
Detection and Treatment of Intracardiac Thrombus 
Formation##1005-53·256A
Exaggerated Exercise Blood Pressure Response Is Related to 
a State of Pronounced Inflammatory Activation, Impaired 
Thrombosis/Fibrinolysis System, and Arterial Stiffening 
in Essential Hypertensive Subjects##1002-37·318A
Flow Cytometric Assessment of Vasodilatator Stimulated 
Phosphoprotein: Prognostic Value of Recurrent 
Cardiovascular Events After Acute Coronary 
Syndrome##1014-3·355A
High Frequency of Intracardiac Thrombosis and Embolic 
Events in 116 Autopsy or Explant Cases of Cardiac 
Amyloidosis##1010-102·56A
High Prevalance of Left Atrial Thrombus in Patients With 
Atrial Fibrillation Undergoing Defibrillator Implantation: 
A Case for Routine Transesophageal Echocardiographic 
Screening##915-224·167A
Impact of High Clopidogrel Maintenance Dosing on Thrombin 
Generation in Patients With Diabetes Mellitus##1026-
4·403A
Impact of Higher Clopidogrel Loading and Maintenance Dose 
on Platelet Function and Antithrombosis in Patients 
Undergoing Percutaneous Coronary Intervention 
Measured by Thromboelastogram## 815-6·376A
Inhibition of Platelet Aggregation by Clopidogrel Is Unaffected 
by the CYP2C19 681G>A Polymorphism in Patients With 
Coronary Artery Disease## 815-4·375A
Is In-Stent Late Loss Related to the Risk of Drug-Eluting Stent 
Thrombosis? A Meta-Regression From 21 Randomized 
Trials##1001-156·191A
Mechanism of Coagulum Formation in Radiofrequency 
Ablation and a Novel Method to Prevent it## 410-6·422A
Outcomes in Patients with a Previous Vascular Intervention 
Enrolled in the REduction of Atherothrombosis for 
Continued Health (REACH) Registry in the United 
States##1026-127·410A
Paclitaxel-Eluting Stents Compared to Bare Metal Stents in an 
Underserved Hispanic Population Presenting With Acute 
ST-Segment Myocardial Infarction##1019-115·225A
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Patients with Metabolic Syndrome Demonstrate High Platelet 
Reactivity and Increased Procoagulant Markers##1026-
128·410A
Platelet Aggregometry and Receptor Binding to Predict the 
Magnitude of Antithrombotic and Bleeding Time Effects 
of Clopidogrel in Rabbits## 815-8·376A
Sticky Platelet Syndrome: Platelet Hyperfunction, Alone or 
With Other Recognized Thrombophilias, Is Strongly 
Associated With Venous and Arterial Thrombosis##1014-
11·357A
Timing of Stent Thrombosis in the Real World: Comparison 
of Bare Metal Stents Versus Drug-Eluting Stents## 802-
5·208A
Transition to an Unstable Coronary Syndrome Is Marked 
by Hypercoagulability, Platelet Activation, Heightened 
Platelet Reactivity and Inflammation: Results of the 
Thrombotic Risk Progression Study##1202-250·196A
Use of Aspirin Among Patients with Atherothrombotic Disease 
in the United States: The REduction of Atherothrombosis 
for Continued Health (REACH) Registry##1026-
123·409A
Von Willebrand Factor but Not Tissue Factor or Soluble CD40 
Ligand Are Associated With Increased Risk of Recurrent 
Events After Acute Coronary Syndrome in PROVE IT-
TIMI 22##1001-115·188A
Thyroid hormones
Hemodynamic Changes in Hyperthyroidism-Related 
Pulmonary Hypertension: A Prospective 
Echocardiographic Study##1014-84·363A
Subclinical Hypothyroidism as a Risk Factor for Poor Outcome 
in Patients With Chronic Heart Failure: A Prospective 
Study##1010-66·54A
The Atrial Vulnerability Parameters in Lone Atrial Fibrillation 
Patients With Subclinical Hypothyroidism: A New Entity 
in Idiopathic Atrial Fibrillation?##916-237·35A
Tilt-testing, head up
Different Biological Pattern in Adenosine Sensitive Syncope 
and Tilt-Induced Vasovagal Syncope## 818-5·3A
Tomography
A New Approach to Noninvasive Coronary Angiography 
by Multidetector Computed Tomography: Preliminary 
Experience Using Gadolinium##915-229·168A
Anatomical Correlates of a Normal Perfusion Scan 
Using 64-Slice Computed Tomography Coronary 
Angiography##901-229·117A
Assessment of Left Ventricular Function by Computed 
Tomography: Effects of the Number of Reconstructed 
Phases on the Calculated Ejection Fraction##905-
231·132A
Clinical Impact of 64-Multi-Detector Computed Tomography 
on Percutaneous Coronary Intervention of Chronic Total 
Occlusion: Focus on Regional Calcium Score##916-
230·172A
Comparison of Positron Emission Tomography and Magnetic 
Resonance Imaging for the Evaluation of Infarct Size in 
Acute Myocardial Infarction Patients##911-232·154A
Correlation Between Coronary Calcium Score and Presence of 
Ischemia on Rubidium-82 Positron Emission Tomography 
Stress Test## 811-5·101A
Diagnostic Accuracy of Coronary 64-Row Multi Detector 
Computed Tomography in Clinical Setting##905-
229·131A
Gender Normal Limits for Dipyridamole-Induced Changes 
in Left Ventricular Volumes and Transient Dilatation 
With Rubidium-82 Positron Emission Tomography 
Imaging##907-235·140A
Logistic Regression Models to Identify Negative Predictors 
of Agreement of Findings of 64-Slice Computed 
Tomography and Conventional Coronary Angiogram for 
Evaluation of Patency of Drug-Eluting Stents and Bare 
Metal Stents in Coronary Arteries##1013-177·218A
Logistic Regression Models to Identify Predictors of 
Deep Venous Thrombosis and Pulmonary Arterial 
Thromboembolism After Total Knee Replacement Using 
Multislice Computed Tomography##1014-85·363A
Low Fetuin-A Concentrations Predict the Progression of Aortic 
Valve Calcification## 839-6·311A
Multi-Detector Computed Tomography Coronary Angiography 
Detects a High Prevalence of Obstructive, Noncalcified 
Plaques in Symptomatic Patients and Zero Calcium 
Score##904-230·128A
Prediction of Impairment Factors for Evaluation of Patency of 
Drug-Eluting Stent and Bare Metal Stents in Coronary 
Arteries Using 64-Slice Computed Tomography in 
Logistic Regression Models##1020-14·379A
Predictive Value of Coronary CT Angiography for Late 
Adverse Cardiac Events in Patients With Chest Pain 
Syndromes## 831-5·106A
Relationship Between Circulating Uncarboxylated Matrix-Gla 
Protein Concentrations and Aortic Valve Calcification## 
839-7·311A
Usefulness of Computed Tomography Angiography in 
the Follow-Up of Abdominal Aortic Aneurysm 
Treatment##911-231·154A
Usefulness of Multiple Detector-Row Computed Tomography 
in Renal Transplant Candidates##913-230·161A
Transfect
Successful In Vivo Imaging of the Enhanced Transcriptional 
Activity of GATA in the Heart During the Progression 
of Angiotensin II-Induced Hypertrophy in Mice##1010-
62·54A
Transient ischemic attack
Increased Risk of Coronary Heart Disease After Recurrent 
Cerebrovascular Events: Findings From the SPARCL 
Study## 804-4·351A
Transplantation
Aggressive Prophylaxis Against Cytomegalovirus Plays a Key 
Role in Preserving Epicardial Artery Flow Early After 
Cardiac Transplantation##1022-106·78A
Cardiomyocyte Engraftment in Human Gender-Mismatched 
Heart Transplantation Preserves Microvascular 
Function##1028-106·94A
Central Aortic Stiffness Is Increased in Stable Heart Transplant 
Patients and Is Associated With Higher Mortality## 
828-4·84A
Characterization of Ion Channels in Human Adipose Tissue-
Derived Stem Cells##904-234·15A
Clustered Homeobox Gene Expression During 
Cardiogenesis##1028-61·90A
Cytomegalovirus Replication Is Associated With 
Endothelial Dysfunction in Pediatric Heart Transplant 
Recipients##1023-30·264A
Differential Regulatory Network Patterns During Rejection and 
Quiescence in Peripheral Blood Mononuclear Cell Gene 
Signatures##1004-139·48A
Evidence Does Not Support Obesity as a Relative 
Contraindication to Heart Transplantation##1016-
108·70A
Evidence Does Support Glomerular Filtration Rate <40 
ml/min as a Relative Contraindication to Heart 
Transplantation##1016-107·70A
High Mortality of UNOS Status 1 Heart Transplant Candidates: 
Call for Consideration of Mechanical Circulatory 
Support##1022-107·78A
Human Cord Blood Endothelial Progenitors Decrease 
Neointimal Hyperplasia in SCID Mouse Vein Grafts## 
849-8·419A
Hypoxic Preconditioning Promotes Bone Marrow 
Mesenchymal Stem Cells Survival by Enhancing Stem 
Cell Autocrine Action## 827-7·234A
In Vivo Intravascular Ultrasound Derived Cardiac Allograft 
Vasculopathy Characterization Using Ultrasound 
Radiofrequency Analysis## 828-3·84A
Longitudinal Changes in Chronotropic Response to Exercise 
and Heart Rate Recovery in Pediatric Heart Transplant 
Recipients##1023-32·265A
Mechanistic Insights From Serial Cardiac Magnetic Resonance 
Imaging at 3 and 15 Months After Application of 
Blood-Derived Progenitor Cells in Recanalized Chronic 
Coronary Total Occlusions## 824-3·104A
Medium-Term Renal Outcome of Pediatric Heart Transplant 
Patients on Reduced Calcineurin Inhibitor and 
Rapamycin##1004-109·48A
New Insights in the Management of Cardiogenic Shock 
Complicating Myocardial Infarction: Role of Urgent 
Heart Transplantation##1007-197·206A
Normalization of Fixed Pulmonary Hypertension in Severe 
Heart Failure Patients With Placement of Left Ventricular 
Assist Device##1010-109·58A
Peripheral Blood Leukocyte Gene Expression Signatures of 
Antibody Mediated Cardiac Allograft Rejection##1028-
107·94A
Predictors of Reduced Coronary Flow Reserve in Heart 
Transplant Recipients Without Cardiac Allograft 
Vasculopathy: A Contrast-Enhanced Echocardiographic 
Study##904-226·127A
Relationship Between Insulin Resistance Features and 
Progression of Cardiac Allograft Vasculopathy##1010-
108·57A
Strain and Strain Rate by Velocity Vector Imaging 
in Diagnosing Acute Rejection After Heart 
Transplantation##1010-107·57A
Transplantation of Bone Marrow Mesenchymal Stem Cells 
Induces Angiogenesis and Attenuates the Remodeling of 
Diabetic Cardiomyopathy## 807-5·62A
Usefulness and Place of Multislice Coronary Computed 
Tomography Scan in Heart Transplant Patients##915-
228·168A
Usefulness of Multiple Detector-Row Computed Tomography 
in Renal Transplant Candidates##913-230·161A
Tricuspid regurgitation
Association Between the Frequency of Endomyocardial 
Biopsy and the Development of Significant Tricuspid 
Regurgitation Following Cardiac Transplantation: A 10-
Year Experience##1004-110·48A
Clinical Significance of Mitral Valve Prolapse in Adult Patients 
With Atrial Septal Defect##1023-50·266A
Septal-Lateral Right Ventricular Dilatation Determines 
the Severity of Functional Tricuspid Regurgitation 
With Sinus Rhythm: A Real-Time Three-Dimensional 
Echocardiography Study##1015-25·306A
Troponin
Cardiac Myolysis and Left Ventricular Dysfunction In Patients 
With Duchenne Muscular Dystrophy -Inhibitory Effect of 
Carvedilol on Cardiac Myolysis##1028-102·93A
Cardiac Troponin Levels Predicts Left Ventricular Dysfunction 
and Mortality in Septic Shock Patients##1028-60·90A
Combined Measurements of Cardiac Troponin T and Brain 
Natriuretic Peptide in Patients With Congestive Heart 
Failure From Various Etiology##1201-244·51A
Comparison of Five Different Cardiac Troponin Assays in 
Patients With End-Stage Renal Disease on Chronic 
Hemodialysis##1013-69·209A
Correlation Between Troponin Elevation and Vasoactive 
Medication Use in Patients With Septic Shock##1001-
112·187A
Creatinine Kinase-MB Enzyme Elevation in the Presence 
of Normal Troponin Is a Powerful Predictor of 
Cardiovascular Complications in Non-ST-Segment 
Elevation Acute Coronary Syndrome##1019-158·228A
Relationship of Acute Cardiac Dysfunction With Clinical 
Severity of Subarachnoid Hemorrhage: Results From the 
SAHMII Study##1008-43·338A
Relationship of Mild Troponin-I Elevations to Cardiac 
Function and Pulmonary Congestion in Patients With 
Subarachnoid Hemorrhage: Results From the SAHMII 
Study##1002-83·322A
Troponin Elevation Is Highly Predictive of Outcomes in 
Patients With Infective Endocarditis##1205-272·301A
Value of Serial Measurements of C-Reactive Protein 
in Non-ST-Segment Elevation Acute Coronary 
Syndromes##1001-92·186A
Vasp Phosphorylation Analysis Predicts Ischemic Recurrence 
in Patients Undergoing Coronary Angioplasty## 409-
5·421A
Ultrasonic diagnosis
A New Method for Strain Determination in Adjacent Slices of 
the Left Ventricle on the Same Beat##915-227·167A
A Novel Noninvasive Technique for Pulse-Wave Imaging and 
Characterization of Vascular Mechanical Properties In 
Vivo##906-228·135A
Contrast-Enhanced Carotid Ultrasound Shows Greater 
Intraplaque Neovascularization in High Risk 
Plaques##903-226·124A
Ethnic and Geographic Differences in Coronary 
Atherosclerotic Plaque Composition: A Report From 
the Global Virtual Histology Intravascular Ultrasound 
Registry##1026-41·403A
Experimental Studies With a 9-French Forward-Looking 
Intracardiac Imaging and Ablation Catheter Developed in 
a National Institutes of Health Supported Bioengineering 
Research Partnership Grant Program## 846-3·8A
High-Density Lipoprotein Cholesterol Is an Independent Risk 
Factor for Progression of Intimal-Medial Thickness: 
Results From the Atherosclerosis Risk in Communities 
Study##1026-35·402A
Imaging and Quantification of Coronary Plaque 
Neovascularization With Contrast-Enhanced Intravascular 
Ultrasound and a New Computational Image Analysis 
Technique##905-228·131A
Impact of a Cardiovascular Limited Ultrasound Examination 
Using a Hand-Carried Ultrasound Device: Changes 
in Clinical Management Outcomes in a Primary-Care 
Clinic##1008-162·346A
Intracoronary Sinus Echocardiography: A New Approach to 
Guide Cardiac Interventional Procedures##906-223·133A
Is It possible to Measure Noninvasively the Intima Thickness 
of Carotid Artery? Comparison of 40 MHz Ultrasound 
With Histology in Rats##1014-82·363A
Lung Echo and Cardiac Doppler Study Can Diagnose the 
Etiologies of Acute Respiratory Distress in the Emergency 
Room##1204-266·277A
Multi-Functional Echogenic Liposomes for Image-Guided and 
Ultrasound-Controlled PPAR Agonist Delivery##1014-
89·365A
Noninvasive Detection and Characterization of Abdominal 
Aortic Aneurysms in Mice Using Ultrasound##909-
222·144A
Phase Analysis of Gated Myocardial Perfusion Single-Photon 
Emission Computed Tomography Compared to Tissue 
Doppler Imaging for the Assessment of Left Ventricular 
Dyssynchrony##905-235·132A
Relationship of Inflammation With Endothelial Dysfunction 
and Coronary Flow Reserve in Patients With Cardiac 
Syndrome X##1019-175·229A
Ultrasound Biomicroscopy of Rat Carotid Intima and Wall 
Thicknesses##1026-83·406A
Ultrasound Lung Comet Is Useful and Specific Sign of Lung 
Disease: Importance of Doppler Study to Diagnose Lung 
Congestion##1018-190·285A
Ultrasound-Guided Thrombin Injection for the Treatment of 
Iatrogenic Upper Extremity Pseudoaneurysm##1014-
79·362A
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Unstable angina
Blood Rheology in Stable Angina and Acute Coronary 
Syndrome: A Logical Basis for the Transition?##1007-
96·200A
Chromogranin A Is an Independent Prognostic Indicator Across 
the Spectrum of Acute Coronary Syndromes##1019-
159·228A
Circulating Human Monocytes Express a Characteristic 
Proteome Profile During the Acute Coronary 
Syndrome##1001-72·184A
Clinical Utility of Serial Monitoring of Myeloperoxidase 
Levels in Patients Presenting for Evaluation of Chest 
Pain##1007-155·203A
Cystatin C Is an Independent Predictor of Recurrent 
Spontaneous Myocardial Infarction or Death in High 
Risk Non-ST-Elevation Acute Coronary Syndrome 
Patients##1013-174·217A
Demand Ischemia Is the Predominant Etiology of Perioperative 
Myocardial Infarction: Implications for Perioperative Risk 
Stratification##1025-111·239A
Diagnostic accuracy of 64-Slice Computed Tomography 
Coronary Angiography in Patients With Unstable 
Angina and Non-ST-Segment Elevation Myocardial 
Infarction##915-230·168A
Diagnostic Performance of the Modified Rush Score Across 
Risk Strata and Prespecified Clinical Subgroups, Is 
Superior to the TIMI Risk Score for Prediction of In-
Hospital Mortality in Acute Coronary Syndromes##1025-
112·239A
Does C-Reactive Protein Measured at Admission, Discharge, 
or 1 Month Have Incremental Clinical Value to Predict 
Outcome in Acute Coronary Disease?##1007-95·199A
Does Early Invasive Strategy Provide a Clinically Important 
Advantage Over Early Conservative Strategy in the 
Management of Acute Coronary Syndromes?##1025-
114·240A
Does Progression of Coronary Artery Disease Differ in Patients 
With Stable and Acute Coronary Syndrome?##1007-
112·200A
Flow Cytometric Assessment of Vasodilatator Stimulated 
Phosphoprotein: Prognostic Value of Recurrent 
Cardiovascular Events After Acute Coronary 
Syndrome##1014-3·355A
High-Dose Atorvastatin Modifies the Protein Profile of 
Human Circulating Monocytes After an Acute Coronary 
Syndrome## 809-6·355A
Long Pentraxin 3 Is More Specific Than C-Reactive Protein as 
a Marker for Vascular Inflammation##1020-2·377A
Long-Term Prognostic Value and Therapeutic Implications of 
Continuous ST-Segment Monitoring in Acute Coronary 
Syndrome##1007-156·204A
Major Bleeding in Acute Coronary Syndrome Patients is 
Associated with a Marked Pro-Inflammatory Response: 
Results from the ACUITY Inflammatory Biomarker Sub-
Study## 615-5·209A
Manganese Superoxide Dismutase Polymorphism Is 
Associated With Acute Coronary Syndrome##1001-
73·185A
Multislice Computed Tomography and Intravascular 
Ultrasound for Risk Stratification in Non-ST-Elevation 
Myocardial Infarction and Unstable Angina##902-
230·121A
Noninvasive Assessment of the Low-Density Plaque in 
Culprit Lesion of Patients With Unstable Angina Pectoris 
by Multi-Slice Computed Tomographic Coronary 
Angiography##903-230·125A
Prolonged Inflammatory Activity Is Associated With Rapid 
Progression of Nonculprit Complex Lesion in Non-ST-
Segment Elevation Acute Coronary Syndromes##1001-
111·187A
Safety and Tolerability of a Novel Tissue Factor/Factor VIIa 
Inhibitor rNAPc2 in Patients With Non-ST Elevation 
Acute Coronary Syndrome Managed Invasively: Results 
From the ANTHEM-TIMI 32 Trial##1202-252·196A
Soluble CXCL16 Independently Predicts Long-Term Mortality 
in Acute Coronary Syndromes##1025-155·243A
Soluble Lectin-Like Oxidized-Low Density Lipoprotein 
Receptor-1: Is a Prognostic Biomarker for Acute Coronary 
Syndrome to Predict Recurrence or Death##1001-
155·191A
The Impact of Aspirin Resistance on Long-Term 
Cardiovascular Mortality in Patients With Non-ST 
Elevation Acute Coronary Syndromes##1025-116·240A
The Prognostic Value of the 12-Lead Electrocardiogram (ECG) 
in Patients Presenting With Acute Coronary Syndromes: 
Insights From the GRACE ECG Substudy##1001-
95·187A
The Release of Long Pentraxin 3 in Vulnerable Plaques In 
Vivo##1020-37·380A
Value of Serial Measurements of C-Reactive Protein 
in Non-ST-Segment Elevation Acute Coronary 
Syndromes##1001-92·186A
Von Willebrand Factor but Not Tissue Factor or Soluble CD40 
Ligand Are Associated With Increased Risk of Recurrent 
Events After Acute Coronary Syndrome in PROVE IT-
TIMI 22##1001-115·188A
Valvular disease
Aortic Regurgitation: Role of Proteoglycans in Myocardial 
Fibrosis?##1021-20·307A
Bicuspid Calcified Aortic Valves Are Associated With 
a Splice Variant of Notch1 Expression in Human 
Tissues and Stenotic Bicuspid Aortic Valve From the 
Hypercholesterolemic eNOS Null Mouse, Which 
Improves With Atorvastatin##1003-25·300A
Calcific Aortic Stenosis Is Independently Associated With 
Increased Parathormone Serum Level in Coronary Artery 
Disease Patients## 839-4·310A
Clinically Relevant Valvular Heart Disease Is Rare 
in Parkinson’s Disease Patients Treated With 
Pergolide##1009-22·303A
Comparison of Stentless Valve Implantation Techniques 
in Large Cohort of Patients From the Freestyle Valve 
Registry##1027-15·401A
Does Preoperative Statin Therapy Improve Outcomes in 
Patients Undergoing Cardiac Valve Surgery?##1021-
19·307A
Early North American Experience With Percutaneous Aortic 
Valve Replacement in Patients Unsuitable for Surgical 
Aortic Valve Replacement## 816-5·309A
Effect of Valvular Replacement on Apoptotic Markers and Left 
Ventricular Diastolic Function in Patients With Aortic 
Regurgitation##1009-17·302A
Geometry of the Proximal Isovelocity Surface Area of Mitral 
Regurgitation by Three-Dimensional Color Doppler 
Echocardiography: Difference Between Functional Mitral 
Regurgitation and Mitral Valve Prolapse##1205-270·301A
Influence of Mitral Inlet Geometry on the Flow Convergence 
Beyond the Anatomic Orifice in Patients With Mitral 
Stenosis: Importance of Flattened Leaflet Shape##1027-
20·313A
Is B-Type Natriuretic Peptide Superior to Contractile Reserve 
in Predicting Outcome in Low-Flow Aortic Stenosis? 
Results From the Multicenter TOPAS Study##1205-
269·300A
Low Fetuin-A Concentrations Predict the Progression of Aortic 
Valve Calcification## 839-6·311A
LRP5 Stem Cell-Mediated Prosthetic Valve 
Calcification##1003-17·298A
Prevention of Postoperative Atrial Fibrillation With 
Statins in Persons Undergoing Isolated Aortic Valve 
Replacement##1009-16·302A
Quantitative Assessment of Mechanical Valve Using Multi-
Detector Computed Tompgraphy##1027-21·313A
Rapid Rise in Cardiac Auscultation Skill After a Single 
90-Minute Intervention: A Quality Improvement 
Study##1006-193·276A
Seventeen Year Clinical and Echocardiographic Follow-Up 
Results of Mitral Balloon Valvuloplasty in 520 Patients 
and Predictors of Long-Term Outcome## 816-8·310A
Significant Reduction in Mitral Regurgitation 6 Months 
Following Percutaneous Mitral Valve Repair With the 
MitraClip™## 816-7·310A
The Role of Hepatic Resection in Patients With Carcinoid 
Heart Disease##1027-23·313A
Tooth Extraction and Tooth Brushing Both Produce Bacteremia 
of Endocarditis-Related Pathogens##1205-271·301A
Valvuloplasty
Intracardiac Echocardiography for Conservative Aortic Valve 
Surgery: A New Investigative Tool##914-224·163A
Is Wilkins Score a Predictor of Echocardiographic Restenosis 
in a Young Population After Percutaneous Mitral Balloon 
Valvotomy?##1021-25·308A
Recurrent Mitral Regurgitation Late After Annuloplasty for 
Ischemic Mitral Regurgitation: An Echocardiographic 
Study##1021-17·307A
Seventeen Year Clinical and Echocardiographic Follow-Up 
Results of Mitral Balloon Valvuloplasty in 520 Patients 
and Predictors of Long-Term Outcome## 816-8·310A
Vascular biology
12/15-Lipoxygenase Transgenic Mice Have More Neointimal 
Formation Than C57BL/6 Mice in Response to Wire 
Endothelial Denudation## 849-5·418A
A Novel, Rationally Engineered Heparin (M118) Prevents 
Thrombosis More Effectively Than Unfractionated 
Heparin in a Canine Model of Deep Arterial 
Injury##1020-34·379A
Aortic Stiffness Is Increased in Patients With Hepatitis C Virus 
Seropositivity##1020-79·383A
Cardiac Side Population Cells Represent Endothelial 
Differentiation Potential##1025-70·236A
Combined Valsartan (Vn) and Simvastatin (Sn) Therapy 
Decreases Early and Late Manifestations of Vulnerable 
Atherosclerostic Plaque in Diabetic Hyperlipidemic Pigs: 
A Longitudinal Intravascular Ultrasound (IVUS) and 
Histology Study##1026-87·407A
Dissociation of Aldehyde Dehydrogenase Activity From 
Nitrate Effect, Bioconversion and Tolerance in Humans## 
406-6·420A
Efonidipine Simultaneously Improves Endothelial 
Function and Metabolic Parameters In Patients With 
Hypertension##1002-5·316A
Endothelial Dysfunction and Circulating Endothelial 
Progenitor Cells in Young People With Type 1 
Diabetes##1025-117·241A
Endothelial Layer Restoration After Vascular Injury Is Delayed 
With Aging Bone Marrow While the Inflammatory 
Response and Intimal Formation are Increased##1002-
38·319A
Endothelial Progenitor Cells Do Not Incorporate Into New 
Vessels but Indirectly Augment Angiogenesis: Insights 
From a Novel In Vitro Human Angiogenesis Assay## 
832-4·394A
Graded Relationship Between Adiponectin Levels and Arterial 
Stiffening in Newly Diagnosed Essential Hypertensive 
Subjects## 840-7·416A
Human Cord Blood Endothelial Progenitors Decrease 
Neointimal Hyperplasia in SCID Mouse Vein Grafts## 
849-8·419A
Impaired Aortic Distensibility as an Independent Marker of 
Coronary Artery Disease##1014-44·360A
Increased Neointimal Formation After Vascular Injury in the 
Thrombospondin-2 Knockout Mice Is Not Mediated by 
Cd36 Pathway## 849-4·418A
Insulin-Like Growth Factor I Prevents Atherosclerosis 
Progression in Aged Apolipoprotein E Deficient 
Mice##1008-38·337A
Involvement of Epigenetic Variation in Restenosis After 
Percutaneous Coronary Intervention##1014-4·356A
Is It possible to Measure Noninvasively the Intima Thickness 
of Carotid Artery? Comparison of 40 MHz Ultrasound 
With Histology in Rats##1014-82·363A
Kruppel-Like Factor 4 Regulates Endothelial Inflammation## 
409-6·421A
Long Pentraxin 3 Is More Specific Than C-Reactive Protein as 
a Marker for Vascular Inflammation##1020-2·377A
Long-Term Outcome of Autologous Transplantation of 
Bone Marrow Mononuclear Cells in Patients With 
Thromboangiitis Obliterans##1008-40·338A
Low Endothelial Shear Stress Leads to Expansive Remodeling 
of Atherosclerotic Coronary Subsegments: An In-Vivo 
Follow-Up Intravascular Ultrasound Study##1008-9·335A
Low Endothelial Shear Stress Predicts the Development 
of High-Risk Coronary Atherosclerotic Plaques: A 
Correlative Intravascular Ultrasound and Histopathology 
Natural History Study##1008-3·334A
Low-Grade Inflammation and Hypoadiponectinemia Have 
an Additive Detrimental Effect on Aortic Stiffness in 
Essential Hypertensive Patients: A “Double-Edged 
Sword” of Vascular Damage##1002-36·318A
Multi-Functional Echogenic Liposomes for Image-Guided and 
Ultrasound-Controlled PPAR Agonist Delivery##1014-
89·365A
Nebulized Delivery of Nano-Scale All-Trans Retinoic Acid 
Particles Inhibited Monocrotaline-Induced Pulmonary 
Hypertension in Rats##1008-88·342A
Noninvasive Detection and Characterization of Abdominal 
Aortic Aneurysms in Mice Using Ultrasound##909-
222·144A
Obstructive Sleep Apnea Syndrome Adversely Affects Cerebral 
Blood Flow##1002-77·321A
Pioglitazone Reduces Neointimal Response by Suppression of 
the Early Inflammatory Reaction via NFkB Dependent 
MCP-1 Mediated Pathway in a Porcine Coronary Stent 
Model## 849-7·419A
Selective Loss of Inhibition on Vascular Smooth Muscle Cell 
Proliferation by RGS2 in Vascular Remodeling##1020-
7·378A
Short-Term Exposure to Secondhand Smoke Leads to 
Mobilization of Dysfunctional Endothelial Progenitor 
Cells in Nonsmokers##1014-41·360A
Stat3 Signal Transduction Pathway Correlates With 
Proliferation and Apoptosis of Rat Vascular Smooth 
Muscle Cells## 849-3·418A
Tetrahydrobiopterin-dependent eNOS Coupling Determines 
Vascular Remodeling Through Accelerated Endothelial 
Regeneration## 409-8·421A
The Release of Long Pentraxin 3 in Vulnerable Plaques In 
Vivo##1020-37·380A
Ultrasound Biomicroscopy of Rat Carotid Intima and Wall 
Thicknesses##1026-83·406A
Vascular Stiffness Is Attenuated by Arginase Inhibition in Aged 
Rats## 832-7·395A
Vascular surgery
Culprit Coronary Lesions Requiring Percutaneous Coronary 
Intervention Following Vascular Surgery Often Arise 
From Non-Obstructive Disease##1013-159·217A
Incidence of a Left Main Stenosis Among High-Risk Patients 
Presenting for Elective Vascular Surgery and Long-Term 
Outcomes## 814-6·374A
Preoperative C-Reactive Protein and N-Terminal Portion 
of Probrain Natriuretic Peptide Predicts Postoperative 
Cardiac Events in Patients Undergoing Noncardiac 
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Fraction: Data From the Heart and Soul Study##903-
221·122A
Acute Effects of Dual Versus Single Site Right Ventricular 
Pacing iIn Heart Failure Patients##907-240·21A
Aging-Related Myocardial Intolerence to Stress: Recapitulated 
in Adults by K
ATP




An Endocardial to Epicardial Myocardial Contraction Gradient 
Is Present in Severe Compensated Aortic Stenosis: Does 
It Reverse After Aortic Valve Replacement?##1003-
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Statin Therapy Improves Left Ventricular Function 
and Carotid Arterial Stiffness in Patients With 
Hypercholesterolemia##1002-44·320A
Stent Implantation in Left Main Lesion Without Routine Intra-
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Radiofrequency Ablation Unmasks Multiple Accessory 
Pathways in a Mouse Model of Familial Wolff-Parkinson-
White Syndrome##912-234·28A
